Science.gov

Sample records for alternativer til ny

  1. Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.

    PubMed

    Lee, Hee Jin; Kim, Joo Young; Song, In Hye; Park, In Ah; Yu, Jong Han; Gong, Gyungyub

    2015-01-01

    Accumulating evidence suggests that immunotherapy has great potential for treating triple-negative breast cancer (TNBC). We analyzed the expression of NY-ESO-1, which is a potent immunogenic cancer testis antigen, and its association with clinicopathological factors in large cohorts of breast cancer patients. A total of 623 consecutive breast cancer patients who underwent surgery between 1993 and 1998 and 612 TNBC patients who underwent surgery between 2004 and 2010 at Asan Medical Center were included. Immunohistochemical staining for NY-ESO-1 was performed using tissue microarrays. NY-ESO-1 was expressed in 2.6% of consecutive breast cancers, all of which were TNBC (p < 0.001). NY-ESO-1 expression was identified in 9.7% of the TNBC cohort and was significantly correlated with a higher level of tumor-infiltrating lymphocytes (TIL; p = 0.026). In survival analyses, a lower level of TIL (all, p < 0.001) and the absence of NY-ESO-1 expression (p = 0.024) were significantly associated with poor disease-free survival. Additionally, positive NY-ESO-1 expression was an independent favorable prognostic factor in TNBC patients (p = 0.046). NY-ESO-1 is specifically expressed in TNBC, and NY-ESO-1 expression is an independent good prognostic factor in TNBC. Evaluation of NY-ESO-1 expression in TNBC might be useful for selecting patients who may benefit from vaccination therapy and also has a prognostic significance in TNBC. © 2015 S. Karger AG, Basel.

  2. Ny-Alesund Geodetic Observatory

    NASA Technical Reports Server (NTRS)

    Sieber, Moritz

    2013-01-01

    In 2012 the 20-m telescope at Ny-Alesund, Svalbard, operated by the Norwegian Mapping Authority (NMA), took part in 163 out of 168 scheduled sessions of the IVS program. Since spring, all data was transferred by network, and the receiver monitoring computer was replaced by a bus-coupler. In autumn, the NMA received building permission for a new observatory from the Governor of Svalbard. The bidding process and first construction work for the infrastructure will start in 2013.

  3. Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients.

    PubMed

    Kawabata, Ryohei; Wada, Hisashi; Isobe, Midori; Saika, Takashi; Sato, Shuichiro; Uenaka, Akiko; Miyata, Hiroshi; Yasuda, Takushi; Doki, Yuichiro; Noguchi, Yuji; Kumon, Hiromi; Tsuji, Kazuhide; Iwatsuki, Keiji; Shiku, Hiroshi; Ritter, Gerd; Murphy, Roger; Hoffman, Eric; Old, Lloyd J; Monden, Morito; Nakayama, Eiichi

    2007-05-15

    NY-ESO-1 specific humoral responses are frequently observed in patients with various types of NY-ESO-1 antigen expressing tumors. In a large proportion of NY-ESO-1 antibody-positive patients of NY-ESO-1-specific CD8 T-cells can also be detected suggesting that monitoring of the NY-ESO-1 specific humoral immune response may be a relevant and more practical surrogate for estimating the overall immune response against NY-ESO-1 in clinical vaccine studies. We have immunized 9 cancer patients with full length NY-ESO-1 protein formulated with cholesterol-bearing hydrophobized pullulan (CHP-NY-ESO-1) and investigated the humoral immune responses against NY-ESO-1. Seven patients were NY-ESO-1 antibody-negative and 2 patients were positive prior to vaccination. Vaccination with CHP-NY-ESO-1 resulted in the induction or increase of NY-ESO-1 antibody responses in all 9 patients immunized. Epitope analysis revealed 5 regions in the NY-ESO-1 protein molecule that were recognized by antibodies induced after vaccination. The 5 regions were also recognized by antibodies present in nonvaccinated, NY-ESO-1 antibody-positive cancer patients. A peptide spanning amino acids 91-108 was recognized in 6 out of 9 vaccinated patients and in 8 out of 9 nonvaccinated, sero-positive patients, being the most dominant antigenic epitope in NY-ESO-1 for antibody recognition in cancer patients. In conclusion, we showed that CHP-NY-ESO-1 protein vaccination had a potent activity for inducing humoral immune responses against NY-ESO-1 antigen in cancer patients. The antigenic epitopes recognized by antibodies in the vaccinated patients were similar to those recognized in cancer patients with spontaneous humoral immunity against NY-ESO-1. (c) 2007 Wiley-Liss, Inc.

  4. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

    PubMed

    Matsuzaki, Junko; Gnjatic, Sacha; Mhawech-Fauceglia, Paulette; Beck, Amy; Miller, Austin; Tsuji, Takemasa; Eppolito, Cheryl; Qian, Feng; Lele, Shashikant; Shrikant, Protul; Old, Lloyd J; Odunsi, Kunle

    2010-04-27

    NY-ESO-1 is a "cancer-testis" antigen frequently expressed in epithelial ovarian cancer (EOC) and is among the most immunogenic tumor antigens defined to date. In an effort to understand in vivo tolerance mechanisms, we assessed the phenotype and function of NY-ESO-1-specific CD8(+) T cells derived from peripheral blood lymphocytes (PBLs), tumor-infiltrating lymphocytes (TILs), and tumor-associated lymphocytes (TALs) of EOC patients with NY-ESO-1-expressing tumors, with or without humoral immunity to NY-ESO-1. Whereas NY-ESO-1-specific CD8(+) T cells were readily detectable ex vivo with tetramers in TILs and TALs of seropositive patients, they were only detectable in PBLs following in vitro stimulation. Compared with PBLs, tumor-derived NY-ESO-1-specific CD8(+) T cells demonstrated impaired effector function, preferential usage of dominant T-cell receptor, and enriched coexpression of inhibitory molecules LAG-3 and PD-1. Expression of LAG-3 and PD-1 on CD8(+) T cells was up-regulated by IL-10, IL-6 (cytokines found in tumor ascites), and tumor-derived antigen-presenting cells. Functionally, CD8(+)LAG-3(+)PD-1(+) T cells were more impaired in IFN-gamma/TNF-alpha production compared with LAG-3(+)PD-1(-) or LAG-3(-)PD-1(-) subsets. Dual blockade of LAG-3 and PD-1 during T-cell priming efficiently augmented proliferation and cytokine production by NY-ESO-1-specific CD8(+) T cells, indicating that antitumor function of NY-ESO-1-specific CD8(+) T cells could potentially be improved by therapeutic targeting of these inhibitory receptors.

  5. 46 CFR 7.25 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2014 CFR

    2014-10-01

    ... 46 Shipping 1 2014-10-01 2014-10-01 false Montauk Point, NY to Atlantic Beach, NY. 7.25 Section 7... LINES Atlantic Coast § 7.25 Montauk Point, NY to Atlantic Beach, NY. (a) A line drawn from Shinnecock... Light 348° true to the southernmost extremity of the spit of land at the western end of Oak Beach. (d) A...

  6. 46 CFR 7.25 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 1 2010-10-01 2010-10-01 false Montauk Point, NY to Atlantic Beach, NY. 7.25 Section 7... LINES Atlantic Coast § 7.25 Montauk Point, NY to Atlantic Beach, NY. (a) A line drawn from Shinnecock... Light 348° true to the southernmost extremity of the spit of land at the western end of Oak Beach. (d) A...

  7. 46 CFR 7.25 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 46 Shipping 1 2011-10-01 2011-10-01 false Montauk Point, NY to Atlantic Beach, NY. 7.25 Section 7... LINES Atlantic Coast § 7.25 Montauk Point, NY to Atlantic Beach, NY. (a) A line drawn from Shinnecock... Light 348° true to the southernmost extremity of the spit of land at the western end of Oak Beach. (d) A...

  8. 46 CFR 7.25 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 46 Shipping 1 2012-10-01 2012-10-01 false Montauk Point, NY to Atlantic Beach, NY. 7.25 Section 7... LINES Atlantic Coast § 7.25 Montauk Point, NY to Atlantic Beach, NY. (a) A line drawn from Shinnecock... Light 348° true to the southernmost extremity of the spit of land at the western end of Oak Beach. (d) A...

  9. 46 CFR 7.25 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... 46 Shipping 1 2013-10-01 2013-10-01 false Montauk Point, NY to Atlantic Beach, NY. 7.25 Section 7... LINES Atlantic Coast § 7.25 Montauk Point, NY to Atlantic Beach, NY. (a) A line drawn from Shinnecock... Light 348° true to the southernmost extremity of the spit of land at the western end of Oak Beach. (d) A...

  10. NY Her: possible discovery of negative superhumps

    NASA Astrophysics Data System (ADS)

    Sosnovskij, A.; Pavlenko, E.; Pit, N.; Antoniuk, K.

    2017-09-01

    We presents result of CDD photometry for SU UMa dwarf nova NY Her during 6 nights in June 2017 when object was in quiescence. Light curves clearly show strong amplitude variations in a range of 0Time series analysis revealed a period 0.07141(5) d, that we identified as the period of possible negative superhumps of NY Her.

  11. Urban metabolism in Syracuse, NY – introduction

    Treesearch

    David J. Nowak

    2016-01-01

    This special issue of Urban Ecosystems contains a series of papers related to assessing urban metabolism in Syracuse, NY. These papers were developed under the Urban Long-Term Research Area Exploratory Awards Program funded by the National Science Foundation. Objectives of this two-year project (2009–2011) in Syracuse, NY were to investigate: a)...

  12. Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.

    PubMed

    Moon, Edmund K; Ranganathan, Raghuveer; Eruslanov, Evgeniy; Kim, Soyeon; Newick, Kheng; O'Brien, Shaun; Lo, Albert; Liu, Xiaojun; Zhao, Yangbing; Albelda, Steven M

    2016-01-15

    Tumor-infiltrating lymphocytes (TILs) become hypofunctional, although the mechanisms are not clear. Our goal was to generate a model of human tumor-induced TIL hypofunction to study mechanisms and to test anti-human therapeutics. We transduced human T cells with a published, optimized T-cell receptor (TCR) that is directed to a peptide within the cancer testis antigen, NY-ESO-1. After demonstrating antigen-specific in vitro activity, these cells were used to target a human lung cancer line that expressed NY-ESO-1 in the appropriate HLA context growing in immunodeficient mice. The ability of anti-PD1 antibody to augment efficacy was tested. Injection of transgenic T cells had some antitumor activity, but did not eliminate the tumors. The injected T cells became profoundly hypofunctional accompanied by upregulation of PD1, Tim3, and Lag3 with coexpression of multiple inhibitory receptors in a high percentage of cells. This model allowed us to test reagents targeted specifically to human T cells. We found that injections of an anti-PD1 antibody in combination with T cells led to decreased TIL hypofunction and augmented the efficacy of the adoptively transferred T cells. This model offers a platform for preclinical testing of adjuvant immunotherapeutics targeted to human T cells prior to transition to the bedside. Because the model employs engineering of human T cells with a TCR clone instead of a CAR, it allows for study of the biology of tumor-reactive TILs that signal through an endogenous TCR. The lessons learned from TCR-engineered TILs can thus be applied to tumor-reactive TILs. ©2015 American Association for Cancer Research.

  13. 49 CFR 372.201 - Albany, NY.

    Code of Federal Regulations, 2013 CFR

    2013-10-01

    ... Albany, N.Y., within which transportation by motor vehicle, in interstate or foreign commerce, not under... combined areas defined in paragraphs (b) and (c) of this section, and (e) All of any municipality...

  14. New Fundamental Station in Ny-Alesund

    NASA Technical Reports Server (NTRS)

    Langkaas, Line; Dahlen, Terje; Opseth, Per Erik

    2010-01-01

    The Norwegian Mapping Authority s (NMA) geodetic observatory has been operating in Ny-Alesund since 1994. To adapt to the VLBI2010 standard and extend our activity to also integrate SLR, NMA is in the process of funding a new fundamental station. Handling more intensive observations in real time requires a fiber optic cable to Ny-Alesund. The Norwegian Mapping Authority is currently applying for project funding of 26 million euros.

  15. 33 CFR 80.160 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Beach, NY. 80.160 Section 80.160 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... to Atlantic Beach, NY. (a) A line drawn from the Shinnecock Inlet East Breakwater Light to Shinnecock... southernmost extremity of the spit of land at the western end of Oak Beach. (d) A line drawn from Jones Inlet...

  16. 33 CFR 80.160 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... Beach, NY. 80.160 Section 80.160 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... to Atlantic Beach, NY. (a) A line drawn from the Shinnecock Inlet East Breakwater Light to Shinnecock... southernmost extremity of the spit of land at the western end of Oak Beach. (d) A line drawn from Jones Inlet...

  17. 33 CFR 80.160 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... Beach, NY. 80.160 Section 80.160 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... to Atlantic Beach, NY. (a) A line drawn from the Shinnecock Inlet East Breakwater Light to Shinnecock... southernmost extremity of the spit of land at the western end of Oak Beach. (d) A line drawn from Jones Inlet...

  18. 33 CFR 80.160 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Beach, NY. 80.160 Section 80.160 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... to Atlantic Beach, NY. (a) A line drawn from the Shinnecock Inlet East Breakwater Light to Shinnecock... southernmost extremity of the spit of land at the western end of Oak Beach. (d) A line drawn from Jones Inlet...

  19. 33 CFR 80.160 - Montauk Point, NY to Atlantic Beach, NY.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... Beach, NY. 80.160 Section 80.160 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... to Atlantic Beach, NY. (a) A line drawn from the Shinnecock Inlet East Breakwater Light to Shinnecock... southernmost extremity of the spit of land at the western end of Oak Beach. (d) A line drawn from Jones Inlet...

  20. 37. Webster Avenue Bridge. New Rochelle, Westchester Co., NY. Sec. ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    37. Webster Avenue Bridge. New Rochelle, Westchester Co., NY. Sec. 4207, MP 19.12. - Northeast Railroad Corridor, Amtrak Route between New Jersey/New York & New York/Connecticut State Lines, New York County, NY

  1. 36. Webster Avenue Bridge. New Rochelle, Westchester Co., NY. Sec. ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    36. Webster Avenue Bridge. New Rochelle, Westchester Co., NY. Sec. 4207, MP 19.12. - Northeast Railroad Corridor, Amtrak Route between New Jersey/New York & New York/Connecticut State Lines, New York County, NY

  2. 24. Pedestrian Overbridges. West Farms, Bronx Co., NY. Sec. 4207, ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    24. Pedestrian Overbridges. West Farms, Bronx Co., NY. Sec. 4207, MP 12.50. - Northeast Railroad Corridor, Amtrak Route between New Jersey/New York & New York/Connecticut State Lines, New York County, NY

  3. 49 CFR 372.235 - New York, NY.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 49 Transportation 5 2010-10-01 2010-10-01 false New York, NY. 372.235 Section 372.235... ZONES, AND TERMINAL AREAS Commercial Zones § 372.235 New York, NY. The zone adjacent to, and commercially a part of, New York, NY, within which transportation by motor vehicle, in interstate or foreign...

  4. 49 CFR 372.235 - New York, NY.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 49 Transportation 5 2011-10-01 2011-10-01 false New York, NY. 372.235 Section 372.235... ZONES, AND TERMINAL AREAS Commercial Zones § 372.235 New York, NY. The zone adjacent to, and commercially a part of, New York, NY, within which transportation by motor vehicle, in interstate or foreign...

  5. New York City, Hudson River, NY, USA

    NASA Technical Reports Server (NTRS)

    1991-01-01

    This color infrared photo of New York City, Hudson River, NY, (41.0N, 74.0W) shows a unique view of the dense urban development of the New York City metropolitan area in downstate New York, Long Island and New Jersey. The heavily populated city areas appear as white or gray while vegetated areas appear as shades of red. Central park clearly shows up on Manhattan Island as an illustration of the delineation between cultural and natural features.

  6. Discovery of ATP-Competitive Inhibitors of tRNAIle Lysidine Synthetase (TilS) by High-Throughput Screening.

    PubMed

    Shapiro, Adam B; Plant, Helen; Walsh, Jarrod; Sylvester, Mark; Hu, Jun; Gao, Ning; Livchak, Stephania; Tentarelli, Sharon; Thresher, Jason

    2014-09-01

    A novel, ultrahigh-throughput, fluorescence anisotropy-based assay was developed and used to screen a 1.4-million-sample library for compounds that compete with adenosine triphosphate (ATP) for binding to Escherichia coli tRNA(Ile) lysidine synthetase (TilS), an essential, conserved, ATP-dependent, tRNA-modifying enzyme of bacterial pathogens. TilS modifies a cytidine base in the anticodon loop of Ile2 tRNA by attaching lysine, thereby altering codon recognition of the CAU anticodon from AUG (methionine) to AUA (isoleucine). A scintillation proximity assay for the incorporation of lysine into Ile2 tRNA was used to eliminate false positives in the initial screen resulting from detection artifacts as well as compounds competitive with the fluorescent label instead of ATP, and to measure inhibitor potencies against E. coli and Pseudomonas aeruginosa TilS isozymes. The tRNA(Ile) substrate for P. aeruginosa TilS was identified for the first time to enable these measurements. ATP-competitive binding of inhibitors was confirmed by one-dimensional ligand-observe nuclear magnetic resonance. A preliminary structure-activity relationship is shown for two inhibitor series.

  7. 75 FR 54419 - Environmental Impact Statement: Queens County, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-09-07

    ..., 2004. FOR FURTHER INFORMATION CONTACT: Jeffrey W. Kolb, Division Administrator, Federal Highway..., 2010. Jeffrey W. Kolb, Division Administrator, Federal Highway Administration, Albany, NY. BILLING...

  8. 33 CFR 110.59 - Eastern Long Island, NY.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 1 2012-07-01 2012-07-01 false Eastern Long Island, NY. 110.59... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.59 Eastern Long Island, NY. (a) Huntington Harbor... adjacent to the easterly side of Centre Island, westerly of a line on range with Cold Spring Harbor Light...

  9. 33 CFR 110.59 - Eastern Long Island, NY.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 1 2014-07-01 2014-07-01 false Eastern Long Island, NY. 110.59... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.59 Eastern Long Island, NY. (a) Huntington Harbor... adjacent to the easterly side of Centre Island, westerly of a line on range with Cold Spring Harbor Light...

  10. 33 CFR 110.59 - Eastern Long Island, NY.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Eastern Long Island, NY. 110.59... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.59 Eastern Long Island, NY. (a) Huntington Harbor... adjacent to the easterly side of Centre Island, westerly of a line on range with Cold Spring Harbor Light...

  11. 33 CFR 110.59 - Eastern Long Island, NY.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 1 2013-07-01 2013-07-01 false Eastern Long Island, NY. 110.59... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.59 Eastern Long Island, NY. (a) Huntington Harbor... adjacent to the easterly side of Centre Island, westerly of a line on range with Cold Spring Harbor Light...

  12. 33 CFR 110.59 - Eastern Long Island, NY.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Eastern Long Island, NY. 110.59... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.59 Eastern Long Island, NY. (a) Huntington Harbor... adjacent to the easterly side of Centre Island, westerly of a line on range with Cold Spring Harbor Light...

  13. 46 CFR 7.30 - New York Harbor, NY.

    Code of Federal Regulations, 2011 CFR

    2011-10-01

    ... 46 Shipping 1 2011-10-01 2011-10-01 false New York Harbor, NY. 7.30 Section 7.30 Shipping COAST GUARD, DEPARTMENT OF HOMELAND SECURITY PROCEDURES APPLICABLE TO THE PUBLIC BOUNDARY LINES Atlantic Coast § 7.30 New York Harbor, NY. A line drawn from East Rockaway Inlet Breakwater Light to Ambrose Light...

  14. 46 CFR 7.30 - New York Harbor, NY.

    Code of Federal Regulations, 2010 CFR

    2010-10-01

    ... 46 Shipping 1 2010-10-01 2010-10-01 false New York Harbor, NY. 7.30 Section 7.30 Shipping COAST GUARD, DEPARTMENT OF HOMELAND SECURITY PROCEDURES APPLICABLE TO THE PUBLIC BOUNDARY LINES Atlantic Coast § 7.30 New York Harbor, NY. A line drawn from East Rockaway Inlet Breakwater Light to Ambrose Light...

  15. 46 CFR 7.30 - New York Harbor, NY.

    Code of Federal Regulations, 2012 CFR

    2012-10-01

    ... 46 Shipping 1 2012-10-01 2012-10-01 false New York Harbor, NY. 7.30 Section 7.30 Shipping COAST GUARD, DEPARTMENT OF HOMELAND SECURITY PROCEDURES APPLICABLE TO THE PUBLIC BOUNDARY LINES Atlantic Coast § 7.30 New York Harbor, NY. A line drawn from East Rockaway Inlet Breakwater Light to Ambrose Light...

  16. 33 CFR 110.208 - Buffalo Harbor, N.Y.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 1 2012-07-01 2012-07-01 false Buffalo Harbor, N.Y. 110.208 Section 110.208 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.208 Buffalo Harbor, N.Y. (a) The anchorage grounds—(1...

  17. 33 CFR 110.208 - Buffalo Harbor, N.Y.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 1 2014-07-01 2014-07-01 false Buffalo Harbor, N.Y. 110.208 Section 110.208 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.208 Buffalo Harbor, N.Y. (a) The anchorage grounds—(1...

  18. 33 CFR 110.208 - Buffalo Harbor, N.Y.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 1 2013-07-01 2013-07-01 false Buffalo Harbor, N.Y. 110.208 Section 110.208 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.208 Buffalo Harbor, N.Y. (a) The anchorage grounds—(1...

  19. 33 CFR 110.136 - Lake Champlain, NY and VT.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Lake Champlain, NY and VT. 110... ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.136 Lake Champlain, NY and VT. (a) Burlington Harbor, Vt. (1) The waters bounded by a line connecting the following points: Latitude Longtitude...

  20. 33 CFR 110.136 - Lake Champlain, NY and VT.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 1 2014-07-01 2014-07-01 false Lake Champlain, NY and VT. 110... ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.136 Lake Champlain, NY and VT. (a) Burlington Harbor, Vt. (1) The waters bounded by a line connecting the following points: Latitude Longtitude...

  1. 33 CFR 110.136 - Lake Champlain, NY and VT.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 1 2012-07-01 2012-07-01 false Lake Champlain, NY and VT. 110... ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.136 Lake Champlain, NY and VT. (a) Burlington Harbor, Vt. (1) The waters bounded by a line connecting the following points: Latitude Longtitude...

  2. 33 CFR 110.136 - Lake Champlain, NY and VT.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Lake Champlain, NY and VT. 110... ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.136 Lake Champlain, NY and VT. (a) Burlington Harbor, Vt. (1) The waters bounded by a line connecting the following points: Latitude Longtitude...

  3. 33 CFR 110.136 - Lake Champlain, NY and VT.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 1 2013-07-01 2013-07-01 false Lake Champlain, NY and VT. 110... ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.136 Lake Champlain, NY and VT. (a) Burlington Harbor, Vt. (1) The waters bounded by a line connecting the following points: Latitude Longtitude...

  4. 33 CFR 110.208 - Buffalo Harbor, N.Y.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Buffalo Harbor, N.Y. 110.208 Section 110.208 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.208 Buffalo Harbor, N.Y. (a) The anchorage...

  5. 33 CFR 110.208 - Buffalo Harbor, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Buffalo Harbor, N.Y. 110.208 Section 110.208 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.208 Buffalo Harbor, N.Y. (a) The anchorage grounds—(1...

  6. HAER NY,55GRO,1 (sheet 1 of 3) AveryBartholomew Patent Railroad ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    HAER NY,55-GRO,1- (sheet 1 of 3) - Avery-Bartholomew Patent Railroad Iron Bridge, Town park south of Route 222, west of Owasco Inlet (moved from Elm Street Extension spanning Fall Creek, Nubia, NY), Groton, Tompkins County, NY

  7. HAER NY,55GRO,1 (sheet 3 of 3) AveryBartholomew Patent Railroad ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    HAER NY,55-GRO,1- (sheet 3 of 3) - Avery-Bartholomew Patent Railroad Iron Bridge, Town park south of Route 222, west of Owasco Inlet (moved from Elm Street Extension spanning Fall Creek, Nubia, NY), Groton, Tompkins County, NY

  8. HAER NY,55GRO,1 (sheet 2 of 3) AveryBartholomew Patent Railroad ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    HAER NY,55-GRO,1- (sheet 2 of 3) - Avery-Bartholomew Patent Railroad Iron Bridge, Town park south of Route 222, west of Owasco Inlet (moved from Elm Street Extension spanning Fall Creek, Nubia, NY), Groton, Tompkins County, NY

  9. NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus.

    PubMed

    Chen, Ji-Li; Dawoodji, Amina; Tarlton, Andrea; Gnjatic, Sacha; Tajar, Abdelouahid; Karydis, Ioannis; Browning, Judy; Pratap, Sarah; Verfaille, Christian; Venhaus, Ralph R; Pan, Linda; Altman, Douglas G; Cebon, Jonathan S; Old, Lloyd L; Nathan, Paul; Ottensmeier, Christian; Middleton, Mark; Cerundolo, Vincenzo

    2015-03-15

    Vaccination strategies based on repeated injections of NY-ESO-1 protein formulated in ISCOMATRIX particles (NY-ESO-1 ISCOMATRIX) have shown to elicit combined NY-ESO-1 specific antibody and T cell responses. However, it remains unclear whether heterologous prime-boost strategies based on the combination with NY-ESO-1 ISCOMATRIX with different NY-ESO-1 boosting reagents could be used to increase NY-ESO-1 CD8(+) or CD4(+) T cell responses. To address this question, we carried out a randomized clinical trial in 39 high-risk, resected melanoma patients vaccinated with NY-ESO-1 ISCOMATRIX, and then boosted with repeated injections of either recombinant fowlpox virus encoding full length NY-ESO-1 (rF-NY-ESO-1) (Arm A) or NY-ESO-1 ISCOMATRIX alone (Arm B). We have comprehensively analyzed NY-ESO-1 specific T cells and B cells response in all patients before and after vaccination for a total of seven time points per patient. NY-ESO-1 ISCOMATRIX alone elicited a strong NY-ESO-1 specific CD4(+) T cell and antibody response, which was maintained by both regiments at similar levels. However, CD8(+) T cell responses were significantly boosted in 3 out of 18 patients in Arm A after the first rF-NY-ESO-1 injection and such responses were maintained until the end of the trial, while no patients in Arm B showed similar CD8(+) T cell responses. In addition, our results clearly identified immunodominant regions in the NY-ESO-1 protein: NY-ESO-179-102 and NY-ESO-1115-138 for CD4+ T cells and NY-ESO-185-108 for CD8+ T cells in a large proportion of vaccinated patients. These regions of NY-ESO-1 protein should be considered in future clinical trials as immunodominant epitopes. © 2014 UICC.

  10. RadNet Air Data From Yaphank, NY

    EPA Pesticide Factsheets

    This page presents radiation air monitoring and air filter analysis data for Yaphank, NY from EPA's RadNet system. RadNet is a nationwide network of monitoring stations that measure radiation in air, drinking water and precipitation.

  11. RadNet Air Data From Albany, NY

    EPA Pesticide Factsheets

    This page presents radiation air monitoring and air filter analysis data for Albany, NY from EPA's RadNet system. RadNet is a nationwide network of monitoring stations that measure radiation in air, drinking water and precipitation.

  12. RadNet Air Data From Rochester, NY

    EPA Pesticide Factsheets

    This page presents radiation air monitoring and air filter analysis data for Rochester, NY from EPA's RadNet system. RadNet is a nationwide network of monitoring stations that measure radiation in air, drinking water and precipitation.

  13. RenewableNY - An Industrial Energy Conservation Initiative

    SciTech Connect

    Lubarr, Tzipora

    2009-09-30

    The New York Industrial Retention Network (NYIRN) manages the RenewableNY program to assist industrial companies in New York City to implement energy efficiency projects. RenewableNY provides companies with project management assistance and grants to identify opportunities for energy savings and implement energy efficiency projects. The program helps companies identify energy efficient projects, complete an energy audit, and connect with energy contractors who install renewable energy and energy efficient equipment. It also provides grants to help cover the costs of installation for new systems and equipment. RenewableNY demonstrates that a small grant program that also provides project management assistance can incentivize companies to implement energy efficiency projects that might otherwise be avoided. Estimated savings through RenewableNY include 324,500 kWh saved through efficiency installations, 158 kW of solar energy systems installed, and 945 thm of gas avoided.

  14. RadNet Air Data From New York City, NY

    EPA Pesticide Factsheets

    This page presents radiation air monitoring and air filter analysis data for New York, NY from EPA's RadNet system. RadNet is a nationwide network of monitoring stations that measure radiation in air, drinking water and precipitation.

  15. RadNet Air Data From Syracuse, NY

    EPA Pesticide Factsheets

    This page presents radiation air monitoring and air filter analysis data for Syracuse, NY from EPA's RadNet system. RadNet is a nationwide network of monitoring stations that measure radiation in air, drinking water and precipitation.

  16. RadNet Air Data From Lockport, NY

    EPA Pesticide Factsheets

    This page presents radiation air monitoring and air filter analysis data for Lockport, NY from EPA's RadNet system. RadNet is a nationwide network of monitoring stations that measure radiation in air, drinking water and precipitation.

  17. 33 CFR 110.84b - Buffalo, N.Y.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 1 2013-07-01 2013-07-01 false Buffalo, N.Y. 110.84b Section 110... REGULATIONS Special Anchorage Areas § 110.84b Buffalo, N.Y. The area within the Port of Buffalo known as Port of Buffalo Small Boat Harbor commencing at a point on shore at latitude 42°51′05″ N., longitude 78°51...

  18. 33 CFR 110.84b - Buffalo, N.Y.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 1 2014-07-01 2014-07-01 false Buffalo, N.Y. 110.84b Section 110... REGULATIONS Special Anchorage Areas § 110.84b Buffalo, N.Y. The area within the Port of Buffalo known as Port of Buffalo Small Boat Harbor commencing at a point on shore at latitude 42°51′05″ N., longitude 78°51...

  19. 33 CFR 110.84b - Buffalo, N.Y.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Buffalo, N.Y. 110.84b Section 110... REGULATIONS Special Anchorage Areas § 110.84b Buffalo, N.Y. The area within the Port of Buffalo known as Port of Buffalo Small Boat Harbor commencing at a point on shore at latitude 42°51′05″ N., longitude...

  20. 33 CFR 110.84b - Buffalo, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Buffalo, N.Y. 110.84b Section 110... REGULATIONS Special Anchorage Areas § 110.84b Buffalo, N.Y. The area within the Port of Buffalo known as Port of Buffalo Small Boat Harbor commencing at a point on shore at latitude 42°51′05″ N., longitude 78°51...

  1. Middle Holocene Unconformity in Seneca Lake, NY

    NASA Astrophysics Data System (ADS)

    Curtin, T. M.; Crocker, M.; Loddengaard, K.

    2008-12-01

    The post-glacial history of the Finger Lakes, NY have involved several changes in lake levels throughout the latest Pleistocene and Holocene, resulting from the changing position of the retreating Laurentide ice sheet, river outlet position, glacial rebound, and water balance. Previous studies of high-resolution seismic reflection profiles from three Finger Lakes define a middle Holocene erosional surface at water depths as great as 26 m in the northern end of each of lake. There are two proposed hypotheses to explain the origin of the observed erosional surfaces: 1) subaerial erosion during a lake lowstand and 2) erosion resulting from increased internal seiche activity. To evaluate these hypotheses, we examined a series of 2 to 5 m long piston cores collected along a north-south transect from one of the Finger Lakes, Seneca Lake. Cores were correlated using distinctive changes in the profiles of grain size, loss-on-ignition, and magnetic susceptibility. We recognize a significant erosional unconformity of early to middle Holocene sediment at modern depths <60 m because portions of the normal deepwater sediment sequence were missing in cores and were commonly replaced by a thin zone of sand and abraded shells (bivalves, gastropods). At water depths >60 m, the unconformity continues as a conformable zone. We attribute the unconformity to wave abrasion and nearshore current winnowing of the shoreface during a lowstand. With an assumption of an effective 20 m wave base, the depth to the low level lake surface responsible for the unconformity is estimated to be 40 m. The age of the unconformity is ~6 ka, based on radiocarbon ages of lithologic boundaries in the sediment cores. Because the unconformity grades into a conformable zone in deepwater cores that display no change in lithology, we hypothesize that the large-scale lake level drop is likely not the result of climate change, but rather a change in accommodation space in the northern portion of the lake basin due

  2. Autoimmune thyroid disease elicited by NY-ESO-1 vaccination.

    PubMed

    Vita, Roberto; Guarneri, Fabrizio; Agah, Ravin; Benvenga, Salvatore

    2014-02-01

    Immunotherapies and targeted therapies are frequently associated with thyroid dysfunction, which is in contrast with the rare thyroid abnormalities induced by cytotoxic agents. Immunotherapy with NY-ESO-1, a tumor-associated antigen expressed by a number of malignancies, was reported to trigger hyperthyroidism or hypothyroidism in two HLA-A2 patients with ovarian cancer. We describe now a case of Graves' disease triggered by NY-ESO-1 in a HLA-A2-negative woman. A 32-year-old woman with a synovial sarcoma received radiotherapy, chemotherapy, and finally NY-ESO-1 vaccine. The patient was found to have HLA A11/A33(19), B13/B56(22), Cw3/-. One month after the beginning of immunotherapy, thyroid dysfunction was clinically suspected and Graves' disease was biochemically confirmed. Fearful of the antithyroid drugs' side effects, the patient was treated with a beta-blocker (propranolol, 80-20 mg/day). As hyperthyroidism progressively worsened, the patient underwent total thyroidectomy. We hypothesized that NY-ESO-1 shared partial homology with thyroid autoantigens (the so-called molecular mimicry mechanism) and that at least one pair of homologous sequences contained amino acid sequence binding motifs to a restricted number of HLA molecules. We used BLAST software to search amino acid sequence homologies between NY-ESO-1 and thyroid autoantigens (thyrotropin receptor [TSH-R], thyroperoxidase, and thyroglobulin), and the HLA ligand/motif database to look for HLA/T-cell receptor binding motifs in the regions of NY-ESO-1 and thyroid autoantigens that were homologous. We found 15 epitopic regions of NY-ESO-1 homologous to 15 regions of thyroid autoantigens, some of which epitopic: 5 of TSH-R, 8 of thyroglobulin, and 2 of thyroperoxidase. These homologous sequences contain binding motifs belonging to several HLA class I antigens, including HLA A2 and the patient's A11 and A33. Genetically predisposed patients who receive NY-ESO-1 vaccination are at risk to develop thyroid

  3. Evaluation of TILS for use as the orbiter landing NAVAID

    NASA Technical Reports Server (NTRS)

    Tate, J. M.

    1974-01-01

    An evaluation of the tactical instrument landing systems (TILS) for use in the orbiter autoland system was made. It was found that with certain modifications, the TILS can satisfy orbiter autoland requirements. These modifications, include (1) addition of DME equipment, (2) expansion of elevation coverage from 0-10 deg to 0-30 deg, and (3) expansion to redundant systems with associated ground monitors. Additional modifications that are not necessary to meet the orbiter requirements, but that can enhance performance margin are (1) tightening of elevation antenna beam width from 1.3 deg to 0.5 deg and (2) split site configuration to provide azimuth and range coverage through rollout.

  4. Telltale Tumor Infiltrating Lymphocytes (TIL) in Oral, Head & Neck Cancer

    PubMed Central

    Lei, Yu; Xie, Yuying; Tan, Yee Sun; Prince, Mark E.; Moyer, Jeffrey S.; Nör, Jacques; Wolf, Gregory T.

    2017-01-01

    Evidence gleaned from recent studies on the role of tumor-infiltrating lymphocytes (TILs) suggests that cancer is not only a genetic disease but also an immunologic disease. Head and Neck Squamous Cell Carcinoma (HNSCC) has been a significant model to study cancer cell-immune cell interactions. First, immune cell infiltration is an important feature of these tumors. Second, HNSCC frequently develops resistance to immunogenic cytotoxicity, which provides a window to decipher how tumors engage the immune system to establish immune tolerance. Finally, chemoradiation therapy, as a central modality for HNSCC treatment, has been shown to elicit immune activation. The presence of effector immune cells in the tumor microenvironment is often associated with superior clinical response to adjuvant therapy. On the other hand, an activated immune system, in addition to limiting tumor initiation and progression, could also exert selective pressure to promote the growth of less immunogenic tumors, as a pivotal immunoediting process. But it remains unclear how cancer cell signaling regulates tumor immunogenicity and how to mitigate HNSCC-potentiated TIL suppression. In this review, we will revisit the prognostic role of TILs in HNSCC, and collectively discuss how cancer cell machinery impacts upon the plasticity of TILs. PMID:27553942

  5. Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions

    PubMed Central

    Teng, Feifei; Meng, Xiangjiao; Wang, Xin; Yuan, Jupeng; Liu, Sujing; Mu, Dianbin; Zhu, Hui; Kong, Li; Yu, Jinming

    2016-01-01

    Purpose Currently, adjuvant chemotherapy is recommended for patients with high risk stage I non-small cell lung cancer (NSCLC). However, identifying high risk patients remains a challenge. This study aims to identify the patient cohorts more likely to benefit from adjuvant chemotherapy based on the tumor micro-immune environment. Results CD8+TILs significantly associated with disease-free survival (DFS) and overall survial (OS) (p=0.002; 0.040). Patients with high risk factors may also predict shorter DFS (P=0.056). When compared together, patients with high-CD8+TILs showed better DFS than patients with low-CD8+TILs, no matter their risk factors status. There's no correlation between PD-L1 expressions and survival. PD-L1 was highly expressed in men, squamous and well differentiated carcinoma. In addition, Foxp3+TILs alone didn't show any prognostic effects, but low-Foxp3/high-CD8+TILs were associated with prolonged DFS (p=0.031). Methods A total of 126 patients with surgically resected stage I NSCLC were included to perform immunohistochemistry of CD8+ tumor infiltrating lymphocytes (TILs), programmed death ligand-1(PD-L1) and forkhead box P3 (Foxp3)+TILs. Conclusion CD8+TILs are effective prognostic predictors. Patients with surgically resected stage I NSCLC showing low CD8+TILs could be considered for adjuvant chemotherapy, even if they have no high risk features. PMID:27602763

  6. 33 CFR 110.87 - Henderson Harbor, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Henderson Harbor, N.Y. 110.87... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.87 Henderson Harbor, N.Y. (a) Area A. The area in the... latitude 43°51′08.8″ N, longitude 76°12′08.9″ W, thence to latitude 43°51′09.0″ N, longitude 76°12′19.0″ W...

  7. NY32649 ELECTRICAL SUBSTATION (BUILDING 2675) AND EDUCATION CENTER (BUILDING 2670) ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    NY-326-49 ELECTRICAL SUBSTATION (BUILDING 2675) AND EDUCATION CENTER (BUILDING 2670) AT NORTH END OF ARIZONA AVENUE. VIEW TO NORTHEAST. - Plattsburgh Air Force Base, U.S. Route 9, Plattsburgh, Clinton County, NY

  8. 77 FR 50630 - Radio Broadcasting Services; Westfield, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-22

    ... COMMISSION 47 CFR Part 73 Radio Broadcasting Services; Westfield, NY AGENCY: Federal Communications... Review Act, see 5 U.S.C. 801(a)(1)(A). List of Subjects in 47 CFR Part 73 Radio, Radio broadcasting... reasons discussed in the preamble, the Federal Communications Commission amends 47 CFR part 73 as...

  9. Interoperability of Demand Response Resources Demonstration in NY

    SciTech Connect

    Wellington, Andre

    2014-03-31

    The Interoperability of Demand Response Resources Demonstration in NY (Interoperability Project) was awarded to Con Edison in 2009. The objective of the project was to develop and demonstrate methodologies to enhance the ability of customer sited Demand Response resources to integrate more effectively with electric delivery companies and regional transmission organizations.

  10. 76 FR 58329 - New York Disaster Number NY-00108

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-20

    ... From the Federal Register Online via the Government Publishing Office ] SMALL BUSINESS ADMINISTRATION New York Disaster Number NY-00108 AGENCY: U.S. Small Business Administration. ACTION: Amendment 5... to include the following areas as adversely affected by the disaster: Primary Counties:...

  11. 78 FR 44187 - New York Disaster # NY-00136

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-07-23

    ... From the Federal Register Online via the Government Publishing Office SMALL BUSINESS ADMINISTRATION New York Disaster NY-00136 AGENCY: U.S. Small Business Administration. ACTION: Notice. SUMMARY... locations. The following areas have been determined to be adversely affected by the disaster:...

  12. 76 FR 58328 - New York Disaster Number NY-00108

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-20

    ... From the Federal Register Online via the Government Publishing Office SMALL BUSINESS ADMINISTRATION New York Disaster Number NY-00108 AGENCY: U.S. Small Business Administration. ACTION: Amendment 6... include the following areas as adversely affected by the disaster: Primary Counties: (Physical Damage...

  13. 76 FR 59766 - New York Disaster Number NY-00110

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-27

    ... From the Federal Register Online via the Government Publishing Office SMALL BUSINESS ADMINISTRATION New York Disaster Number NY-00110 AGENCY: U.S. Small Business Administration. ACTION: Amendment 2... hereby amended to include the following areas as adversely affected by the disaster: Primary...

  14. 77 FR 16800 - Radio Broadcasting Services; Westfield, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-22

    ... COMMISSION 47 CFR Part 73 Radio Broadcasting Services; Westfield, NY AGENCY: Federal Communications... filing procedures for comments, see 47 CFR 1.415 and 1.420. List of Subjects in 47 CFR Part 73 Radio, Radio broadcasting. Federal Communications Commission. Nazifa Sawez, Assistant Chief, Audio Division...

  15. 77 FR 37316 - Drawbridge Operation Regulations; Reynolds Channel, Nassau, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-21

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Reynolds Channel, Nassau, NY AGENCY... the Long Beach Bridge, mile 4.7, across Reynolds Channel, at Nassau, New York. This temporary... Operations, telephone 202-366-9826. SUPPLEMENTARY INFORMATION: The Long Beach Bridge, across Reynolds...

  16. No Retreat: Lorna Peterson--University at Buffalo, NY

    ERIC Educational Resources Information Center

    Library Journal, 2005

    2005-01-01

    When Clark Atlanta University announced in 2003 it would close its library school, Lorna Peterson, a library educator at the University at Buffalo, NY, mounted a campaign to save the program, which has graduated more black library leaders than any other. "I did not want this to happen without a fight. It cannot be said that librarians, Friends of…

  17. Rapid variability of the EXor star NY Ori

    NASA Astrophysics Data System (ADS)

    Lorenzetti, D.; Arkharov, A. A.; Efimova, N.; Giannini, T.; Antoniucci, S.; Di Paola, A.; Larionov, V. M.

    2016-03-01

    We report on a rapid brightness variability of the classical EXor star NY Ori observed with the AZT24 1m IR telescope (Campo Imperatore, Italy), as a part of our program EXORCISM (EXOR OptiCal and Infrared Systematic Monitoring - Antoniucci et al. 2013 PPVI; Lorenzetti et al. 2009 ApJ 693, 1056).

  18. 78 FR 7848 - New York Disaster Number NY-00130

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-04

    ... From the Federal Register Online via the Government Publishing Office SMALL BUSINESS ADMINISTRATION New York Disaster Number NY-00130 AGENCY: U.S. Small Business Administration. ACTION: Amendment 5.... Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth,...

  19. 76 FR 35937 - New York Disaster #NY-00105

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-20

    ...: 2011-15133] U.S. SMALL BUSINESS ADMINISTRATION [Disaster Declaration 12634 and 12635] New York Disaster NY-00105 AGENCY: U.S. Small Business Administration. ACTION: Notice. SUMMARY: This is a Notice of the...: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement...

  20. 33 CFR 110.84b - Buffalo, N.Y.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... REGULATIONS Special Anchorage Areas § 110.84b Buffalo, N.Y. The area within the Port of Buffalo known as Port of Buffalo Small Boat Harbor commencing at a point on shore at latitude 42°51′05″ N., longitude 78°51...

  1. 78 FR 43063 - Drawbridge Operation Regulations; Arthur Kill, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-07-19

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Arthur Kill, NY AGENCY: Coast Guard... District, has issued a temporary deviation from the regulations governing the operation of the Arthur Kill AK Railroad Bridge across Arthur Kill, mile 11.6, between Staten Island, New York and Elizabeth,...

  2. No Retreat: Lorna Peterson--University at Buffalo, NY

    ERIC Educational Resources Information Center

    Library Journal, 2005

    2005-01-01

    When Clark Atlanta University announced in 2003 it would close its library school, Lorna Peterson, a library educator at the University at Buffalo, NY, mounted a campaign to save the program, which has graduated more black library leaders than any other. "I did not want this to happen without a fight. It cannot be said that librarians, Friends of…

  3. 78 FR 34893 - Drawbridge Operation Regulations; Reynolds Channel, Lawrence, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-06-11

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Reynolds Channel, Lawrence, NY... operation of the Atlantic Beach Bridge, mile 0.4, across Reynolds Channel, at Lawrence, New York. This... Lawrence, New York, has a vertical clearance in the closed position of 25 feet at mean high water and 30...

  4. 78 FR 27031 - Amendment of Class E Airspace; Kingston, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-09

    ... Federal Aviation Administration 14 CFR Part 71 Amendment of Class E Airspace; Kingston, NY AGENCY: Federal Aviation Administration (FAA), DOT. ACTION: Final rule. SUMMARY: This action amends Class E Airspace at... published in the Federal Register a notice of proposed rulemaking to amend Class E airspace at Kingston,...

  5. 78 FR 47816 - New York Disaster Number NY-00136

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-06

    ... From the Federal Register Online via the Government Publishing Office SMALL BUSINESS ADMINISTRATION New York Disaster Number NY-00136 AGENCY: U.S. Small Business Administration. ACTION: Amendment 2...: Submit completed loan applications to: U.S. Small Business Administration, Processing And Disbursement...

  6. 78 FR 47817 - New York Disaster Number NY-00136

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-06

    ... From the Federal Register Online via the Government Publishing Office SMALL BUSINESS ADMINISTRATION New York Disaster Number NY-00136 AGENCY: U.S. Small Business Administration. ACTION: Amendment 1...: Submit completed loan applications to: U.S. Small Business Administration, Processing And Disbursement...

  7. 77 FR 14690 - Drawbridge Operation Regulations; Hutchinson River, Bronx, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-13

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Hutchinson River, Bronx, NY AGENCY... the Amtrak Pelham Bay Railroad Bridge, mile 0.5, across the Hutchinson River at the Bronx, New York.... SUPPLEMENTARY INFORMATION: The Amtrak Pelham Bay Railroad Bridge, across the Hutchinson River, mile 0.5, at the...

  8. 76 FR 76297 - Drawbridge Operation Regulations; Hutchinson River, Bronx, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-07

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Hutchinson River, Bronx, NY AGENCY... the Amtrak Pelham Bay Railroad Bridge at mile 0.5, across the Hutchinson River at the Bronx, New York... Bridge, across the Hutchinson River at mile 0.5, at the Bronx, New York, has a vertical clearance in the...

  9. NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer

    PubMed Central

    Ademuyiwa, Foluso O.; Bshara, Wiam; Attwood, Kristopher; Morrison, Carl; Edge, Stephen B.; Ambrosone, Christine B.; O’Connor, Tracey L.; Levine, Ellis G.; Miliotto, Anthony; Ritter, Erika; Ritter, Gerd; Gnjatic, Sacha; Odunsi, Kunle

    2012-01-01

    Purpose NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore the potential for NY-ESO-1 antigen directed immunotherapy in triple negative breast cancer (TNBC) by determining the frequency of expression by immunohistochemistry (IHC) and the degree of inherent immunogenicity to NY-ESO-1. Experimental Design 168 TNBC and 47 ER+/HER2- primary breast cancer specimens were used to determine NY-ESO-1 frequency by IHC. As previous studies have shown that patients with a robust innate humoral immune response to CT antigens are more likely to develop CD8 T-cell responses to NY-ESO-1 peptides, we evaluated the degree to which patients with NY-ESO-1 expression had inherent immunogenicity by measuring antibodies. The relationship between NY-ESO-1 expression and CD8+ T lymphocytes was also examined. Results The frequency of NY-ESO-1 expression in the TNBC cohort was 16% versus 2% in ER+/HER2- patients. A higher NY-ESO-1 score was associated with a younger age at diagnosis in the TNBC patients with NY-ESO-1 expression (p = 0.026). No differences in OS (p = 0.278) or PFS (p = 0.238) by NY-ESO-1 expression status were detected. Antibody responses to NY-ESO-1 were found in 73% of TNBC patients whose tumors were NY-ESO-1 positive. NY-ESO-1 positive patients had higher CD8 counts than negative patients (p = 0.018). Conclusion NY-ESO-1 is expressed in a substantial subset of TNBC patients and leads to a high humoral immune response in a large proportion of these individuals. Given these observations, patients with TNBC may benefit from targeted therapies directed against NY-ESO-1. PMID:22761704

  10. NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.

    PubMed

    Ademuyiwa, Foluso O; Bshara, Wiam; Attwood, Kristopher; Morrison, Carl; Edge, Stephen B; Karpf, Adam R; James, Smith A; Ambrosone, Christine B; O'Connor, Tracey L; Levine, Ellis G; Miliotto, Anthony; Ritter, Erika; Ritter, Gerd; Gnjatic, Sacha; Odunsi, Kunle

    2012-01-01

    NY-ESO-1 cancer testis (CT) antigen is an attractive candidate for immunotherapy as a result of its high immunogenicity. The aim of this study was to explore the potential for NY-ESO-1 antigen directed immunotherapy in triple negative breast cancer (TNBC) by determining the frequency of expression by immunohistochemistry (IHC) and the degree of inherent immunogenicity to NY-ESO-1. 168 TNBC and 47 ER+/HER2- primary breast cancer specimens were used to determine NY-ESO-1 frequency by IHC. As previous studies have shown that patients with a robust innate humoral immune response to CT antigens are more likely to develop CD8 T-cell responses to NY-ESO-1 peptides, we evaluated the degree to which patients with NY-ESO-1 expression had inherent immunogenicity by measuring antibodies. The relationship between NY-ESO-1 expression and CD8+ T lymphocytes was also examined. The frequency of NY-ESO-1 expression in the TNBC cohort was 16% versus 2% in ER+/HER2- patients. A higher NY-ESO-1 score was associated with a younger age at diagnosis in the TNBC patients with NY-ESO-1 expression (p = 0.026). No differences in OS (p = 0.278) or PFS (p = 0.238) by NY-ESO-1 expression status were detected. Antibody responses to NY-ESO-1 were found in 73% of TNBC patients whose tumors were NY-ESO-1 positive. NY-ESO-1 positive patients had higher CD8 counts than negative patients (p = 0.018). NY-ESO-1 is expressed in a substantial subset of TNBC patients and leads to a high humoral immune response in a large proportion of these individuals. Given these observations, patients with TNBC may benefit from targeted therapies directed against NY-ESO-1.

  11. 76 FR 77175 - New York Fun Factory Fireworks Display, Western Long Island Sound; Mamaroneck, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-12

    ... Island Sound; Mamaroneck, NY AGENCY: Coast Guard, DHS. ACTION: Notice of proposed rulemaking. SUMMARY... Island Sound in the vicinity of Mamaroneck, NY in support of the New York Fun Factory Fireworks display... fireworks display on the waters of western Long Island Sound, Mamaroneck, NY, no rain date is scheduled...

  12. 78 FR 24677 - Safety Zone; XA The Experimental Agency Fireworks, Pier 34, East River, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-26

    ... Pier 34, Manhattan, NY. This temporary safety zone is necessary to protect spectators and vessels from... navigable waters of the East River, in the vicinity of Pier 34, Manhattan, NY. All persons and vessels shall... position 40 42'28.5'' N, 073 59'9.9'' W, approximately 182 yards south east of Pier 34, Manhattan, NY. (b...

  13. Slaty-backed Gull in Sullivan Co., NY

    USGS Publications Warehouse

    Freer, V.; Haas, J.; Buckley, P.A.

    2002-01-01

    An adult Slaty-backed Gull (Larus schistisagus) was found and photographed at Neversink Reservoir, Sullivan Co., NY on 20 February 2002. A native of northeastern Eurasia and northern Japan, this species is rare along the Bering coast of Alaska, and there are only a handful of scattered records in the lower 48 state since the first in St Louis along the Mississippi River in late 1983. There is one previous New York State occurrence, in the Niagara River Gorge area of NY/ONT, 24 November-29 December 1992. The Sullivan Co. adult is the closest confirmed Slaty-backed Gull to the Atlantic Coast; recent single individuals along the Susquehanna River in MD, and at Cape Hatteras NC remain in dispute.

  14. Results of the NY-Alesund ozone measurements intercomparison NAOMI

    NASA Technical Reports Server (NTRS)

    Steinbrecht, W.; Gross, M.; McGee, T.; Neuber, R.; Gathen, P. V. D.; Wahl, P.; Klein, U.; Langer, J.

    1998-01-01

    Worldwide, about ten Differential Absorption Lidars are used for long-term monitoring of stratospheric ozone. These systems are an important component of the Network for the Detection of Stratospheric Change. Although DIALs are self-calibrating in principle, regular intercomparisons with other ozone-lidars, microwave radiometers or ozone-sondes are highly desirable to ensure high data quality at a well known level. The Network for the Detection of Stratospheric Change (NDSC) validation policy suggests that such intercomparisons be "blind", meaning all participants submit their data to an impartial referee, without seeing results from the other participants. Here we report on the "blind" intercomparison taking place from January 20th to February 10th 1998 at Ny-Alesund, Spitsbergen (78.92 deg N, 11.95 deg E). Participating groups were from the Alfred Wegener Institute, Potsdam, operating the NDSC DIAL system at Ny-Alesund, from the University of Bremen operating the NDSC microwave radiometer for ozone profiling at Ny-Alesund, and the NASA Goddard Space Flight Center group with the "NDSC travelling standard" STROZ-LITE. The first author acted as the impartial referee. Also used for the intercomparison were data from ECC-6A/Vaisala RS80 ozone sondes routinely launched at Ny-Alesund by the AWI group. A 1% KI solution (3 ml) and the 1986 ECC pump correction (1.092 at 5 hPa) are used. The ECC-data were available to all participants during the campaign and thus were not "blind". Table 1 summarizes the expected performance of the instruments participating in the ozone intercomparison reported in this paper.

  15. Hearing in Drosophila Requires TilB, a Conserved Protein Associated With Ciliary Motility

    PubMed Central

    Kavlie, Ryan G.; Kernan, Maurice J.; Eberl, Daniel F.

    2010-01-01

    Cilia were present in the earliest eukaryotic ancestor and underlie many biological processes ranging from cell motility and propulsion of extracellular fluids to sensory physiology. We investigated the contribution of the touch insensitive larva B (tilB) gene to cilia function in Drosophila melanogaster. Mutants of tilB exhibit dysfunction in sperm flagella and ciliated dendrites of chordotonal organs that mediate hearing and larval touch sensitivity. Mutant sperm axonemes as well as sensory neuron dendrites of Johnston's organ, the fly's auditory organ, lack dynein arms. Through deficiency mapping and sequencing candidate genes, we identified tilB mutations in the annotated gene CG14620. A genomic CG14620 transgene rescued deafness and male sterility of tilB mutants. TilB is a 395-amino-acid protein with a conserved N-terminal leucine-rich repeat region at residues 16–164 and a coiled-coil domain at residues 171–191. A tilB-Gal4 transgene driving fluorescently tagged TilB proteins elicits cytoplasmic expression in embryonic chordotonal organs, in Johnston's organ, and in sperm flagella. TilB does not appear to affect tubulin polyglutamylation or polyglycylation. The phenotypes and expression of tilB indicate function in cilia construction or maintenance, but not in intraflagellar transport. This is also consistent with phylogenetic association of tilB homologs with presence of genes encoding axonemal dynein arm components. Further elucidation of tilB functional mechanisms will provide greater understanding of cilia function and will facilitate understanding ciliary diseases. PMID:20215474

  16. NY-ESO-1 expression and immunogenicity in prostate cancer patients.

    PubMed

    Gati, Asma; Lajmi, Nesrine; Derouiche, Amine; Marrakchi, Raja; Chebil, Mohamed; Benammar-Elgaaied, Amel

    2011-10-01

    Prostate cancer is the second leading cause of men cancer-related death. Cancer immunotherapy has been investigated as a treatment which might be instituted at the point of detection of androgen-independent metastatic disease. to investigate the expression and humoral response against NYESO-1 in patients with prostate cancer (PC) and to analyze the relationship between expression of NY-ESO-1 and clinicopathological features. NY-ESO-1 mRNA in surgically resected PC and benign prostatic hyperplasia (BPH) were examined by reverse transcriptionpolymerase chain reaction. The antibody response to NY-ESO-1 was examined by enzyme-linked Elisa assay using recombinant NYESO-1 protein. NY-ESO-1 mRNA was detected in 9 of 23 (39%) PC patients. Antibodies against NY-ESO-1 protein were detected in 12 of 23 (52%) sera of PC patients and in 5 of 9 (55%) of NY-ESO-1 expressing tumors. However, no mRNA copy or NY-ESO-1 antibodies were detected in all BPH patients tested. The present study has demonstrated the expression of NY-ESO-1mRNA in prostate Cancer patients and NY-ESO-1 antibody production. Our data suggest that NY-ESO-1 could be used as a tumor marker and constitute a good candidate for vaccine-based immunotherapy for hormonal resistant prostate cancer patients.

  17. NY-ESO-1 antibody as a novel tumour marker of gastric cancer.

    PubMed

    Fujiwara, S; Wada, H; Kawada, J; Kawabata, R; Takahashi, T; Fujita, J; Hirao, T; Shibata, K; Makari, Y; Iijima, S; Nishikawa, H; Jungbluth, A A; Nakamura, Y; Kurokawa, Y; Yamasaki, M; Miyata, H; Nakajima, K; Takiguchi, S; Nakayama, E; Mori, M; Doki, Y

    2013-03-19

    NY-ESO-1 antibodies are specifically observed in patients with NY-ESO-1-expressing tumours. We analysed whether the NY-ESO-1 humoral immune response is a useful tumour marker of gastric cancer. Sera from 363 gastric cancer patients were screened by enzyme-linked immunosorbent assay (ELISA) to detect NY-ESO-1 antibodies. Serial serum samples were obtained from 25 NY-ESO-1 antibody-positive patients, including 16 patients with curative resection and 9 patients who received chemotherapy alone. NY-ESO-1 antibodies were detected in 3.4% of stage I, 4.4% of stage II, 25.3% of stage III, and 20.0% of stage IV patients. The frequency of antibody positivity increased with disease progression. When the NY-ESO-1 antibody was used in combination with carcinoembryonic antigen and CA19-9 to detect gastric cancer, information gains of 11.2% in stages III and IV, and 5.8% in all patients were observed. The NY-ESO-1 immune response levels of the patients without recurrence fell below the cutoff level after surgery. Two of the patients with recurrence displayed incomplete decreases. The nine patients who received chemotherapy alone continued to display NY-ESO-1 immune responses. When combined with conventional tumour markers, the NY-ESO-1 humoral immune response could be a useful tumour marker for detecting advanced gastric cancer and inferring the post-treatment tumour load in seropositive patients.

  18. Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

    PubMed

    Wada, Hisashi; Isobe, Midori; Kakimi, Kazuhiro; Mizote, Yu; Eikawa, Shingo; Sato, Eiichi; Takigawa, Nagio; Kiura, Katsuyuki; Tsuji, Kazuhide; Iwatsuki, Keiji; Yamasaki, Makoto; Miyata, Hiroshi; Matsushita, Hirokazu; Udono, Heiichiro; Seto, Yasuyuki; Yamada, Kazuhiro; Nishikawa, Hiroyoshi; Pan, Linda; Venhaus, Ralph; Oka, Mikio; Doki, Yuichiro; Nakayama, Eiichi

    2014-01-01

    We conducted a clinical trial of an NY-ESO-1 cancer vaccine using 4 synthetic overlapping long peptides (OLP; peptides #1, 79-108; #2, 100-129; #3, 121-150; and #4, 142-173) that include a highly immunogenic region of the NY-ESO-1 molecule. Nine patients were immunized with 0.25 mg each of three 30-mer and a 32-mer long NY-ESO-1 OLP mixed with 0.2 KE Picibanil OK-432 and 1.25 mL Montanide ISA-51. The primary endpoints of this study were safety and NY-ESO-1 immune responses. Five to 18 injections of the NY-ESO-1 OLP vaccine were well tolerated. Vaccine-related adverse events observed were fever and injection site reaction (grade 1 and 2). Two patients showed stable disease after vaccination. An NY-ESO-1-specific humoral immune response was observed in all patients and an antibody against peptide #3 (121-150) was detected firstly and strongly after vaccination. NY-ESO-1 CD4 and CD8 T-cell responses were elicited in these patients and their epitopes were identified. Using a multifunctional cytokine assay, the number of single or double cytokine-producing cells was increased in NY-ESO-1-specific CD4 and CD8 T cells after vaccination. Multiple cytokine-producing cells were observed in PD-1 (-) and PD-1 (+) CD4 T cells. In conclusion, our study indicated that the NY-ESO-1 OLP vaccine mixed with Picibanil OK-432 and Montanide ISA-51 was well tolerated and elicited NY-ESO-1-specific humoral and CD4 and CD8 T-cell responses in immunized patients.

  19. The Educational Thought of Cornelius Van Til: Philosophical Foundations of the Contemporary Christian School Movement.

    ERIC Educational Resources Information Center

    Maffet, Gregory J.; Dye, Charles M.

    This paper gives an account of the thoughts of Cornelius Van Til on the contemporary Christian school movement. An account of the historical development of Christian compromise is given, followed by a critique of the compromise among contemporary Christian educators. Van Til claims that any educational position which falls short of being founded…

  20. Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors.

    PubMed

    Hall, MacLean; Liu, Hao; Malafa, Mokenge; Centeno, Barbara; Hodul, Pamela J; Pimiento, José; Pilon-Thomas, Shari; Sarnaik, Amod A

    2016-01-01

    We evaluated whether tumor infiltrating lymphocytes (TIL) could be expanded from surgically resected tumors from pancreatic cancer patients. Tumors were resected from pancreatic cancer patients. Tumors were minced into fragments and cultured in media containing high dose interleukin-2 (IL-2) for up to 6 weeks. T cell phenotype, activation markers, and reactivity were measured. TIL expansion was measured in 19 patient samples. The majority of these TIL were CD4(+) T cells and were highly activated. Purified CD8(+) T cells produced IFN-γ in response to HLA-matched pancreatic tumor targets. PD-1 blockade and 4-1BB stimulation were demonstrated as effective strategies to improve effective TIL yield, including the production of tumor-reactive pancreatic TIL. TIL expanded from pancreatic tumors are functional and able to respond to pancreatic tumor associated antigens. PD-1 blockade, 41BB stimulation, and CD8(+) T cell enrichment are effective strategies to improve TIL yield and tumor reactivity. These results support the development of adoptive cell therapy strategies using TIL for the treatment of pancreatic cancer.

  1. SciTil Detector for the PANDA experiment at FAIR

    NASA Astrophysics Data System (ADS)

    Suzuki, Ken; Gruber, Lukas; Brunner, Stefan; Marton, Johann; Orth, Herbert; Schwarz, Carsten; Scitil/Panda Collaboration

    2014-09-01

    The PANDA experiment at the Facility for Antiproton and Ion Research (FAIR) is a fixed-target experiment installed in a antiproton storage ring (HESR) in the energy range of 1 GeV to 15 GeV. FAIR is being build on the area of the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt, Germany. The universal PANDA detector together with the HESR enables to study fundamental questions of hadron and nuclear physics, e.g. gluonic excitations, the physics of strange and charm quarks and nucleon structure. The SciTil detector is a barrel time-of-flight detector and is a relatively new subcomponent to the system. The demand arose in order to provide a securer event tagging at the event rates of 20-100 MHz instantaneous event rate, to improve a particle identification capability of relatively low momentum particles, and to allow a faster track finding with pattern recognition. The beam test of the SciTil prototype detector in January 2014 showed a promising result. We report the status and outlook of the project.

  2. NY-ESO-1 — EDRN Public Portal

    Cancer.gov

    NY-ESO-1, official name CTAG1B, is an antigen that is expressed in normal testis and ovary and overexpressed in a wide variety of cancers. The CTAG1B gene is found in a duplicated region of the X-chromosome and therefore has a neighboring gene of identical sequence. CTAG1B is expressed from 18 weeks until birth in human fetal testis. In the adult testis, is strongly expressed in spermatogonia and in primary spermatocytes, but not in post-meiotic cells or in testicular somatic cells (at protein level).

  3. 33 CFR 110.87 - Henderson Harbor, N.Y.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.87 Henderson Harbor, N.Y. (a) Area A. The area in the... latitude 43°51′08.8″ N, longitude 76°12′08.9″ W, thence to latitude 43°51′09.0″ N, longitude 76°12′19.0″ W, thence to latitude 43°51′33.4″ N, longitude 76°12′19.0″ W, thence to latitude 43°51′33.4″ N, longitude 76...

  4. 33 CFR 110.87 - Henderson Harbor, N.Y.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... ANCHORAGE REGULATIONS Special Anchorage Areas § 110.87 Henderson Harbor, N.Y. (a) Area A. The area in the... latitude 43°51′08.8″ N, longitude 76°12′08.9″ W, thence to latitude 43°51′09.0″ N, longitude 76°12′19.0″ W, thence to latitude 43°51′33.4″ N, longitude 76°12′19.0″ W, thence to latitude 43°51′33.4″ N, longitude 76...

  5. Characterization of the near-Earth Asteroid 2002 NY40

    DTIC Science & Technology

    2007-09-01

    8 – 3. Images Several near-Earth asteroids have been imaged by radar (Hudson et al. 2003; Benner et al. 2002), and several main belt asteroids ...This analysis found the asteroid had a main period of 19.98±0.01 h with a secondary period of 18.43±0.01 h, indicating that the asteroid is tumbling...ar X iv :0 70 9. 09 84 v1 [ as tr o- ph ] 7 S ep 2 00 7 Characterization of the near-Earth Asteroid 2002 NY40 1 Lewis C. Roberts, Jr., Doyle T

  6. 77 FR 52058 - Notice of Inventory Completion: Longyear Museum of Anthropology, Colgate University, Hamilton, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-28

    ... Museum of Anthropology, Department of Sociology and Anthropology, Colgate University, 13 Oak Dr... Anthropology, Department of Sociology and Anthropology, Colgate University, 13 Oak Dr., Hamilton, NY 13346...

  7. 76 FR 48178 - Notice of Inventory Completion: Longyear Museum of Anthropology, Colgate University, Hamilton, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-08

    ... Anthropology, Department of Sociology and Anthropology, Colgate University, 13 Oak Dr., Hamilton, NY 13346.... Jordan Kerber, Longyear Museum of Anthropology, Department of Sociology and Anthropology, Colgate...

  8. NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.

    PubMed

    Wadle, Andreas; Mischo, Axel; Strahl, Sabine; Nishikawa, Hiroyoshi; Held, Gerhard; Neumann, Frank; Wullner, Beate; Fischer, Eliane; Kleber, Sascha; Karbach, Julia; Jager, Elke; Shiku, Hiroshi; Odunsi, Kunle; Shrikant, Protul A; Knuth, Alexander; Cerundolo, Vincenzo; Renner, Christoph

    2010-11-01

    Vaccine strategies that target dendritic cells to elicit potent cellular immunity are the subject of intense research. Here we report that the genetically engineered yeast Saccharomyces cerevisiae, expressing the full-length tumour-associated antigen NY-ESO-1, is a versatile host for protein production. Exposing dendritic cells (DCs) to soluble NY-ESO-1 protein linked to the yeast a-agglutinin 2 protein (Aga2p) protein resulted in protein uptake, processing and MHC class I cross-presentation of NY-ESO-1-derived peptides. The process of antigen uptake and cross-presentation was dependent on the glycosylation pattern of NY-ESO-1-Aga2p protein and the presence of accessible mannose receptors. In addition, NY-ESO-1-Aga2p protein uptake by dendritic cells resulted in recognition by HLA-DP4 NY-ESO-1-specific CD4(+) T cells, indicating MHC class II presentation. Finally, vaccination of mice with yeast-derived NY-ESO-1-Aga2p protein led to an enhanced humoral and cellular immune response, when compared to the bacterially expressed NY-ESO-1 protein. Together, these data demonstrate that yeast-derived full-length NY-ESO-1-Aga2p protein is processed and presented efficiently by MHC class I and II complexes and warrants clinical trials to determine the potential value of S. cerevisiae as a host for cancer vaccine development. Copyright © 2010 John Wiley & Sons, Ltd.

  9. Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma

    PubMed Central

    Giavina-Bianchi, Mara; Giavina-Bianchi, Pedro; Sotto, Mirian Nacagami; Muzikansky, Alona; Kalil, Jorge; Festa-Neto, Cyro; Duncan, Lyn M.

    2015-01-01

    NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein was detected in 20% of invasive melanomas (16/79), rarely in in situ melanoma (1/10) and not in benign nevi (0/20). Marked intratumoral heterogeneity of NY-ESO-1 protein expression was observed. NY-ESO-1 expression was associated with increased primary tumor thickness (P = 0.007) and inversely correlated with superficial spreading melanoma (P < 0.02). NY-ESO-1 expression was also associated with reduced numbers and density of CD3+ tumor infiltrating lymphocytes (P = 0.017). When NY-ESO-1 protein was expressed, CD3+ T cells were less diffusely infiltrating the tumor and were more often arranged in small clusters (P = 0.010) or as isolated cells (P = 0.002) than in large clusters of more than five lymphocytes. No correlation of NY-ESO-1 expression with gender, age, tumor site, ulceration, lymph node sentinel status, or survival was observed. NY-ESO-1 expression in melanoma was associated with tumor progression, including increased tumor thickness, and with reduced tumor infiltrating lymphocytes. PMID:25954764

  10. Increased NY-ESO-1 expression and reduced infiltrating CD3+ T cells in cutaneous melanoma.

    PubMed

    Giavina-Bianchi, Mara; Giavina-Bianchi, Pedro; Sotto, Mirian Nacagami; Muzikansky, Alona; Kalil, Jorge; Festa-Neto, Cyro; Duncan, Lyn M

    2015-01-01

    NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein was detected in 20% of invasive melanomas (16/79), rarely in in situ melanoma (1/10) and not in benign nevi (0/20). Marked intratumoral heterogeneity of NY-ESO-1 protein expression was observed. NY-ESO-1 expression was associated with increased primary tumor thickness (P = 0.007) and inversely correlated with superficial spreading melanoma (P < 0.02). NY-ESO-1 expression was also associated with reduced numbers and density of CD3+ tumor infiltrating lymphocytes (P = 0.017). When NY-ESO-1 protein was expressed, CD3+ T cells were less diffusely infiltrating the tumor and were more often arranged in small clusters (P = 0.010) or as isolated cells (P = 0.002) than in large clusters of more than five lymphocytes. No correlation of NY-ESO-1 expression with gender, age, tumor site, ulceration, lymph node sentinel status, or survival was observed. NY-ESO-1 expression in melanoma was associated with tumor progression, including increased tumor thickness, and with reduced tumor infiltrating lymphocytes.

  11. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.

    PubMed

    Lai, Jin-Ping; Robbins, Paul F; Raffeld, Mark; Aung, Phyu Phyu; Tsokos, Maria; Rosenberg, Steven A; Miettinen, Markku M; Lee, Chyi-Chia Richard

    2012-06-01

    A promising targeted therapy against NY-ESO-1 (CTAG 1B) using genetically modified T-cells in synovial sarcomas was recently demonstrated in a clinical trial at the NCI. To investigate the role of NY-ESO-1 immunohistochemistry in patient selection and gain better insight into the incidence of NY-ESO-1 expression in synovial sarcomas and other mesenchymal tumors, we evaluated NY-ESO-1 expression by immunohistochemistry in 417 tumors. This collection of samples included: 50 SS18/SSX1/2 fusion positive synovial sarcomas, 155 gastrointestinal stromal tumors (GIST), 135 other spindle cell sarcomas as well as 77 other sarcomas (chondrosarcoma, osteosarcoma, dedifferentiated liposarcoma, alveolar soft part sarcoma, rhabdomyosarcoma, angiosarcoma, malignant mesothelioma, and Ewing's sarcoma). We report that 76% of synovial sarcomas expressed NY-ESO-1 in a strong and diffuse pattern (2-3+, >50-70% of tumor cells). In contrast, only rare cases of other spindle cell mesenchymal tumor expressed NY-ESO-1 (GIST (2/155), malignant peripheral nerve sheath tumors (1/34), and dermatofibrosarcoma protuberans (2/20)). Individual cases of other sarcomas (angiosarcoma, malignant mesothelioma, chondrosarcoma, osteosarcoma, dedifferentiated liposarcoma, alveolar soft part sarcoma, and Ewing's sarcoma) were positive for NY-ESO-1. However, no positive cases were identified amongst our cohort of leiomyosarcomas (0/24), hemangiopericytoma/solitary fibrous tumors (0/40), and cellular schwannomas (0/17). In summary, we find that NY-ESO-1 is strongly and diffusely expressed in a majority of synovial sarcomas, but only rarely in other mesenchymal lesions. Beyond its role in patient selection for targeted therapy, immunohistochemistry for NY-ESO-1 may be diagnostically useful for the distinction of synovial sarcoma from other spindle cell neoplasms.

  12. Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival.

    PubMed

    Khammari, Amir; Knol, Anne-Chantal; Nguyen, Jean-Michel; Bossard, Céline; Denis, Marc-Guillaume; Pandolfino, Marie-Christine; Quéreux, Gaëlle; Bercegeay, Sylvain; Dréno, Brigitte

    2014-01-01

    Two first analyses of our clinical trial on TIL as adjuvant therapy for melanoma were published in 2002 and 2007. We present here an update of the clinical results after a 17-year median followup. In this trial, disease-free patients were randomly assigned to receive either TIL/IL-2 or IL-2. The relapse-free survival (RFS) was the primary objective. Eighty-eight patients were enrolled. A new analysis performed in May 2013 did not show significant changes in RFS or OS duration. However, our first finding on the association between the number of invaded lymph nodes and TIL effectiveness was strengthened. The Cox model adjusted on this interaction showed for the first time a significant treatment effect when considering the overall population, both on the RFS and OS. Patients treated with TIL had a longer RFS (P = 0.023) or OS (P = 0.020). This study being with a very long followup (17 years), confirmed the association between TIL effectiveness and the number of invaded lymph nodes, indicating that a low tumor burden could be a crucial factor enhancing the curative effect of TIL in possible microscopic residual disease. Moreover, we confirmed that a prolonged survival was associated with the presence of specific TIL and a decrease in Foxp3 expression.

  13. Flow and chloride transport in the tidal Hudson River, NY

    USGS Publications Warehouse

    Weiss, Lawrence A.; Schaffranek, Raymond W.; de Vries, M. Peter

    1994-01-01

    A one-dimensional dynamic-flow model and a one-dimensional solute-transport model were used to evaluate the effects of hypothetical public-supply water withdrawals on saltwater intrusion in a 133-mile reach of the tidal Hudson River between Green Island dam, near Troy, N.Y., and Hastings-on-Hudson, N.Y. Regression techniques were used in analyses of current and extreme historical conditions, and numerical models were used to investigate the effect of various water withdrawals. Of four withdrawal scenarios investigated, simulations of a 27-day period during which discharges at Green Island dam averaged 7,090 ft3/s indicate that increasing the present Chelsea pumping-station withdrawal rate of 100 Mgal/d (million gallons per day) to 300 Mgal/d would have the least effect on upstream saltwater movement. A 90-day simulation, during which discharges at Green Island dam averaged 25,200 ft3/s, indicates that withdrawals of 1,940 Mgal/d at Chelsea would not measurably increase chloride concentrations at Chelsea under normal tidal and meteorological conditions, but withdrawals of twice that rate (3,880 Mgal/d) could increase the chloride concentration at Chelsea to 250 mg/L.

  14. Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.

    PubMed

    Yang, Jihua; Jiao, Shunchang; Kang, Jingbo; Li, Rong; Zhang, Guanzhong

    2015-01-01

    NY-ESO-1 antibody is one of the cancer-related antibodies. The purpose of this study was to investigate the diagnostic role of the NY-ESO-1 humoral immune response in small cell lung cancer (SCLC). We recombined the recombinant protein of NY-ESO-1 antibody and NSE, analyzed them by Enzyme-linked immunosorbent assay, and then established the Receiver Operating Characteristic (ROC) curve to estimate the diagnostic value of NY-ESO-1 antibody, NSE and their combinations. According to detection, the positive rate of NY-ESO-1 humoral immune response (26.3%), NSE (43.8%) and their combinations (10.5%) were all lower than the negative rate which indicated that the NY-ESO-1 antibody might be down-regulated in SCLC. And the positive rate wasn't related to clinicopathologic characteristics. The ROC curve demonstrated that with a 37.17% sensitivity and a 91.7% specificity along with a AUC of 0.619 for NY-ESO-1ab as well as with a 48.3% sensitivity and a 90.87% specificity along with a AUC value of 0.773 for NSE, their diagnostic value were both high. Besides, the diagnostic value of their combinations was also good for a AUC of 0.83 and a 69.12% sensitivity and a 91.8% specificity. There were significant difference of diagnostic value among three types above (NY-ESO-1 vs. NSE, P < 0.01; The Combinations vs. NY-ESO-1, P < 0.0001; and the Combinations vs. NSE, P < 0.04). In conclusion, NY-ESO-1ab, NSE and their combinations all were important diagnostic markers for SCLC. Moreover, the diagnostic value of their combinations was higher than any single of them. And NY-ESO-1 humoral immune to NSE might be a potential diagnostic indicator in SCLC.

  15. Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.

    PubMed

    Tsuji, Kazuhide; Hamada, Toshitada; Uenaka, Akiko; Wada, Hisashi; Sato, Eiichi; Isobe, Midori; Asagoe, Kenji; Yamasaki, Osamu; Shiku, Hiroshi; Ritter, Gerd; Murphy, Roger; Hoffman, Eric W; Old, Lloyd J; Nakayama, Eiichi; Iwatsuki, Keiji

    2008-10-01

    NY-ESO-1 is a cancer/testis antigen highly immunogenic in cancer patients. Cholesterol-bearing hydrophobized pullulan (CHP) is a nanoparticle-forming antigen-delivery vehicle and CHP complexed with NY-ESO-1 protein (CHP-NY-ESO-1) efficiently activates CD4 and CD8 T cells in vitro. In this study we report on a 50-year-old male melanoma patient with multiple skin and organ metastases (T4N3M1c) who was vaccinated with CHP-NY-ESO-1 at biweekly intervals and who had an unusual disease course. We characterized in this patient humoral and cellular immune responses, immune regulatory cells, and cytokine profiles in the peripheral blood and at local tumor sites. Ten days after the second CHP-NY-ESO-1 vaccination (day 25), blisters appeared on the skin at the metastatic lesions associated with inflammatory changes. A skin biopsy showed the presence of many NY-ESO-1-expressing apoptotic melanoma cells as determined by a terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) test. However, the tumors continued to grow, and the patient died of pulmonary failure due to multiple metastases on day 48. Serum antibody responses were detected after the second CHP-NY-ESO-1 vaccination and antibody titer increased with subsequent vaccinations. Th1 dependent IgG1 was the predominant immunoglobulin subtype. Both, NY-ESO-1-specific CD4 and CD8 T cell responses were detected in PBMC by IFN-gamma secretion assays. After CHP-NY-ESO-1 vaccination a slight decrease in CD4(+)CD25(+)Foxp3(+) Tregs was observed in PBMC but significantly increased numbers of CD4(+)CD25(+)Foxp3(+) Tregs and CD68(+) immunoregulatory macrophages were detected at the local tumor sites. CD4(+)CD25(+)Foxp3(+) Tregs were also increased in the blister fluid. Cytokines in the serum suggested a polarization towards a Th1 pattern in the PBMC and those in the blister fluid suggested a Th2-type response at the tumor site. Our observations indicate induction of specific humoral and

  16. Wind-blown sand movement periods on the Nyírség alluvial fan, Hungary

    NASA Astrophysics Data System (ADS)

    Buró, Botond; Lóki, József; Sipos, György; Négyesi, Gábor; Andrási, Bence; Jakab, Attila; Félegyházi, Enikő; Molnár, Mihály

    2017-04-01

    Wind-blown sand movement periods on the Nyírség alluvial fan, Hungary The Nyírség is an alluvial fan, was built by rivers, which were flown down from the NE Carpathians. When the weather was dry, wind-blown sand was blowed out and the wind started to develop the aeolian landforms. The first significant sand movements in the Nyírség was in the Upper plenniglacial and the Late glacial. The main landforms of the Nyírség were developed at this time. The aeolic transformation of the land was not completed in the Nyírség at the end of the Pleistocene. In the Holocene the sand moved within small area, mainly by anthropogenic impact. Our aim is clarify the age of the wind-blown sand movements period, with different absolute (Radiocarbon dating method, OSL), and relative (Archaeological finds, Pollen analyses) dating methods. We have collected for the age determining charcoal from many sand quarry (Gégény, Kántorjánosi, Nyíradony, Nagyvarsány, Máriapócs and Lövőpetri) which contain fossil soil layer. For the OSL measurements samples were collected from Baktalórántháza, Gégény and Kántorjánosi sand quarries. We collected samples from 5 places for the pollen analyses (Nyírtanya, Máriapócs, Nyírbéltek-Nyírlúgos, Nyírábrány, Vámospércs), and also from an archaeological excavation (Nyíregyháza- Oros). The new age dates show us, that in the Nyírség the first significant sand movements were in the cold and drier period of the Upper pleniglacial and Late glacial (Baktalórántháza, Nyírtanya, Vámospércs). At the end of the Pleistocene the sand movements not competed in the Nyírség (Gégény, Kántorjánosi, Nyírábrány). In the Holocene there were many little sand movement periods, mainly caused by anthropogenic impact (Nyíradony, Nyíregyháza-Oros). The research was supported by the European Union and the State of Hungary, co-financed by the European Regional Development Fund in the project of GINOP-2.3.2.-15-2016-00009 'ICER

  17. 33 CFR 207.600 - Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 3 2011-07-01 2011-07-01 false Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation. 207.600 Section 207.600 Navigation and Navigable Waters CORPS OF... (Charlotte) Harbor, N.Y.; use, administration, and navigation. (a)-(b) (c) No vessel shall moor or anchor to...

  18. 33 CFR 207.580 - Buffalo Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 3 2010-07-01 2010-07-01 false Buffalo Harbor, N.Y.; use, administration, and navigation. 207.580 Section 207.580 Navigation and Navigable Waters CORPS OF ENGINEERS, DEPARTMENT OF THE ARMY, DEPARTMENT OF DEFENSE NAVIGATION REGULATIONS § 207.580 Buffalo Harbor, N.Y.; use...

  19. 33 CFR 207.600 - Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 3 2010-07-01 2010-07-01 false Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation. 207.600 Section 207.600 Navigation and Navigable Waters CORPS OF... (Charlotte) Harbor, N.Y.; use, administration, and navigation. (a)-(b) (c) No vessel shall moor or anchor to...

  20. 33 CFR 207.580 - Buffalo Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 3 2011-07-01 2011-07-01 false Buffalo Harbor, N.Y.; use, administration, and navigation. 207.580 Section 207.580 Navigation and Navigable Waters CORPS OF ENGINEERS, DEPARTMENT OF THE ARMY, DEPARTMENT OF DEFENSE NAVIGATION REGULATIONS § 207.580 Buffalo Harbor, N.Y.; use...

  1. 75 FR 39839 - Regulated Navigation Area; Hudson River and Port of NY/NJ

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-07-13

    ... to begin. Due to delays on other construction projects in the Gulf of Mexico, the calendar dates for... over the Harlem River. The replacement bridge span for this project is being constructed at Port Coeymans, NY on the Hudson River, approximately 115 nautical miles north of The Battery, Manhattan, NY....

  2. 75 FR 38710 - Special Local Regulation, Fran Schnarr Open Water Championships, Huntington Bay, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-07-06

    ..., Huntington Bay, NY AGENCY: Coast Guard, DHS. ACTION: Final rule. SUMMARY: The Coast Guard is establishing a permanent Special Local Regulation on the navigable waters of Huntington Bay, New York due to the annual... Championships, Huntington Bay, NY'' in the Federal Register (75 FR 13454). The Coast Guard received no comments...

  3. EPA Proposes Changes to Cleanup Plan at Olean Well Field Site - AVX Property in Olean, NY

    EPA Pesticide Factsheets

    (New York, N.Y.) The U.S. Environmental Protection Agency is proposing to modify a cleanup plan originally issued in 1996 to address soil and groundwater at the AVX property at the Olean Well Field Superfund Site in Cattaraugus County, Olean, NY. Soil and

  4. EPA Finalizes Changes to Cleanup Plan at Olean Well Field Site - AVX Property in Olean, NY

    EPA Pesticide Factsheets

    (New York, N.Y.) The U.S. Environmental Protection Agency has finalized its changes to a cleanup plan originally issued in 1996 to address soil and groundwater at the AVX property at the Olean Well Field Superfund Site in Cattaraugus County, Olean, NY. Soi

  5. 33 CFR 162.15 - Manhasset Bay, N.Y.; seaplane restricted area.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 2 2013-07-01 2013-07-01 false Manhasset Bay, N.Y.; seaplane restricted area. 162.15 Section 162.15 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND... Bay, N.Y.; seaplane restricted area. (a) The restricted area. An area in Manhasset Bay between...

  6. EPA Will Remove Contaminated Soil at Ithaca Falls Creek Gorge, N.Y.

    EPA Pesticide Factsheets

    (New York, N.Y) The U.S. Environmental Protection Agency will remove lead contaminated soil this month at a property between the base of a cliff wall and a walkway at the Falls Creek Gorge in Ithaca, N.Y.

  7. 33 CFR 110.150 - Block Island Sound, N.Y.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 1 2013-07-01 2013-07-01 false Block Island Sound, N.Y. 110.150 Section 110.150 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.150 Block Island Sound, N.Y. (a) The anchorage ground. A...

  8. 33 CFR 110.150 - Block Island Sound, N.Y.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 1 2012-07-01 2012-07-01 false Block Island Sound, N.Y. 110.150 Section 110.150 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.150 Block Island Sound, N.Y. (a) The anchorage ground. A...

  9. 33 CFR 110.150 - Block Island Sound, N.Y.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Block Island Sound, N.Y. 110.150 Section 110.150 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.150 Block Island Sound, N.Y. (a) The anchorage ground. A...

  10. 33 CFR 110.150 - Block Island Sound, N.Y.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 1 2014-07-01 2014-07-01 false Block Island Sound, N.Y. 110.150 Section 110.150 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.150 Block Island Sound, N.Y. (a) The anchorage ground. A...

  11. 77 FR 39408 - Safety Zone; Buffalo July 4th Fireworks, Lake Erie, Buffalo, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-03

    ... SECURITY Coast Guard 33 CFR Part 165 RIN 1625-AA00 Safety Zone; Buffalo July 4th Fireworks, Lake Erie, Buffalo, NY AGENCY: Coast Guard, DHS. ACTION: Temporary final rule. SUMMARY: The Coast Guard is establishing a temporary safety zone on Lake Erie, Buffalo, NY. This safety zone is intended to...

  12. Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.

    PubMed

    Odunsi, Kunle; Matsuzaki, Junko; James, Smitha R; Mhawech-Fauceglia, Paulette; Tsuji, Takemasa; Miller, Austin; Zhang, Wa; Akers, Stacey N; Griffiths, Elizabeth A; Miliotto, Anthony; Beck, Amy; Batt, Carl A; Ritter, Gerd; Lele, Shashikant; Gnjatic, Sacha; Karpf, Adam R

    2014-01-01

    The cancer-testis/cancer-germline antigen NY-ESO-1 is a vaccine target in epithelial ovarian cancer (EOC), but its limited expression is a barrier to vaccine efficacy. As NY-ESO-1 is regulated by DNA methylation, we hypothesized that DNA methyltransferase (DNMT) inhibitors may augment NY-ESO-1 vaccine therapy. In agreement, global DNA hypomethylation in EOC was associated with the presence of circulating antibodies to NY-ESO-1. Pre-clinical studies using EOC cell lines showed that decitabine treatment enhanced both NY-ESO-1 expression and NY-ESO-1-specific CTL-mediated responses. Based on these observations, we performed a phase I dose-escalation trial of decitabine, as an addition to NY-ESO-1 vaccine and doxorubicin liposome (doxorubicin) chemotherapy, in 12 patients with relapsed EOC. The regimen was safe, with limited and clinically manageable toxicities. Both global and promoter-specific DNA hypomethylation occurred in blood and circulating DNAs, the latter of which may reflect tumor cell responses. Increased NY-ESO-1 serum antibodies and T cell responses were observed in the majority of patients, and antibody spreading to additional tumor antigens was also observed. Finally, disease stabilization or partial clinical response occurred in 6/10 evaluable patients. Based on these encouraging results, evaluation of similar combinatorial chemo-immunotherapy regimens in EOC and other tumor types is warranted.

  13. Expression and immunogenicity of NY-ESO-1 in colorectal cancer

    PubMed Central

    Li, Ya; Song, Ruifeng; Li, Xinqiang; Xu, Feng

    2017-01-01

    Serum assays of NY-ESO-1 antibodies provide a guide to discriminate between patients who suffer from different types of cancer. In the present study, the expression of NY-ESO-1 was detected with the aim to identify a novel tumor antigen in colorectal cancer (CRC). Sera were obtained from 89 healthy individuals and 236 patients with CRC with stage I, II, III and IV tumors. The NY-ESO-1 autoantibody levels were determined using an enzyme-linked immunosorbent assay. The mRNA and protein expression levels of NY-ESO-1 were detected using reverse transcription-polymerase chain reaction and immunohistochemistry, respectively, in 60 CRC and paired adjacent non-tumor tissues. NY-ESO-1 antibody was detected in 40 of the 236 (16.9%) patients with CRC. The NY-ESO-1 antibody combined with carcinoembryonic antigen enhanced the sensitivity, from 52.1 to 62.7%, of the diagnosis of CRC. The frequency of antibody positivity increased with the TNM cancer stage (8.8 vs. 28.3% in stages I+II and III+IV, respectively). The mRNA and protein expression levels of NY-ESO-1 were significantly higher in CRC tissue than in adjacent non-tumor tissue. In conclusion, NY-ESO-1 is frequently expressed in CRC with the capacity of inducing a humoral immune response in CRC patients, exhibiting the potential to be a promising biomarker for CRC. PMID:28588683

  14. NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.

    PubMed

    von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries

    2013-01-01

    During cancer progression, malignant cells may evade immunosurveillance. However, evidence for immunological escape in humans is scarce. We report here the clinical course of a melanoma patient whose initial tumor was positive for the antigens NY-ESO-1, MAGE-C1, and Melan-A. Upon immunization with a recombinant vaccinia/fowlpox NY-ESO-1 construct, the patient experienced a mixed clinical response and spreading of the NY-ESO-1 epitopes in the CD4+ T cell compartment. After NY-ESO-1 protein + CpG immunization, the patient's anti-NY-ESO-1 IgG response increased. Over the following years, progressing lesions were resected and found to be NY-ESO-1-negative while being positive for MAGE-C1, Melan-A, and MHC-I. The fatal, inoperable brain metastasis was analyzed after his death and also proved to be NY-ESO-1-negative, while being positive for MAGE-C1 and Melan-A, as well as MHC-I. We propose that cancer control and cancer escape in this patient were governed by NY-ESO-1-specific immunological pressure. Our findings provide evidence for the existence of immunoediting and immunoescape in this cancer patient.

  15. Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer

    PubMed Central

    Odunsi, Kunle; Matsuzaki, Junko; James, Smitha R.; Mhawech-Fauceglia, Paulette; Tsuji, Takemasa; Miller, Austin; Zhang, Wa; Akers, Stacey N.; Griffiths, Elizabeth A.; Miliotto, Anthony; Beck, Amy; Batt, Carl A; Ritter, Gerd; Lele, Shashikant; Gnjatic, Sacha; Karpf, Adam R.

    2013-01-01

    The cancer-testis/cancer-germline antigen NY-ESO-1 is a vaccine target in epithelial ovarian cancer (EOC), but its limited expression is a barrier to vaccine efficacy. As NY-ESO-1 is regulated by DNA methylation, we hypothesized that DNA methyltransferase (DNMT) inhibitors may augment NY-ESO-1 vaccine therapy. In agreement, global DNA hypomethylation in EOC was associated with the presence of circulating antibodies to NY-ESO-1. Pre-clinical studies using EOC cell lines showed that decitabine treatment enhanced both NY-ESO-1 expression and NY-ESO-1-specific CTL-mediated responses. Based on these observations, we performed a phase I dose-escalation trial of decitabine, as an addition to NY-ESO-1 vaccine and doxorubicin liposome (doxorubicin) chemotherapy, in 12 patients with relapsed EOC. The regimen was safe, with limited and clinically manageable toxicities. Both global and promoter-specific DNA hypomethylation occurred in blood and circulating DNAs, the latter of which may reflect tumor cell responses. Increased NY-ESO-1 serum antibodies and T cell responses were observed in the majority of patients, and antibody spreading to additional tumor antigens was also observed. Finally, disease stabilization or partial clinical response occurred in 6/10 evaluable patients. Based on these encouraging results, evaluation of similar combinatorial chemo-immunotherapy regimens in EOC and other tumor types is warranted. PMID:24535937

  16. Expression and immunogenicity of NY-ESO-1 in colorectal cancer.

    PubMed

    Li, Ya; Song, Ruifeng; Li, Xinqiang; Xu, Feng

    2017-06-01

    Serum assays of NY-ESO-1 antibodies provide a guide to discriminate between patients who suffer from different types of cancer. In the present study, the expression of NY-ESO-1 was detected with the aim to identify a novel tumor antigen in colorectal cancer (CRC). Sera were obtained from 89 healthy individuals and 236 patients with CRC with stage I, II, III and IV tumors. The NY-ESO-1 autoantibody levels were determined using an enzyme-linked immunosorbent assay. The mRNA and protein expression levels of NY-ESO-1 were detected using reverse transcription-polymerase chain reaction and immunohistochemistry, respectively, in 60 CRC and paired adjacent non-tumor tissues. NY-ESO-1 antibody was detected in 40 of the 236 (16.9%) patients with CRC. The NY-ESO-1 antibody combined with carcinoembryonic antigen enhanced the sensitivity, from 52.1 to 62.7%, of the diagnosis of CRC. The frequency of antibody positivity increased with the TNM cancer stage (8.8 vs. 28.3% in stages I+II and III+IV, respectively). The mRNA and protein expression levels of NY-ESO-1 were significantly higher in CRC tissue than in adjacent non-tumor tissue. In conclusion, NY-ESO-1 is frequently expressed in CRC with the capacity of inducing a humoral immune response in CRC patients, exhibiting the potential to be a promising biomarker for CRC.

  17. 77 FR 34894 - Safety Zone; Bostock 50th Anniversary Fireworks, Long Island Sound; Manursing Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-12

    ... Island Sound; Manursing Island, NY AGENCY: Coast Guard, DHS. ACTION: Notice of proposed rulemaking... Island Sound in the vicinity of Manursing Island, NY for a fireworks display. This temporary safety zone.... This rule is intended to restrict all vessels from a portion of Long Island Sound before, during, and...

  18. 78 FR 35596 - Special Local Regulation; Long Beach Regatta, Powerboat Race, Atlantic Ocean, Long Beach, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-06-13

    ... Race, Atlantic Ocean, Long Beach, NY AGENCY: Coast Guard, DHS. ACTION: Notice of Proposed Rulemaking... Atlantic Ocean off Long Beach, NY during the Long Beach Regatta Powerboat Race scheduled for August 24-25, 2013. This action is necessary to provide for the safety of life of participants and spectators...

  19. 78 FR 25008 - Safety Zone; Fairfield Estates Fireworks Display, Atlantic Ocean, Sagaponack, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-29

    ..., Atlantic Ocean, Sagaponack, NY AGENCY: Coast Guard, DHS. ACTION: Notice of Proposed Rulemaking. SUMMARY... Ocean, in Sagaponack, NY for the Fairfield Estates fireworks display. This action is necessary to provide for the safety of life on navigable waters during the event. Entering into, transiting...

  20. Alignment between the Science Curriculum and Assessment in Selected NY State Regents Exams

    ERIC Educational Resources Information Center

    Liu, Xiufeng; Fulmer, Gavin

    2008-01-01

    This article reports on an analysis of alignment between NY state core curricula and NY Regents tests in physics and chemistry. Both the curriculum and test were represented by a two dimensional table consisting of topics and cognitive demands. The cell values of the table were numbers of major understandings in the curriculum and points of test…

  1. 33 CFR 207.580 - Buffalo Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 3 2014-07-01 2014-07-01 false Buffalo Harbor, N.Y.; use, administration, and navigation. 207.580 Section 207.580 Navigation and Navigable Waters CORPS OF ENGINEERS, DEPARTMENT OF THE ARMY, DEPARTMENT OF DEFENSE NAVIGATION REGULATIONS § 207.580 Buffalo Harbor, N.Y.;...

  2. 33 CFR 207.580 - Buffalo Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 3 2012-07-01 2012-07-01 false Buffalo Harbor, N.Y.; use, administration, and navigation. 207.580 Section 207.580 Navigation and Navigable Waters CORPS OF ENGINEERS, DEPARTMENT OF THE ARMY, DEPARTMENT OF DEFENSE NAVIGATION REGULATIONS § 207.580 Buffalo Harbor, N.Y.;...

  3. 33 CFR 207.580 - Buffalo Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 3 2013-07-01 2013-07-01 false Buffalo Harbor, N.Y.; use, administration, and navigation. 207.580 Section 207.580 Navigation and Navigable Waters CORPS OF ENGINEERS, DEPARTMENT OF THE ARMY, DEPARTMENT OF DEFENSE NAVIGATION REGULATIONS § 207.580 Buffalo Harbor, N.Y.;...

  4. 33 CFR 165.170 - Safety Zone: Triathlon, Ulster Landing, Hudson River, NY.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 2 2010-07-01 2010-07-01 false Safety Zone: Triathlon, Ulster Landing, Hudson River, NY. 165.170 Section 165.170 Navigation and Navigable Waters COAST GUARD, DEPARTMENT... § 165.170 Safety Zone: Triathlon, Ulster Landing, Hudson River, NY. (a) Regulated area. The...

  5. 33 CFR 165.166 - Safety Zone: Macy's July 4th Fireworks, East River, NY.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Fireworks, East River, NY. 165.166 Section 165.166 Navigation and Navigable Waters COAST GUARD, DEPARTMENT... § 165.166 Safety Zone: Macy's July 4th Fireworks, East River, NY. (a) Regulated area. The following area...) in length, carrying persons for the purpose of viewing the fireworks, may take position in an...

  6. 33 CFR 165.166 - Safety Zone: Macy's July 4th Fireworks, East River, NY.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... Fireworks, East River, NY. 165.166 Section 165.166 Navigation and Navigable Waters COAST GUARD, DEPARTMENT... § 165.166 Safety Zone: Macy's July 4th Fireworks, East River, NY. (a) Regulated area. The following area...) in length, carrying persons for the purpose of viewing the fireworks, may take position in an...

  7. 33 CFR 165.166 - Safety Zone: Macy's July 4th Fireworks, East River, NY.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... Fireworks, East River, NY. 165.166 Section 165.166 Navigation and Navigable Waters COAST GUARD, DEPARTMENT... § 165.166 Safety Zone: Macy's July 4th Fireworks, East River, NY. (a) Regulated area. The following area...) in length, carrying persons for the purpose of viewing the fireworks, may take position in an...

  8. 33 CFR 165.166 - Safety Zone: Macy's July 4th Fireworks, East River, NY.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Fireworks, East River, NY. 165.166 Section 165.166 Navigation and Navigable Waters COAST GUARD, DEPARTMENT... § 165.166 Safety Zone: Macy's July 4th Fireworks, East River, NY. (a) Regulated area. The following area...) in length, carrying persons for the purpose of viewing the fireworks, may take position in an...

  9. 33 CFR 165.T01-0727 - Regulated Navigation Area; Arthur Kill, NY and NJ.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... Kill, NY and NJ. 165.T01-0727 Section 165.T01-0727 Navigation and Navigable Waters COAST GUARD... § 165.T01-0727 Regulated Navigation Area; Arthur Kill, NY and NJ. (a) Regulated area. The following area..., and Gulfport Reach in the Arthur Kill; bounded in the northeast by a line drawn from position 40°...

  10. 33 CFR 165.T01-0727 - Regulated Navigation Area; Arthur Kill, NY and NJ.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Kill, NY and NJ. 165.T01-0727 Section 165.T01-0727 Navigation and Navigable Waters COAST GUARD... § 165.T01-0727 Regulated Navigation Area; Arthur Kill, NY and NJ. (a) Regulated area. The following area..., and Gulfport Reach in the Arthur Kill; bounded in the northeast by a line drawn from position 40°...

  11. 33 CFR 207.600 - Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 3 2012-07-01 2012-07-01 false Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation. 207.600 Section 207.600 Navigation and Navigable Waters CORPS OF... (Charlotte) Harbor, N.Y.; use, administration, and navigation. (a)-(b) (c) No vessel shall moor or anchor...

  12. 33 CFR 207.600 - Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 3 2014-07-01 2014-07-01 false Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation. 207.600 Section 207.600 Navigation and Navigable Waters CORPS OF... (Charlotte) Harbor, N.Y.; use, administration, and navigation. (a)-(b) (c) No vessel shall moor or anchor...

  13. 33 CFR 207.600 - Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 3 2013-07-01 2013-07-01 false Rochester (Charlotte) Harbor, N.Y.; use, administration, and navigation. 207.600 Section 207.600 Navigation and Navigable Waters CORPS OF... (Charlotte) Harbor, N.Y.; use, administration, and navigation. (a)-(b) (c) No vessel shall moor or anchor...

  14. Alignment between the Science Curriculum and Assessment in Selected NY State Regents Exams

    ERIC Educational Resources Information Center

    Liu, Xiufeng; Fulmer, Gavin

    2008-01-01

    This article reports on an analysis of alignment between NY state core curricula and NY Regents tests in physics and chemistry. Both the curriculum and test were represented by a two dimensional table consisting of topics and cognitive demands. The cell values of the table were numbers of major understandings in the curriculum and points of test…

  15. Cancer/testis antigen NY-SAR-35 enhances cell proliferation, migration, and invasion.

    PubMed

    Song, Myung-Ha; Kim, Ye-Rin; Lee, Jun-Won; Lee, Chang-Hun; Lee, Sang-Yull

    2016-02-01

    The cancer/testis antigen NY-SAR-35 is aberrantly expressed in various cancer tissues and cancer cell lines but not in normal tissues except for the testis. A previous study demonstrated that the expression of NY-SAR-35 is activated by hypomethylation in cancer cells. However, the functions of this antigen remain unexplored. In the present study, we investigated the role of NY-SAR‑35 in human embryonic kidney (HEK) 293 cells using exogenous expression system of the gene. NY-SAR‑35 was predominantly expressed at the cytoplasm and was mainly observed in spermatogonia and spermatocytes. Expression of NY-SAR-35 in stable HEK293 transfectant clones was 2-fold higher than the control cells promoting cell growth and proliferation. NY-SAR-35 overexpression also enhanced cell migration and invasion ~2-fold and 4-fold more than the control, respectively. In contrast, small interfering RNA-mediated knockdown of NY-SAR-35 suppressed cell proliferation, migration, and invasion in HEK293 stable transfectants. We concluded that NY-SAR-35 as a cancer/testis antigen enhanced cell proliferation and invasion.

  16. 33 CFR 110.8 - Lake Champlain, N.Y. and Vt.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 1 2014-07-01 2014-07-01 false Lake Champlain, N.Y. and Vt. 110... ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.8 Lake Champlain, N.Y. and Vt. (a) Ticonderoga...) Shelburne, Vt. An area shoreward of a line bearing 142° from the eastern point of Collymer Pt. to Allen...

  17. 33 CFR 110.8 - Lake Champlain, N.Y. and Vt.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 1 2012-07-01 2012-07-01 false Lake Champlain, N.Y. and Vt. 110... ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.8 Lake Champlain, N.Y. and Vt. (a) Ticonderoga...) Shelburne, Vt. An area shoreward of a line bearing 142° from the eastern point of Collymer Pt. to Allen...

  18. 33 CFR 110.8 - Lake Champlain, N.Y. and Vt.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Lake Champlain, N.Y. and Vt. 110... ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.8 Lake Champlain, N.Y. and Vt. (a) Ticonderoga...) Shelburne, Vt. An area shoreward of a line bearing 142° from the eastern point of Collymer Pt. to Allen...

  19. 33 CFR 110.8 - Lake Champlain, N.Y. and Vt.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 1 2013-07-01 2013-07-01 false Lake Champlain, N.Y. and Vt. 110... ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.8 Lake Champlain, N.Y. and Vt. (a) Ticonderoga...) Shelburne, Vt. An area shoreward of a line bearing 142° from the eastern point of Collymer Pt. to Allen...

  20. 33 CFR 110.8 - Lake Champlain, N.Y. and Vt.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Lake Champlain, N.Y. and Vt. 110... ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.8 Lake Champlain, N.Y. and Vt. (a) Ticonderoga...) Shelburne, Vt. An area shoreward of a line bearing 142° from the eastern point of Collymer Pt. to Allen...

  1. 78 FR 7394 - Foreign-Trade Zone 121-Albany, NY; Authorization of Production Activity; Albany Molecular...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-01

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Foreign-Trade Zone 121--Albany, NY; Authorization of Production Activity; Albany Molecular Research, Inc.; Subzone 121A (Pharmaceutical Chemicals Production); Rensselaer, NY On September 26...

  2. 75 FR 19644 - West Oaks Energy NY/NE, LP; Supplemental Notice That Initial Market-Based Rate Filing Includes...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-15

    ...] West Oaks Energy NY/NE, LP; Supplemental Notice That Initial Market-Based Rate Filing Includes Request...-referenced proceeding of West Oaks Energy NY/NE LP's application for market-based rate authority, with an...

  3. NY-ESO-1 antibody as a novel tumour marker of gastric cancer

    PubMed Central

    Fujiwara, S; Wada, H; Kawada, J; Kawabata, R; Takahashi, T; Fujita, J; Hirao, T; Shibata, K; Makari, Y; Iijima, S; Nishikawa, H; Jungbluth, A A; Nakamura, Y; Kurokawa, Y; Yamasaki, M; Miyata, H; Nakajima, K; Takiguchi, S; Nakayama, E; Mori, M; Doki, Y

    2013-01-01

    Background: NY-ESO-1 antibodies are specifically observed in patients with NY-ESO-1-expressing tumours. We analysed whether the NY-ESO-1 humoral immune response is a useful tumour marker of gastric cancer. Methods: Sera from 363 gastric cancer patients were screened by enzyme-linked immunosorbent assay (ELISA) to detect NY-ESO-1 antibodies. Serial serum samples were obtained from 25 NY-ESO-1 antibody-positive patients, including 16 patients with curative resection and 9 patients who received chemotherapy alone. Results: NY-ESO-1 antibodies were detected in 3.4% of stage I, 4.4% of stage II, 25.3% of stage III, and 20.0% of stage IV patients. The frequency of antibody positivity increased with disease progression. When the NY-ESO-1 antibody was used in combination with carcinoembryonic antigen and CA19-9 to detect gastric cancer, information gains of 11.2% in stages III and IV, and 5.8% in all patients were observed. The NY-ESO-1 immune response levels of the patients without recurrence fell below the cutoff level after surgery. Two of the patients with recurrence displayed incomplete decreases. The nine patients who received chemotherapy alone continued to display NY-ESO-1 immune responses. Conclusion: When combined with conventional tumour markers, the NY-ESO-1 humoral immune response could be a useful tumour marker for detecting advanced gastric cancer and inferring the post-treatment tumour load in seropositive patients. PMID:23403818

  4. NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer.

    PubMed

    Grupp, Katharina; Ospina-Klinck, Daniel; Tsourlakis, Maria Christina; Koop, Christina; Wilczak, Waldemar; Adam, Meike; Simon, Ronald; Sauter, Guido; Izbicki, Jakob Robert; Graefen, Markus; Huland, Hartwig; Steurer, Stefan; Schlomm, Thorsten; Minner, Sarah; Quaas, Alexander

    2014-07-01

    NY-ESO-1 has been suggested as therapeutic cancer vaccine in prostate cancer. This study was undertaken to explore the relationship of NY-ESO-1 with tumor phenotype, biochemical recurrence, and molecular subgroups in hormone-naive prostate cancers. NY-ESO-1 immunohistochemistry was analyzed on a tissue microarray containing 11,152 prostate cancer samples. Results were compared to clinically follow-up data, ERG status, and deletions on PTEN, 3p13, 5q21, and 6q15. NY-ESO-1 expression was absent in benign prostate glands. In prostate cancer, NY-ESO-1 positivity was found 8.8% of our 8,761 interpretable tumors including 5.8% with weak, 2.5% with moderate, and 0.5% with strong expression. There was a threefold higher rate of NY-ESO-1 expression in ERG fusion positive tumors than in ERG negative cancers (P < 0.0001). There was a significant association with early PSA recurrence, which was largely limited to ERG positive cancers. Within the ERG positive subgroup, high NY-ESO-1 expression was associated with early biochemical recurrence (P = 0.0002) and high Gleason grade (P < 0.0001). In ERG negative cancers, NY-ESO-1 expression was also linked to PTEN (P = 0.0012) and 6q15 deletions (P = 0.0005). Our observations indicate a tight link of NY-ESO-1 expression to ERG activation and (to a lesser extent) PTEN- and 6q15-deletions in prostate cancer. The impact of these interactions on the likelihood of response to immunotherapy is unclear. The prognostic impact of NY-ESO-1 expression is little and not independent of histologic variables. © 2014 Wiley Periodicals, Inc.

  5. EnviroAtlas - New York, NY - Block Groups

    EPA Pesticide Factsheets

    This EnviroAtlas dataset is the base layer for the New York, NY EnviroAtlas community. The block groups are from the US Census Bureau and are included/excluded based on EnviroAtlas criteria described in the procedure log. This dataset was produced by the US EPA to support research and online mapping activities related to EnviroAtlas. EnviroAtlas (https://www.epa.gov/enviroatlas) allows the user to interact with a web-based, easy-to-use, mapping application to view and analyze multiple ecosystem services for the contiguous United States. The dataset is available as downloadable data (https://edg.epa.gov/data/Public/ORD/EnviroAtlas) or as an EnviroAtlas map service. Additional descriptive information about each attribute in this dataset can be found in its associated EnviroAtlas Fact Sheet (https://www.epa.gov/enviroatlas/enviroatlas-fact-sheets).

  6. EnviroAtlas - New York, NY - Atlas Area Boundary

    EPA Pesticide Factsheets

    This EnviroAtlas dataset shows the boundary of the New York, NY EnviroAtlas Community. It represents the outside edge of all the block groups included in the EnviroAtlas community. This dataset was produced by the US EPA to support research and online mapping activities related to EnviroAtlas. EnviroAtlas (https://www.epa.gov/enviroatlas) allows the user to interact with a web-based, easy-to-use, mapping application to view and analyze multiple ecosystem services for the contiguous United States. The dataset is available as downloadable data (https://edg.epa.gov/data/Public/ORD/EnviroAtlas) or as an EnviroAtlas map service. Additional descriptive information about each attribute in this dataset can be found in its associated EnviroAtlas Fact Sheet (https://www.epa.gov/enviroatlas/enviroatlas-fact-sheets)

  7. Spectroscopy and Photometry of the Earth Grazer 2002 NY40

    NASA Technical Reports Server (NTRS)

    Rivkin, A. S.; Howell, E. S.; Bus, S. J.; Hicks, M.; Reach, W. T.; Jarrett, T. H.; Binzel, R. P.

    2003-01-01

    The near-Earth asteroid 2002 NY40 was discovered on July 14, 2002 by the LINEAR survey. The object was predicted to make a close pass by the Earth on August 18, which led to observations at a large range of wavelengths, including radar. The combination of visible and near-infrared spectroscopy/spectrophotometry gives some indication of the composition. Thermal emission in the 3-4m spectral region gives constraints on the albedo, which is consistent with the spectral type and with the available size from the radar measurements. The lightcurve was well measured by a large number of observers, which helps to determine the rotation phase of the observations at the various wavelengths. The favorable observing conditions and rapid dissemination of the astrometry have led to a good physical characterization of this object which is relatively rare for a newly discovered near-Earth asteroid.

  8. Spectroscopy and Photometry of the Earth Grazer 2002 NY40

    NASA Technical Reports Server (NTRS)

    Rivkin, A. S.; Howell, E. S.; Bus, S. J.; Hicks, M.; Reach, W. T.; Jarrett, T. H.; Binzel, R. P.

    2003-01-01

    The near Earth asteroid 2002 NY40 was discovered on July 14, 2002 by the LINEAR survey. The object was predicted to make a close pass by the Earth on August 18, which led to observations at a large range of wavelengths, including radar. The combination of visible and near infrared spectroscopy/spectrophotometry gives some indication of the composition. Thermal emission in the 3 micron spectral region gives constraints on the albedo, which is consistent with the spectral type and with the available size from the radar measurements. The lightcurve was well measured by a large number of observers, which helps to determine the rotation phase of the observations at the various wavelengths. The favorable observing conditions and rapid dissemination of the astrometry have led to a good physical characterization of this object, which is relatively rare for a newly discovered near Earth asteroid. The data sets reported in this abstract are shown.

  9. 33 CFR 165.159 - Safety Zone: New York Air Show at Jones Beach State Park, Wantagh, NY.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... Jones Beach State Park, Wantagh, NY. 165.159 Section 165.159 Navigation and Navigable Waters COAST GUARD... § 165.159 Safety Zone: New York Air Show at Jones Beach State Park, Wantagh, NY. (a) Location. The following waters of the Atlantic Ocean off of Jones Beach State Park, Wantagh, NY are designated a safety...

  10. 33 CFR 207.590 - Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Buffalo, N.Y.; use, administration, and navigation. 207.590 Section 207.590 Navigation and Navigable... Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation. (a) The term “canal... immediately to the Black Rock Lock, foot of Bridge Street, Buffalo, N.Y., telephone 876-5454. (k) Ferry...

  11. 33 CFR 207.590 - Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... Buffalo, N.Y.; use, administration, and navigation. 207.590 Section 207.590 Navigation and Navigable... Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation. (a) The term “canal... immediately to the Black Rock Lock, foot of Bridge Street, Buffalo, N.Y., telephone 876-5454. (k) Ferry...

  12. 33 CFR 207.590 - Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Buffalo, N.Y.; use, administration, and navigation. 207.590 Section 207.590 Navigation and Navigable... Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation. (a) The term “canal... immediately to the Black Rock Lock, foot of Bridge Street, Buffalo, N.Y., telephone 876-5454. (k) Ferry...

  13. 33 CFR 207.590 - Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... Buffalo, N.Y.; use, administration, and navigation. 207.590 Section 207.590 Navigation and Navigable... Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation. (a) The term “canal... immediately to the Black Rock Lock, foot of Bridge Street, Buffalo, N.Y., telephone 876-5454. (k) Ferry...

  14. 33 CFR 207.590 - Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... Buffalo, N.Y.; use, administration, and navigation. 207.590 Section 207.590 Navigation and Navigable... Black Rock Canal and Lock at Buffalo, N.Y.; use, administration, and navigation. (a) The term “canal... immediately to the Black Rock Lock, foot of Bridge Street, Buffalo, N.Y., telephone 876-5454. (k) Ferry...

  15. 75 FR 3249 - Wyeth Pharmaceuticals, a Subsidiary of Wyeth, Currently Known as Pfizer, Rouses Point, NY; Wyeth...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-01-20

    ... Employment and Training Administration Wyeth Pharmaceuticals, a Subsidiary of Wyeth, Currently Known as Pfizer, Rouses Point, NY; Wyeth Pharmaceuticals, a Subsidiary of Wyeth, Currently Known as Pfizer, Chazy, NY; Wyeth Pharmaceuticals, a Subsidiary of Wyeth, Currently Known as Pfizer, Plattsburgh, NY; Amended...

  16. NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer.

    PubMed

    Szender, J Brian; Papanicolau-Sengos, Antonios; Eng, Kevin H; Miliotto, Anthony J; Lugade, Amit A; Gnjatic, Sacha; Matsuzaki, Junko; Morrison, Carl D; Odunsi, Kunle

    2017-06-01

    NY-ESO-1 is a cancer testis antigen and a promising target for immunotherapy. The purpose of this study was to determine the expression frequency, immunogenicity, and clinical impact of NY-ESO-1 in ovarian cancer. Immunohistochemistry (IHC), reverse-transcription polymerase chain reaction (RT-PCR), and quantitative-PCR (qRT-PCR) were utilized in an ovarian cancer (including Fallopian tube and primary peritoneal cancers) patient cohort; humoral responses against NY-ESO-1 were determined by ELISA. Clinicopathologic outcomes including progression-free (PFS) and overall (OS) survival were evaluated based on NY-ESO-1 expression. Cohen's kappa (κ) tested agreement between expression tests. NY-ESO-1 expression was detected by any method in 40.7% of 1002 patients' tumors (NY-ESO-1+) and baseline humoral response was identified in 19.0% of 689 tested patients. NY-ESO-1+ patients were older (p<0.001), higher stage (85% stage III/IV vs. 76.4%, p=0.015), less likely to have a complete response to initial therapy (53.9% vs. 68.9%, p=0.002), had more serous histotype (74.5% vs. 66.9%, p=0.011), and had more grade 3 tumors (83.7% vs. 70.8%, p<0.001). There was a trend towards shorter PFS (22.2 vs. 25.0months, p=0.07) and significantly shorter OS (42.9 vs. 50.0months, p=0.003) among NY-ESO-1+ patients. A subset analysis of NY-ESO-1+ patients that received immunotherapy demonstrated improved OS by >2years (52.6 vs. 27.2months, p<0.001). This study is the first demonstration of an association between NY-ESO-1 expression and an aggressive cancer phenotype. The relatively high expression frequency of NY-ESO-1 in ovarian cancer patients coupled with the poor clinical outcomes in NY-ESO-1+ patients reveals an underappreciated need for targeted therapy against this antigen. In support, our study reveals that NY-ESO-1+ patients enrolled on immunotherapy trials targeting the antigen exhibited an improvement in OS. Copyright © 2017 Elsevier Inc. All rights reserved.

  17. T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma.

    PubMed

    Singh, Nathan; Kulikovskaya, Irina; Barrett, David M; Binder-Scholl, Gwendolyn; Jakobsen, Bent; Martinez, Daniel; Pawel, Bruce; June, Carl H; Kalos, Michael D; Grupp, Stephan A

    The cancer-testis antigen NY-ESO-1 is expressed by many solid tumors and has limited expression by mature somatic tissues, making it a highly attractive target for tumor immunotherapy. Targeting NY-ESO-1 using engineered T cells has demonstrated clinical efficacy in the treatment of some adult tumors. Neuroblastoma is a significant cause of cancer mortality in children, and is a tumor type shown to be responsive to immunotherapies. We evaluated a large panel of primarily resected neuroblastoma samples and demonstrated that 23% express NY-ESO-1. After confirming antigen-specific activity of T cells genetically engineered to express an NY-ESO-1 directed high-affinity transgenic T cell receptor in vitro, we performed xenograft mouse studies assessing the efficacy of NY-ESO-1-targeted T cells in both localized and disseminated models of neuroblastoma. Disease responses were monitored by tumor volume measurement and in vivo bioluminescence. After delivery of NY-ESO-1 transgenic TCR T cells, we observed significant delay of tumor progression in mice bearing localized and disseminated neuroblastoma, as well as enhanced animal survival. These data demonstrate that NY-ESO-1 is an antigen target in neuroblastoma and that targeted T cells represent a potential therapeutic option for patients with neuroblastoma.

  18. NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma.

    PubMed

    Giesen, Eva; Jilaveanu, Lucia B; Parisi, Fabio; Kluger, Yuval; Camp, Robert L; Kluger, Harriet M

    2014-07-30

    Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this disease. We employed tissue microarrays containing >300 unique RCC cases and adjacent benign renal tissue to determine NY-ESO-1 expression using a quantitative immunofluorescence method. In addition, we studied NY-ESO-1 expression in 35 matched primary and metastatic RCC specimens to assess concordance between different tumor sites. NY-ESO-1 was highly expressed in a subset of RCCs. Expression in primary RCC specimens was significantly higher than adjacent normal renal tissue (P<0.0001) and higher in clear cell carcinomas than papillary RCC (P<0.0001). Expression levels in metastatic specimens were higher than in matched primary samples (P=0.0018), and the correlation between the two sites was modest (χ2=3.5, p=0.06). Aberrant NY-ESO-1 expression seen in clear cell RCC suggests that NY-ESO-1 targeting approaches should be studied in this disease. Expression is higher in metastatic sites, and discordance between primary and metastatic sites in some patients suggests that patient selection for these therapies should be based on expression in metastatic rather than nephrectomy specimens.

  19. NY-ESO-1 as a potential immunotherapeutic target in renal cell carcinoma

    PubMed Central

    Parisi, Fabio; Kluger, Yuval; Camp, Robert L.; Kluger, Harriet M.

    2014-01-01

    Background: Novel immune therapies targeting tumor specific antigens are being developed. Our purpose was to determine expression of the cancer testes antigen NY-ESO-1 in renal cell carcinoma (RCC), as NY-ESO-1 targeting approaches, particularly adoptive cell therapy, have not been evaluated in this disease. Methods: We employed tissue microarrays containing >300 unique RCC cases and adjacent benign renal tissue to determine NY-ESO-1 expression using a quantitative immunofluorescence method. In addition, we studied NY-ESO-1 expression in 35 matched primary and metastatic RCC specimens to assess concordance between different tumor sites. Results: NY-ESO-1 was highly expressed in a subset of RCCs. Expression in primary RCC specimens was significantly higher than adjacent normal renal tissue (P<0.0001) and higher in clear cell carcinomas than papillary RCC (P<0.0001). Expression levels in metastatic specimens were higher than in matched primary samples (P=0.0018), and the correlation between the two sites was modest (χ2=3.5, p=0.06). Conclusions: Aberrant NY-ESO-1 expression seen in clear cell RCC suggests that NY-ESO-1 targeting approaches should be studied in this disease. Expression is higher in metastatic sites, and discordance between primary and metastatic sites in some patients suggests that patient selection for these therapies should be based on expression in metastatic rather than nephrectomy specimens. PMID:24970819

  20. T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma

    PubMed Central

    Singh, Nathan; Kulikovskaya, Irina; Barrett, David M.; Binder-Scholl, Gwendolyn; Jakobsen, Bent; Martinez, Daniel; Pawel, Bruce; June, Carl H.; Kalos, Michael D.; Grupp, Stephan A.

    2016-01-01

    abstract The cancer-testis antigen NY-ESO-1 is expressed by many solid tumors and has limited expression by mature somatic tissues, making it a highly attractive target for tumor immunotherapy. Targeting NY-ESO-1 using engineered T cells has demonstrated clinical efficacy in the treatment of some adult tumors. Neuroblastoma is a significant cause of cancer mortality in children, and is a tumor type shown to be responsive to immunotherapies. We evaluated a large panel of primarily resected neuroblastoma samples and demonstrated that 23% express NY-ESO-1. After confirming antigen-specific activity of T cells genetically engineered to express an NY-ESO-1 directed high-affinity transgenic T cell receptor in vitro, we performed xenograft mouse studies assessing the efficacy of NY-ESO-1-targeted T cells in both localized and disseminated models of neuroblastoma. Disease responses were monitored by tumor volume measurement and in vivo bioluminescence. After delivery of NY-ESO-1 transgenic TCR T cells, we observed significant delay of tumor progression in mice bearing localized and disseminated neuroblastoma, as well as enhanced animal survival. These data demonstrate that NY-ESO-1 is an antigen target in neuroblastoma and that targeted T cells represent a potential therapeutic option for patients with neuroblastoma. PMID:26942053

  1. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.

    PubMed

    Park, Tristen S; Groh, Eric M; Patel, Krishna; Kerkar, Sid P; Lee, Chyi-Chia Richard; Rosenberg, Steven A

    2016-01-01

    Melanoma-associated antigen-A (MAGE-A) and New York esophageal squamous cell cancer-1 (NY-ESO-1) are 2 cancer testis antigens (CTA) demonstrating potential for use in targeted immunotherapy. Clinical trials in melanoma and synovial sarcomas targeting these antigens in immune-based therapies have demonstrated durable tumor regression. Although protein expression of NY-ESO-1 has been assessed in a variety of cancer types, the expression of MAGE-A has not been studied in depth. In this study we analyzed MAGE-A and NY-ESO-1 expression in 314 melanoma specimens from 301 melanoma patients, 38 patients with squamous cell cancers and 111 patients with adenocarcinomas. Our results demonstrated higher expression of MAGE-A compared with NY-ESO-1 in melanomas (32% vs. 13%) and squamous cell carcinomas (45% vs. 7.9%), and higher expression of both CTAs in metastatic versus primary tumors. CTA expression in adenocarcinomas was low (MAGE-A: 10%, NY-ESO-1: 0.9%). In addition, we looked at concordance of expression among metastatic melanoma lesions within the same patient and found concordant expression in 38 of 47 patients for MAGE-A and 43 of 47 patients for NY-ESO-1. Our study demonstrated that the MAGE-A family may be of greater utility than NY-ESO-1 for targeted immunotherapy in a variety of cancer histologies, in particular metastatic melanomas and squamous cell carcinomas.

  2. A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy

    PubMed Central

    Gupta, Anurag; Nuber, Natko; Esslinger, Christoph; Wittenbrink, Mareike; Treder, Martin; Landshammer, Alexandro; Noguchi, Takuro; Kelly, Marcus; Gnjatic, Sacha; Ritter, Erika; von Boehmer, Lotta; Nishikawa, Hiroyoshi; Shiku, Hiroshi; Old, Lloyd; Ritter, Gerd; Knuth, Alexander; van den Broek, Maries

    2013-01-01

    We investigated whether antibodies against intracellular tumor-associated antigens support tumor-specific immunity when administered together with a treatment that destroys the tumor. We propose that released antigens form immune complexes with the antibodies, which are then efficiently taken up by dendritic cells. We cloned the first human monoclonal antibodies against the Cancer/Testis (CT) antigen, NY-ESO-1. We tested whether the monoclonal anti-NY-ESO-1 antibody (12D7) facilitates cross-presentation of a NY-ESO-1-derived epitope by dendritic cells to human CD8+ T cells, and whether this results in the maturation of dendritic cells in vitro. We investigated the efficacy of 12D7 in combination with chemotherapy using BALB/c mice bearing syngeneic CT26 tumors that express intracellular NY-ESO-1. Human dendritic cells that were incubated with NY-ESO-1:12D7 immune complexes efficiently stimulated NY-ESO-1157–165/HLA-A2-specific human CD8+ T cells to produce interferon-γ, whereas NY-ESO-1 alone did not. Furthermore, the incubation of dendritic cells with NY-ESO-1:12D7 immune complexes resulted in the maturation of dendritic cells. Treatment of BALB/c mice that bear CT26/NY-ESO-1 tumors with 5-fluorouracil (5-FU) plus 12D7 was significantly more effective than chemotherapy alone. We propose systemic injection of monoclonal antibodies (mAbs) against tumor-associated antigens plus a treatment that promotes the local release of those antigens resulting in immune complex formation as a novel therapeutic modality for cancer. PMID:23390374

  3. A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy.

    PubMed

    Gupta, Anurag; Nuber, Natko; Esslinger, Christoph; Wittenbrink, Mareike; Treder, Martin; Landshammer, Alexandro; Noguchi, Takuro; Kelly, Marcus; Gnjatic, Sacha; Ritter, Erika; von Boehmer, Lotta; Nishikawa, Hiroyoshi; Shiku, Hiroshi; Old, Lloyd; Ritter, Gerd; Knuth, Alexander; van den Broek, Maries

    2013-01-01

    We investigated whether antibodies against intracellular tumor-associated antigens support tumor-specific immunity when administered together with a treatment that destroys the tumor. We propose that released antigens form immune complexes with the antibodies, which are then efficiently taken up by dendritic cells. We cloned the first human monoclonal antibodies against the Cancer/Testis (CT) antigen, NY-ESO-1. We tested whether the monoclonal anti-NY-ESO-1 antibody (12D7) facilitates cross-presentation of a NY-ESO-1-derived epitope by dendritic cells to human CD8+ T cells, and whether this results in the maturation of dendritic cells in vitro. We investigated the efficacy of 12D7 in combination with chemotherapy using BALB/c mice bearing syngeneic CT26 tumors that express intracellular NY-ESO-1. Human dendritic cells that were incubated with NY-ESO-1:12D7 immune complexes efficiently stimulated NY-ESO-1(157-165)/HLA-A2-specific human CD8+ T cells to produce interferon-γ, whereas NY-ESO-1 alone did not. Furthermore, the incubation of dendritic cells with NY-ESO-1:12D7 immune complexes resulted in the maturation of dendritic cells. Treatment of BALB/c mice that bear CT26/NY-ESO-1 tumors with 5-fluorouracil (5-FU) plus 12D7 was significantly more effective than chemotherapy alone. We propose systemic injection of monoclonal antibodies (mAbs) against tumor-associated antigens plus a treatment that promotes the local release of those antigens resulting in immune complex formation as a novel therapeutic modality for cancer.

  4. Horizontal and Vertical Transmission of West Nile Virus Genotype NY99 by Culex salinarius and Genotypes NY99 and WN02 by Culex tarsalis

    PubMed Central

    Anderson, John F.; Main, Andy J.; Cheng, Gong; Ferrandino, Francis J.; Fikrig, Erol

    2012-01-01

    Culex tarsalis is a superior horizontal and vertical vector of West Nile virus (WNV) compared with Culex salinarius. Culex salinarius transmitted WNV genotype NY99 (CT 2741-99 strain) horizontally to suckling mice at significantly lower rates than Cx. tarsalis on Days 8, 9, 10, and 12 post-infection, and Cx. salinarius transmitted WNV genotype NY99 to offspring at a lower vertical transmission infection rate than Cx. tarsalis. Culex tarsalis transmitted WNV genotypes NY99 and WN02 (CT S0084-08 strain) with equal efficiency. Daily percent horizontal transmission of genotype NY99 by Cx. tarsalis-infected per os and by intra-thoracic infection was not significantly different from daily transmission of genotype WN02 from Days 5–23 and Days 2–9 post-infection, respectively. Our findings do not support the previously published hypothesis that genotype NY99 was replaced in the New World by WN02 because of a shorter extrinsic incubation of WN02. PMID:22232464

  5. Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer

    PubMed Central

    Kashiwagi, Shinichiro; Goto, Wataru; Takada, Koji; Takahashi, Katsuyuki; Noda, Satoru; Takashima, Tsutomu; Onoda, Naoyoshi; Tomita, Shuhei; Ohsawa, Masahiko; Hirakawa, Kosei

    2017-01-01

    Background Eribulin mesylate (eribulin) is currently indicated for treatment of locally advanced or metastatic breast cancer (MBC). It is a cytotoxic agent with unique mechanisms that suppress epithelial-mesenchymal transition (EMT) of cancer cells. On the other hand, Tumor-infiltrating lymphocytes (TILs), which are considered indicators of immune response monitoring, have been reported as prognostic factors and predictors of therapeutic efficacy. We thought that eribulin, which has an EMT-inhibiting mechanism, may produce an antitumor effect by improving the immune microenvironment, and in this study investigated the effects of breast cancer eribulin chemotherapy on the immune microenvironment with TILs as a marker. Methods TILs was evaluated in 52 patients with MBC who underwent chemotherapy with eribulin. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of eribulin chemotherapy, was investigated retrospectively. Results Of the 52 MBC patients, 29 (55.8%) were in the high TILs group and 23 (44.2%) were in the low TILs group. The high TILs group included significantly more triple-negative breast cancer (TNBC) (p = 0.008) than the low TILs group. In an analysis of outcomes, TNBC patients in the high TILs group had significantly longer disease-free survival than TNBC patients in the low TILs group (p = 0.033, log-rank), but no significant differences were seen in all breast cancer patients (p = 0.489, log-rank) or in non-TNBC patients (p = 0.878, log-rank). In a multivariate analysis of recurrence in TNBC patients, being in the high TILs group was again an independent factor for a good outcome (p = 0.031, HR = 0.063). Conclusion The results of this study suggest that TILs may be useful as a predictive marker of the therapeutic effect of eribulin chemotherapy in TNBC. PMID:28166544

  6. Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells

    PubMed Central

    Song, Myung-Ha; Kim, Ye-Rin; Bae, Jae-Ho; Lee, Chang-Hun; Lee, Sang-Yull

    2017-01-01

    NY-SAR-35 is a cancer/testis (CT) antigen that was identified by serological analysis of recombinant complementary DNA expression libraries. The gene encoding NY-SAR-35 is located on the × chromosome and is aberrantly expressed in a number of cancer types and germ cells, such as those in the testes, but not in normal tissue. It has been reported that treatment with a demethylating agent induced the expression of NY-SAR-35 in several types of cancer cells. However, the function of NY-SAR-35 in cancer remains undetermined. In present study, the role of NY-SAR-35 in human lung adenocarcinoma (SK-LC-14) and hepatocellular carcinoma (SNU-449) cells was investigated following stable transfection of the NY-SAR-35 gene. NY-SAR-35 was observed to be expressed in the cytoplasm of the cells. In addition, the bromodeoxyuridine incorporation assay and immunofluorescence staining for proliferating cell nuclear antigen and Ki-67 demonstrated that proliferation was increased in cells transfected with NY-SAR-35. In addition, the trypan blue exclusion assay indicated that NY-SAR-35 increased cancer cell viability. Furthermore, NY-SAR-35 increased the migration and invasion of the cells. These results indicate that NY-SAR-35 increases cancer cell viability, proliferation, migration and invasion. PMID:28356959

  7. Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells.

    PubMed

    Song, Myung-Ha; Kim, Ye-Rin; Bae, Jae-Ho; Lee, Chang-Hun; Lee, Sang-Yull

    2017-02-01

    NY-SAR-35 is a cancer/testis (CT) antigen that was identified by serological analysis of recombinant complementary DNA expression libraries. The gene encoding NY-SAR-35 is located on the × chromosome and is aberrantly expressed in a number of cancer types and germ cells, such as those in the testes, but not in normal tissue. It has been reported that treatment with a demethylating agent induced the expression of NY-SAR-35 in several types of cancer cells. However, the function of NY-SAR-35 in cancer remains undetermined. In present study, the role of NY-SAR-35 in human lung adenocarcinoma (SK-LC-14) and hepatocellular carcinoma (SNU-449) cells was investigated following stable transfection of the NY-SAR-35 gene. NY-SAR-35 was observed to be expressed in the cytoplasm of the cells. In addition, the bromodeoxyuridine incorporation assay and immunofluorescence staining for proliferating cell nuclear antigen and Ki-67 demonstrated that proliferation was increased in cells transfected with NY-SAR-35. In addition, the trypan blue exclusion assay indicated that NY-SAR-35 increased cancer cell viability. Furthermore, NY-SAR-35 increased the migration and invasion of the cells. These results indicate that NY-SAR-35 increases cancer cell viability, proliferation, migration and invasion.

  8. NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery.

    PubMed

    Xu, Heng; Gu, Na; Liu, Zhao-Bo; Zheng, Min; Xiong, Fang; Wang, Si-Ying; Li, Ning; Lu, Jun

    2012-01-01

    NY-ESO-1 belongs to the cancer testis antigens (CTA) family, and is identified in a variety of tumors. Certain studies have demonstrated that NY-ESO-1 predicts tumor recurrence and treatment response. No reports are currently available regarding the correlation between NY-ESO-1 and the recurrence of hepatocellular carcinoma (HCC) following surgery. The purpose of the present study was to evaluate the association between NY-ESO-1 and relapse of HCC and to explore the possible mechanisms for this correlation. A total of 120 HCC patients were analyzed for the expression of NY-ESO-1 by immunohistochemistry (IHC). A stable NY-ESO-1 over-expressed HepG2 cell line (ESO-HepG2) was established to determine the biological effects of NY-ESO-1 on cell proliferation, cell cycle and migration by using the xCELLigence DP system, flow cytometry and xCELLigence SP system. NY-ESO-1 was positive in 28 of 120 (23.3%) HCC tumor tissues. NY-ESO-1 was not detectable in adjacent normal liver tissues. A close correlation was found between NY-ESO-1 expression and the recurrence of HCC following surgery (P=0.007). Kaplan-Meier analysis showed a shorter recurrence-free survival (RFS) for patients positive for NY-ESO-1 (log-rank test, P=0.003). The Cox regression model demonstrated that NY-ESO-1 expression was a significant independent predictor for the recurrence of HCC following curative surgery (P=0.022). Compared with HepG2 cells, ESO-HepG2 cells have increased migration but not proliferation ability. In conclusion, NY-ESO-1 expression is associated with worse HCC outcome following surgery, and the mechanism for this finding may be that NY-ESO-1 increases tumor cell migration.

  9. Ny-Ålesund Observatory: What Has Been Done?

    NASA Astrophysics Data System (ADS)

    Tangen, Leif Morten

    2016-12-01

    The existing 20-m radio telescope in Ny-Ålesund was put into operation in 1994. The telescope is more than 20 years old now and is ready for retirement. We decided to build a VGOS core site with twin telescopes. The existing telescope is just 70 meters away from the airport runway and the CAA did not allow us to build anything new as close. The new site is about 1,500 meters northwest of the old telescope and we had to build a road with a bridge. This was finished in summer 2014 and the construction work at the new site started in October 2014. It is challenging to do construction work during the winter time at 79°N with permafrost. During the winter, the VLBI foundation was built. The station, SLR, and gravity buildings were built as well. This presentation will show what has been done until now and different solutions for the telescopes. The telescopes are scheduled to arrive in April 2016.

  10. Sediment chemistries and chironomid deformities in the Buffalo River (NY)

    SciTech Connect

    Stewart, K.M.; Diggins, T.P.

    1994-12-31

    The authors examined the surficial sediment chemistry (heavy metals) and the frequency of chironomid (Diptera) larvae mouthpart deformities from multiple PONAR grabs samples at each of 20 sites along the Buffalo River (NY) area of concern (AOC). Because of the potential for patchy invertebrate distribution and high variance in sediment chemistry, repeated spatial and temporal sampling is important to obtain a better integrated picture of contamination in rivers. The findings suggest that the Buffalo River has one of the highest percentages of deformed chironomids in AOC`s of the Great Lakes basin. One river site that was traditionally thought to be a chemical hot spot was less contaminated than another downstream section. At another site, sediment concentrations for V., Mn and AS appeared to be strongly associated with the proximity of combined sewer overflows from a region which is primarily residential. Interestingly, a demonstration project of the US Army Corps of Engineers, during which three types of dredges were used to carefully remove upper sediments from two different short reaches along the river, seemed to have no significant impact on proximate sediment chemistries or biota.

  11. 77 FR 46023 - Proposed Foreign-Trade Zone-Chenango County, NY; Under Alternative Site Framework

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-02

    ...-Trade Zone--Chenango County, NY; Under Alternative Site Framework An application has been submitted to... alternative site framework (ASF) adopted by the Board (15 CFR 400.2(c)). The ASF is an option for grantees for...

  12. Alignment Between the Science Curriculum and Assessment in Selected NY State Regents Exams

    NASA Astrophysics Data System (ADS)

    Liu, Xiufeng; Fulmer, Gavin

    2008-08-01

    This article reports on an analysis of alignment between NY state core curricula and NY Regents tests in physics and chemistry. Both the curriculum and test were represented by a two dimensional table consisting of topics and cognitive demands. The cell values of the table were numbers of major understandings in the curriculum and points of test items in the test. The Porter alignment index was computed for each test. It was found that, overall, there was a high alignment between the NY core curriculum and the NY Regents test, and the alignment remained fairly stable from test to test. However, there were considerable discrepancies in emphases on different cognitive levels and topics between the core curriculum and the test. Issues related to the nature of alignment, and the nature and validity of content standards were raised, and implications for science curriculum and instructions were also discussed.

  13. NEW YORK (8TH NY ARTILLERY) MONUMENT, SECTIONS B AND D, ...

    Library of Congress Historic Buildings Survey, Historic Engineering Record, Historic Landscapes Survey

    NEW YORK (8TH NY ARTILLERY) MONUMENT, SECTIONS B AND D, WITH BRICK PERIMETER WALL BEHIND. VIEW TO SOUTH¬WEST. - Cold Harbor National Cemetery, 6038 Cold Harbor Road, Mechanicsville, Hanover County, VA

  14. 75 FR 7044 - Samuel Aaron, Inc., Long Island City, NY; Notice of Negative Determination Regarding Application...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-02-16

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF LABOR Employment and Training Administration Samuel Aaron, Inc., Long Island City, NY; Notice of Negative... requested administrative reconsideration of the Department's negative determination regarding eligibility...

  15. 75 FR 7030 - Dawson Metal Company, Inc., Industrial Division, Jamestown, NY; Notice of Affirmative...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-02-16

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF LABOR Employment and Training Administration Dawson Metal Company, Inc., Industrial Division, Jamestown, NY; Notice... determination based on the finding that imports of precision sheet metal fabrication did not...

  16. 75 FR 15739 - International Business Machines Corporation: Armonk, NY; Notice of Termination of Investigation

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-30

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF LABOR Employment and Training Administration International Business Machines Corporation: Armonk, NY; Notice of... Business Machines Corporation, Armonk, New York. The petitioning group of workers is covered by...

  17. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.

    PubMed

    Ries, Jutta; Mollaoglu, Nur; Vairaktaris, Eleftherios; Neukam, Friedrich W; Nkenke, Emeka

    2009-12-01

    Cancer/testis antigen 1B (NY-ESO-1) is exclusively expressed in various types of tumor but not in healthy normal tissue, except testis, and induces strong cellular and humoral immune responses. Therefore, it represents an ideal target for diagnostic and immunotherapeutic applications. The aim of the study was to investigate the expression of NY-ESO-1 in oral squamous cell carcinoma (OSCC) to determine its impact as a diagnostic parameter or a therapeutic target for oral cancer. A total of 65 OSCC and 20 normal oral mucosal samples of otherwise healthy volunteers were included in this study. Expression of NY-ESO-1 was determined using reverse transcriptase polymerase chain reaction (RT-PCR). The results were correlated to diagnosis and clinicopathological parameters. NY-ESO-1 was expressed in 27.7% of the investigated tumor samples, but not in normal oral mucosal. The correlation between NY-ESO-1 expression and malignancy was significant (p=0.008). The prevalence of NY-ESO-1 expression was significantly associated with tumor size (p=0.033), but not with histological grading, positive lymph node status or clinical stage of disease. NY-ESO-1 expression is restricted to OSCC, clearly indicating malignancy. However, the expression rate of this antigen is too low for clinical application but it might be a useful additional biomarker within a multiple marker system for the diagnosis of OSCC. In addition, NY-ESO-1 might be a candidate for immunotherapy and polyvaccination in patients suffering from OSCC.

  18. 33 CFR 110.150 - Block Island Sound, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Block Island Sound, N.Y. 110.150... ANCHORAGE REGULATIONS Anchorage Grounds § 110.150 Block Island Sound, N.Y. (a) The anchorage ground. A 3/4... following coordinates: latitude 41°06′12″ N., longitude 72°00′05″ W., latitude 41°07′40″ N., longitude 72°01...

  19. 33 CFR 110.85 - Niagara River, Youngstown, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Niagara River, Youngstown, N.Y... ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.85 Niagara River, Youngstown, N.Y. (a) Area 1... of the Niagara River at latitude 43°14′33″ N, longitude 79°03′7.5″ W; thence westerly to a point at...

  20. Three novel NY-ESO-1 epitopes bound to DRB1*0803, DQB1*0401 and DRB1*0901 recognized by CD4 T cells from CHP-NY-ESO-1-vaccinated patients.

    PubMed

    Mizote, Yu; Taniguchi, Taku; Tanaka, Kei; Isobe, Midori; Wada, Hisashi; Saika, Takashi; Kita, Shoichi; Koide, Yukari; Uenaka, Akiko; Nakayama, Eiichi

    2010-07-19

    Three novel NY-ESO-1 CD4 T cell epitopes were identified using PBMC obtained from patients who were vaccinated with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein (CHP-NY-ESO-1). The restriction molecules were determined by antibody blocking and using various EBV-B cells with different HLA alleles as APC to present peptides to CD4 T cells. The minimal epitope peptides were determined using various N- and C-termini truncated peptides deduced from 18-mer overlapping peptides originally identified for recognition. Those epitopes were DRB1*0901-restricted NY-ESO-1 87-100, DQB1*0401-restricted NY-ESO-1 95-107 and DRB1*0803-restricted NY-ESO-1 124-134. CD4 T cells used to determine those epitope peptides recognized EBV-B cells or DC that were treated with recombinant NY-ESO-1 protein or NY-ESO-1-expressing tumor cell lysate, suggesting that the epitope peptides are naturally processed. These CD4 T cells showed a cytokine profile with Th1 characteristics. Furthermore, NY-ESO-1 87-100 peptide/HLA-DRB1*0901 tetramer staining was observed. Multiple Th1-type CD4 T cell responses are beneficial for inducing effective anti-tumor responses after NY-ESO-1 protein vaccination. (c) 2010 Elsevier Ltd. All rights reserved.

  1. NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.

    PubMed

    Endo, Makoto; de Graaff, Marieke A; Ingram, Davis R; Lim, Simin; Lev, Dina C; Briaire-de Bruijn, Inge H; Somaiah, Neeta; Bovée, Judith V M G; Lazar, Alexander J; Nielsen, Torsten O

    2015-04-01

    New York esophageal squamous cell carcinoma 1 (NY-ESO-1, CTAG1B) is a cancer-testis antigen and currently a focus of several targeted immunotherapeutic strategies. We performed a large-scale immunohistochemical expression study of NY-ESO-1 using tissue microarrays of mesenchymal tumors from three institutions in an international collaboration. A total of 1132 intermediate and malignant and 175 benign mesenchymal lesions were enrolled in this study. Immunohistochemical staining was performed on tissue microarrays using a monoclonal antibody for NY-ESO-1. Among mesenchymal tumors, myxoid liposarcomas showed the highest positivity for NY-ESO-1 (88%), followed by synovial sarcomas (49%), myxofibrosarcomas (35%), and conventional chondrosarcomas (28%). Positivity of NY-ESO-1 in the remaining mesenchymal tumors was consistently low, and no immunoreactivity was observed in benign mesenchymal lesions. On the basis of these findings, nearly 90% of myxoid liposarcomas, as well as a significant proportion of synovial sarcomas, myxofibrosarcomas, and conventional chondrosarcomas are good candidates for immunotherapy targeting NY-ESO-1.

  2. [Prokaryotic expression, purification and identification of NY-ESO-1/GST fusion protein in E.coli].

    PubMed

    Tang, Lei; Song, Chao-jun; Sun, Yuan-jie; Li, Na; Wei, Yu-ying; Sun, Yi; Yang, Kun

    2012-10-01

    To construct an expression plasmid for NY-ESO-1 gene and identify the expression of recombinant protein NY-ESO-1/GST in E.coli. NY-ESO-1 segment was amplified from the testis cDNA library by RT-PCR and cloned into the prokaryotic expression vector pGEX4T-1 downstream tagged by GST to construct the expression plasmid pGEX-4T1-NY-ESO-1. The recombinant vector was transformed to BL21 (DE3) and NY-ESO-1/GST fusion protein was induced expression by IPTG. The protein was purified by urea elution and identified by SDS-PAGE and Western blotting. The NY-ESO-1 segment was successfully amplified and its sequence was identical with that published in GenBank. The BL21 (DE3) pLysS containing the pGEX-4T1-NY-ESO-1 expressed a M(r); 44 000 fusion protein under the induction of IPTG. The purity of the protein was 90%. Western blotting proved that NY-ESO-1/GST had a specific reaction with anti-GST mAb. The prokaryotic expression vector of NY-ESO-1 has been constructed and the fusion protein NY-ESO-1/GST of high purity is successfully expressed.

  3. Aircraft borne combined measurements of the Fukushima radionuclide Xe-133 and fossil fuel combustion generated pollutants in the TIL - Implications for Cyclone induced lift and TIL physical-chemical processes

    NASA Astrophysics Data System (ADS)

    Arnold, Frank; Schlager, Hans; Simgen, Hardy; Aufmhoff, Heinfried; Baumann, Robert; Lindemann, Sigfried; Rauch, Ludwig; Kaether, Frank; Pirjolla, Liisa; Schumann, Ulrich

    2013-04-01

    The radionuclide Xe-133, released by the March 2011 nuclear disaster at Fukushima/Daiichi (hereafter FD), represents an ideal tracer for atmospheric transport. We report the, to our best knowledge, only aircraft borne measurements of FD Xe-133 in the Tropopause Inversion Layer (TIL), indicating rapid lift of Xe-133 rich planetary boundary layer air to the TIL. On the same research aircraft (FALCON), we have also conducted on-line measurements of fossil fuel combustion generated pollutant gases (SO2, NOx, HNO3,NOy), which were found to have increased concentrations in the TIL. In addition, we have conducted supporting model simulations of transport, chemical processes, and aerosol processes. Our investigations reveal a potentially important influence of East-Asian cyclone induced pollutants transport to the TIL, particularly influencing aerosol formation in the TIL.

  4. Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432.

    PubMed

    Aoki, Masatoshi; Ueda, Shugo; Nishikawa, Hiroyoshi; Kitano, Shigehisa; Hirayama, Michiko; Ikeda, Hiroaki; Toyoda, Hideki; Tanaka, Kyosuke; Kanai, Michiyuki; Takabayashi, Arimichi; Imai, Hiroshi; Shiraishi, Taizo; Sato, Eiichi; Wada, Hisashi; Nakayama, Eiichi; Takei, Yoshiyuki; Katayama, Naoyuki; Shiku, Hiroshi; Kageyama, Shinichi

    2009-11-16

    Combination vaccines of the NY-ESO-1 protein complexed with cholesteryl pullulan (CHP), CHP-NY-ESO-1, and the truncated 146HER2 protein with CHP, CHP-HER2, were subcutaneously administered with the immuno-adjuvant OK-432 to eight esophageal cancer patients. Vaccination was well-tolerated. NY-ESO-1- and HER2-specific antibody responses were analyzed using the patients' sera and samples from previous single CHP-NY-ESO-1 or CHP-HER2 vaccine trial. The responses to NY-ESO-1 in the combination vaccine study were comparable to the single vaccine. For responses to HER2, there were fewer antibody responses in the combination vaccines. Although there were marked individual variations in the antibody responses to the NY-ESO-1 and HER2 antigens, the reaction patterns to these antigens were comparable within each patient. Antibodies to OK-432 were not augmented. Protein cancer vaccines targeting multiple antigens are feasible.

  5. Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC).

    PubMed

    Adams, Sylvia; Goldstein, Lori J; Sparano, Joseph A; Demaria, Sandra; Badve, Sunil S

    2015-09-01

    Upon analysis of archived primary tumors of 482 patients with triple negative breast cancer (TNBC) enrolled in two randomized Phase III adjuvant chemotherapy trials, we have found that tumor infiltrating lymphocytes (TILs), as assessed and quantified by hematoxylin and eosin (H&E) staining are a robust and independent predictor of disease-free survival (DFS), distant recurrence-free interval (DRFI) and overall survival (OS).(1) Our findings provide confirmation of results observed in TNBC in a European adjuvant chemotherapy dataset and therefore elevate TILs as prognostic biomarker for operable TNBC to level I evidence.

  6. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.

    PubMed

    Kawada, Junji; Wada, Hisashi; Isobe, Midori; Gnjatic, Sacha; Nishikawa, Hiroyoshi; Jungbluth, Achim A; Okazaki, Nami; Uenaka, Akiko; Nakamura, Yurika; Fujiwara, Shinichi; Mizuno, Naoaki; Saika, Takashi; Ritter, Erika; Yamasaki, Makoto; Miyata, Hiroshi; Ritter, Gerd; Murphy, Roger; Venhaus, Ralph; Pan, Linda; Old, Lloyd J; Doki, Yuichiro; Nakayama, Eiichi

    2012-02-01

    NY-ESO-1 is a prototypic cancer/testis antigen. In a recent phase I clinical trial, we vaccinated 13 patients bearing NY-ESO-1-expressing tumors with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein (CHP-NY-ESO-1) and showed efficient induction of NY-ESO-1 antibody, and CD4 and CD8 T cell responses using peripheral blood from the patients. In our study, we analyzed heteroclitic serological responses in those patients after vaccination. Serological response against 11 tumor antigens including MAGE-A1, MAGE-A3, MAGE-A4, CT7/MAGEC1, CT10/MAGEC2, CT45, CT46/HORMAD1, SOX2, SSX2, XAGE1B and p53 was examined by enzyme-linked immunosorbent assay (ELISA) using sera from ten vaccinated patients. Expression of tumor antigens was determined by reverse transcription-polymerase chain reaction or immunohistochemistry. Eight of nine patients who showed antibody responses against NY-ESO-1 also showed an antibody response against at least 1 of these 11 tumor antigens after vaccination. In one patient, seven tumor antigens were recognized. Specificity analysis of the antibody response by ELISA using control recombinant proteins and synthetic peptides and by Western blot showed that the response was not against His6-tag and/or bacterial products included in a preparation of CHP-NY-ESO-1 used for vaccination. Thus, heteroclitic serological responses appear to be indicative of the overall immune response against the tumor, and their analysis could be useful for immune monitoring in cancer vaccine. Copyright © 2011 UICC.

  7. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

    PubMed Central

    Everson, Richard G.; Antonios, Joseph P.; Lisiero, Dominique N.; Soto, Horacio; Scharnweber, Rudi; Garrett, Matthew C.; Yong, William H.; Li, Ning; Li, Gang; Kruse, Carol A.; Liau, Linda M.; Prins, Robert M.

    2016-01-01

    Background Immunotherapy is an ideal treatment modality to specifically target the diffusely infiltrative tumor cells of malignant gliomas while sparing the normal brain parenchyma. However, progress in the development of these therapies for glioblastoma has been slow due to the lack of immunogenic antigen targets that are expressed uniformly and selectively by gliomas. Methods We utilized human glioblastoma cell cultures to induce expression of New York–esophageal squamous cell carcinoma (NY-ESO-1) following in vitro treatment with the demethylating agent decitabine. We then investigated the phenotype of lymphocytes specific for NY-ESO-1 using flow cytometry analysis and cytotoxicity against cells treated with decitabine using the xCelligence real-time cytotoxicity assay. Finally, we examined the in vivo application of this immune therapy using an intracranially implanted xenograft model for in situ T cell trafficking, survival, and tissue studies. Results Our studies showed that treatment of intracranial glioma–bearing mice with decitabine reliably and consistently induced the expression of an immunogenic tumor-rejection antigen, NY-ESO-1, specifically in glioma cells and not in normal brain tissue. The upregulation of NY-ESO-1 by intracranial gliomas was associated with the migration of adoptively transferred NY-ESO-1–specific lymphocytes along white matter tracts to these tumors in the brain. Similarly, NY-ESO-1–specific adoptive T cell therapy demonstrated antitumor activity after decitabine treatment and conferred a highly significant survival benefit to mice bearing established intracranial human glioma xenografts. Transfer of NY-ESO-1–specific T cells systemically was superior to intracranial administration and resulted in significantly extended and long-term survival of animals. Conclusion These results reveal an innovative, clinically feasible strategy for the treatment of glioblastoma. PMID:26330563

  8. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.

    PubMed

    Everson, Richard G; Antonios, Joseph P; Lisiero, Dominique N; Soto, Horacio; Scharnweber, Rudi; Garrett, Matthew C; Yong, William H; Li, Ning; Li, Gang; Kruse, Carol A; Liau, Linda M; Prins, Robert M

    2016-03-01

    Immunotherapy is an ideal treatment modality to specifically target the diffusely infiltrative tumor cells of malignant gliomas while sparing the normal brain parenchyma. However, progress in the development of these therapies for glioblastoma has been slow due to the lack of immunogenic antigen targets that are expressed uniformly and selectively by gliomas. We utilized human glioblastoma cell cultures to induce expression of New York-esophageal squamous cell carcinoma (NY-ESO-1) following in vitro treatment with the demethylating agent decitabine. We then investigated the phenotype of lymphocytes specific for NY-ESO-1 using flow cytometry analysis and cytotoxicity against cells treated with decitabine using the xCelligence real-time cytotoxicity assay. Finally, we examined the in vivo application of this immune therapy using an intracranially implanted xenograft model for in situ T cell trafficking, survival, and tissue studies. Our studies showed that treatment of intracranial glioma-bearing mice with decitabine reliably and consistently induced the expression of an immunogenic tumor-rejection antigen, NY-ESO-1, specifically in glioma cells and not in normal brain tissue. The upregulation of NY-ESO-1 by intracranial gliomas was associated with the migration of adoptively transferred NY-ESO-1-specific lymphocytes along white matter tracts to these tumors in the brain. Similarly, NY-ESO-1-specific adoptive T cell therapy demonstrated antitumor activity after decitabine treatment and conferred a highly significant survival benefit to mice bearing established intracranial human glioma xenografts. Transfer of NY-ESO-1-specific T cells systemically was superior to intracranial administration and resulted in significantly extended and long-term survival of animals. These results reveal an innovative, clinically feasible strategy for the treatment of glioblastoma. © The Author(s) 2015. Published by Oxford University Press on behalf of the Society for Neuro

  9. NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches.

    PubMed

    Baia, Gilson S; Caballero, Otavia L; Ho, Janelle S Y; Zhao, Qi; Cohen, Tzeela; Binder, Zev A; Salmasi, Vafi; Gallia, Gary L; Quinones-Hinojosa, Alfredo; Olivi, Alessandro; Brem, Henry; Burger, Peter; Strausberg, Robert L; Simpson, Andrew J G; Eberhart, Charles G; Riggins, Gregory J

    2013-11-01

    Meningiomas are the most common primary intracranial tumors. Surgical resection remains the treatment of choice for these tumors. However, a significant number of tumors are not surgically accessible, recur, or become malignant, necessitating the repetition of surgery and sometimes radiation. Chemotherapy is rarely used and is generally not recognized as an effective treatment. Cancer/testis (CT) genes represent a unique class of genes, which are expressed by germ cells, normally silenced in somatic cells, but activated in various cancers. CT proteins can elicit spontaneous immune responses in patients with cancer and this feature makes them attractive targets for immunotherapy-based approaches. We analyzed mRNA expression of 37 testis-restricted CT genes in a discovery set of 18 meningiomas by reverse transcription PCR. The overall frequency of expression of CT genes ranged from 5.6% to 27.8%. The most frequently expressed was NY-ESO-1, in 5 patients (27.8%). We subsequently analyzed NY-ESO-1 protein expression in a larger set of meningiomas by immunohistochemistry and found expression in 108 of 110 cases. In some cases, NY-ESO-1 expression was diffused and homogenous, but in most instances it was heterogeneous. Importantly, NY-ESO-1 expression was positively correlated with higher grade and patients presenting with higher levels of NY-ESO-1 staining had significantly worse disease-free and overall survival. We have also shown that NY-ESO-1 expression may lead to humoral immune response in patients with meningioma. Considering the limited treatment options for patients with meningioma, the potential of NY-ESO-1-based immunotherapy should be explored. ©2013 AACR.

  10. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma.

    PubMed

    Goydos, J S; Patel, M; Shih, W

    2001-06-15

    As tumor cells spread beyond their primary site they undergo changes in their gene expression that may be detectable and useful for microstaging. The cancer/testis (CT) antigens are a family of proteins that include MAGE 1-3, NY-ESO-1, SSX 1-5, and others that are potential markers for microstaging melanoma. CT antigens are produced by many tumor types but few normal tissues other than testis. One CT antigen, CTp11, was shown to be expressed by metastasizing melanoma cell lines but not by nonmetastasizing variants. We tested this finding by studying the expression of CTp11 and NY-ESO-1 by melanoma samples from different stages of progression. We collected 20 primary, 22 locoregional, and 10 distant metastatic melanoma samples. We extracted total RNA, and reverse transcription yielded cDNA, which was PCR-amplified using primers to detect beta-actin, tyrosinase, MART-1, NY-ESO-1, and CTp11. The PCR products were separated on ethidium bromide-stained agarose gels and visualized by UV transillumination. All samples were positive for beta-actin and MART-1 and all but two were positive for tyrosinase, confirming RNA integrity and the presence of melanoma. Twenty-seven samples were positive for NY-ESO-1, CTp11, or both. CTp11 tended to be expressed by primary melanomas and NY-ESO-1 by metastatic samples (P < 0.02). There is a statistically significant difference in the distribution of the expression of CTp11 and NY-ESO-1 in melanoma from different stages of progression. NY-ESO-1 may be a marker of more advanced disease and CTp11 of less advanced disease. Copyright 2001 Academic Press.

  11. Submarine Groundwater Discharge in Stony Brook Harbor, NY

    NASA Astrophysics Data System (ADS)

    Durand, J. M.; Young, C.; Wong, T.; Hanson, G. N.

    2012-12-01

    As nutrients can significantly impact coastal ecosystems, understanding their path to embayments and oceans is crucial. In Stony Brook Harbor (Long Island, NY), submarine groundwater discharge (SGD) is the only significant contribution of freshwater and thus constitutes the main pathway for nutrients, which may eventually reach Long Island Sound. Subterranean estuaries have been shown to be highly reactive zones where nitrogen attenuation can occur. Understanding the fate of nitrogen in Stony Brook Harbor requires knowing the volume of groundwater entering the bay as well as the amount of denitrification, in the context of the hydrogeological framework. This is achieved by combining electrical resistivity survey, water sampling in piezometers, point conductivity and seepage measurements. A Trident probe inserted 60 cm deep into the sediments allows measuring the conductivity and temperature of the sediments and the overlying seawater. In spring 2011, five Trident transects spreading across the head of the harbor were used as a preliminary study to reveal potential locations for SGD. Locations with significant difference between sediment and seawater temperature and/or conductivities were further investigated using an AGI SuperSting 8-channel receiver resistivity meter. Two ultrasonic seepage meters were deployed in May and July 2011 about 20 m below the low tide mark. Five piezometers were aligned parallel to one resistivity survey. Our resistivity data indicate superficial mixing in the intertidal zone. The freshwater extends quite far under the seafloor, above 67 meters after the low tide mark for one location. The freshwater/saltwater interface seems to be almost horizontal. The piezometer data agree relatively well with the resistivity data. The preliminary average seepage rates observed vary from 3 to 60 cm/d. The resistivity sections reveal the presence of a thin layer of high conductivity above the low tide mark. This matches the observation of a superficial

  12. High precision cell slicing by harmonically actuated ultra-sharp SixNy blades

    NASA Astrophysics Data System (ADS)

    Jeong, Hwapyeong; Li, Tao; Gianchandani, Yogesh B.; Park, Jaesung

    2015-02-01

    We describe a micro-knife system with an ultra-sharp blade that is harmonically actuated by lead zirconate titanate (PZT). In particular, harmonic actuation along its cutting direction is demonstrated to provide clean and sharp cut lines for hepatocytes. Such performance is not provided by ordinary ultrasonic actuation. The blade is 500 nm-thick silicon nitride (SixNy); it can cut a single cell. Finite element analysis and measurements of displacement around resonant frequencies were used to optimize the dimensions, driving frequency and voltage. To evaluate the cutting precision, commercial scalpels and the SixNy blade without and with harmonic actuation were compared. When used to cut primary hepatocytes in a mono-layer, a commercial stainless scalpel burst cells, and the SixNy blade without harmonic actuation cut cells with a wide and ragged line. However, due to the controlled ultrasonic mode shape, operating frequency, high frequency and low applied power, the SixNy blade with harmonic actuation at 1Vpp and 70.1 kHz provided a clean and sharp cut line which was as narrow as 2 µm. The SixNy blade with harmonic actuation has potential applications as a tool for minimally invasive surgery.

  13. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

    PubMed

    Kakimi, Kazuhiro; Isobe, Midori; Uenaka, Akiko; Wada, Hisashi; Sato, Eiichi; Doki, Yuichiro; Nakajima, Jun; Seto, Yasuyuki; Yamatsuji, Tomoki; Naomoto, Yoshio; Shiraishi, Kenshiro; Takigawa, Nagio; Kiura, Katsuyuki; Tsuji, Kazuhide; Iwatsuki, Keiji; Oka, Mikio; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Nakayama, Eiichi

    2011-12-15

    We conducted a phase I clinical trial of a cancer vaccine using a 20-mer NY-ESO-1f peptide (NY-ESO-1 91-110) that includes multiple epitopes recognized by antibodies, and CD4 and CD8 T cells. Ten patients were immunized with 600 μg of NY-ESO-1f peptide mixed with 0.2 KE Picibanil OK-432 and 1.25 ml Montanide ISA-51. Primary end points of the study were safety and immune response. Subcutaneous injection of the NY-ESO-1f peptide vaccine was well tolerated. Vaccine-related adverse events observed were fever (Grade 1), injection-site reaction (Grade 1 or 2) and induration (Grade 2). Vaccination with the NY-ESO-1f peptide resulted in an increase or induction of NY-ESO-1 antibody responses in nine of ten patients. The sera reacted with recombinant NY-ESO-1 whole protein as well as the NY-ESO-1f peptide. An increase in CD4 and CD8 T cell responses was observed in nine of ten patients. Vaccine-induced CD4 and CD8 T cells responded to NY-ESO-1 91-108 in all patients with various HLA types with a less frequent response to neighboring peptides. The findings indicate that the 20-mer NY-ESO-1f peptide includes multiple epitopes recognized by CD4 and CD8 T cells with distinct specificity. Of ten patients, two with lung cancer and one with esophageal cancer showed stable disease. Our study shows that the NY-ESO-1f peptide vaccine was well tolerated and elicited humoral, CD4 and CD8 T cell responses in immunized patients. Copyright © 2011 UICC.

  14. Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.

    PubMed

    Chu, Hongjin; Du, Fengcai; Gong, Zhaohua; Lian, Peiwen; Wang, Zhixin; Li, Peng; Hu, Baohong; Chi, Cheng; Chen, Jian

    2017-08-01

    To evaluate the clinical efficiency of tumor-infiltrating lymphocytes (TILs) compared to cisplatin for malignant pleural effusion and ascites through intrapleural and intraperitoneal infusion. Thirteen patients with malignant pleural effusion and ascites were divided into a TIL-treated group and a cisplatin-treated group. Patients were given TILs or cisplatin, through intrapleural and intraperitoneal infusion respectively, after drainage of the malignant serous effusion by thoracentesis or abdominocentesis. The overall response rate and disease control rate of the TIL-treated group (33.33% and 83.33%) were higher than that of the cisplatin-treated group (28.57% and 71.43%). The progression-free survival for the TIL-treated group was significantly longer (p=0.002) and better than that of the cisplatin-treated group (66.67% vs. 28.57%). Quality of life apparently improved in the TIL-treated group and was clearly higher than that in the cisplatin-treated group. The use of TILs has a better clinical efficiency for malignant pleural effusion and ascites than cisplatin through intrapleural and intraperitoneal infusion without severe adverse effects. Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

  15. TIL 2.0: More effective and predictive T-cell products by enrichment for defined antigen specificities.

    PubMed

    Schober, Kilian; Busch, Dirk H

    2016-06-01

    Adoptive transfer of in vitro-expanded T cells derived from tumor-infiltrating lymphocytes (TILs) in melanoma patients started the era of tumor immunotherapy three decades ago. The approach has demonstrated remarkable clinical responses in several studies since. Reinfusion of TIL-derived T cells represents a highly personalized form of immunotherapy, taking into account the enormous interindividual tumor heterogeneity. However, despite its successes, TIL therapy does not lead to objective clinical responses in all cases. It is thus crucial to find out which tumor antigens are particularly valuable targets and to develop strategies to enhance the reactivity of T-cell products toward them. In this issue of the European Journal of Immunology, Kelderman et al. [Eur. J. Immunol. 2016. 46: 1351-1360] present a platform for the generation of antigen-specific TIL therapy. Combining recently developed technologies for clinical identification and enrichment of antigen-specific CD8(+) T cells, such as MHC Streptamers and UV-mediated peptide exchange, the authors could enrich T-cell populations with defined antigen specificities from melanoma-derived TILs. This T-cell product showed higher reactivity against autologous tumor cell lines than bulk TIL-derived T cells. The novel platform might enable the generation of more effective and predictable TIL-derived T-cell products for future clinical applications. © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  16. Anomalous C-12H4:C-13H4 strengths in 3 ny sub 3

    NASA Technical Reports Server (NTRS)

    Brault, J. W.; Fox, K.; Jennings, D. E.; Margolis, J. S.

    1981-01-01

    The C-12:C-13 ratios in the atmospheres of the outer planets are important parameters with which to test models for isotope formation and fractionation during the early history of the solar system, yielding insight into processes occurring in the primitive solar nebula. The 3 ny sub 3 spectra of methane were obtained using the Kitt Peak Solar Fourier Transform Spectrometer and a 6 m White cell. The experimental results are summarized in a table. The strength ratios for the R-branch of 3 ny sub 3 exhibit strong anomalies, with C-13H4 lines consistently weaker than their C-12H4 counterparts. The C-12:C-13 abundance ratios for the atmospheres of Jupiter and Saturn have been redetermined using the 3 ny sub 3 line-strength ratios measured.

  17. Spontaneous CD8 T cell responses against the melanocyte differentiation antigen RAB38/NY-MEL-1 in melanoma patients.

    PubMed

    Walton, Senta M; Gerlinger, Marco; de la Rosa, Olga; Nuber, Natko; Knights, Ashley; Gati, Asma; Laumer, Monika; Strauss, Laura; Exner, Carolin; Schäfer, Niklaus; Urosevic, Mirjana; Dummer, Reinhard; Tiercy, Jean-Marie; Mackensen, Andreas; Jaeger, Elke; Lévy, Frédéric; Knuth, Alexander; Jäger, Dirk; Zippelius, Alfred

    2006-12-01

    The melanocyte differentiation Ag RAB38/NY-MEL-1 was identified by serological expression cloning (SEREX) and is expressed in the vast majority of melanoma lesions. The immunogenicity of RAB38/NY-MEL-1 has been corroborated previously by the frequent occurrence of specific Ab responses in melanoma patients. To elucidate potential CD8 T cell responses, we applied in vitro sensitization with overlapping peptides spanning the RAB38/NY-MEL-1 protein sequence and the reverse immunology approach. The identified peptide RAB38/NY-MEL-1(50-58) exhibited a marked response in ELISPOT assays after in vitro sensitization of CD8 T cells from HLA-A *0201(+) melanoma patients. In vitro digestion assays using purified proteasomes provided evidence of natural processing of RAB38/NY-MEL-1(50-58) peptide. Accordingly, monoclonal RAB38/NY-MEL-1(50-58)-specific T cell populations were capable of specifically recognizing HLA-A2(+) melanoma cell lines expressing RAB38/NY-MEL-1. Applying fluorescent HLA-A2/RAB38/NY-MEL-1(50-58) multimeric constructs, we were able to document a spontaneously developed memory/effector CD8 T cell response against this peptide in a melanoma patient. To elucidate the Ag-processing pathway, we demonstrate that RAB38/NY-MEL-1(50-58) is produced efficiently by the standard proteasome and the immunoproteasome. In addition to the identification of a RAB38/NY-MEL-1-derived immunogenic CD8 T cell epitope, this study is instrumental for both the onset and monitoring of future RAB38/NY-MEL-1-based vaccination trials.

  18. Gallium nitride surface protection during RTA annealing with a GaOxNy cap-layer

    NASA Astrophysics Data System (ADS)

    Khalfaoui, Wahid; Oheix, T.; Cayrel, F.; Benoit, R.; Yvon, A.; Collard, E.; Alquier, D.

    2016-04-01

    Gallium nitride (GaN) is generally considered a good candidate for power electronic devices such as Schottky barrier diodes (SBDs). Nevertheless, GaN has a strong sensitivity to high temperature treatments and a cap-layer is mandatory to protect the material surface during annealing at high temperature such as post-implantation treatments. In this work, an oxidized gallium nitride layer (GaOxNy) was generated with Oxford PECVD equipment using a N2O plasma treatment to protect the GaN surface during a rapid thermal annealing (RTA), in the range of 1000 °C-1150 °C for a few minutes. Before annealing, c-TLM patterns were processed on the GaOxNy/GaN sample to characterize its sheet resistance. After the N2O plasma treatment, the sample exhibited lower sheet resistance, indicating a better n-type conduction of the GaOxNy layer due to an excess of free carriers, compared to the as-grown GaN layer. The GaOxNy/GaN surface was then annealed at 1150 °C for 3 min and observed through AFM imaging. The surface exhibited a good quality with a low roughness, nevertheless, a low density of small hexagonal pits appeared after annealing. Finally, studies to determine an efficient etching process of the GaOxNy cap-layer were conducted using both chemical and physical approaches. We observed that efficient etching of the layer was achieved using a heated hydrofluoridric acid (HF 25%) solution. To conclude, GaOxNy has proved to be an efficient cap-layer for GaN protection at high temperature.

  19. Clinical masking with tragal rubbing and the Bárány noise-box.

    PubMed

    Swan, I R

    1989-12-01

    When assessing hearing by free-field voice testing, it is essential to mask the non-test ear. An appropriate method of masking must be chosen to suit the stimulus used. This study demonstrates that tragal rubbing is an effective means of masking a whispered or conversational voice, but a Bárány noise-box is required to mask a loud voice. However, a Bárány noise-box should not be used routinely as it is likely to overmask a normal or mildly impaired ear.

  20. 33 CFR 162.20 - Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 2 2011-07-01 2011-07-01 false Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. 162.20 Section 162.20 Navigation and Navigable Waters COAST... NAVIGATION REGULATIONS § 162.20 Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. (a...

  1. 33 CFR 162.20 - Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 2 2010-07-01 2010-07-01 false Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. 162.20 Section 162.20 Navigation and Navigable Waters COAST... NAVIGATION REGULATIONS § 162.20 Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. (a...

  2. 77 FR 63874 - Birds Eye Foods, LLC; Fulton, NY Plant; A Wholly-Owned Subsidiary of Pinnacle Foods Group LLC...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-17

    ... Employment and Training Administration Birds Eye Foods, LLC; Fulton, NY Plant; A Wholly-Owned Subsidiary of... December 21, 2011, applicable to workers and former workers of Birds Eye Foods, LLC, Fulton, NY Plant, a...-site at the Fulton, New York location of Birds Eye Foods, LLC. The Department has determined that...

  3. 33 CFR 162.20 - Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... 33 Navigation and Navigable Waters 2 2013-07-01 2013-07-01 false Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. 162.20 Section 162.20 Navigation and Navigable Waters COAST... NAVIGATION REGULATIONS § 162.20 Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area....

  4. 33 CFR 162.20 - Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... 33 Navigation and Navigable Waters 2 2012-07-01 2012-07-01 false Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. 162.20 Section 162.20 Navigation and Navigable Waters COAST... NAVIGATION REGULATIONS § 162.20 Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area....

  5. 33 CFR 162.20 - Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 2 2014-07-01 2014-07-01 false Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area. 162.20 Section 162.20 Navigation and Navigable Waters COAST... NAVIGATION REGULATIONS § 162.20 Flushing Bay near La Guardia Airport, Flushing, N.Y.; restricted area....

  6. 75 FR 16700 - Special Local Regulation, Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-02

    ... SECURITY Coast Guard 33 CFR Part 100 RIN 1625-AA08 Special Local Regulation, Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain's Cove Seaport, Bridgeport, CT AGENCY: Coast Guard, DHS... Long Island Sound between Port Jefferson, NY and Captain's Cove Seaport, Bridgeport, CT due to...

  7. 75 FR 34634 - Special Local Regulation; Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-18

    ... SECURITY Coast Guard 33 CFR Part 100 RIN 1625-AA08 Special Local Regulation; Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain's Cove Seaport, Bridgeport, CT AGENCY: Coast Guard, DHS... navigable waters of Long Island Sound between Port Jefferson, NY and Captain's Cove Seaport, Bridgeport,...

  8. 76 FR 25300 - Foreign-Trade Zone 141-Rochester, NY; Application for Manufacturing Authority, Firth Rixson, Inc...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-04

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Foreign-Trade Zone 141--Rochester, NY; Application for Manufacturing Authority, Firth Rixson, Inc. d/b/a Firth Rixson Monroe (Aircraft Turbine Components), Rochester, NY A request has been submitted to the Foreign-Trade Zones...

  9. 77 FR 42510 - Notice of Inventory Completion: New York University College of Dentistry, New York, NY; Correction

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-19

    ... National Park Service Notice of Inventory Completion: New York University College of Dentistry, New York... College of Dentistry, New York, NY. The human remains were removed from Bronx County, NY. This notice is... was made by New York University College of Dentistry professional staff in consultation...

  10. 77 FR 9227 - AP Gas & Electric (NY), LLC; Supplemental Notice That Initial Market-Based Rate Filing Includes...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-02-16

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF ENERGY Federal Energy Regulatory Commission AP Gas & Electric (NY), LLC; Supplemental Notice That Initial Market-Based... above-referenced proceeding of AP Gas & Electric (NY), LLC's application for market-based rate...

  11. 77 FR 43158 - Special Local Regulation; Battle on the Bay Powerboat Race Atlantic Ocean, Fire Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-24

    ... Race Atlantic Ocean, Fire Island, NY AGENCY: Coast Guard, DHS. ACTION: Temporary final rule. SUMMARY... Atlantic Ocean off Smith Point Park, Fire Island, NY during the Battle on the Bay Powerboat Race. This action is necessary to provide for the safety of life of participants and spectators during this...

  12. NY-ESO-1–specific immunological pressure and escape in a patient with metastatic melanoma

    PubMed Central

    von Boehmer, Lotta; Mattle, Muriel; Bode, Peter; Landshammer, Alexandro; Schäfer, Carolin; Nuber, Natko; Ritter, Gerd; Old, Lloyd; Moch, Holger; Schäfer, Niklaus; Jäger, Elke; Knuth, Alexander; van den Broek, Maries

    2013-01-01

    During cancer progression, malignant cells may evade immunosurveillance. However, evidence for immunological escape in humans is scarce. We report here the clinical course of a melanoma patient whose initial tumor was positive for the antigens NY-ESO-1, MAGE-C1, and Melan-A. Upon immunization with a recombinant vaccinia/fowlpox NY-ESO-1 construct, the patient experienced a mixed clinical response and spreading of the NY-ESO-1 epitopes in the CD4+ T cell compartment. After NY-ESO-1 protein + CpG immunization, the patient’s anti-NY-ESO-1 IgG response increased. Over the following years, progressing lesions were resected and found to be NY-ESO-1-negative while being positive for MAGE-C1, Melan-A, and MHC-I. The fatal, inoperable brain metastasis was analyzed after his death and also proved to be NY-ESO-1-negative, while being positive for MAGE-C1 and Melan-A, as well as MHC-I. We propose that cancer control and cancer escape in this patient were governed by NY-ESO-1-specific immunological pressure. Our findings provide evidence for the existence of immunoediting and immunoescape in this cancer patient. PMID:23882157

  13. 78 FR 38310 - Kiwi Energy NY LLC; Supplemental Notice That Initial Market-Based Rate Filing Includes Request...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-06-26

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF ENERGY Federal Energy Regulatory Commission Kiwi Energy NY LLC; Supplemental Notice That Initial Market-Based Rate... notice in the above-referenced proceeding, of Kiwi Energy NY LLC's application for market-based...

  14. A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression.

    PubMed

    Gunda, Viswanath; Frederick, Dennie T; Bernasconi, Maria J; Wargo, Jennifer A; Parangi, Sareh

    2014-08-01

    NY-ESO-1 is one of the most immunogenic members of the cancer/testis antigen family and its levels can be increased after exposure to demethylating and deacetylating agents. This cytoplasmic antigen can serve as a potent target for cancer immunotherapy and yet has not been well studied in differentiated thyroid cancer cells. We studied the baseline expression of NY-ESO-1 messenger RNA and protein before and after exposure to 5-aza-2'-deoxycytidine (DAC) (72 hours) in a panel of thyroid cancer cell lines using quantitative polymerase chain reaction and Western blot. HLA-A2+, NY-ESO-1+ thyroid cell lines were then co-cultured with peripheral blood lymphocytes transduced with NY-ESO-1 specific T-cell receptor (TCR) and assayed for interferon-gamma and Granzyme-B release in the medium. SCID mice injected orthotopically with BCPAP cells were treated with DAC to evaluate for NY-ESO-1 gene expression in vivo. None of the thyroid cancer cell lines showed baseline expression of NY-ESO-1. Three cell lines, BCPAP, TPC-1, and 8505c, showed an increase in NY-ESO-1 gene expression with DAC treatment and were found to be HLA-A2 positive. DAC-treated target BCPAP and TPC-1 tumor cells with up-regulated NY-ESO-1 levels were able to mount an appropriate interferon-gamma and Granzyme-B response upon co-culture with the NY-ESO-1-TCR-transduced peripheral blood lymphocytes. In vivo DAC treatment was able to increase NY-ESO-1 expression in an orthotopic mouse model with BCPAP cells. Our data suggest that many differentiated thyroid cancer cells can be pressed to express immune antigens, which can then be utilized in TCR-based immunotherapeutic interventions.

  15. A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression

    PubMed Central

    Gunda, Viswanath; Frederick, Dennie T.; Bernasconi, Maria J.; Wargo, Jennifer A.

    2014-01-01

    Background: NY-ESO-1 is one of the most immunogenic members of the cancer/testis antigen family and its levels can be increased after exposure to demethylating and deacetylating agents. This cytoplasmic antigen can serve as a potent target for cancer immunotherapy and yet has not been well studied in differentiated thyroid cancer cells. Methods: We studied the baseline expression of NY-ESO-1 messenger RNA and protein before and after exposure to 5-aza-2′-deoxycytidine (DAC) (72 hours) in a panel of thyroid cancer cell lines using quantitative polymerase chain reaction and Western blot. HLA-A2+, NY-ESO-1+ thyroid cell lines were then co-cultured with peripheral blood lymphocytes transduced with NY-ESO-1 specific T-cell receptor (TCR) and assayed for interferon-gamma and Granzyme-B release in the medium. SCID mice injected orthotopically with BCPAP cells were treated with DAC to evaluate for NY-ESO-1 gene expression in vivo. Results: None of the thyroid cancer cell lines showed baseline expression of NY-ESO-1. Three cell lines, BCPAP, TPC-1, and 8505c, showed an increase in NY-ESO-1 gene expression with DAC treatment and were found to be HLA-A2 positive. DAC-treated target BCPAP and TPC-1 tumor cells with up-regulated NY-ESO-1 levels were able to mount an appropriate interferon-gamma and Granzyme-B response upon co-culture with the NY-ESO-1-TCR-transduced peripheral blood lymphocytes. In vivo DAC treatment was able to increase NY-ESO-1 expression in an orthotopic mouse model with BCPAP cells. Conclusion: Our data suggest that many differentiated thyroid cancer cells can be pressed to express immune antigens, which can then be utilized in TCR-based immunotherapeutic interventions. PMID:24811699

  16. 77 FR 55265 - Environmental Impact Statement for the Northeast Corridor Between Washington, DC, New York, NY...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-09-07

    ... Washington, DC, New York, NY, and Boston, MA AGENCY: Federal Railroad Administration (FRA), U.S. Department... potential passenger rail improvements between Washington, DC, New York City, and Boston, MA was published in... Scoping meetings held from August 13th through August 22nd at nine different venues between Washington,...

  17. 77 FR 58439 - Environmental Impact Statement for the Northeast Corridor Between Washington, DC, New York, NY...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-09-20

    ... Washington, DC, New York, NY and Boston, MA AGENCY: Federal Railroad Administration (FRA), Department of... W12-140, Washington, DC 20590-0001, by hand delivery to West Building Ground Floor, Room W12-140, 1200 New Jersey Ave. SE., Washington, DC (between 9 a.m. and 5 p.m. ET, Monday through Friday,...

  18. 78 FR 13811 - Safety Zone; Underwater Escape Event, Seaport, East River, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-01

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF HOMELAND SECURITY Coast Guard 33 CFR Part 165 Safety Zone; Underwater Escape Event, Seaport, East River, NY AGENCY... escape artist event and associated pyrotechnics display. During the enforcement period, no person...

  19. 75 FR 33329 - Notice of Inventory Completion: New York University College of Dentistry, New York, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-11

    ... Dentistry, New York, NY. The human remains were removed from Lovelock Cave, Churchill County, NV. This... representing a minimum of one individual were removed from Lovelock Cave, Churchill County, NV. The remains... occupation of the cave, circa 2500-1500 B.C. The morphology of the remains is consistent with an individual...

  20. FIELD PERFORMANCE OF ADVANCED TECHNOLOGY WOODSTOVES IN GLEN FALLS, NY, 1988-89 - VOLUME I

    EPA Science Inventory

    The report gives results of an evaluation of particulate emission trends for three models of catalytic and two models of non- catalytic woodstoves under in-home burning conditions during the 1988-89 heating season in Glens Falls, NY. he results (averaging 9.4 g/h and 9.4 g/kg) sh...

  1. 77 FR 41048 - Safety Zone; Hudson Valley Triathlon, Ulster Landing, Hudson River, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-12

    ... Landing, NY for the 16th Annual Hudson Valley Triathlon swim event. This temporary safety zone is.... Regulatory History and Information The Hudson Valley Triathlon swim is an annual recurring event that has a... Valley Triathlon swim event will occur on July 15, 2012. On May 22, 2012, the sponsor of the event...

  2. Enhanced poly gate critical dimension control by using a SiOxNy ARC film

    NASA Astrophysics Data System (ADS)

    Bencher, Christopher; Chu, Tony; Tan, Way Tat; Zou, Gang; Lin, Qunying; Yi, Xu; Dong, Wang Xu; Wen, Ma Wei

    1997-08-01

    In this study, a silicon oxy-nitride (SiOxNy) film deposited using the plasma enhanced chemical vapor deposition method has been developed and applied to improve poly-gate level resist line CD control. The desired optical properties of a SiOxNy anti-reflective coating (ARC) film and its optimum thickness were targeted by using a photolithography simulator. A process matrix study has led to the identification of an optimized SiOxNy film Dielectric ARC deposition process for i-line photolithography applications. Using the optimized SiOxNy film as the ARC, significant improvements, compared to the standard and top ARC techniques, have been achieved, including 5 times reduction in does to clear swing ratio and complete elimination of reflection induced photoresist notching and necking effects. Moreover, a 2500 wafer marathon run demonstrated that the refractive index, extinction coefficient and thickness of this film can be controlled to +/- 0.04, +/- 0.03 and +/- 12A, respectively and that the particle performance is excellent.

  3. Structural and magnetic properties of nanocomposite iron-containing SiCxNy films

    NASA Astrophysics Data System (ADS)

    Pushkarev, R. V.; Fainer, N. I.; Maurya, K. K.

    2017-02-01

    New ferromagnetic films with composition SiCxNyFez were synthesized using chemical vapor deposition technique. Films were deposited using ferrocene, 1,1,1,3,3,3-hexamethyldisilazane (HMDS) and hydrogen gaseous mixture. Chemical and phase composition of the films were studied by FTIR, Raman spectroscopy and X-ray diffraction with grazing incidence (GI-XRD). FTIR spectra analysis confirmed the existence of Si-C and Si-N bonds. Graphite inclusions and amorphous carbon were determined by Raman spectra analysis. The surface of the SiCxNyFez films studied by SEM is covered by nanocrystallites of iron oxide Fe3O4 phase. The main purpose of GI-XRD analysis is to describe the layered structure of the films in detail. It was shown by GI-XRD study, that phase composition of the SiCxNyFez films varies from iron oxide Fe3O4 to iron silicide Fe3Si and silicon carbide SiC with the deposition temperature growing. It was established, that SiCxNyFez films are perspective for application in the spintronic field.

  4. 77 FR 38495 - Safety Zone; Village of Sodus Point Fireworks Display, Sodus Bay, Sodus Point, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-28

    ..., Chief of Waterways Management, U.S. Coast Guard Sector Buffalo; telephone 716- 843-9343, email SectorBuffaloMarineSafety@uscg.mil . If you have questions on viewing or submitting material to the docket, call..., NY. The Captain of the Port Buffalo has determined that fireworks launched proximate to a gathering...

  5. 78 FR 40081 - Safety Zone; Antique Boat Show, Niagara River, Grand Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-07-03

    ... or email LT Christopher Mercurio, Chief of Waterway Management, U.S. Coast Guard Sector Buffalo; telephone 716-843-9343, email SectorBuffaloMarineSafety@uscg.mil . If you have questions on viewing or... near the Buffalo Launch Club in Grand Island, NY. Typically, the event takes place on the first or...

  6. 78 FR 49921 - Safety Zone; Thunder on the Niagara, Niagara River, North Tonawanda, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-16

    ... Mercurio, Chief of Waterways Management, U.S. Coast Guard Sector Buffalo; telephone 716-843-9573, email SectorBuffaloMarineSafety@uscg.mil . If you have questions on viewing the docket, call Barbara Hairston... River near North Tonawanda, NY. The Captain of the Port Buffalo has determined that hydroplane races...

  7. 77 FR 30443 - Safety Zone; Alexandria Bay Chamber of Commerce, St. Lawrence River, Alexandria Bay, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-23

    .... Coast Guard Sector Buffalo; telephone 716-843-9343, email SectorBuffaloMarineSafety@uscg.mil . If you... the St. Lawrence River near Alexandria Bay, NY. The Captain of the Port Buffalo has determined that... authorized by the Captain of the Port Buffalo or his on-scene representative. The Captain of the Port or his...

  8. 76 FR 20530 - Safety Zone; Boom Days, Buffalo Outer Harbor, Buffalo, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-04-13

    ... SECURITY Coast Guard 33 CFR Part 165 RIN 1625-AA00 Safety Zone; Boom Days, Buffalo Outer Harbor, Buffalo... temporary safety zone in the Buffalo Outer Harbor, Buffalo, NY for the Boom Days Fireworks. This zone is intended to restrict vessels from Doug's Dive, the NFTA small boat harbor and a portion of the Buffalo...

  9. 76 FR 43712 - Notice of Inventory Completion: American Museum of Natural History, New York, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-07-21

    ... National Park Service Notice of Inventory Completion: American Museum of Natural History, New York, NY AGENCY: National Park Service, Interior. ACTION: Notice. SUMMARY: The American Museum of Natural History... human remains may contact the American Museum of Natural History. Repatriation of the human remains...

  10. Contribution of Cultural Eutrophication to Marsh Loss in Jamaica Bay (NY)

    EPA Science Inventory

    Loss of salt marsh area in the Jamaica Bay Estuary (NY) has accelerated in recent years, with loss rates as high as 45 acres per year. A contributing factor to this acceleration is likely cultural eutrophication due to over 6 decades of sewage effluent inputs. We examined marsh...

  11. 78 FR 74009 - Safety Zone; Nike Fireworks, Upper New York Bay, Ellis Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-12-10

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF HOMELAND SECURITY Coast Guard 33 CFR Part 165 Safety Zone; Nike Fireworks, Upper New York Bay, Ellis Island, NY..., 2011 (76 FR 69614). ] Table 1 1. Nike Fireworks Ellis Launch site: A barge located Island Safety Zone...

  12. 77 FR 60044 - Safety Zone; DeStefano Wedding Fireworks Display, Patchogue Bay, Patchogue, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-02

    ... SECURITY Coast Guard 33 CFR Part 165 RIN 1625-AA00 Safety Zone; DeStefano Wedding Fireworks Display...Stefano family wedding fireworks display. This action is necessary to provide for the safety of life on... Zone; DeStefano Wedding Fireworks Display, Patchogue Bay, Patchogue, NY in the Federal Register (77...

  13. 77 FR 51473 - Safety Zone; Bostock 50th Anniversary Fireworks, Long Island Sound; Manursing Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-24

    ... Island Sound; Manursing Island, NY AGENCY: Coast Guard, DHS. ACTION: Final rule. SUMMARY: The Coast Guard is establishing a temporary safety zone on the navigable waters of Long Island Sound in the vicinity... all vessels from a portion of Long Island Sound before, during, and immediately after the...

  14. 78 FR 51061 - Special Anchorage Areas; Port of New York, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-20

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF HOMELAND SECURITY Coast Guard 33 CFR Part 110 RIN 1625-AA01 Special Anchorage Areas; Port of New York, NY AGENCY... convenient access to public transportation, onshore shopping and amenities which facilitate interstate...

  15. 33 CFR 165.172 - Safety Zone; Underwater Hazard, Gravesend Bay, Brooklyn, NY.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 2 2011-07-01 2011-07-01 false Safety Zone; Underwater Hazard... § 165.172 Safety Zone; Underwater Hazard, Gravesend Bay, Brooklyn, NY. (a) Location. The following area... into, transiting through, diving, dredging, dumping, fishing, trawling, conducting salvage operations...

  16. 77 FR 25400 - Foreign-Trade Zone 109-Watertown, NY; Application for Manufacturing Authority; North American...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-04-30

    ... Foreign-Trade Zones Board Foreign-Trade Zone 109--Watertown, NY; Application for Manufacturing Authority; North American Tapes, LLC; Comment Period on New Evidence The FTZ Board is inviting public comment on new evidence submitted on behalf of North American Tapes, LLC (NAT), in the applicant's rebuttal...

  17. 75 FR 33327 - Notice of Inventory Completion: New York University College of Dentistry, New York, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-11

    ... National Park Service Notice of Inventory Completion: New York University College of Dentistry, New York... Dentistry, New York, NY. The human remains were removed from the Allred Bluff and Salts Bluff Rockshelters... assessment of the human remains was made by the New York University College of Dentistry professional...

  18. 75 FR 33329 - Notice of Inventory Completion: New York University College of Dentistry, New York, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-11

    ... National Park Service Notice of Inventory Completion: New York University College of Dentistry, New York... of Dentistry, New York, NY. The human remains were removed from the cemetery at Kienuka, Niagara... assessment of the human remains was made by the New York University College of Dentistry professional...

  19. 77 FR 43167 - Safety Zone; Electric Zoo Fireworks, East River, Randall's Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-24

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF HOMELAND SECURITY Coast Guard 33 CFR Part 165 RIN 1625-AA00 Safety Zone; Electric Zoo Fireworks, East River, Randall... Zone; Electronic Zoo Fireworks, East River, Randall's Island, NY. (a) Regulated Area. The following...

  20. ATMOSPHERIC MERCURY BEHAVIOR AT DIFFERENT ALTITUDES AT NY-ALESUND DURING SPRING 2003

    EPA Science Inventory

    Intensive field measurements of atmospheric mercury and related species were carried out in Ny Alesund, Spitsbergen during the spring of 2003 at two altitudes. Measurements were made at the Italian research station Dirigibile Italia (12m a.s.l.) and on the top of Zeppelin Mountai...

  1. 33 CFR 100.106 - Freeport Grand Prix, Long Beach, NY.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Freeport Grand Prix, Long Beach... Beach, NY. (a) Regulated area. The regulated area is a trapezoidal area on the coastal Atlantic waters of Long Island to the south of Long Beach, New York. The regulated area is one and one quarter (11/4...

  2. Contribution of Cultural Eutrophication to Marsh Loss in Jamaica Bay (NY)

    EPA Science Inventory

    Loss of salt marsh area in the Jamaica Bay Estuary (NY) has accelerated in recent years, with loss rates as high as 45 acres per year. A contributing factor to this acceleration is likely cultural eutrophication due to over 6 decades of sewage effluent inputs. We examined marsh...

  3. 77 FR 49730 - Safety Zone; Antique Boat Show, Niagara River, Grand Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-17

    ... Mercurio, Chief of Waterway Management, U.S. Coast Guard Sector Buffalo; telephone 716-843-9343, email SectorBuffaloMarineSafety@uscg.mil . If you have questions on viewing or submitting material to the... Grand Island, NY. ] The Captain of the Port Buffalo has determined that hydroplane racing...

  4. 77 FR 30451 - Safety Zone; Olcott Fireworks, Lake Ontario, Olcott, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-23

    ... Management, U.S. Coast Guard Sector Buffalo; telephone 716-843-9343, email SectorBuffaloMarineSafety@uscg.mil... near Olcott, NY. The Captain of the Port Buffalo has determined that fireworks launched proximate to... anchoring within the proposed safety zone is prohibited unless authorized by the Captain of the Port...

  5. 77 FR 39406 - Safety Zone; Tom Graves Memorial Fireworks, Port Bay, Wolcott, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-03

    .... Coast Guard Sector Buffalo; telephone 716- 843-9343, email SectorBuffaloMarineSafety@uscg.mil . If you... display will be held on Port Bay near Wolcott, NY. The Captain of the Port Buffalo has determined that... Buffalo has determined that this temporary safety zone is necessary to ensure the safety of spectators...

  6. 77 FR 38482 - Safety Zone; Oswego Independence Celebration Fireworks, Oswego Harbor, Oswego, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-28

    ..., Chief of Waterways Management, U.S. Coast Guard Sector Buffalo; telephone 716- 843-9343, email SectorBuffaloMarineSafety@uscg.mil . If you have questions on viewing or submitting material to the docket, call... be held on Oswego Harbor near Oswego, NY. The Captain of the Port Buffalo has determined...

  7. NY-ESO-1 expression in DCIS: A new predictor of good prognosis.

    PubMed

    Coombes, R Charles; Caballero, Otavia L; Shousha, Sami; Ghaem-Maghami, Sadaf; Woodley-Barker, Laura; Wilhelm-Benartzi, Charlotte S; Neville, A Munro

    2017-03-01

    At present, it is difficult to predict which patients with ductal carcinoma-in-situ (DCIS) will subsequently develop frank invasive breast cancer (IDC). A recent survey by our group has shown that NY-ESO-1 and MAGEA are both expressed in DCIS. This study was aimed at determining whether expression of these antigens was related to the later development of IDC. 14 of 42 (33%) of patients developed invasive breast cancer during the follow up period. Only one of those DCIS cases that relapsed was positive for NYESO-1 at diagnosis. In contrast, DCIS samples of 15 of the 28 (54%) of those patients who remained disease-free expressed NY-ESO-1. (Permutation chi square p=0.0033). We identified 42 patients with DCIS, and followed them up for more than 10 years. NY-ESO-1 and MAGEA were demonstrated by immunostaining as were CD8+ infiltrates on all sections together with the conventional markers, ER, PR, and HER2. Expression of NY-ESO-1 may predict those patients who will not subsequently develop invasive breast cancer and could therefore potentially be helpful in defining prognosis in patients with DCIS.

  8. 78 FR 31454 - Drawbridge Operation Regulation; Hudson River, Troy and Green Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-24

    .... USCG-2013-0257] RIN 1625-AA09 Drawbridge Operation Regulation; Hudson River, Troy and Green Island, NY... modify the operating schedule that governs the highway bridge (Troy Green Island) across the Hudson River, mile 152.7, between Troy and Green Island, New York. The owner of the bridge, New York State Department...

  9. 33 CFR 110.156 - Randall Bay, Freeport, Long Island, N.Y.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... Island, N.Y. 110.156 Section 110.156 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.156 Randall Bay, Freeport, Long Island, N... available, may be assigned to any vessel by the Captain of the Port of Long Island Sound. (2) The Captain of...

  10. 33 CFR 110.156 - Randall Bay, Freeport, Long Island, N.Y.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Randall Bay, Freeport, Long Island, N.Y. 110.156 Section 110.156 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.156 Randall Bay, Freeport, Long Island, N...

  11. 33 CFR 110.156 - Randall Bay, Freeport, Long Island, N.Y.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ... Island, N.Y. 110.156 Section 110.156 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.156 Randall Bay, Freeport, Long Island, N... available, may be assigned to any vessel by the Captain of the Port of Long Island Sound. (2) The Captain of...

  12. 33 CFR 110.156 - Randall Bay, Freeport, Long Island, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Randall Bay, Freeport, Long Island, N.Y. 110.156 Section 110.156 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.156 Randall Bay, Freeport, Long Island, N...

  13. 33 CFR 110.156 - Randall Bay, Freeport, Long Island, N.Y.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... Island, N.Y. 110.156 Section 110.156 Navigation and Navigable Waters COAST GUARD, DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Anchorage Grounds § 110.156 Randall Bay, Freeport, Long Island, N... available, may be assigned to any vessel by the Captain of the Port of Long Island Sound. (2) The Captain of...

  14. 78 FR 41844 - Safety Zone; Fairfield Estates Fireworks Display, Atlantic Ocean, Sagaponack, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-07-12

    ..., Atlantic Ocean, Sagaponack, NY AGENCY: Coast Guard, DHS. ACTION: Temporary final rule. SUMMARY: The Coast Guard is establishing a temporary safety zone on the navigable waters of the Atlantic Ocean, in... safety of life on navigable waters during the event. Entering into, transiting through,...

  15. ATMOSPHERIC MERCURY BEHAVIOR AT DIFFERENT ALTITUDES AT NY-ALESUND DURING SPRING 2003

    EPA Science Inventory

    Intensive field measurements of atmospheric mercury and related species were carried out in Ny Alesund, Spitsbergen during the spring of 2003 at two altitudes. Measurements were made at the Italian research station Dirigibile Italia (12m a.s.l.) and on the top of Zeppelin Mountai...

  16. NY Serpentis: SU UMa-type nova in the period gap with diversity of normal outbursts

    NASA Astrophysics Data System (ADS)

    Pavlenko, Elena P.; Kato, Taichi; Antonyuk, Oksana I.; Ohshima, Tomohito; Hambsch, Franz-Josef; Antonyuk, Kirill A.; Sosnovskij, Aleksei A.; Baklanov, Alex V.; Shugarov, Sergey Yu.; Pit, Nikolaj V.; Nakata, Chikako; Masi, Gianluca; Nakajima, Kazuhiro; Maehara, Hiroyuki; Dubovsky, Pavol A.; Kudzej, Igor; Andreev, Maksim V.; Kuznyetsova, Yuliana G.; Vasiliskov, Kirill A.

    2014-12-01

    We present a photometric study of NY Ser, an in-the-gap SU UMa-type nova, in 2002 and 2013. We determined the duration of its superoutburst and the mean period of its superhump are 18 d and 0.10458 d, respectively. We detected in 2013 that NY Ser showed two distinct states separated by a superoutburst. A state of rather infrequent normal outbursts lasted at least 44 d before the superoutburst, and a state of frequent outbursts started immediately after the superoutburst and lasted at least 34 d. Unlike a typical SU UMa star with a bimodal distribution of outburst duration, NY Ser displayed a diversity of normal outbursts. In the state of infrequent outbursts, we detected a wide ˜ 12 d outburst accompanied by 0.098 d orbital modulation but without superhumps ever established in NY Ser. We classified this as a "wide normal outburst." The orbital period was dominant both in quiescence and during normal outbursts in this state. In the state of the most frequent normal outbursts, the 0.10465 d positive superhump period was dominant and coexisted with the orbital modulation. In 2002 we detected the normal outburst of "intermediate" 5-6 d duration that was also accompanied by orbital modulations.

  17. 76 FR 4078 - Television Broadcasting Services; North Pole and Plattsburgh, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-01-24

    ... From the Federal Register Online via the Government Publishing Office FEDERAL COMMUNICATIONS COMMISSION 47 CFR Part 73 Television Broadcasting Services; North Pole and Plattsburgh, NY AGENCY: Federal... CFR Part 73 Television, Television broadcasting. For the reasons discussed in the preamble, the...

  18. 77 FR 51614 - CSX Transportation, Inc.-Abandonment Exemption-in Niagara County, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-24

    ... Surface Transportation Board CSX Transportation, Inc.--Abandonment Exemption--in Niagara County, NY CSX... over the line either is pending with the Surface Transportation Board (Board) or with any U.S. District... September 13, 2012, with the Surface Transportation Board, 395 E Street SW., Washington, DC 20423-0001....

  19. SOURCE CHARACTERIZATION AND CONTROL TECHNOLOGY ASSESSMENT OF METHYLENE CHLORIDE EMISSIONS FROM EASTMAN KODAK COMPANY, ROCHESTER, NY

    EPA Science Inventory

    The report gives results of an assessment of potential control technologies for methylene chloride (also known as dichloromethane or DCM) emission sources at Eastman Kodak Company's Kodak Park facility in Rochester, NY. DCM is a solvent used by Kodak in the manufacture of cellulo...

  20. 33 CFR 165.166 - Safety Zone: Macy's July 4th Fireworks, East River, NY.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 2 2010-07-01 2010-07-01 false Safety Zone: Macy's July 4th... OF HOMELAND SECURITY (CONTINUED) PORTS AND WATERWAYS SAFETY REGULATED NAVIGATION AREAS AND LIMITED... § 165.166 Safety Zone: Macy's July 4th Fireworks, East River, NY. (a) Regulated area. The following area...

  1. 77 FR 37737 - Environmental Impact Statement for the Northeast Corridor Between Washington, DC, New York, NY...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-22

    ... Washington, DC, New York, NY, and Boston, MA AGENCY: Federal Railroad Administration (FRA), DOT. ACTION...) to evaluate potential passenger rail improvements between Washington, DC, New York City, and Boston..., 1200 New Jersey Avenue SE., Washington, DC 20590; by email at info@necfuture.com , or; through the NEC...

  2. 77 FR 39638 - Safety Zone; Barbara Harder Wedding Fireworks, Lake Erie, Lake View, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-05

    ... No. USCG-2012-0568] RIN 1625-AA00 Safety Zone; Barbara Harder Wedding Fireworks, Lake Erie, Lake View... temporary safety zone on Lake Erie, Lake View, NY. This safety zone is intended to restrict vessels from a portion of Lake Erie during the Barbara Harder Wedding Fireworks. This temporary safety zone is necessary...

  3. 77 FR 41271 - Safety Zone; Newburgh to Beacon Swim, Newburgh, Hudson River, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-13

    ... SECURITY Coast Guard 33 CFR Part 165 RIN 1625-AA00 Safety Zone; Newburgh to Beacon Swim, Newburgh, Hudson... Newburgh, NY for the annual Newburgh Beacon Swim event. This temporary safety zone is necessary to protect... Beacon Swim is an annual recurring event that has a permanent safety zone found at 33 CFR 165.160. The...

  4. 78 FR 33972 - Safety Zone; RXR Sea Faire Celebration Fireworks, Glen Cove, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-06-06

    ... SECURITY Coast Guard 33 CFR Part 165 RIN 1625-AA00 Safety Zone; RXR Sea Faire Celebration Fireworks, Glen... Cove, NY for a fireworks display. This temporary safety zone is necessary to protect spectators and vessels from the hazards associated with fireworks displays. This rule is intended to restrict all...

  5. 77 FR 13516 - Safety Zone; Antique Boat Show, Niagara River, Grand Island, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-07

    ... SECURITY Coast Guard 33 CFR Part 165 RIN 1625--AA00 Safety Zone; Antique Boat Show, Niagara River, Grand... intended to restrict vessels from a portion of the Niagara River during the Antique Boat Show powerboat... power boat races will take place on the Niagara River near Grand Island, NY. The Captain of the Port...

  6. 78 FR 23845 - Drawbridge Operation Regulations; Narrow Bay, Smith Point, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-23

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Narrow Bay, Smith Point, NY AGENCY... the Smith Point Bridge, mile 6.1, across Narrow Bay, between Smith Point and Fire Island, New York. The deviation is necessary to facilitate the Smith Point Triathlon. This deviation allows the bridge...

  7. 76 FR 60733 - Drawbridge Operation Regulations; Narrow Bay, Smith Point, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-30

    ... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Narrow Bay, Smith Point, NY AGENCY... the Smith Point Bridge, 6.1, across Narrow Bay, between Smith Point and Fire Island, New York. The.... SUPPLEMENTARY INFORMATION: The Smith Point Bridge, across Narrow Bay, mile 6.1, between Smith Point and Fire...

  8. POLLUTION PREVENTION OPPORTUNITY ASSESSMENT: GENERAL MAIL AND VEHICLE MAINTENANCE FACILITY, UNITED STATES POSTAL SERVICE, BUFFALO, NY

    EPA Science Inventory

    The Pollution Prevention Opportunity Assessment (PPOA) summarized here was conducted at a U.S.Postal Service (USPS) Facility in Buffalo, NY. The PPOA documented and quantified waste generation at the General Mail Facility (GMF) where mail is processed, and at the Vehicle Maintena...

  9. POLLUTION PREVENTION OPPORTUNITY ASSESSMENT: GENERAL MAIL AND VEHICLE MAINTENANCE FACILITY, UNITED STATES POSTAL SERVICE, BUFFALO, NY

    EPA Science Inventory

    The Pollution Prevention Opportunity Assessment (PPOA) summarized here was conducted at a U.S.Postal Service (USPS) Facility in Buffalo, NY. The PPOA documented and quantified waste generation at the General Mail Facility (GMF) where mail is processed, and at the Vehicle Maintena...

  10. 78 FR 27856 - Golden Nematode; Removal of Regulated Areas in Livingston and Steuben Counties, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-13

    ... Animal and Plant Health Inspection Service 7 CFR Part 301 Golden Nematode; Removal of Regulated Areas in Livingston and Steuben Counties, NY AGENCY: Animal and Plant Health Inspection Service, USDA. ACTION... rule concerning Executive Order 12866 and the Regulatory Flexibility Act, Executive Orders 12372...

  11. FIELD PERFORMANCE OF ADVANCED TECHNOLOGY WOODSTOVES IN GLEN FALLS, NY, 1988-89 - VOLUME I

    EPA Science Inventory

    The report gives results of an evaluation of particulate emission trends for three models of catalytic and two models of non- catalytic woodstoves under in-home burning conditions during the 1988-89 heating season in Glens Falls, NY. he results (averaging 9.4 g/h and 9.4 g/kg) sh...

  12. 76 FR 19910 - Drawbridge Operation Regulations; Harlem River, New York, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-04-11

    ... the 103rd Street (Wards Island) Pedestrian Bridge, mile 0.0, across the Harlem River at New York City... Street (Wards Island) Pedestrian Bridge, across the Harlem River, mile 0.0, at New York City, New York... SECURITY Coast Guard 33 CFR Part 117 Drawbridge Operation Regulations; Harlem River, New York, NY AGENCY...

  13. 75 FR 65523 - Dawson Metal Company, Inc., Industrial Division, Jamestown, NY; Notice of Negative Determination...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-10-25

    ... Employment and Training Administration Dawson Metal Company, Inc., Industrial Division, Jamestown, NY; Notice... metal fabrication. The initial negative determination based on the findings that the subject firm did... regarding ] purchases of precision sheet metal fabrication for 2007, 2008, and January through April...

  14. 75 FR 66796 - Multina, USA, Including On-Site Leased Workers From Westaff, Plattsburgh, NY; Amended...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-10-29

    ... working on-site at the ] Plattsburgh, New York location of Multina, USA. The amended notice applicable to... Employment and Training Administration Multina, USA, Including On-Site Leased Workers From Westaff, Plattsburgh, NY; Amended Certification Regarding Eligibility To Apply for Worker Adjustment Assistance...

  15. 75 FR 31511 - Oneida Financial Corp., Oneida, NY; Approval of Conversion Application

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-03

    ... Office of Thrift Supervision Oneida Financial Corp., Oneida, NY; Approval of Conversion Application... Oneida Financial, MHC and Oneida Savings Bank, Oneida, New York, to convert to the stock form of... 20552, and the OTS Northeast Regional Office, Harborside Financial Center Plaza Five, Suite 1600,...

  16. 75 FR 11938 - BG Labs, Binghamton, NY; Notice of Termination of Investigation

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-12

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF LABOR Employment and Training Administration BG Labs, Binghamton, NY; Notice of Termination of Investigation... a petition filed on May 26, 2009 by a company official on behalf of workers of BG Labs, Binghamton...

  17. 77 FR 73648 - Town of Stuyvesant, NY; Albany Engineering Corporation; Notice of Availability of Final...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-11

    ...] Town of Stuyvesant, NY; Albany Engineering Corporation; Notice of Availability of Final Environmental Assessment In accordance with the National Environmental Policy Act of 1969 and the Federal Energy Regulatory... Project located on Kinderhook Creek in Columbia County, New York, and prepared a final Environmental...

  18. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".

    PubMed

    Yang, Yutao; Alcaraz, Ana A; Snyder, James P

    2009-03-27

    Nearly 35 years after its discovery and 11 years after FDA approval of paclitaxel (PTX) as a breakthrough anticancer drug, the 3-D structure of the agent bound to its beta-tubulin target was proposed to be T-Taxol. The latter bioactive form has recently been challenged by the Ojima group with a structure, "PTX-NY" ("REDOR Taxol"), in which the C-13 side chain is proposed to adopt a different conformation and an alternative hydrogen-bonding pattern in the tubulin binding site. Previously, the two conformers were compared to show that only T-Taxol fits the PTX-derived electron crystallographic density. That work has been extended by molecular mechanics and quantum chemical methods to reveal that the PTX-NY conformation is relatively less stable, on average, by 10-11 kcal/mol. In agreement with NMR studies, an 11 ns molecular dynamics treatment for PTX in an explicit water pool locates T-Taxol along the trajectory, but not PTX-NY. Docking of various PTX conformers into the electron crystallographic binding site of tubulin demonstrates that PTX-NY cannot be accommodated unless the pocket is reorganized in violation of the experimental constraints. Finally, analysis of the structures of T-Taxol and PTX-NY for their capacity to predict the existence of superpotent PTX analogues discloses that only the former forecasts such analogues, as now established by the T-Taxol-inspired synthesis of bridged taxanes. In sum, all empirical criteria support T-Taxol as the bound conformation of PTX on beta-tubulin in microtubules.

  19. NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.

    PubMed

    Theurillat, Jean-Philippe; Zürrer-Härdi, Ursina; Varga, Zsuzsanna; Storz, Martina; Probst-Hensch, Nicole M; Seifert, Burkhardt; Fehr, Mathias K; Fink, Daniel; Ferrone, Soldano; Pestalozzi, Bernhard; Jungbluth, Achim A; Chen, Yao-Tseng; Jäger, Dirk; Knuth, Alexander; Moch, Holger

    2007-11-01

    NY-BR-1 is a recently identified differentiation antigen of the mammary gland. To use NY-BR-1 for T-cell-based immunotherapy, analysis of its co-expression with HLA class I antigens is required. In the present tissue microarray study, primary breast cancers (n = 1,444), recurrences (n = 88), lymph node (n = 525) and distant metastases (n = 91) were studied for NY-BR-1 expression using a novel monoclonal antibody. NY-BR-1 expression was compared with prognosis, estrogen receptor, HER2-status, EGFR and HLA class I antigen expression. NY-BR-1 was more frequently expressed in grade 1 (82%) than in grade 2 (69%) and grade 3 (46%) carcinomas (P < 0.0001). Moreover, NY-BR-1 expression correlated directly with estrogen receptor expression (P < 0.0001) and inversely correlated with HER2-status and EGFR expression (P < 0.0001 for both). Considering high expression level of co-expression, 198/1,321 (15%) primary breast carcinomas and 4/65 (6%) distant metastases expressed NY-BR-1 and HLA class I, suggesting that active immunotherapy can be applied to about 10% of breast cancer patients. Survival analysis showed an association of NY-BR-1 expression with better patient outcome (P = 0.015). No difference between NY-BR-1 expression of primary tumors and metastases could be found, indicating that the presence of NY-BR-1 in metastases can be deduced from their corresponding primary. Forty-three paired biopsies taken from patients before and after chemotherapy suggest that NY-BR-1 expression is not influenced by preceding chemotherapy (kappa = 0.89, P < 0.0001). In summary, the co-expression of NY-BR-1 with HLA class I antigens and its expression in metastases without modification by chemotherapy suggest that NY-BR-1 targeted immunotherapy represents a viable strategy in addition to other targeted cancer drug therapies of breast cancer.

  20. Efficiency of gate control in double-interdigitated (TIL) GTO thyristors

    NASA Astrophysics Data System (ADS)

    Silard, A. P.

    1986-04-01

    The research reported in this work was focused on the efficiency of gate control during turn-off in the recently developed double-interdigitated (TIL) GTO thyristors. The 8 mm 2 area, TO-220 packaged, high voltage test devices were investigated under both current and voltage input conditions. The main monitored parameters were: the peak turn-off gain Koff(max), the components of the turn-off time and the gate pulse width tgr. During the tests the TIL GTOs were driven up to an anode current iT = 50 A, a value equal to the non-repetitive peak on-state current ( ITSM) of these thyristors. The performed investigations have shown that these novel GTO devices possess a good efficiency of gate control expressed by: 1) low power consumption by the gate under both current and voltage drive conditions; 2) extremely high turn-off gain Koff(max), which is an increasing function of the anode current in a wide range of gate signals amplitudes and durations; 3) fast turn-off of large amounts of anode current with relatively short gate pulse widths; 4) substantial reduction of the storage time ts and fall time tf through adequate current or voltage drive. Design/behavioral details are given, which are useful in the implementation of the TIL concept in GTOs and other power switching devices, such as the bipolar transistors.

  1. Temperature-induced lipocalin (TIL): a shield against stress-inducing environmental shocks in Saccharomyces cerevisiae.

    PubMed

    Berterame, Nadia Maria; Bertagnoli, Stefano; Codazzi, Vera; Porro, Danilo; Branduardi, Paola

    2017-09-01

    The yeast Saccharomyces cerevisiae is a well-established workhorse, either for recombinant or natural products, thanks to its natural traits and easily editable metabolism. However, during a bio-based industrial process it meets multiple stresses generated by operative conditions such as non-optimal temperature, pH, oxygenation and product accumulation. The development of tolerant strains is therefore indispensable for the improvement of production, yield and productivity of fermentative processes. In this regard, plants as resilient organisms are a generous source for fishing genes and/or metabolites that can help the cell factory to counteract environmental constraints. Plants possess proteins named temperature-induced lipocalins, TIL, whose levels in the cells correlates with the tolerance to sudden temperature changes and with the scavenging of reactive oxygen species. In this work, the gene encoding for the Arabidopsis thaliana TIL protein was for the first time expressed in S. cerevisiae. The recombinant strain was compared and analysed against the parental counterpart under heat shock, freezing, exposure to organic acid and oxidative agents. In all the tested conditions, TIL expression conferred a higher tolerance to the stress imposed, making this strain a promising candidate for the development of robust cell factories able to overtake the major impairments of industrial processes. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

  2. Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo.

    PubMed

    Liu, Yanan; Tian, Xiaoli; Leitner, Wolfgang W; Aldridge, Michael E; Zheng, Junying; Yu, Zhiya; Restifo, Nicholas P; Weiss, Richard; Scheiblhofer, Sandra; Xie, Chong; Sun, Ren; Cheng, Genhong; Zeng, Gang

    2011-10-28

    In search of intrinsic factors that contribute to the distinctively strong immunogenicity of a non-mutated cancer/testis antigen, we found that NY-ESO-1 forms polymeric structures through disulfide bonds. NY-ESO-1 binding to immature dendritic cells was dependent on its polymeric structure and involved Toll-like receptor-4 (TLR4) on the surface of immature dendritic cells in mouse and human. Gene gun-delivered plasmid encoding the wild-type NY-ESO-1 readily induced T cell-dependent antibody (Ab) responses in wild-type C57BL/10 mice but not TLR4-knock-out C57BL/10ScNJ mice. Disrupting polymeric structures of NY-ESO-1 by cysteine-to-serine (Cys-to-Ser) substitutions lead to diminished immunogenicity and altered TLR4-dependence in the induced Ab response. To demonstrate its adjuvant effect, NY-ESO-1 was fused with a major mugwort pollen allergen Art v 1 and a tumor-associated antigen, carbonic anhydrase 9. Plasmid DNA vaccines encoding the fusion genes generated robust immune responses against otherwise non-immunogenic targets in mice. Polymeric structure and TLR4 may play important roles in rendering NY-ESO-1 immunogenic and thus serve as a potent molecular adjuvant. NY-ESO-1 thus represents the first example of a cancer/testis antigen that is a also damage-associated molecular pattern.

  3. Polymeric Structure and Host Toll-like Receptor 4 Dictate Immunogenicity of NY-ESO-1 Antigen in Vivo*

    PubMed Central

    Liu, Yanan; Tian, Xiaoli; Leitner, Wolfgang W.; Aldridge, Michael E.; Zheng, Junying; Yu, Zhiya; Restifo, Nicholas P.; Weiss, Richard; Scheiblhofer, Sandra; Xie, Chong; Sun, Ren; Cheng, Genhong; Zeng, Gang

    2011-01-01

    In search of intrinsic factors that contribute to the distinctively strong immunogenicity of a non-mutated cancer/testis antigen, we found that NY-ESO-1 forms polymeric structures through disulfide bonds. NY-ESO-1 binding to immature dendritic cells was dependent on its polymeric structure and involved Toll-like receptor-4 (TLR4) on the surface of immature dendritic cells in mouse and human. Gene gun-delivered plasmid encoding the wild-type NY-ESO-1 readily induced T cell-dependent antibody (Ab) responses in wild-type C57BL/10 mice but not TLR4-knock-out C57BL/10ScNJ mice. Disrupting polymeric structures of NY-ESO-1 by cysteine-to-serine (Cys-to-Ser) substitutions lead to diminished immunogenicity and altered TLR4-dependence in the induced Ab response. To demonstrate its adjuvant effect, NY-ESO-1 was fused with a major mugwort pollen allergen Art v 1 and a tumor-associated antigen, carbonic anhydrase 9. Plasmid DNA vaccines encoding the fusion genes generated robust immune responses against otherwise non-immunogenic targets in mice. Polymeric structure and TLR4 may play important roles in rendering NY-ESO-1 immunogenic and thus serve as a potent molecular adjuvant. NY-ESO-1 thus represents the first example of a cancer/testis antigen that is a also damage-associated molecular pattern. PMID:21900253

  4. Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.

    PubMed

    Schuberth, P C; Jakka, G; Jensen, S M; Wadle, A; Gautschi, F; Haley, D; Haile, S; Mischo, A; Held, G; Thiel, M; Tinguely, M; Bifulco, C B; Fox, B A; Renner, C; Petrausch, U

    2013-04-01

    The cancer-testis antigen NY-ESO-1 is a potential target antigen for immune therapy expressed in a subset of patients with multiple myeloma. We generated chimeric antigen receptors (CARs) recognizing the immunodominant NY-ESO-1 peptide 157-165 in the context of HLA-A*02:01 to re-direct autologous CD8(+) T cells towards NY-ESO-1(+) myeloma cells. These re-directed T cells specifically lysed NY-ESO-1(157-165)/HLA-A*02:01-positive cells and secreted IFNγ. A total of 40% of CCR7(-) re-directed T cells had an effector memory phenotype and 5% a central memory phenotype. Based on CCR7 cell sorting, effector and memory CAR-positive T cells were separated and CCR7(+) memory cells demonstrated after antigen-specific re-stimulation downregulation of CCR7 as sign of differentiation towards effector cells accompanied by an increased secretion of memory signature cytokines such as IL-2. To evaluate NY-ESO-1 as potential target antigen, we screened 78 bone marrow biopsies of multiple myeloma patients where NY-ESO-1 protein was found to be expressed by immunohistochemistry in 9.7% of samples. Adoptively transferred NY-ESO-1-specific re-directed T cells protected mice against challenge with endogenously NY-ESO-1-positive myeloma cells in a xenograft model. In conclusion, re-directed effector- and central memory T cells specifically recognized NY-ESO-1(157-165)/ HLA-A*02:01-positive cells resulting in antigen-specific functionality in vitro and in vivo.

  5. NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma.

    PubMed

    Pollack, Seth M; Jungbluth, Achim A; Hoch, Benjamin L; Farrar, Erik A; Bleakley, Marie; Schneider, David J; Loggers, Elizabeth T; Rodler, Eve; Eary, Janet F; Conrad, Ernest U; Jones, Robin L; Yee, Cassian

    2012-09-15

    Myxoid/round cell liposarcoma (MRCL) is the second most common liposarcoma subtype, accounting for >33% of liposarcomas and approximately 10% of all soft tissue sarcomas. Although MRCL is a chemosensitive subtype, patients with metastatic disease have a poor outcome. NY-ESO-1 is a cancer-testis antigen (also known as cancer germ cell antigen) that has been successfully targeted in vaccine trials and in adoptive T-cell therapy trials for the treatment of several solid tumors. The authors investigated the feasibility of targeting NY-ESO-1 in patients with MRCL by evaluating the prevalence of NY-ESO-1 expression in tumors using immunohistochemistry and quantitative reverse transcriptase-polymerase chain reaction analysis. NY-ESO-1-specific tumor recognition by NY-ESO-1-specific T-cells also was analyzed using a chromium release assay. A search of the University of Washington Sarcoma Tissue Bank identified paraffin-embedded tumor samples from 25 patients with MRCL. NY-ESO-1 expression was observed in every MRCL tumor assessed (100%); in 18 tumors (72%), staining was homogenous. In all but 2 tumors, staining was sufficiently robust (2+) that such patients would be eligible for clinical trials of NY-ESO-1-directed therapy. By using NY-ESO-1 specific, CD8-positive T-cells, the in vitro sensitivity of myxoid liposarcoma cell lines to antigen-specific lysis was demonstrated. The current results establish NY-ESO-1 as an important target antigen for the treatment of patients with MRCL. Copyright © 2012 American Cancer Society.

  6. Enhancing whole-tumor cell vaccination by engaging innate immune system through NY-ESO-1/dendritic cell interactions.

    PubMed

    Xu, Le; Zheng, Junying; Nguyen, David H; Luong, Quang T; Zeng, Gang

    2013-10-01

    NY-ESO-1 is a cancer/germline antigen (Ag) with distinctively strong immunogenicity. We have previously demonstrated that NY-ESO-1 serves as an endogenous adjuvant by engaging dendritic cell (DC)-surface receptors of calreticulin (CRT) and toll-like receptor (TLR) 4. In the present study, NY-ESO-1 was investigated for its immunomodulatory roles as a molecular adjuvant in whole-tumor cell vaccines using the Renca kidney cancer model. Renca cells were genetically engineered to express NY-ESO-1 on the cell surface to enhance direct interactions with DC. The effect of ectopic cell-surface expression of NY-ESO-1 was investigated on tumor immunogenicity, DC activation, cytotoxic T lymphocytes against model tumor-associated Ags, and the effectiveness of the modified tumor cells as a therapeutic whole-cell vaccine. Cell-surface expression of NY-ESO-1 was able to reduce the tumor growth of Renca cells in BALB/c mice, although the modification did not alter cell proliferation rate in vitro. Directly engaging the innate immune system through NY-ESO-1 facilitated the interaction of tumor cells with DC, leading to enhanced DC activation and subsequent tumor-specific T-cell priming. When used as a therapeutic whole-cell vaccine, Renca cells with NY-ESO-1 on the surface mediated stronger inhibitory effects on tumor growth and metastasis compared with parental Renca or Renca cells expressing a control protein GFP on the surface. Augmented antitumor efficacy correlated with increased CD8 T-cell infiltration into tumors and decreased myeloid-derived suppressor cells and regulatory T cells in the spleen. As a cancer/germline Ag and as an immunomodulatory adjuvant through engaging innate immune receptors, NY-ESO-1 offers a unique opportunity for improved whole-tumor cell vaccinations upon the classic GM-CSF-engineered cell vaccines.

  7. Preclinical safety pharmacology study of a novel protein-based cancer vaccine CHP-NY-ESO-1.

    PubMed

    Harada, Naozumi; Hoshiai, Kiyotaka; Takahashi, Yoshiyasu; Sakaguchi, Yasue; Kuno, Takayoshi; Hishida, Tadashi; Shiku, Hiroshi

    2008-05-23

    CHP-NY-ESO-1 is a novel therapeutic cancer vaccine consisting of a recombinant protein of cancer antigen NY-ESO-1 and a polysaccharide-based delivery system, cholesteryl pullulan. A pilot clinical study of CHP-NY-ESO-1 in cancer patients was previously conducted, and the adverse events related to this drug were observed to be limited to skin reactions at injection sites. To further establish the safety of CHP-NY-ESO-1, we studied the effects of its subcutaneous injection on vital functions such as the central nervous system, cardiovascular system and respiratory system using preclinical animal models. The effects of CHP-NY-ESO-1 on the cardiovascular system were investigated in dogs using a telemetry system for blood pressure and heart rate and the Holter monitoring for ambulatory electrocardiograms. No drug-related changes were observed in these parameters. The effect of CHP-NY-ESO-1 on the hERG-dependent potassium currents was also examined using in vitro cultured cell system, and no inhibition of hERG currents was observed. The effects of CHP-NY-ESO-1 on the central nervous system were examined in rats using functional observational battery method, and no drug-related changes were observed in home cage observations, open field observations, hand held observations, and perception and motor function observations. The effect of CHP-NY-ESO-1 on the respiratory system was investigated in rats by measuring tidal volume, minute volume and respiratory rate using whole-body plethysmograph method, and no significant changes were found in these parameters. These results indicate that CHP-NY-ESO-1 would not have any pharmacological effects on vital functions and support the safety of this cancer vaccine for clinical use.

  8. Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.

    PubMed

    Theurillat, Jean-Philippe; Zürrer-Härdi, Ursina; Varga, Zsuzsanna; Barghorn, André; Saller, Elisabeth; Frei, Claudia; Storz, Martina; Behnke, Silvia; Seifert, Burkhardt; Fehr, Mathias; Fink, Daniel; Rageth, Christoph; Linsenmeier, Claudia; Pestalozzi, Bernhard; Chen, Yao-Tseng; Knuth, Alexander; Jäger, Dirk; Moch, Holger

    2008-04-01

    NY-BR-1 is a differentiation antigen and a potential target for cancer immunotherapy. Its mRNA expression is restricted to breast, testis, prostate and breast cancer by RT-PCR. In this study, we correlated NY-BR-1 protein and mRNA expression on tissue microarrays of mammary, prostatic and testicular malignancies using immunohistochemistry and in situ hybridization with probes for exon 4-7 and 30-33. NY-BR-1 mRNA was confined to primary spermatocytes, suggesting a role in spermatogenesis. Exon 4-7 and 30-33 were equally expressed this cell type. However, NY-BR-1 was absent in all germ cell tumours analyzed (n = 475) and present in one of 56 (2%) prostate carcinomas. In breast, NY-BR-1 mRNA expression was detected in 307 of 442 (70%) primary carcinomas, with strong correlation to its protein expression (p < 0.0001). mRNA expression was significantly stronger and more frequently detected by the exon 30-33 probe than by the exon 4-7 probe (70% vs. 35%, p < 0.0001), indicating the presence of alternative splice variants that lack 5-prime sequences. A similar restricted mRNA pattern was also observed in the normal breast epithelium. NY-BR-1 protein and mRNA correlated significantly with estrogen receptor alpha (ER alpha) protein expression (p < 0.0001), with stronger association to NY-BR-1 mRNA than protein (odds ratio 7.7 compared to 4.6). We identified 4 estrogen response elements (ERE)-like sequences nearby the promoter region, suggesting that NY-BR-1 transcription might be controlled by ER alpha. Accordingly, analysis of matching pairs of primary tumors with their recurrences showed a marked decrease of NY-BR-1 expression in recurrences after tamoxifen treatment (p < 0.0001).

  9. MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma.

    PubMed

    Bujas, T; Marusic, Z; Peric Balja, M; Mijic, A; Kruslin, B; Tomas, D

    2011-03-21

    In the present study we analyzed immunohistochemical expression of MAGE-A 3/4 and NY-ESO-1 in 55 samples of esophageal squamous cell carcinomas (ESCC) and their respective lymph node metastases. To our knowledge this is the first study to assess and compare the expression of these antigens in ESCC lymph node metastases. Fifty (90.9%) primary ESCC were positive for MAGE-A 3/4 and 53 (96.6%) were positive for NY-ESO-1. MAGE-A 3/4 was expressed in all lymph node metastases and the intensity of expression was high in a majority of cases. NY-ESO-1 was negative in 2 (7.1%) lymph nodes metastases, while the reaction was predominantly moderate in the positive group. In primary tumors MAGE-A 3/4 showed a significantly higher intensity of expression compared to NY-ESO-1 (P=0.047), while in lymph node metastases the intensity of expression was not significantly different (P=0.387). Primary tumors with and without lymph node metastases showed no significant differences in MAGE-A 3/4 (P=0.672) and NY-ESO-1 (P=0.444) expression. Intensity of MAGE-A 3/4 (P=0.461) and NY-ESO-1 (P=0.414) expression in primary tumors was not significantly different compared to the expression in their respective lymph nodes metastases. Expression of MAGE-A 3/4 in primary tumors showed significant positive correlation with primary tumor expression of NY-ESO-1 (P=0.021) but no significant correlation with the expression of MAGE-A 3/4 in lymph node metastases (P=0.056). Expression of NY-ESO-1 in primary tumors showed significant positive correlation with the expression of NY-ESO-1 in lymph node metastases (P=0.001) and significant negative correlation with patients’ age (P<0.001). Expression of MAGE-A 3/4 and NY-ESO-1 in primary tumors and lymph node metastases showed no significant correlation with prognostic parameters such as tumor grade and TNM stage (P>0.05). We have shown different levels of MAGE-A 3/4 and NY-ESO-1 expression in almost all specimens of primary tumor and lymph node

  10. Evaluation of particulate filtering respirators using inward leakage (IL) or total inward leakage (TIL) testing--Korean experience.

    PubMed

    Han, Don-Hee; Lee, Jinheon

    2005-10-01

    Korean certification regulation for particulate filtering respirators requires inward leakage (IL) or total inward leakage (TIL) testing according to European Standard EN 13274-1, and the standard levels of compliance are similar to those of the European Standard. This study was conducted to evaluate particulate filtering respirators being commercially used in the Korean market using an IL or TIL test and the validity of standard level in Korea. Three half masks and 10 filtering facepieces (two top class, four 1st class and four 2nd class)-a total of 13 brand name respirators-were selected for the test with panels of 10 subjects. Each subject was classified with nine facial dimension grid squares in accordance with face length and lip length. IL or TIL testing was conducted at the laboratory of the 3M Innovation Center in which the experimental instruments and systems were established in compliance with European standards. The testing procedure followed EN 13274-1 (2001). As expected, leakages of half masks were less than those of filtering facepieces and the latter were significantly different among brands. TILs of the 1st class filtering facepieces were found to be much more than those of the 2nd class and the result may cause a wearer to get confused when selecting a mask. The main route leakage for filtering facepieces may not be the filter medium but the face seal. Therefore, it is necessary to develop well-fitting filtering facepieces for Koreans. Because leakages were significantly different for different facial dimensions, a defined test panel for IL or TIL testing according to country or race should be developed. A more precise method to demonstrate fit, for example, fit testing such as in the US regulations, will be needed before IL or TIL testing or when selecting a respirator. Another finding implies that geometric mean of five exercises for IL or TIL may be better than arithmetic mean to establish a standard individual subject mean.

  11. NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC.

    PubMed

    Takeoka, Tomohira; Nagase, Hirotsugu; Kurose, Koji; Ohue, Yoshihiro; Yamasaki, Makoto; Takiguchi, Shuji; Sato, Eiichi; Isobe, Midori; Kanazawa, Takayuki; Matsumoto, Mitsunobu; Iwahori, Kota; Kawashima, Atsunari; Morimoto-Okazawa, Akiko; Nishikawa, Hiroyoshi; Oka, Mikio; Pan, Linda; Venhaus, Ralph; Nakayama, Eiichi; Mori, Masaki; Doki, Yuichiro; Wada, Hisashi

    2017-03-23

    We conducted a clinical trial of a cancer vaccine using NY-ESO-1 protein with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose (poly-ICLC) and/or OK-432 against solid tumors. A total of 15 patients were sequentially enrolled in 4 cohorts. Patients in cohort 1 received NY-ESO-1 protein; cohort 2a received NY-ESO-1 protein+OK-432; cohort 2b received NY-ESO-1 protein+poly-ICLC; cohort 3 received NY-ESO-1 protein+OK-432+poly-ICLC with Montanide ISA-51. The endpoints of this trial were safety, NY-ESO-1 immune responses, and clinical response. Vaccine-related adverse events observed were fever and injection-site reaction (grade 1). Two patients showed stable disease after vaccination. NY-ESO-1 antibodies were observed in 4 patients at the baseline (sero-positive) and augmented in all patients after vaccination. Eleven patients showed a conversion of negative antibody responses at baseline to positive after vaccination (seroconversion). The seroconversions were observed in all 11 sero-negative patients by the fourth immunization; in particular, it was observed by the second immunization in patients with poly-ICLC, and these induced antibody responses were stronger than those in patients immunized without poly-ICLC. The number of NY-ESO-1-specific interferon (IFN)γ-producing T cells was increased in patients immunized with poly-ICLC and/or OK-432, and furthermore, the increase of IFNγ-producing CD8 T cells in patients immunized with poly-ICLC was significantly higher than that in patients without poly-ICLC. Nonspecific activations of T-cell or antigen presenting cells were not observed. Our present study showed that poly-ICLC is a promising adjuvant for cancer vaccines.

  12. Thermophysical characterisation of ZrCxNy ceramics fabricated via carbothermic reduction-nitridation

    NASA Astrophysics Data System (ADS)

    Harrison, R.; Ridd, O.; Jayaseelan, D. D.; Lee, W. E.

    2014-11-01

    Thermophysical properties of ZrCxNy ceramics prepared from powders produced via a two-step carbothermic reduction-nitridation of zirconia were characterised to 2200 K. Preliminary evidence for the mechanism of nitridation shows a gas-solid phase reaction at the ZrC particle surface which is the first such observation with this system. Electrical and thermal conductivities were higher than commercially available ZrC and ZrN. Thermal conductivity values of the ZrCxNy phases at room temperature were between 35 and 43 Wm-1 K-1, increasing with nitrogen content due to increased electronic contribution to thermal conduction and increased to 40-50 Wm-1 K-1 with temperature. Electrical conductivity also increased with nitrogen content and values were in the range of 100-450 × 104 Ω-1 m1, but decreased with increasing temperature showing metallic behaviour.

  13. [Bárány's discovery and its reception by his contemporaries].

    PubMed

    Wyklicky, H

    1986-09-26

    Bárány's main achievement is that he unified known, but apparently contradictory facts into one perspective. The concept of a method for examining each ear individually by means of the caloric test fundamentally advanced diagnostics. In 1914 he was honoured with the Nobel Prize, but in his home town of Vienna he was denied the title of professor. Many debates took place about this. In 1917 he moved to Uppsala where he eventually became head of the laryngology department. Two reasons justify the fact that we may call Bárány an Austrian Nobel Prize Winner, firstly that he kept his loyalty to Vienna, his birth place and, secondly, that all his work for which he was awarded the Nobel Prize was done in the Vienna General Hospital.

  14. Gene-Environment Interaction and Breast Cancer on Long Island, NY

    DTIC Science & Technology

    2008-05-01

    present in many consumer products as well as many common household materials such as plastics and fragrances . Given the rising rates of asthma and...Prevention, Atlanta, GA , USA cDepartment of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA Received 30 March 2007; received in revised form...purposes such as adding flexibility to plastics and making fragrances last ARTICLE IN PRESS S.L. Teitelbaum et al. / Environmental Research 106 (2008) 257

  15. Gene-Environment Interaction and Breast Cancer on Long Island, NY

    DTIC Science & Technology

    2005-05-01

    essential for primary prevention. 14. SUBJECT TERMS 15. NUMBER OF PAGES Epidemiology, environmental exposure, endocrine disruptors , estrogen 7 receptor...residential pesticide use on Long Island, NY" 4 W81XWH-04-1-0507 o American Association for Cancer Research (AACR) and co-chaired mini-symposium on "The...estrogens, including bisphenol A, phthalates and pyrethroid pesticides . "o The collection of serial urine samples will be completed in April 2005. "o

  16. Cultural Resources Survey for the Oneida Creek Flood Control Project, NY

    DTIC Science & Technology

    1981-01-01

    PERIOD COVERED Cultural Resources Survey for the Oneida Final Creek Flood Control Project, N.Y. S. PERFORMING ORG. REPORT NUMBER... Silurian and Devonian deposits. These are, in turn, overlaid in some areas by deposits of commercial grade gypsum, glass sand and rock salt (Van Driver...the Wisconsin STate Historical Society. 1972 Crew member on excavations conducted by Dr. Jan Spector. 1972 - 1980 During this period I was a volunteer

  17. Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens.

    PubMed

    Hayes, Stephen J; Hng, Keng Ngee; Clark, Peter; Thistlethwaite, Fiona; Hawkins, Robert E; Ang, Yeng

    2014-04-14

    To assess NY-ESO-1 expression in a cohort of esophageal adenocarcinomas. A retrospective search of our tissue archive for esophageal resection specimens containing esophageal adenocarcinoma was performed, for cases which had previously been reported for diagnostic purposes, using the systematised nomenclature of human and veterinary medicine coding system. Original haematoxylin and eosin stained sections were reviewed, using light microscopy, to confirm classification and tumour differentiation. A total of 27 adenocarcinoma resection specimens were then assessed using immunohistochemistry for NY-ESO-1 expression: 4 well differentiated, 14 moderately differentiated, 4 moderate-poorly differentiated, and 5 poorly differentiated. Four out of a total of 27 cases of esophageal adenocarcinoma examined (15%) displayed diffuse cytoplasmic and nuclear expression for NY-ESO-1. They displayed a heterogeneous and mosaic-type pattern of diffuse staining. Diffuse cytoplasmic staining was not identified in any of these structures: stroma, normal squamous epithelium, normal submucosal gland and duct, Barrett's esophagus (goblet cell), Barrett's esophagus (non-goblet cell) and high grade glandular dysplasia. All adenocarcinomas showed an unexpected dot-type pattern of staining at nuclear, paranuclear and cytoplasmic locations. Similar dot-type staining, with varying frequency and size of dots, was observed on examination of Barrett's metaplasia, esophageal submucosal gland acini and the large bowel negative control, predominantly at the crypt base. Furthermore, a prominent pattern of apical (luminal) cytoplasmic dot-type staining was observed in some cases of Barrett's metaplasia and also adenocarcinoma. A further morphological finding of interest was noted on examination of haematoxylin and eosin stained sections, as aggregates of lymphocytes were consistently noted to surround submucosal glands. We have demonstrated for the first time NY-ESO-1 expression by esophageal

  18. NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability

    PubMed Central

    Sommermeyer, Daniel; Conrad, Heinke; Krönig, Holger; Gelfort, Haike; Bernhard, Helga; Uckert, Wolfgang

    2013-01-01

    The cancer-testis antigen NY-ESO-1 has been used as a target for different immunotherapies like vaccinations and adoptive transfer of antigen-specific cytotoxic T cells, as it is expressed in various tumor types and has limited expression in normal cells. The in vitro generation of T cells with defined antigen specificity by T cell receptor (TCR) gene transfer is an established method to create cells for immunotherapy. However, an extensive characterization of TCR which are candidates for treatment of patients is crucial for successful therapies. The TCR has to be efficiently expressed, their affinity to the desired antigen should be high enough to recognize low amounts of endogenously processed peptides on tumor cells, and the TCR should not be cross-reactive to other antigens. We characterized three NY-ESO-1 antigen-reactive cytotoxic T lymphocyte clones which were generated by different approaches of T cell priming (autologous, allogeneic), and transferred their TCR into donor T cells for more extensive evaluations. Although one TCR most efficiently bound MHC-multimers loaded with NY-ESO-1 peptide, T cells expressing this transgenic TCR were not able to recognize endogenously processed antigen. A second TCR recognized HLA-A2 independent of the bound peptide beside its much stronger recognition of NY-ESO-1 bound to HLA-A2. A third TCR displayed an intermediate but peptide-specific performance in all functional assays and, therefore, is the most promising candidate TCR for further clinical development. Our data indicate that multiple parameters of TCR gene-modified T cells have to be evaluated to identify an optimal TCR candidate for adoptive therapy. PMID:22907642

  19. Benign paroxysmal vertigo, and Bárány's caloric reactions.

    PubMed

    Pearce, J M S

    2007-01-01

    The Nobel Prize winner Robert Bárány described benign positional vertigo and related it to the otoliths in 1921. Dix and Hallpike further elucidated this clinically distinctive, common disorder in 1952. The displacement of otoliths from the utricle or saccule into one of the semicircular canals later proved to be the underlying mechanism, described by Schuknecht and utilised therapeutically by Semont and Epley.

  20. CIRCUMBINARY PLANETS ORBITING THE RAPIDLY PULSATING SUBDWARF B-TYPE BINARY NY Vir

    SciTech Connect

    Qian, S.-B.; Zhu, L.-Y.; Dai, Z.-B.; He, J.-J.; Xiang, F.-Y.

    2012-02-15

    We report here the tentative discovery of a Jovian planet in orbit around the rapidly pulsating subdwarf B-type (sdB-type) eclipsing binary NY Vir. By using newly determined eclipse times together with those collected from the literature, we detect that the observed-calculated (O - C) curve of NY Vir shows a small-amplitude cyclic variation with a period of 7.9 yr and a semiamplitude of 6.1 s, while it undergoes a downward parabolic change (revealing a period decrease at a rate of P-dot = -9.2 x 10{sup -12}). The periodic variation was analyzed for the light-travel-time effect via the presence of a third body. The mass of the tertiary companion was determined to be M{sub 3}sin i' = 2.3({+-} 0.3)M{sub Jupiter} when a total mass of 0.60 M{sub Sun} for NY Vir is adopted. This suggests that it is most probably a giant circumbinary planet orbiting NY Vir at a distance of about 3.3 astronomical units (AU). Since the rate of period decrease cannot be explained by true angular momentum loss caused by gravitational radiation or/and magnetic braking, the observed downward parabolic change in the O - C diagram may be only a part of a long-period (longer than 15 years) cyclic variation, which may reveal the presence of another Jovian planet ({approx}2.5 M{sub Jupiter}) in the system.

  1. 77 FR 63290 - Foreign-Trade Zone 121-Albany, NY; Notification of Proposed Production Activity; Albany Molecular...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-16

    ...; Albany Molecular Research, Inc., Subzone 121A, (Pharmaceutical Chemicals Production), Rensselaer, NY... originally approved by the Board in 1994 for the production of bulk pharmaceutical chemicals and... an active pharmaceutical ingredient, dexpramipexole dihydrochloride monohydrate, under zone...

  2. Kate Bárány: a life of science, teaching, and service.

    PubMed

    Solaro, R John; Rao, Mrinalini C

    2012-12-01

    We celebrate the lives of Michael and Kate Bárány in this issue of the Journal of Muscle Research and Cell Motility. Kate and Michael died within weeks of each other in 2011. Joe Chalovich has written about Michael and we write about Kate. As emphasized by Joe, Kate, and Michael were remarkable individuals who survived the Holocaust, the Hungarian revolution, and emerged from as much adversity as one might imagine to become productive scientists, educators, citizens, and symbols of the durability of the human spirit. They present their own story in an essay (Bárány and Bárány 2000) published in a monograph "Selected Topics in the History of Biochemistry." Rather than repeating much of the list of scientific achievements chronicled in these papers, we focus here on Kate, especially in her role as an individual and partner in science, while at the same time being an accomplished teacher, and a champion of women in science.

  3. The 1-min Screening Test for Reading Problems in College Students: Psychometric Properties of the 1-min TIL.

    PubMed

    Fernandes, Tânia; Araújo, Susana; Sucena, Ana; Reis, Alexandra; Castro, São Luís

    2017-02-01

    Reading is a central cognitive domain, but little research has been devoted to standardized tests for adults. We, thus, examined the psychometric properties of the 1-min version of Teste de Idade de Leitura (Reading Age Test; 1-min TIL), the Portuguese version of Lobrot L3 test, in three experiments with college students: typical readers in Experiment 1A and B, dyslexic readers and chronological age controls in Experiment 2. In Experiment 1A, test-retest reliability and convergent validity were evaluated in 185 students. Reliability was >.70, and phonological decoding underpinned 1-min TIL. In Experiment 1B, internal consistency was assessed by presenting two 45-s versions of the test to 19 students, and performance in these versions was significantly associated (r = .78). In Experiment 2, construct validity, criterion validity and clinical utility of 1-min TIL were investigated. A multiple regression analysis corroborated construct validity; both phonological decoding and listening comprehension were reliable predictors of 1-min TIL scores. Logistic regression and receiver operating characteristics analyses revealed the high accuracy of this test in distinguishing dyslexic from typical readers. Therefore, the 1-min TIL, which assesses reading comprehension and potential reading difficulties in college students, has the necessary psychometric properties to become a useful screening instrument in neuropsychological assessment and research. Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

  4. Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High Risk Melanoma

    PubMed Central

    Gnjatic, Sacha; Cruz, Crystal M.; Vengco, Isabelita; Hasan, Farah; Spadaccia, Meredith; Darvishian, Farbod; Chiriboga, Luis; Holman, Rose Marie; Escalon, Juliet; Muren, Caroline; Escano, Crystal; Yepes, Ethel; Sharpe, Dunbar; Vasilakos, John P.; Rolnitzsky, Linda; Goldberg, Judith; Mandeli, John; Adams, Sylvia; Jungbluth, Achim; Pan, Linda; Venhaus, Ralph; Ott, Patrick A.; Bhardwaj, Nina

    2015-01-01

    The TLR7/8 agonist, Resiquimod has been used as an immune adjuvant in cancer vaccines. We evaluated the safety and immunogenicity of the cancer testis antigen NY-ESO-1 given in combination with Montanide with or without Resiquimod in high-risk melanoma patients. In Part I of the study, patients received 100ug full length NY-ESO-1 protein emulsified in 1.25mL Montanide (day 1) followed by topical application of 1000mg of 0.2% Resiquimod gel on days 1 and 3 (Cohort 1) versus days 1, 3, and 5 (Cohort 2) of a 21 day cycle. In Part II, patients were randomized to receive 100ug NY-ESO-1 protein plus Montanide (day 1) followed by topical application of placebo gel (Arm-A; N=8) or 1000mg of 0.2% Resiquimod gel (Arm-B; N=12) using the dosing regimen established in Part I. The vaccine regimens were generally well-tolerated. NY-ESO-1-specific humoral responses were induced or boosted in all patients, many of whom had high titer antibodies. In Part II, 16 of 20 patients in both arms had NY-ESO-1-specific CD4+ T-cell responses. CD8+ T-cell responses were only seen in 3 of 12 patients in Arm B. Patients with TLR7 SNP rs179008 had a greater likelihood of developing NY-ESO-1-specific CD8+ responses. In conclusion, NY-ESO-1 protein in combination with Montanide with or without topical Resiquimod is safe and induces both antibody and CD4+ T-cell responses in the majority of patients; the small proportion of CD8+ T-cell responses suggests that the addition of topical Resiquimod to Montanide is not sufficient to induce consistent NY-ESO-1-specific CD8+ T-cell responses. PMID:25633712

  5. A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.

    PubMed

    Ebert, Lisa M; MacRaild, Sarah E; Zanker, Damien; Davis, Ian D; Cebon, Jonathan; Chen, Weisan

    2012-01-01

    Cancer vaccines are designed to expand tumor antigen-specific T cells with effector function. However, they may also inadvertently expand regulatory T cells (Treg), which could seriously hamper clinical efficacy. To address this possibility, we developed a novel assay to detect antigen-specific Treg based on down-regulation of surface CD3 following TCR engagement, and used this approach to screen for Treg specific to the NY-ESO-1 tumor antigen in melanoma patients treated with the NY-ESO-1/ISCOMATRIX™ cancer vaccine. All patients tested had Treg (CD25(bright) FoxP3(+) CD127(neg)) specific for at least one NY-ESO-1 epitope in the blood. Strikingly, comparison with pre-treatment samples revealed that many of these responses were induced or boosted by vaccination. The most frequently detected response was toward the HLA-DP4-restricted NY-ESO-1(157-170) epitope, which is also recognized by effector T cells. Notably, functional Treg specific for an HLA-DR-restricted epitope within the NY-ESO-1(115-132) peptide were also identified at high frequency in tumor tissue, suggesting that NY-ESO-1-specific Treg may suppress local anti-tumor immune responses. Together, our data provide compelling evidence for the ability of a cancer vaccine to expand tumor antigen-specific Treg in the setting of advanced cancer, a finding which should be given serious consideration in the design of future cancer vaccine clinical trials.

  6. Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cells.

    PubMed

    Pollack, Seth M; Jones, Robin L; Farrar, Erik A; Lai, Ivy P; Lee, Sylvia M; Cao, Jianhong; Pillarisetty, Venu G; Hoch, Benjamin L; Gullett, Ashley; Bleakley, Marie; Conrad, Ernest U; Eary, Janet F; Shibuya, Kendall C; Warren, Edus H; Carstens, Jason N; Heimfeld, Shelly; Riddell, Stanley R; Yee, Cassian

    2014-01-01

    Adoptive T cell therapy represents an attractive modality for the treatment of patients with cancer. Peripheral blood mononuclear cells have been used as a source of antigen specific T cells but the very low frequency of T cells recognizing commonly expressed antigens such as NY-ESO-1 limit the applicability of this approach to other solid tumors. To overcome this, we tested a strategy combining IL-21 modulation during in vitro stimulation with first-in-class use of tetramer-guided cell sorting to generate NY-ESO-1 specific cytotoxic T lymphocytes (CTL). CTL generation was evaluated in 6 patients with NY-ESO-1 positive sarcomas, under clinical manufacturing conditions and characterized for phenotypic and functional properties. Following in vitro stimulation, T cells stained with NY-ESO-1 tetramer were enriched from frequencies as low as 0.4% to >90% after single pass through a clinical grade sorter. NY-ESO-1 specific T cells were generated from all 6 patients. The final products expanded on average 1200-fold to a total of 36 billion cells, were oligoclonal and contained 67-97% CD8(+), tetramer(+) T cells with a memory phenotype that recognized endogenous NY-ESO-1. This study represents the first series using tetramer-guided cell sorting to generate T cells for adoptive therapy. This approach, when used to target more broadly expressed tumor antigens such as WT-1 and additional Cancer-Testis antigens will enhance the scope and feasibility of adoptive T cell therapy.

  7. A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma

    PubMed Central

    Ebert, Lisa M.; MacRaild, Sarah E.; Zanker, Damien; Davis, Ian D.

    2012-01-01

    Cancer vaccines are designed to expand tumor antigen-specific T cells with effector function. However, they may also inadvertently expand regulatory T cells (Treg), which could seriously hamper clinical efficacy. To address this possibility, we developed a novel assay to detect antigen-specific Treg based on down-regulation of surface CD3 following TCR engagement, and used this approach to screen for Treg specific to the NY-ESO-1 tumor antigen in melanoma patients treated with the NY-ESO-1/ISCOMATRIXTM cancer vaccine. All patients tested had Treg (CD25bright FoxP3+ CD127neg) specific for at least one NY-ESO-1 epitope in the blood. Strikingly, comparison with pre-treatment samples revealed that many of these responses were induced or boosted by vaccination. The most frequently detected response was toward the HLA-DP4-restricted NY-ESO-1157–170 epitope, which is also recognized by effector T cells. Notably, functional Treg specific for an HLA-DR-restricted epitope within the NY-ESO-1115–132 peptide were also identified at high frequency in tumor tissue, suggesting that NY-ESO-1-specific Treg may suppress local anti-tumor immune responses. Together, our data provide compelling evidence for the ability of a cancer vaccine to expand tumor antigen-specific Treg in the setting of advanced cancer, a finding which should be given serious consideration in the design of future cancer vaccine clinical trials. PMID:23110239

  8. Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHC.

    PubMed

    Klippel, Z K; Chou, J; Towlerton, A M; Voong, L N; Robbins, P; Bensinger, W I; Warren, E H

    2014-03-01

    Adoptive immunotherapy of tumors with T cells specific for the cancer-testis antigen NY-ESO-1 has shown great promise in preclinical models and in early stage clinical trials. Tumor persistence or recurrence after NY-ESO-1-specific therapy occurs, however, and the mechanisms of recurrence remain poorly defined. In a murine xenograft model of NY-ESO-1(+) multiple myeloma, we observed tumor recurrence after adoptive transfer of CD8(+) T cells genetically redirected to the prototypic NY-ESO-1157-165 peptide presented by HLA-A*02:01. Analysis of the myeloma cells that had escaped from T-cell control revealed intact expression of NY-ESO-1 and B2M, but selective, complete loss of HLA-A*02:01 expression from the cell surface. Loss of heterozygosity (LOH) in the major histocompatibility complex (MHC) involving the HLA-A locus was identified in the tumor cells, and further analysis revealed selective loss of the allele encoding HLA-A*02:01. Although LOH involving the MHC has not been described in myeloma patients with persistent or recurrent disease after immune therapies such as allogeneic hematopoietic cell transplantation (HCT), it has been described in patients with acute myelogenous leukemia who relapsed after allogeneic HCT. These results suggest that MHC loss should be evaluated in patients with myeloma and other cancers who relapse after adoptive NY-ESO-1-specific T-cell therapy.

  9. Factors Influencing Divergent Patterns of Phosphorus Availability in NY and PA Biogeochemical `Hotspots'

    NASA Astrophysics Data System (ADS)

    Saia, S. M.; Hofmeister, K.; Regan, J. M.; Buda, A. R.; Carrick, H. J.; Walter, M. T.

    2016-12-01

    Anthropogenic alteration of the soil phosphorus (P) cycle leads to subsequent water quality issues in agricultural dominated watersheds. In the humid Northeastern United States (NE US), variably saturated areas can generate surface runoff that transports P and stimulates biogeochemical processes; these hydrologically dynamic locations are often called biogeochemical `hotspots'. Many studies have evaluated nitrogen and carbon cycling in biogeochemical hot spots but few have focused on P. We hypothesized seasonally wet parts of the landscape (i.e., hotspots) have smaller biologically available P pools because runoff events frequently carry away nutrients like P. To test this hypothesis, we generated soil wetness index (SWI) maps from soil (SURRGO) and elevation (LiDAR rescaled to 3 m) data and used these maps to direct seasonal soil sampling near Klingerstown, Pennsylvania (PA) and Ithaca, New York (NY). We collected 5cm deep soil samples in PA (bimonthly) and NY (monthly) along soil moisture gradients for a range of land cover types (forest, fallow, and cropped) from May through October. We measured soil moisture in the field and percent organic matter (OM), pH, and three increasingly strong soil P extractions (dilute-salt-extractable P, oxalate-extractable P, and total-extractable P) in the laboratory. Our results indicated a negative relationship between dilute-salt-extractable P concentrations and SWI in PA and no relationship between these same variables in NY. We also found positive relationships between each of the three P extractions in PA but only a positive relationship between oxalate-extractable P and total-extractable P in NY. Our findings in PA support our hypothesis; namely, less biologically available P (i.e. dilute-salt-extractable P) is found in wetter areas of the landscape. However, divergent P availability patterns in NY point to further complexities and confounding variables in our understanding in soil P processes. Further studies will look

  10. Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients.

    PubMed

    Karbach, Julia; Neumann, Antje; Atmaca, Akin; Wahle, Claudia; Brand, Kathrin; von Boehmer, Lotta; Knuth, Alexander; Bender, Armin; Ritter, Gerd; Old, Lloyd J; Jäger, Elke

    2011-02-15

    NY-ESO-1, one of the most immunogenic tumor antigens, is expressed in 15% to 25% of metastatic prostate cancers. The immunological and clinical effects of vaccination with recombinant NY-ESO-1 protein combined with CpG as adjuvant were evaluated. In a phase I clinical study, patients with advanced prostate cancer were vaccinated with recombinant NY-ESO-1 protein (100 μg) mixed with CpG 7909 (2.5 mg) every 3 weeks intradermally for 4 doses. Objectives of the study were the safety of the vaccine and changes of specific humoral and cellular immunological responses to NY-ESO-1 in relation to detectable NY-ESO-1 expression in the individual tumor. All 12 baseline sero-negative patients developed high-titer NY-ESO-1 antibody responses. B-cell epitope mapping identified NY-ESO-1 p91-110 to be recognized most frequently by vaccine-induced antibodies. Two patients developed significant antibody titers against the adjuvant CpG. NY-ESO-1-specific CD4+ and/or CD8+ T-cell responses were induced in 9 patients (69%). Five of these 9 patients did not express NY-ESO-1 in the autologous tumor. Postvaccine CD8+ T-cell clones recognized and lyzed HLA-matched tumor cell lines in an antigen-specific manner. Our data provide clear evidence for the capacity of NY-ESO-1 protein/CpG vaccine to induce integrated antigen-specific immune responses in vivo and to efficiently prime CD8+ T-cell responses in NY-ESO-1 antigen-negative patients. Our results may also support further clinical vaccination protocols with NY-ESO-1 protein not only focused on the treatment of existing cancer, but also to prevent further development of NY-ESO-1 positive cancers in vivo. ©2010 AACR.

  11. Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients.

    PubMed

    Kageyama, Shinichi; Wada, Hisashi; Muro, Kei; Niwa, Yasumasa; Ueda, Shugo; Miyata, Hiroshi; Takiguchi, Shuji; Sugino, Sahoko H; Miyahara, Yoshihiro; Ikeda, Hiroaki; Imai, Naoko; Sato, Eiichi; Yamada, Tomomi; Osako, Masaharu; Ohnishi, Mami; Harada, Naozumi; Hishida, Tadashi; Doki, Yuichiro; Shiku, Hiroshi

    2013-10-05

    Cholesteryl pullulan (CHP) is a novel antigen delivery system for cancer vaccines. This study evaluated the safety, immune responses and clinical outcomes of patients who received the CHP-NY-ESO-1 complex vaccine, Drug code: IMF-001. Patients with advanced/metastatic esophageal cancer were enrolled and subcutaneously vaccinated with either 100 μg or 200 μg of NY-ESO-1 protein complexed with CHP. The primary endpoints were safety and humoral immune responses, and the secondary endpoint was clinical efficacy. A total of 25 patients were enrolled. Thirteen and twelve patients were repeatedly vaccinated with 100 μg or 200 μg of CHP-NY-ESO-1 with a median of 8 or 9.5 doses, respectively. No serious adverse events related to the vaccine were observed. Three out of 13 patients in the 100-μg cohort and 7 out of 12 patients in the 200-μg cohort were positive for anti-NY-ESO-1 antibodies at baseline. In the 100-μg cohort, an antibody response was observed in 5 out of 10 pre-antibody-negatives patients, and the antibody levels were augmented in 2 pre-antibody-positive patients after vaccination. In the 200-μg cohort, all 5 pre-antibody-negative patients became seropositive, and the antibody level was amplified in all 7 pre-antibody-positive patients. No tumor shrinkage was observed. The patients who received 200 μg of CHP-NY-ESO-1 survived longer than patients receiving 100 μg of CHP-NY-ESO-1, even those who exhibited unresponsiveness to previous therapies or had higher tumor burdens. The safety and immunogenicity of CHP-NY-ESO-1 vaccine were confirmed. The 200 μg dose more efficiently induced immune responses and suggested better survival benefits. (Clinical trial registration number NCT01003808).

  12. Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.

    PubMed

    Eikawa, Shingo; Kakimi, Kazuhiro; Isobe, Midori; Kuzushima, Kiyotaka; Luescher, Immanuel; Ohue, Yoshihiro; Ikeuchi, Kazuhiro; Uenaka, Akiko; Nishikawa, Hiroyoshi; Udono, Heiichiro; Oka, Mikio; Nakayama, Eiichi

    2013-01-15

    Immunogenicity of a long 20-mer NY-ESO-1f peptide vaccine was evaluated in a lung cancer patient TK-f01, immunized with the peptide with Picibanil OK-432 and Montanide ISA-51. We showed that internalization of the peptide was necessary to present CD8 T-cell epitopes on APC, contrasting with the direct presentation of the short epitope. CD8 T-cell responses restricted to all five HLA class I alleles were induced in the patient after the peptide vaccination. Clonal analysis showed that B*35:01 and B*52:01-restricted CD8 T-cell responses were the two dominant responses. The minimal epitopes recognized by A*24:02, B*35:01, B*52:01 and C*12:02-restricted CD8 T-cell clones were defined and peptide/HLA tetramers were produced. NY-ESO-1 91-101 on A*24:02, NY-ESO-1 92-102 on B*35:01, NY-ESO-1 96-104 on B*52:01 and NY-ESO-1 96-104 on C*12:02 were new epitopes first defined in this study. Identification of the A*24:02 epitope is highly relevant for studying the Japanese population because of its high expression frequency (60%). High affinity CD8 T-cells recognizing tumor cells naturally expressing the epitopes and matched HLA were induced at a significant level. The findings suggest the usefulness of a long 20-mer NY-ESO-1f peptide harboring multiple CD8 T-cell epitopes as an NY-ESO-1 vaccine. Characterization of CD8 T-cell responses in immunomonitoring using peptide/HLA tetramers revealed that multiple CD8 T-cell responses comprised the dominant response. Copyright © 2012 UICC.

  13. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

    PubMed

    Kvistborg, Pia; Shu, Chengyi Jenny; Heemskerk, Bianca; Fankhauser, Manuel; Thrue, Charlotte Albæk; Toebes, Mireille; van Rooij, Nienke; Linnemann, Carsten; van Buuren, Marit M; Urbanus, Jos H M; Beltman, Joost B; Thor Straten, Per; Li, Yong F; Robbins, Paul F; Besser, Michal J; Schachter, Jacob; Kenter, Gemma G; Dudley, Mark E; Rosenberg, Steven A; Haanen, John B A G; Hadrup, Sine Reker; Schumacher, Ton N M

    2012-07-01

    There is strong evidence that both adoptive T cell transfer and T cell checkpoint blockade can lead to regression of human melanoma. However, little data are available on the effect of these cancer therapies on the tumor-reactive T cell compartment. To address this issue we have profiled therapy-induced T cell reactivity against a panel of 145 melanoma-associated CD8(+) T cell epitopes. Using this approach, we demonstrate that individual tumor-infiltrating lymphocyte cell products from melanoma patients contain unique patterns of reactivity against shared melanoma-associated antigens, and that the combined magnitude of these responses is surprisingly low. Importantly, TIL therapy increases the breadth of the tumor-reactive T cell compartment in vivo, and T cell reactivity observed post-therapy can almost in full be explained by the reactivity observed within the matched cell product. These results establish the value of high-throughput monitoring for the analysis of immuno-active therapeutics and suggest that the clinical efficacy of TIL therapy can be enhanced by the preparation of more defined tumor-reactive T cell products.

  14. TIL therapy broadens the tumor-reactive CD8+ T cell compartment in melanoma patients

    PubMed Central

    Kvistborg, Pia; Shu, Chengyi Jenny; Heemskerk, Bianca; Fankhauser, Manuel; Thrue, Charlotte Albæk; Toebes, Mireille; van Rooij, Nienke; Linnemann, Carsten; van Buuren, Marit M.; Urbanus, Jos H.M.; Beltman, Joost B.; thor Straten, Per; Li, Yong F.; Robbins, Paul F.; Besser, Michal J.; Schachter, Jacob; Kenter, Gemma G.; Dudley, Mark E.; Rosenberg, Steven A.; Haanen, John B.A.G.; Hadrup, Sine Reker; Schumacher, Ton N.M.

    2012-01-01

    There is strong evidence that both adoptive T cell transfer and T cell checkpoint blockade can lead to regression of human melanoma. However, little data are available on the effect of these cancer therapies on the tumor-reactive T cell compartment. To address this issue we have profiled therapy-induced T cell reactivity against a panel of 145 melanoma-associated CD8+ T cell epitopes. Using this approach, we demonstrate that individual tumor-infiltrating lymphocyte cell products from melanoma patients contain unique patterns of reactivity against shared melanoma-associated antigens, and that the combined magnitude of these responses is surprisingly low. Importantly, TIL therapy increases the breadth of the tumor-reactive T cell compartment in vivo, and T cell reactivity observed post-therapy can almost in full be explained by the reactivity observed within the matched cell product. These results establish the value of high-throughput monitoring for the analysis of immuno-active therapeutics and suggest that the clinical efficacy of TIL therapy can be enhanced by the preparation of more defined tumor-reactive T cell products. PMID:22754759

  15. Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation.

    PubMed

    Luetkens, Tim; Kobold, Sebastian; Cao, Yanran; Ristic, Marina; Schilling, Georgia; Tams, Sinje; Bartels, Britta Marlen; Templin, Julia; Bartels, Katrin; Hildebrandt, York; Yousef, Sara; Marx, Andreas; Haag, Friedrich; Bokemeyer, Carsten; Kröger, Nicolaus; Atanackovic, Djordje

    2014-11-01

    Multiple myeloma (MM) is the malignancy with the most frequent expression of the highly immunogenic cancer-testis antigens (CTA), and we have performed the first analysis of longitudinal expression, immunological properties, and fine specificity of CTA-specific antibody responses in MM. Frequency and characteristics of antibody responses against cancer-testis antigens MAGE-A3, NY-ESO-1, PRAME, and SSX-2 were analyzed using peripheral blood (N = 1094) and bone marrow (N = 200) plasma samples from 194 MM patients. We found that antibody responses against CTA were surprisingly rare, only 2.6 and 3.1 % of patients evidenced NY-ESO-1- and SSX-2-specific antibodies, respectively. NY-ESO-1-specific responses were observed during disease progression, while anti-SSX-2 antibodies appeared after allogeneic stem cell transplantation and persisted during clinical remission. We found that NY-ESO-1- and SSX-2-specific antibodies were both capable of activating complement and increasing CTA uptake by antigen-presenting cells. SSX-2-specific antibodies were restricted to IgG3, NY-ESO-1 responses to IgG1 and IgG3. Remarkably, NY-ESO-1-positive sera recognized various non-contiguous regions, while SSX-2-specific responses were directed against a single 6mer epitope, SSX-2(85-90). We conclude that primary autoantibodies against intracellular MM-specific tumor antigens SSX-2 and NY-ESO-1 are rare but functional. While their contribution to disease control still remains unclear, our data demonstrate their theoretic ability to affect cellular anti-tumor immunity by formation and uptake of mono- and polyvalent immune complexes.

  16. Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.

    PubMed

    Peng, Yu-Hui; Xu, Yi-Wei; Qiu, Si-Qi; Hong, Chao-Qun; Zhai, Tian-Tian; Li, En-Min; Xu, Li-Yan

    2014-09-01

    Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors in Southern China and Southeast Asia, and early detection remains a challenge. Autoantibodies have been found to precede the manifestations of symptomatic cancer by several months to years, making their identification of particular relevance for early detection. In the present study, the diagnostic value of serum autoantibodies against NY-ESO-1 in NPC patients was evaluated. The study included 112 patients with NPC and 138 normal controls. Serum levels of autoantibodies against NY-ESO-1 and classical Epstein-Barr virus marker, viral capsid antigen immunoglobulin A (VCA-IgA), were measured by enzyme-linked immunosorbent assay. Measurement of autoantibodies against NY-ESO-1 and VCA-IgA demonstrated a sensitivity/specificity of 42.9/94.9% [95% confidence interval (CI), 33.7-52.6/89.4-97.8%] and 55.4/95.7% (95% CI, 45.7-64.7/90.4-98.2%), respectively. The area under receiver operating characteristic curve for autoantibodies against NY-ESO-1 (0.821; 95% CI, 0.771-0.871) was marginally lower than that for VCA-IgA (0.860; 95% CI, 0.810-0.910) in NPC. The combination of autoantibodies against NY-ESO-1 and VCA-IgA yielded an enhanced sensitivity of 80.4% (95% CI, 71.6-87.0%) and a specificity of 90.6% (95% CI, 84.1-94.7%). Moreover, detection of autoantibodies against NY-ESO-1 could differentiate early-stage NPC patients from normal controls. Our results suggest that autoantibodies against NY-ESO-1 may serve as a potential biomarker, as a supplement to VCA-IgA, for the screening and diagnosis of NPC.

  17. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.

    PubMed

    Iura, Kunio; Maekawa, Akira; Kohashi, Kenichi; Ishii, Takeaki; Bekki, Hirofumi; Otsuka, Hiroshi; Yamada, Yuichi; Yamamoto, Hidetaka; Harimaya, Katsumi; Iwamoto, Yukihide; Oda, Yoshinao

    2017-03-01

    Synovial sarcoma (SS) is regarded as a relatively chemosensitive sarcoma, but the prognosis of advanced SSs remains poor. Here we identified highly expressed cancer-testis antigens that could be promising immunotherapy targets for SS, using a previously conducted cDNA microarray, and we assessed the clinicopathological or prognostic relationships of these antigens in SS. We compared the gene expression profiles of 11 SSs with those of 3 normal adipose tissues. Among the up-regulated cancer-testis antigens, we analyzed PRAME, MAGEA1, and MAGEA4 and another cancer-testis antigen (NY-ESO-1) together, by immunohistochemistry and real-time polymerase chain reaction in 108 SSs. Immunohistochemically, NY-ESO-1, PRAME, MAGEA4, and MAGEA1 were positive in 66 (61%), 93 (86%), 89 (82%), and 16 (15%) of 108 SSs, respectively, and 104 (96%) of 108 SSs showed the immunohistochemical expression of at least 1 of NY-ESO-1, PRAME, and MAGEA4. Moreover, the high expression of at least 1 of these 3 antigens was observed in 83% of the SSs. High expression of NY-ESO-1 and MAGEA4 was significantly correlated with the presence of necrosis and advanced clinical stage. The immunohistochemical expression of these cancer-testis antigens was not correlated with prognosis, but the coexpression of NY-ESO-1, PRAME, and MAGEA4 was significantly associated with adverse prognosis. The real-time polymerase chain reaction results were closely related to the immunohistochemical results: NY-ESO-1 (P = .0019), PRAME (P = .039), MAGEA4 (P = .0149), and MAGEA1 (P = .0766). These data support the potential utility of NY-ESO-1, PRAME, and MAGEA4 as immunotherapy targets and ancillary prognostic parameters, suggesting the possible benefit of the combined use of these cancer-testis antigens as an SS immunotherapy target. Copyright © 2016 Elsevier Inc. All rights reserved.

  18. Measurement of serum antibodies against NY-ESO-1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer.

    PubMed

    Long, Yan-Yan; Wang, Yu; Huang, Qian-Rong; Zheng, Guang-Shun; Jiao, Shun-Chang

    2014-10-01

    NY-ESO-1 has been identified as one of the most immunogenic antigens; thus, is a highly attractive target for cancer immunotherapy. The present study analyzed the expression of serum antibodies (Abs) against NY-ESO-1 in patients with advanced colorectal cancer (CRC), with the aim of guiding the treatment of NY-ESO-1-based specific-immunotherapy for these patients. Furthermore, the present study was the first to evaluate the kinetic expression of anti-NY-ESO-1 Abs and investigate the possible influencing factors. A total of 239 serum samples from 155 pathologically confirmed patients with advanced CRC (stages III and IV) were collected. The presence of spontaneous Abs against NY-ESO-1 was analyzed using an enzyme-linked immunosorbent assay (ELISA). The results demonstrated that 24.5% (38/155) of the investigated patients were positive for NY-ESO-1-specific Abs. No statistically significant correlations were identified between the expression of anti-NY-ESO-1 Abs and clinicopathological parameters, including age and gender, location, grading, local infiltration, lymph node status, metastatic status and K-ras mutation status (P>0.05). In 59 patients, the kinetic expression of anti-NY-ESO-1 Abs was analyzed, of which 14 patients were initially positive and 45 patients were initially negative. Notably, 16/59 (27.1%) patients changed their expression status during the study period, and the initially positive patients were more likely to change compared with the initially negative patients (85.7 vs. 8.8%; P<0.001). Therefore, monitoring serum Abs against NY-ESO-1 by ELISA is an easy and feasible method. The high expression rate of NY-ESO-1-specific Abs in CRC patients indicates that measuring the levels of serum Abs against NY-ESO-1 may guide the treatment of NY-ESO-1-based specific immunotherapy for patients with advanced CRC.

  19. Measurement of serum antibodies against NY-ESO-1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer

    PubMed Central

    LONG, YAN-YAN; WANG, YU; HUANG, QIAN-RONG; ZHENG, GUANG-SHUN; JIAO, SHUN-CHANG

    2014-01-01

    NY-ESO-1 has been identified as one of the most immunogenic antigens; thus, is a highly attractive target for cancer immunotherapy. The present study analyzed the expression of serum antibodies (Abs) against NY-ESO-1 in patients with advanced colorectal cancer (CRC), with the aim of guiding the treatment of NY-ESO-1-based specific-immunotherapy for these patients. Furthermore, the present study was the first to evaluate the kinetic expression of anti-NY-ESO-1 Abs and investigate the possible influencing factors. A total of 239 serum samples from 155 pathologically confirmed patients with advanced CRC (stages III and IV) were collected. The presence of spontaneous Abs against NY-ESO-1 was analyzed using an enzyme-linked immunosorbent assay (ELISA). The results demonstrated that 24.5% (38/155) of the investigated patients were positive for NY-ESO-1-specific Abs. No statistically significant correlations were identified between the expression of anti-NY-ESO-1 Abs and clinicopathological parameters, including age and gender, location, grading, local infiltration, lymph node status, metastatic status and K-ras mutation status (P>0.05). In 59 patients, the kinetic expression of anti-NY-ESO-1 Abs was analyzed, of which 14 patients were initially positive and 45 patients were initially negative. Notably, 16/59 (27.1%) patients changed their expression status during the study period, and the initially positive patients were more likely to change compared with the initially negative patients (85.7 vs. 8.8%; P<0.001). Therefore, monitoring serum Abs against NY-ESO-1 by ELISA is an easy and feasible method. The high expression rate of NY-ESO-1-specific Abs in CRC patients indicates that measuring the levels of serum Abs against NY-ESO-1 may guide the treatment of NY-ESO-1-based specific immunotherapy for patients with advanced CRC. PMID:25187840

  20. NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-Lymphocyte Responses in Patients with Myelodysplastic Syndrome.

    PubMed

    Griffiths, Elizabeth A; Srivastava, Pragya; Matsuzaki, Junko; Brumberger, Zachary; Wang, Eunice S; Kocent, Justin; Miller, Austin; Roloff, Gregory W; Wong, Hong Yuen; Paluch, Benjamin E; Lutgen-Dunckley, Linda G; Martens, Brandon L; Odunsi, Kunle; Karpf, Adam R; Hourigan, Christopher S; Nemeth, Michael J

    2017-09-25

    Treatment options are limited for patients with high-risk myelodysplastic syndrome (MDS). The azanucleosides, azacitidine and decitabine, are front-line therapy for MDS that induce promoter demethylation and gene expression of the highly immunogenic tumor antigen NY-ESO-1. We demonstrated that AML patients receiving decitabine exhibit induction of NY-ESO-1 expression in circulating blasts. We hypothesized that vaccinating against NY-ESO-1 in MDS patients receiving decitabine would capitalize upon induced NY-ESO-1 expression in malignant myeloid cells to provoke an NY-ESO-1-specific-MDS directed cytotoxic T-cell immune response. In a phase I study, 9 MDS patients received an HLA unrestricted NY-ESO-1 vaccine (CDX-1401 + poly-ICLC) in a non-overlapping schedule every four weeks with standard dose decitabine. Analysis of samples serially obtained from the 7 patients who reached the end-of-study demonstrated induction of NY-ESO-1 expression in 7/7 patients and NY-ESO-1 specific CD4+ and CD8+ T-lymphocyte responses in 6/7 and 4/7 of the vaccinated patients respectively. Myeloid cells expressing NY-ESO-1, isolated from a patient at different time-points during decitabine therapy, were capable of activating a cytotoxic response from autologous NY-ESO-1-specific T-lymphocytes. Vaccine responses were associated with a detectable population of CD141Hi conventional dendritic cells, which are critical for the uptake of NY-ESO-1 vaccine and have a recognized role in anti-tumor immune responses. These data indicate that vaccination against induced NY-ESO-1 expression can produce an antigen-specific immune response in a relatively non-immunogenic myeloid cancer and highlight the potential for induced-antigen directed immunotherapy in a group of patients with limited options. Copyright ©2017, American Association for Cancer Research.

  1. Lidar temperature measurements at NY-Alesund (79N) during winter, 1998

    NASA Technical Reports Server (NTRS)

    McGee, T. J.; Gross, M.; Newman, P.; Beyerle, G.; Beninga, I.; Dahl, A.; Neuber, R.; Wahl, P.; Schrems, O.

    1998-01-01

    During January and February, 1998, a measurements campaign was held at the Network for the Detection of Stratospheric Change (NDSC) Arctic site at Ny-Alesund (78.9N). Lidar measurements of ozone, temperature and aerosol parameters were made along with balloon sonde and microwave measurements of ozone. Atmospheric temperatures were measured between 10 and 70 km. During the time of the campaign an strong warming occurred at the stratopause, elevating the measured temperature by as much as 80 K. The height of the stratopause descended at this time to below 40 km.

  2. The Ny-Alesund aerosol and ozone measurements intercomparison campaign 1997/1998 (NAOMI-1998)

    NASA Technical Reports Server (NTRS)

    Neuber, R.; Beyerle, G.; Beninga, I.; VonderGathen, P.; Rairoux, P.; Schrems, O.; Wahl, P.; Gross, M.; McGee, Th.; Iwasaka, Y.; Fujiwara, M.; Shibata, T.; Klein, U.; Steinbrecht, W.

    1998-01-01

    An intercomparison campaign for Lidar measurements of stratospheric ozone and aerosol has been conducted at the Primary Station of the Network for the Detection of Stratospheric Change (NDSC) in Ny-Alesund/Spitsbergen during January-February 1998. In addition to local instrumentation, the NDSC mobile ozone lidar from NASA/GSFC and the mobile aerosol lidar from Alfred Wegener Institute (AWI) participated. The aim is the validation of stratospheric ozone and aerosol profile measurements according to NDSC guidelines. This paper briefly presents the employed instruments and outlines the campaign. Results of the blind intercomparison of ozone profiles are given in a companion paper and temperature measurements are described in this issue.

  3. Notes on freshwater and terrestrial algae from Ny-Alesund, Svalbard (high Arctic sea area).

    PubMed

    Kim, Gwang Hoon; Klochkova, Tatyana A; Kang, Sung Ho

    2008-07-01

    Field survey of algae and cyanobacteria from terrestrial and freshwater habitats in the vicinity of arctic Ny-Alesund, Svalbard (790N) (high Arctic sea area) was performed in June 2006. Species diversity and abundance were evaluated by using epifluorescence microscopy and culturing methods. In total, 29 taxa in 25 genera were identified, of which Leptolyngbya spp., Trichormus sp. and Chlamydomonas nivalis were abundantly present in almost every sample. In several locations, blooms were formed by species C. nivalis, Scotiellopsis sp., Klebsormidium flaccidum, Zygnema sp., Meridion circulare, Tabellaria fenestrata and Fragilaria sp. Eleven new species from this locality are described.

  4. Two novel poxviruses with unusual genome rearrangements: NY_014 and Murmansk.

    PubMed

    Smithson, Chad; Meyer, Hermann; Gigante, Crystal M; Gao, Jinxin; Zhao, Hui; Batra, Dhwani; Damon, Inger; Upton, Chris; Li, Yu

    2017-07-31

    The genome sequence and annotation of two novel poxviruses, NY_014 and Murmansk, are presented. Despite being isolated on different continents and from different hosts, the viruses are relatively similar, albeit distinct species. The closest known relative of the novel viruses is Yoka poxvirus. Five novel genes were found in these genomes, two of which were MHC class I homologs. Although the core of these genomes was well conserved, the terminal regions showed significant variability with large deletions and surprising evidence of recombination with orthopoxviruses.

  5. TiO2/GeOxNy stacked gate dielectrics for Ge-MOSFETs

    NASA Astrophysics Data System (ADS)

    Bera, M. K.; Mahata, C.; Chakraborty, A. K.; Nandi, S. K.; Tiwari, Jitendra N.; Hung, Jui-Yi; Maiti, C. K.

    2007-12-01

    In this work, we present the results of physical and electrical characterization of Ti-based high-k gate dielectrics on Ge substrates. Titanium tetrakis iso- propoxide (TTIP) was used as the organometallic source for the deposition of ultra-thin TiO2 films on p-Ge (1 0 0) at low temperature (<200 °C) by plasma enhanced chemical vapor deposition (PECVD) technique in a microwave (700 W, 2.45 GHz) plasma cavity discharge system at a pressure of ~65 Pa. The presence of an ultra-thin lossy GeO2 interfacial layer between the deposited high-k film and the substrate, results in frequency-dependent capacitance-voltage (C-V) characteristics in strong accumulation and a high interface state density (~1013 cm-2 eV-1). To improve the electrical properties, nitrogen engineering has been employed to convert the lossy GeO2 interfacial layer to its oxynitride, thus forming TiO2/GeOxNy/Ge stacked-gate structure with improved interface/electrical properties. Different N sources, such as NO, NH3 and NO/NH3, have been used for nitrogen engineering. XPS and Raman spectroscopy analyses have been used for surface morphological study. Electrical properties, such as gate leakage current density, interface state density, charge trapping, flatband voltage shift, etc, have been studied in detail for TiO2/GeOxNy/Ge MIS capacitors using the current-voltage (I-V), capacitance-voltage (C-V), conductance-voltage (G-V) and stress (both constant voltage and current) measurements. Although a significant improvement in electrical characteristics has been observed after nitridation in general, the formation of the interfacial GeOxNy layer, obtained from NO-plasma nitridation, is found to provide the maximum improvement among all the nitridation techniques used in this study. It is shown that the insertion of an ultra-thin oxynitride (GeOxNy) interfacial layer is advantageous for producing gate-quality TiO2 high-k dielectric stacks on Ge substrates.

  6. Drop and Flight Tests on NY-2 Landing Gears Including Measurements of Vertical Velocities at Landing

    NASA Technical Reports Server (NTRS)

    Peck, W D; Beard, A P

    1933-01-01

    This investigation was conducted to obtain quantitative information on the effectiveness of three landing gears for the NY-2 (consolidated training) airplane. The investigation consisted of static, drop, and flight tests on landing gears of the oleo-rubber-disk and the mercury rubber-chord types, and flight tests only on a landing gear of the conventional split-axle rubber-cord type. The results show that the oleo gear is the most effective of the three landing gears in minimizing impact forces and in dissipating the energy taken.

  7. Lidar temperature measurements at NY-Alesund (79N) during winter, 1998

    NASA Technical Reports Server (NTRS)

    McGee, T. J.; Gross, M.; Newman, P.; Beyerle, G.; Beninga, I.; Dahl, A.; Neuber, R.; Wahl, P.; Schrems, O.

    1998-01-01

    During January and February, 1998, a measurements campaign was held at the Network for the Detection of Stratospheric Change (NDSC) Arctic site at Ny-Alesund (78.9N). Lidar measurements of ozone, temperature and aerosol parameters were made along with balloon sonde and microwave measurements of ozone. Atmospheric temperatures were measured between 10 and 70 km. During the time of the campaign an strong warming occurred at the stratopause, elevating the measured temperature by as much as 80 K. The height of the stratopause descended at this time to below 40 km.

  8. Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells.

    PubMed

    Mobergslien, Anne; Vasovic, Vlada; Mathiesen, Geir; Fredriksen, Lasse; Westby, Phuong; Eijsink, Vincent G H; Peng, Qian; Sioud, Mouldy

    2015-01-01

    Given their safe use in humans and inherent adjuvanticity, Lactic Acid Bacteria may offer several advantages over other mucosal delivery strategies for cancer vaccines. The objective of this study is to evaluate the immune responses in mice after oral immunization with Lactobacillus (L) plantarum WCFS1 expressing a cell-wall anchored tumor antigen NY-ESO-1. And to investigate the immunostimulatory potency of this new candidate vaccine on human dendritic cells (DCs). L. plantarum displaying NY-ESO-1 induced NY-ESO-1 specific antibodies and T-cell responses in mice. By contrast, L. plantarum displaying conserved proteins such as heat shock protein-27 and galectin-1, did not induce immunity, suggesting that immune tolerance to self-proteins cannot be broken by oral administration of L. plantarum. With respect to immunomodulation, immature DCs incubated with wild type or L. plantarum-NY-ESO-1 upregulated the expression of co-stimulatory molecules and secreted a large amount of interleukin (IL)-12, TNF-α, but not IL-4. Moreover, they upregulated the expression of immunosuppressive factors such as IL-10 and indoleamine 2,3-dioxygenase. Although L. plantarum-matured DCs expressed inhibitory molecules, they stimulated allogeneic T cells in-vitro. Collectively, the data indicate that L. plantarum-NY-ESO-1 can evoke antigen-specific immunity upon oral administration and induce DC maturation, raising the potential of its use in cancer immunotherapies.

  9. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

    PubMed Central

    2011-01-01

    Background The lack of effective treatments for gliomas makes them a significant health problem and highlights the need for the development of novel and innovative treatment approaches. Immunotherapy is an appealing strategy because of the potential ability for immune cells to traffic to and destroy infiltrating tumor cells. However, the absence of well-characterized, highly immunogenic tumor-rejection antigens (TRA) in gliomas has limited the implementation of targeted immune-based therapies. Methods We hypothesized that treatment with the demethylating agent, decitabine, would upregulate the expression of TRA on tumor cells, thereby facilitating enhanced surveillance by TRA-specific T cells. Results and Discussion Treatment of human glioma cells with decitabine increased the expression of NY-ESO-1 and other well characterized cancer testes antigens. The upregulation of NY-ESO-1 made these tumors susceptible to NY-ESO-1-specific T-cell recognition and lysis. Interestingly, decitabine treatment of T98 glioma cells also sensitized them to Fas-dependent apoptosis with an agonistic antibody, while a Fas blocking antibody could largely prevent the enhanced functional recognition by NY-ESO-1 specific T cells. Thus, decitabine treatment transformed a non-immunogenic glioma cell into an immunogenic target that was efficiently recognized by NY-ESO-1--specific T cells. Conclusions Such data supports the hypothesis that agents which alter epigenetic cellular processes may "immunosensitize" tumor cells to tumor-specific T cell-mediated lysis. PMID:22060015

  10. Novel rhamnolipid biosurfactants produced by a polycyclic aromatic hydrocarbon-degrading bacterium Pseudomonas aeruginosa strain NY3.

    PubMed

    Nie, Maiqian; Yin, Xihou; Ren, Chunyan; Wang, Yang; Xu, Feng; Shen, Qirong

    2010-01-01

    A novel rhamnolipid biosurfactant-producing and Polycyclic Aromatic Hydrocarbon (PAH)-degrading bacterium Pseudomonas aeruginosa strain NY3 was isolated from petroleum-contaminated soil samples. Strain NY3 was characterized by its extraordinary capacity to produce structurally diverse rhamnolipids. A total of 25 rhamnolipid components and 37 different parent molecular ions, representing various metal ion adducts (Na(+), 2Na(+) and K(+)), were detected by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Among these compounds are ten new rhamnolipids. In addition to its biosurfactant production, strain NY3 was shown to be capable of efficient degradation of PAHs as well as synergistic improvement in the degradation of high molecular weight PAHs by its biosurfactant. These findings have added novel members to the rhamnolipid group and expanded current knowledge regarding the diversity and productive capability of rhamnolipid biosurfactants from a single specific strain with variation of only one carbon source. Additionally, this paper lays the foundation for improvement in the yield of NY3BS and study of the degradation pathway(s) of PAHs in P. aeruginosa strain NY3.

  11. Brain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.

    PubMed

    Cui, Min-Hui; Suzuka, Sandra M; Branch, Nicholas A; Ambadipudi, Kamalakar; Thangaswamy, Sangeetha; Acharya, Seetharama A; Billett, Henny H; Branch, Craig A

    2017-02-10

    To characterize the cerebral profile associated with sickle cell disease (SCD), we used in vivo proton MRI and MRS to quantify hemodynamics and neurochemicals in the thalamus of NY1DD mice, a mild model of SCD, and compared them with wild-type (WT) control mice. Compared with WT mice, NY1DD mice at steady state had elevated cerebral blood flow (CBF) and concentrations of N-acetylaspartate (NAA), glutamate (Glu), alanine, total creatine and N-acetylaspartylglutamate. Concentrations of glutathione (GSH) at steady state showed a negative correlation with BOLD signal change in response to 100% oxygen, a marker for oxidative stress, and mean diffusivity assessed using diffusion-tensor imaging, a marker for edematous inflammation. In NY1DD mice, elevated basal CBF was correlated negatively with [NAA], but positively with concentration of glutamine ([Gln]). Immediately after experimental hypoxia (at reoxygenation after 18 hours of 8% O2 ), concentrations of NAA, Glu, GSH, Gln and taurine (Tau) increased only in NY1DD mice. [NAA], [Glu], [GSH] and [Tau] all returned to baseline levels two weeks after the hypoxic episode. The altered neurochemical profile in the NY1DD mouse model of SCD at steady state and following experimental hypoxia/reoxygenation suggests a state of chronic oxidative stress leading to compensatory cerebral metabolic adjustments.

  12. Isolation of a halophilic bacterium, Bacillus sp. strain NY-6 for organic contaminants removal in saline wastewater on ship

    NASA Astrophysics Data System (ADS)

    Gao, Jie; Yu, Zhenjiang; Zhang, Xiaohui; Zhao, Dan; Zhao, Fangbo

    2013-06-01

    The objective of this research was to examine if certain strains of Bacillus bacteria, could survive in dry powder products and if so, could the bacteria degrade organic contaminants in saline wastewater on a ship. As part of the study, we isolated 7 domesticated strains named NY1, NY2,..., and NY7, the strain NY6 showed to have the best performance for organic matter degradation and could survive in dry powder more than 3 months. NY6 was identified as Bacillus aerius, based on the morphological and physic-chemical properties. Its optimal growth conditions were as follows: salinity was 2%; temperature was 37°C; pH was in 6.5-7.0; best ratio of C: N: P was 100:5:1. The capability of its dry powder for Chemical Oxygen Demand (COD) removal was 800mg COD/g in synthesized marine wastewater with 2% salinity. The spores in the dry powder were 1.972×108 g -1.

  13. Penta-BxNy sheet: a density functional theory study of two-dimensional material

    PubMed Central

    Li, Jiao; Fan, Xinyu; Wei, Yanpei; Chen, Gang

    2016-01-01

    By using density functional theory with generalized gradient approximation, we have carried out detailed investigations of two-dimensional BxNy nanomaterials in the Cairo pentagonal tiling geometry fully composed of pentagons (penta-BxNy). Only penta-BN and BN2 planar structures are dynamically stable without imaginary modes in their phonon spectra. Their stabilities have been further evaluated by formation energy analysis, first-principles molecular dynamics simulation, and mechanical stability analysis. Penta-BN2 is superior to penta-BN in structural stability. Its stability analysis against oxidization and functional group adsorption as well as its synthesizing reaction path analysis show possibilities in fabricating penta-BN2 on experiment. Furthermore, the penta-BN2 could be transferred from metallic to semiconducting by ionizing or covalently binding an electron per dinitrogen. Also, it has been found to have superior mechanical properties, such as the negative Poisson’s ratio and the comparable stiffness as that of hexagonal h-BN sheet. These studies on the stabilities, electronic properties, and mechanical properties suggest penta-BN2 as an attractive material to call for further studies on both theory and experiment. PMID:27539445

  14. Structural, optical and electrical properties of WOxNy filmsdeposited by reactive dual magnetron sputtering

    SciTech Connect

    Mohamed, Sodky H.; Anders, Andre

    2006-06-05

    Thin films of tungsten oxynitride were prepared by dual magnetron sputtering of tungsten using argon/oxygen/nitrogen gas mixtures with various nitrogen/oxygen ratios. The presence of even small amounts of oxygen had a great effect not only on the composition but on the structure of WOxNy films, as shown by Rutherford backscattering and x-ray diffraction, respectively. Significant incorporation of nitrogen occurred only when the nitrogen partial pressure exceeded 89 percent of the total reactive gas pressure. Sharp changes in the stoichiometry, deposition rate, room temperature resistivity, electrical activation energy and optical band gap were observed when the nitrogen/oxygen ratio was high.The deposition rate increased from 0.31 to 0.89 nm/s, the room temperature resistivity decreased from 1.65 x 108 to 1.82 x 10-2 ?cm, the electrical activation energy decreased from 0.97 to 0.067 eV, and the optical band gap decreased from 3.19 to 2.94 eV upon nitrogen incorporation into the films. WOxNy films were highly transparent as long as the nitrogen incorporation was low, and were brownish (absorbing) and partially reflecting as nitrogen incorporation became significant.

  15. Penta-BxNy sheet: a density functional theory study of two-dimensional material

    NASA Astrophysics Data System (ADS)

    Li, Jiao; Fan, Xinyu; Wei, Yanpei; Chen, Gang

    2016-08-01

    By using density functional theory with generalized gradient approximation, we have carried out detailed investigations of two-dimensional BxNy nanomaterials in the Cairo pentagonal tiling geometry fully composed of pentagons (penta-BxNy). Only penta-BN and BN2 planar structures are dynamically stable without imaginary modes in their phonon spectra. Their stabilities have been further evaluated by formation energy analysis, first-principles molecular dynamics simulation, and mechanical stability analysis. Penta-BN2 is superior to penta-BN in structural stability. Its stability analysis against oxidization and functional group adsorption as well as its synthesizing reaction path analysis show possibilities in fabricating penta-BN2 on experiment. Furthermore, the penta-BN2 could be transferred from metallic to semiconducting by ionizing or covalently binding an electron per dinitrogen. Also, it has been found to have superior mechanical properties, such as the negative Poisson’s ratio and the comparable stiffness as that of hexagonal h-BN sheet. These studies on the stabilities, electronic properties, and mechanical properties suggest penta-BN2 as an attractive material to call for further studies on both theory and experiment.

  16. Healthy Immigrant Effect: Preterm Births Among Immigrants and Refugees in Syracuse, NY.

    PubMed

    Miller, Lauren S; Robinson, Jonnell Allen; Cibula, Donald A

    2016-02-01

    The healthy immigrant effect is the phenomenon by which immigrants experience more positive health outcomes than the native-born population in developed countries. The strength of this effect appears to be related to country of origin, health outcome, healthcare and integration policies of receiving countries, as well as immigration class. This secondary analysis of birth records examines whether immigrants and mothers from refugee countries have lower adjusted risk of preterm births than US-born mothers in Syracuse, NY, a preferred refugee resettlement area. This secondary analysis included 6354 electronic birth records for residents in the city of Syracuse, NY who gave birth to singleton infants between 2009 and 2011. Multivariate log-binomial regression was used to calculate the adjusted relative risk for preterm birth among foreign-born mothers and mothers from refugee countries, compared to US-born mothers. Infants born to both foreign-born women and to women from refugee countries had decreased risks of being born preterm compared to infants born to US mothers, controlling for race, late/no prenatal care, maternal age less than 18 years and smoking. Our findings support a healthy immigrant effect for preterm births both among all foreign-born immigrants and among the subsample of women from refugee countries. Mother's nativity is likely a proxy for unmeasured factors (e.g., prenatal stress, maternal diet, etc.) that may explain the relationship between mother's nativity and preterm births. Additional research is needed to better understand the underlying factors.

  17. A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus

    SciTech Connect

    Zhang Shuliu; Li Li; Woodson, Sara E.; Huang, Claire Y.-H.; Kinney, Richard M.; Barrett, Alan D.T. ||||; Beasley, David W.C. |||. E-mail: d.beasley@utmb.edu

    2006-09-15

    Substitutions were engineered individually and in combinations at the fusion loop, receptor-binding domain and a stem-helix structure of the envelope protein of a West Nile virus strain, NY99, and their effects on mouse virulence and presentation of epitopes recognized by monoclonal antibodies (MAbs) were assessed. A single substitution within the fusion loop (L107F) attenuated mouse neuroinvasiveness of NY99. No substitutions attenuated NY99 neurovirulence. The L107F mutation also abolished binding of a non-neutralizing MAb, 3D9, whose epitope had not been previously identified. MAb 3D9 was subsequently shown to be broadly cross-reactive with other flaviviruses, consistent with binding near the highly conserved fusion loop.

  18. Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.

    PubMed

    Purbhoo, Marco A; Sutton, Deborah H; Brewer, Joanna E; Mullings, Rebecca E; Hill, Maxine E; Mahon, Tara M; Karbach, Julia; Jäger, Elke; Cameron, Brian J; Lissin, Nikolai; Vyas, Paresh; Chen, Ji-Li; Cerundolo, Vincenzo; Jakobsen, Bent K

    2006-06-15

    Presentation of intracellular tumor-associated Ags (TAAs) in the context of HLA class I molecules offers unique cancer-specific cell surface markers for the identification and targeting of tumor cells. For most peptide Ags, the levels of and variations in cell surface presentation remain unknown, yet these parameters are of crucial importance when considering specific TAAs as targets for anticancer therapy. Here we use a soluble TCR with picomolar affinity for the HLA-A2-restricted 157-165 epitope of the NY-ESO-1 and LAGE-1 TAAs to investigate presentation of this immunodominant epitope on the surface of a variety of cancer cells. By single molecule fluorescence microscopy, we directly visualize HLA-peptide presentation for the first time, demonstrating that NY-ESO-1/LAGE-1-positive tumor cells present 10-50 NY-ESO-1/LAGE-1(157-165) epitopes per cell.

  19. Gulf/RTR oil sands extraction process. [Gulf/Rio Tinto TIL Holding S. A

    SciTech Connect

    Logan, A.; Devenny, D.; Porcari, G.; Corti, A.

    1984-06-01

    The activities carried out and the results obtained from a 15 tons/hour oil sands extraction pilot plant operated in Fort McMurray in Northern Alberta are described. The process is the Rio Tinto TIL Holding S.A. (RTR)/Gulf Canada Lt. Oil Sands Extraction Process. It is a modified hot water extraction process. It is used to extract bitumen from Athabasca oil sands. The test ran from July to December 1981 through ambient conditions ranging from plus 38/sup 0/C to minus 30/sup 0/C (100/sup 0/F to -22/sup 0/F). The process, the on-site facilities, the test program, an analysis of plant performance, an appraisal of the process economics, and an evaluation of its potential application are described.

  20. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy.

    PubMed

    de Carvalho, Fabricio; Vettore, Andre L; Inaoka, Riguel J; Karia, Bruno; Andrade, Valéria C C; Gnjatic, Sacha; Jungbluth, Achim A; Colleoni, Gisele W B

    2011-01-20

    Due to the high homology between the LAGE-1 and NY-ESO-1 proteins, we hypothesized that an anti-NY-ESO-1 vaccine might elicit LAGE-1 immunity and hence may be effective in multiple myeloma (MM) patients with LAGE-1-positive/NY-ESO-1-negative tumors. Therefore, we set out to evaluate LAGE-1 and NY-ESO-1 mRNA and protein expression in MM patients in a bid to evaluate possible benefits of their homology for immunotherapy. LAGE-1 (a and b isoforms) and NY-ESO-1 mRNA expression was studied in 18 normal tissues and 50 bone marrow MM samples by RT-PCR. LAGE-1 and NY-ESO-1 protein expression was analyzed by immunohistochemistry (IHC) in 27 MM specimens using mAbs 219-510-23 and E978. Spontaneous serological immune response against both antigens was analyzed by ELISA in sera from 33 MM patients. LAGE-1 (a and b isoforms) was positive in 42% and NY-ESO-1 in 26% of the MM samples analyzed by RT-PCR. Both genes were found to be expressed in 18% of the cases, while at least one of the genes was found to be expressed in 50% of the cases. In LAGE-1 positive samples, 81% were positive for LAGE-1a and 19% were positive for both LAGE-1a and -1b. LAGE-1 and NY-ESO-1 protein expression could only be detected in two cases by IHC and there was a clear strong spontaneous antibody response to LAGE-1 and NY-ESO-1 in only one MM patient. In conclusion, LAGE-1a and NY-ESO-1 homology cannot be easily exploited in an anti-NY-ESO-1 vaccine given the low frequency of protein expression detected by IHC or serum analysis.

  1. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.

    PubMed

    Yuan, Jianda; Adamow, Matthew; Ginsberg, Brian A; Rasalan, Teresa S; Ritter, Erika; Gallardo, Humilidad F; Xu, Yinyan; Pogoriler, Evelina; Terzulli, Stephanie L; Kuk, Deborah; Panageas, Katherine S; Ritter, Gerd; Sznol, Mario; Halaban, Ruth; Jungbluth, Achim A; Allison, James P; Old, Lloyd J; Wolchok, Jedd D; Gnjatic, Sacha

    2011-10-04

    Ipilimumab, a monoclonal antibody against cytotoxic T lymphocyte antigen 4 (CTLA-4), has been shown to improve survival in patients with advanced metastatic melanoma. It also enhances immunity to NY-ESO-1, a cancer/testis antigen expressed in a subset of patients with melanoma. To characterize the association between immune response and clinical outcome, we first analyzed NY-ESO-1 serum antibody by ELISA in 144 ipilimumab-treated patients with melanoma and found 22 of 140 (16%) seropositive at baseline and 31 of 144 (22%) seropositive following treatment. These NY-ESO-1-seropositive patients had a greater likelihood of experiencing clinical benefit 24 wk after ipilimumab treatment than NY-ESO-1-seronegative patients (P = 0.02, relative risk = 1.8, two-tailed Fisher test). To understand why some patients with NY-ESO-1 antibody failed to experience clinical benefit, we analyzed NY-ESO-1-specific CD4(+) and CD8(+) T-cell responses by intracellular multicytokine staining in 20 NY-ESO-1-seropositive patients and found a surprising dissociation between NY-ESO-1 antibody and CD8 responses in some patients. NY-ESO-1-seropositive patients with associated CD8(+) T cells experienced more frequent clinical benefit (10 of 13; 77%) than those with undetectable CD8(+) T-cell response (one of seven; 14%; P = 0.02; relative risk = 5.4, two-tailed Fisher test), as well as a significant survival advantage (P = 0.01; hazard ratio = 0.2, time-dependent Cox model). Together, our data suggest that integrated NY-ESO-1 immune responses may have predictive value for ipilimumab treatment and argue for prospective studies in patients with established NY-ESO-1 immunity. The current findings provide a strong rationale for the clinical use of modulators of immunosuppression with concurrent approaches to favor tumor antigen-specific immune responses, such as vaccines or adoptive transfer, in patients with cancer.

  2. Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma.

    PubMed

    Sabado, Rachel Lubong; Pavlick, Anna; Gnjatic, Sacha; Cruz, Crystal M; Vengco, Isabelita; Hasan, Farah; Spadaccia, Meredith; Darvishian, Farbod; Chiriboga, Luis; Holman, Rose Marie; Escalon, Juliet; Muren, Caroline; Escano, Crystal; Yepes, Ethel; Sharpe, Dunbar; Vasilakos, John P; Rolnitzsky, Linda; Goldberg, Judith; Mandeli, John; Adams, Sylvia; Jungbluth, Achim; Pan, Linda; Venhaus, Ralph; Ott, Patrick A; Bhardwaj, Nina

    2015-03-01

    The Toll-like receptor (TLR) 7/8 agonist resiquimod has been used as an immune adjuvant in cancer vaccines. We evaluated the safety and immunogenicity of the cancer testis antigen NY-ESO-1 given in combination with Montanide (Seppic) with or without resiquimod in patients with high-risk melanoma. In part I of the study, patients received 100 μg of full-length NY-ESO-1 protein emulsified in 1.25 mL of Montanide (day 1) followed by topical application of 1,000 mg of 0.2% resiquimod gel on days 1 and 3 (cohort 1) versus days 1, 3, and 5 (cohort 2) of a 21-day cycle. In part II, patients were randomized to receive 100-μg NY-ESO-1 protein plus Montanide (day 1) followed by topical application of placebo gel [(arm A; n = 8) or 1,000 mg of 0.2% resiquimod gel (arm B; n = 12)] using the dosing regimen established in part I. The vaccine regimens were generally well tolerated. NY-ESO-1-specific humoral responses were induced or boosted in all patients, many of whom had high titer antibodies. In part II, 16 of 20 patients in both arms had NY-ESO-1-specific CD4⁺ T-cell responses. CD8⁺ T-cell responses were only seen in 3 of 12 patients in arm B. Patients with TLR7 SNP rs179008 had a greater likelihood of developing NY-ESO-1-specific CD8⁺ responses. In conclusion, NY-ESO-1 protein in combination with Montanide with or without topical resiquimod is safe and induces both antibody and CD4⁺ T-cell responses in the majority of patients; the small proportion of CD8⁺ T-cell responses suggests that the addition of topical resiquimod to Montanide is not sufficient to induce consistent NY-ESO-1-specific CD8⁺ T-cell responses. ©2015 American Association for Cancer Research.

  3. Duration of US residence is associated with overweight risk in Filipino immigrants living in NY metro area

    PubMed Central

    Afable, Aimee; Ursua, Rhodora; Wyatt, Laura C.; Aguilar, David; Kwon, Simona C.; Islam, Nadia S.; Trinh-Shevrin, Chau

    2015-01-01

    We examined the association between years living in the US and overweight risk among a community sample of Filipino adult immigrants living in the New York (NY) metropolitan area. We found a significant and adverse association between years living in the US and overweight risk. Compared to Filipinos who lived in the US less than 5 years, those who lived in the US 10 years or longer had a higher overweight risk; this association was only present among Filipinos who migrated to NY metropolitan area at 30 years or younger. Studies on causal mechanisms explaining this pattern are needed. PMID:26605951

  4. EPA Proposes to Add Dutchess County Creek, N.Y. to the Federal Superfund List, Sediment Contaminated with Mercury, Polycyclic Aromatic Hydrocarbons

    EPA Pesticide Factsheets

    (New York, N.Y.) The U.S. Environmental Protection Agency today proposed adding the Wappinger Creek in Dutchess County, N.Y. to its Superfund National Priorities List of the country's most hazardous waste sites. Sediment within the two mile long tidal port

  5. Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system.

    PubMed

    Jakka, Gopinadh; Schuberth, Petra C; Thiel, Markus; Held, Gerhard; Stenner, Frank; Van Den Broek, Maries; Renner, Christoph; Mischo, Axel; Petrausch, Ulf

    2013-10-01

    Tumors can be targeted by the adoptive transfer of chimeric antigen receptor (CAR) redirected T-cells. Antigen-specific expansion protocols are needed to generate large quantities of redirected T-cells. We aimed to establish a protocol to expand functional active NY-ESO-1-specific redirected human CD8(+) T-cells. The anti-idiotypic Fab antibody A4 with specificity for HLA-A 0201/NY-ESO-1157-165 was tested by competition assays using a HLA-A 0201/NY-ESO-1157-165 tetramer. HLA-A 0201/NY-ESO-1157-165 redirected T-cells were generated, expanded and tested for CAR expression, cytokine release, in vitro cytolysis and protection against xenografted HLA-A 0201/NY-ESO-1157-165-positive multiple myeloma cells. A4 demonstrated antigen-specific binding to HLA-A 0201/NY-ESO-1157-165 redirected T-cells. Expansion with A4 resulted in 98% of HLA-A 0201/NY-ESO-1157-165 redirected T-cells. A4 induced strong proliferation, resulting in a 300-fold increase of redirected T-cells. After expansion protocols, redirected T-cells secreted Interleukin-2, (IL-2), interferon gamma (IFNγ) and tumor necrosis factor alpha (TNFα) and lysed target cells in vitro and were protective in vivo. A4 expanded HLA-A 0201/NY-ESO-1157-165 redirected T-cells with preservation of antigen-specific function.

  6. Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.

    PubMed

    Krönig, Holger; Hofer, Kathrin; Conrad, Heinke; Guilaume, Philippe; Müller, Julia; Schiemann, Matthias; Lennerz, Volker; Cosma, Antonio; Peschel, Christian; Busch, Dirk H; Romero, Pedro; Bernhard, Helga

    2009-08-01

    The cancer-testis antigen NY-ESO-1 has been targeted as a tumor-associated antigen by immunotherapeutical strategies, such as cancer vaccines. The prerequisite for a T-cell-based therapy is the induction of T cells capable of recognizing the NY-ESO-1-expressing tumor cells. In this study, we generated human T lymphocytes directed against the immunodominant NY-ESO-1(157-165) epitope known to be naturally presented with HLA-A*0201. We succeeded to isolate autorestricted and allorestricted T lymphocytes with low, intermediate or high avidity TCRs against the NY-ESO-1 peptide. The avidity of the established CTL populations correlated with their capacity of lysing HLA-A2-positive, NY-ESO-1-expressing tumor cell lines derived from different origins, e.g. melanoma and myeloma. The allorestricted NY-ESO-1-specific T lymphocytes displayed TCRs with the highest avidity and best anti-tumor recognition activity. TCRs derived from allorestricted, NY-ESO-1-specific T cells may be useful reagents for redirecting primary T cells by TCR gene transfer and, therefore, may facilitate the development of adoptive transfer regimens based on TCR-transduced T cells for the treatment of NY-ESO-1-expressing hematological malignancies and solid tumors.

  7. A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells.

    PubMed

    Song, Myung-Ha; Kim, Ye-Rin; Bae, Jae-Ho; Shin, Dong-Hoon; Lee, Sang-Yull

    2017-03-04

    The cancer/testis (CT) antigen NY-SAR-35 gene is located on the X chromosome and is aberrantly expressed in various cancers but not in normal tissues, other than testes. Previously, we reported the expression of NY-SAR-35 enhanced cell growth, proliferation, and invasion in HEK293 and cancer cells. To extend understanding of the NY-SAR-35 gene, we used a next generation sequencing (NGS) approach. NY-SAR-35 expression induced growth, proliferation, metastasis, and stemness genes, as indicated by the up-regulations of CXCR4, EpCAM, CD133, and CD44, at the mRNA and protein levels. The expression of NY-SAR-35 in HEK293 cells significantly increased ERK phosphorylation, but not the phosphorylation of AKT. In HEK293/NY-SAR-35 cells, the expressions of pro-apoptotic proteins, including p53, Bax, and p21, were reduced and that of cyclin E was increased. Also, NY-SAR-35 increased the expressions of pluripotency genes (Nanog, Oct-4, and Sox2) and the ability of HEK293 cells to form colonies. Taken together, the present study indicates NY-SAR-35 functions as a CT antigen that triggers oncogenesis and self-renewal. Copyright © 2017 Elsevier Inc. All rights reserved.

  8. Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients

    PubMed Central

    2013-01-01

    Background Cholesteryl pullulan (CHP) is a novel antigen delivery system for cancer vaccines. This study evaluated the safety, immune responses and clinical outcomes of patients who received the CHP-NY-ESO-1 complex vaccine, Drug code: IMF-001. Methods Patients with advanced/metastatic esophageal cancer were enrolled and subcutaneously vaccinated with either 100 μg or 200 μg of NY-ESO-1 protein complexed with CHP. The primary endpoints were safety and humoral immune responses, and the secondary endpoint was clinical efficacy. Results A total of 25 patients were enrolled. Thirteen and twelve patients were repeatedly vaccinated with 100 μg or 200 μg of CHP-NY-ESO-1 with a median of 8 or 9.5 doses, respectively. No serious adverse events related to the vaccine were observed. Three out of 13 patients in the 100-μg cohort and 7 out of 12 patients in the 200-μg cohort were positive for anti-NY-ESO-1 antibodies at baseline. In the 100-μg cohort, an antibody response was observed in 5 out of 10 pre-antibody-negatives patients, and the antibody levels were augmented in 2 pre-antibody-positive patients after vaccination. In the 200-μg cohort, all 5 pre-antibody-negative patients became seropositive, and the antibody level was amplified in all 7 pre-antibody-positive patients. No tumor shrinkage was observed. The patients who received 200 μg of CHP-NY-ESO-1 survived longer than patients receiving 100 μg of CHP-NY-ESO-1, even those who exhibited unresponsiveness to previous therapies or had higher tumor burdens. Conclusions The safety and immunogenicity of CHP-NY-ESO-1 vaccine were confirmed. The 200 μg dose more efficiently induced immune responses and suggested better survival benefits. (Clinical trial registration number NCT01003808). PMID:24093426

  9. Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing

    PubMed Central

    Klar, Agnes S.; Gopinadh, Jakka; Kleber, Sascha; Wadle, Andreas; Renner, Christoph

    2015-01-01

    Background NY-ESO-1 belongs to the cancer/testis antigen (CTA) family and represents an attractive target for cancer immunotherapy. Its expression is induced in a variety of solid tumors via DNA demethylation of the promoter of CpG islands. However, NY-ESO-1 expression is usually very low or absent in some tumors such as breast cancer or multiple myeloma. Therefore, we established an optimized in vitro treatment protocol for up-regulation of NY-ESO-1 expression by tumor cells using the hypomethylating agent 5-aza-2'-deoxycytidine (DAC). Methodology/Principal Findings We demonstrated de novo induction of NY-ESO-1 in MCF7 breast cancer cells and significantly increased expression in U266 multiple myeloma cells. This effect was time- and dose-dependent with the highest expression of NY-ESO-1 mRNA achieved by the incubation of 10 μM DAC for 72 hours. NY-ESO-1 activation was also confirmed at the protein level as shown by Western blot, flow cytometry, and immunofluorescence staining. The detection and quantification of single NY-ESO-1 peptides presented at the tumor cell surface in the context of HLA-A*0201 molecules revealed an increase of 100% and 50% for MCF7 and U266 cells, respectively. Moreover, the enhanced expression of NY-ESO-1 derived peptides at the cell surface was accompanied by an increased specific lysis of MCF7 and U266 cells by HLA-A*0201/NY-ESO-1(157–165) peptide specific chimeric antigen receptor (CAR) CD8+ T cells. In addition, the killing activity of CAR T cells correlated with the secretion of higher IFN-gamma levels. Conclusions/Significance These results indicate that NY-ESO-1 directed immunotherapy with specific CAR T cells might benefit from concomitant DAC treatment. PMID:26447882

  10. Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.

    PubMed

    Klar, Agnes S; Gopinadh, Jakka; Kleber, Sascha; Wadle, Andreas; Renner, Christoph

    2015-01-01

    NY-ESO-1 belongs to the cancer/testis antigen (CTA) family and represents an attractive target for cancer immunotherapy. Its expression is induced in a variety of solid tumors via DNA demethylation of the promoter of CpG islands. However, NY-ESO-1 expression is usually very low or absent in some tumors such as breast cancer or multiple myeloma. Therefore, we established an optimized in vitro treatment protocol for up-regulation of NY-ESO-1 expression by tumor cells using the hypomethylating agent 5-aza-2'-deoxycytidine (DAC). We demonstrated de novo induction of NY-ESO-1 in MCF7 breast cancer cells and significantly increased expression in U266 multiple myeloma cells. This effect was time- and dose-dependent with the highest expression of NY-ESO-1 mRNA achieved by the incubation of 10 μM DAC for 72 hours. NY-ESO-1 activation was also confirmed at the protein level as shown by Western blot, flow cytometry, and immunofluorescence staining. The detection and quantification of single NY-ESO-1 peptides presented at the tumor cell surface in the context of HLA-A*0201 molecules revealed an increase of 100% and 50% for MCF7 and U266 cells, respectively. Moreover, the enhanced expression of NY-ESO-1 derived peptides at the cell surface was accompanied by an increased specific lysis of MCF7 and U266 cells by HLA-A*0201/NY-ESO-1(157-165) peptide specific chimeric antigen receptor (CAR) CD8+ T cells. In addition, the killing activity of CAR T cells correlated with the secretion of higher IFN-gamma levels. These results indicate that NY-ESO-1 directed immunotherapy with specific CAR T cells might benefit from concomitant DAC treatment.

  11. Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.

    PubMed

    Shurell, Elizabeth; Vergara-Lluri, Maria E; Li, Yunfeng; Crompton, Joseph G; Singh, Arun; Bernthal, Nicholas; Wu, Hong; Eilber, Fritz C; Dry, Sarah M

    2016-11-08

    Immunotherapy targeting cancer-testis antigen NY-ESO-1 shows promise for tumors with poor response to chemoradiation. Malignant peripheral nerve sheath tumors (MPNSTs) and liposarcomas (LPS) are chemoresistant and have few effective treatment options. Materials Methods: Using a comprehensive tissue microarray (TMA) of both benign and malignant tumors in primary, recurrent, and metastatic samples, we examined NY-ESO-1 expression in peripheral nerve sheath tumor (PNST) and adipocytic tumors. The PNST TMA included 42 MPNSTs (spontaneous n = 26, NF1-associated n = 16), 35 neurofibromas (spontaneous n = 22, NF-1 associated n = 13), 11 schwannomas, and 18 normal nerves. The LPS TMA included 48 well-differentiated/dedifferentiated (WD/DD) LPS, 13 myxoid/round cell LPS, 3 pleomorphic LPS, 8 lipomas, 1 myelolipoma, and 3 normal adipocytic tissue samples. Stained in triplicate, NY-ESO-1 intensity and density were scored. NY-ESO-1 expression was exclusive to malignant tumors. 100% of myxoid/round cell LPS demonstrated NY-ESO-1 expression, while only 6% of WD/DD LPS showed protein expression, one of which was WD LPS. Of MPNST, 4/26 (15%) spontaneous and 2/16 (12%) NF1-associated MPNSTs demonstrated NY-ESO-1 expression. Strong NY-ESO-1 expression was observed in myxoid/round cell and dedifferentiated LPS, and MPNST in primary, neoadjuvant, and metastatic settings. We found higher prevalence of NY-ESO-1 expression in MPNSTs than previously reported, highlighting a subset of MPNST patients who may benefit from immunotherapy. This study expands our understanding of NY-ESO-1 in WD/DD LPS and is the first demonstration of staining in a WD LPS and metastatic/recurrent myxoid/round cell LPS. These results suggest immunotherapy targeting NY-ESO-1 may benefit patients with aggressive tumors resistant to conventional therapy.

  12. Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma

    PubMed Central

    Shurell, Elizabeth; Vergara-Lluri, Maria E.; Li, Yunfeng; Crompton, Joseph G.; Singh, Arun; Bernthal, Nicholas; Wu, Hong; Eilber, Fritz C.; Dry, Sarah M.

    2016-01-01

    Background Immunotherapy targeting cancer-testis antigen NY-ESO-1 shows promise for tumors with poor response to chemoradiation. Malignant peripheral nerve sheath tumors (MPNSTs) and liposarcomas (LPS) are chemoresistant and have few effective treatment options. Materials Methods Using a comprehensive tissue microarray (TMA) of both benign and malignant tumors in primary, recurrent, and metastatic samples, we examined NY-ESO-1 expression in peripheral nerve sheath tumor (PNST) and adipocytic tumors. The PNST TMA included 42 MPNSTs (spontaneous n = 26, NF1-associated n = 16), 35 neurofibromas (spontaneous n = 22, NF-1 associated n = 13), 11 schwannomas, and 18 normal nerves. The LPS TMA included 48 well-differentiated/dedifferentiated (WD/DD) LPS, 13 myxoid/round cell LPS, 3 pleomorphic LPS, 8 lipomas, 1 myelolipoma, and 3 normal adipocytic tissue samples. Stained in triplicate, NY-ESO-1 intensity and density were scored. Results NY-ESO-1 expression was exclusive to malignant tumors. 100% of myxoid/round cell LPS demonstrated NY-ESO-1 expression, while only 6% of WD/DD LPS showed protein expression, one of which was WD LPS. Of MPNST, 4/26 (15%) spontaneous and 2/16 (12%) NF1-associated MPNSTs demonstrated NY-ESO-1 expression. Strong NY-ESO-1 expression was observed in myxoid/round cell and dedifferentiated LPS, and MPNST in primary, neoadjuvant, and metastatic settings. Conclusions We found higher prevalence of NY-ESO-1 expression in MPNSTs than previously reported, highlighting a subset of MPNST patients who may benefit from immunotherapy. This study expands our understanding of NY-ESO-1 in WD/DD LPS and is the first demonstration of staining in a WD LPS and metastatic/recurrent myxoid/round cell LPS. These results suggest immunotherapy targeting NY-ESO-1 may benefit patients with aggressive tumors resistant to conventional therapy. PMID:27655679

  13. Impact of cirrus on the surface radiative environment at the FIRE ETLA Palisades, NY site

    NASA Technical Reports Server (NTRS)

    Robinson, David A.; Kukla, George; Frei, Allan

    1990-01-01

    FIRE Extended Time Limited Area (ETLA) observations provide year round information critical to gaining a better understanding of cloud/climate interactions. The Lamont/Rutgers team has participated in the ETLS program through the collection and analysis of shortwave and longwave downwelling irradiances at Palisades, NY. These data are providing useful information on surface radiative fluxes with respect to sky condition, solar zenith angle and season. Their utility extends to the calibration and validation of cloud/radiative models and satellite cloud and radiative retrievals. The impact cirrus clouds have on the surface radiative environment is examined using Palisades ETLA information on atmospheric transmissivities and downwelling longwave fluxes for winter and summer cirrus and clear sky episodes in 1987.

  14. Polar cloud observatory at Ny-Ålesund in GRENE Arctic Climate Change Research Project

    NASA Astrophysics Data System (ADS)

    Yamanouchi, Takashi; Takano, Toshiaki; Shiobara, Masataka; Okamoto, Hajime; Koike, Makoto; Ukita, Jinro

    2016-04-01

    Cloud is one of the main processes in the climate system and especially a large feed back agent for Arctic warming amplification (Yoshimori et al., 2014). From this reason, observation of polar cloud has been emphasized and 95 GHz cloud profiling radar in high precision was established at Ny-Ålesund, Svalbard in 2013 as one of the basic infrastructure in the GRENE (Green Network of Excellence Program) Arctic Climate Change Research Project. The radar, "FALCON-A", is a FM-CW (frequency modulated continuous wave) Doppler radar, developed for Arctic use by Chiba University (PI: T. Takano) in 2012, following its prototype, "FALCON-1" which was developed in 2006 (Takano et al., 2010). The specifications of the radar are, central frequency: 94.84 GHz; antenna power: 1 W; observation height: up to 15 km; range resolution: 48 m; beam width: 0.2 degree (15 m at 5 km); Doppler width: 3.2 m/s; time interval: 10 sec, and capable of archiving high sensitivity and high spatial and time resolution. An FM-CW type radar realizes similar sensitivity with much smaller parabolic antennas separated 1.4 m from each other used for transmitting and receiving the wave. Polarized Micro-Pulse Lidar (PMPL, Sigma Space MPL-4B-IDS), which is capable to measure the backscatter and depolarization ratio, has also been deployed to Ny-Ålesund in March 2012, and now operated to perform collocated measurements with FALCON-A. Simultaneous measurement data from collocated PMPL and FALCON-A are available for synergetic analyses of cloud microphysics. Cloud mycrophysics, such as effective radius of ice particles and ice water content, are obtained from the analysis based on algorithm, which is modified for ground-based measurements from Okamoto's retrieval algorithm for satellite based cloud profiling radar and lidar (CloudSat and CALIPSO; Okamoto et al., 2010). Results of two years will be shown in the presentation. Calibration is a point to derive radar reflectivity (dBZ) from original intensity data

  15. Bárány's theory is right, but incomplete. An experimental study in pigeons.

    PubMed

    Wit, H P; Spoelstra, H A; Segenhout, J M

    1990-01-01

    The horizontal semicircular canal in pigeons was thermally stimulated with a miniature Peltier-element device. Sound evoked electric responses from the vestibular organ were modulated by the caloric stimulus. Experiments were performed under minimal influence of gravity, (horizontal canals in horizontal plane), and with the pigeons head tilted forwards or backwards. On the basis of the results it was concluded that the influence of gravity can be described by Bárány's convection theory. Extra effects are, however, present and they are most probably partly of mechanical origin (fluid expansion) and partly due to a direct influence of temperature on the vestibular receptors. Further experiments are needed to investigate the origin of these extra effects in more detail.

  16. Antibiotic usage in 2013 on a dairy CAFO in NY State, USA

    PubMed Central

    Doane, Marie; Sarenbo, Sirkku

    2014-01-01

    Antimicrobial resistance is threatening humans and animals worldwide. Biosecurity and 1-year usage of antibiotics on a dairy concentrated animal feeding operation (CAFO) in NY State, USA, were mapped: how much antibiotics were used, for what purpose, and whether any decrease could be warranted. Approximately 493 kg antibiotics was used, of which 376 kg was ionophores (monensin and lasalocides), 79 kg penicillin, 16.5 kg lincosamides, 8.0 kg aminoglycosides, 7.7 kg sulfamides, 3.4 kg cephalosporin, 2 kg macrolides, 0.7 kg amphenicols, and 0.1 kg fluoroquinolones. Usage reduction by 84% was realistic without compromising the animal welfare. Further reduction could be possible by improving the biosecurity and by utilizing antibiotic sensitivity testing. PMID:24891936

  17. Chemical and geochemical composition of spring-summer Arctic aerosol collected at Ny Alesund, Svalbard Islands.

    NASA Astrophysics Data System (ADS)

    Udisti, Roberto; Becagli, Silvia; Caiazzo, Laura; Cappelletti, David; Giardi, Fabio; Grotti, Marco; Lucarelli, Franco; Moroni, Beatrice; Nava, Silvia; Severi, Mirko; Traversi, Rita

    2017-04-01

    Since March 2010, spring-summer (usually March - September) campaigns were continuously carried out at the Italian Gruvebadet Observatory, Ny Alesund, Svalbard Island. Aerosol was sampled by PM10 (daily) and 4-stage (4-day resolution) collector devices and size distribution was evaluated at 10 min resolution in the range 10 nm - 20 um (106 size classes by a TSI SMPS-APS integrated system). Six-year (2010-2015) PM10 and size-segregated (>10, 10-2.5, 2.5-1, < 1 um) filters were analyzed for ion composition (inorganic anions and cations, and selected organic anions by Ion Chromatography), metal content (major and trace metals, including Rare Earth Elements - REEs, by PIXE and ICP-MS), Pb isotopic composition (by ICP-MS) and Elemental and Organic Carbon (EC-OC) concentrations. The data set was elaborated by multi-parametric statistical analysis (Positive Matrix Factorization - PMF), in order to identifying and quantifying the contribution of the main anthropic and natural aerosol sources. Particular attention was spent in evaluating the anthropic contribution of nss-sulphate, nitrate, EC and heavy metals during the Arctic Haze in spring. The isotopic composition of Pb was used in identifying the source areas (North America, Greenland, North Europe, Siberia, Iceland) of anthropic emissions as a function of seasonality (different atmospheric circulation pathway). Crustal metals and, especially, REEs anomalies (with respect to the Chondrite-normalized profile) allowed characterizing the dust emissions from their Potential Source Areas (PSA). Biogenic markers (especially methane sulfonic acid - MSA - and bio-nss-sulphate) was used to obtain relevant information about the relationship between marine biogenic activity (primary productivity) and sea ice coverage and atmospheric conditions (irradiance, temperature, circulation pathways). The seasonal pattern of the nitrate deposition was also investigated. Chemical and geochemical measurements were compared with high

  18. Simulated climate change: The interaction between vegetation type and microhabitat temperatures at Ny Alesund, Svalbard

    SciTech Connect

    Coulson, S.; Hodkinson, I.D. ); Stathdee, A.; Bale, J.S. ); Block, W.; Worland, M.R. ); Webb, N.R. )

    1993-01-01

    Small polythene tents were used to simulate the effects of climate warming on two contrasting vegetation types (polar semi-desert and tundra heath) at Ny Alesund, Spitzbergen, Svalbard. Temperature microclimates are compared within and without tents and between sites with contrasting vegetation types. Summer temperatures were increased by about 5[degrees]C in the vegetation mat and by about 2[degrees]C in the soil at 3 cm depth. Cumulative day degrees above zero were enhanced by around 35% in the vegetation and by around 9% in the soil. Soil temperatures were greatly influenced by the nature of the overlying vegetation, which at one of the sites appeared to act as an efficient thermal insulator, preventing heat conductance into the soil from above and enhancing thermal contact between the upper soil layer and the cooling permafrost below. The significance of the observed temperature differences for the ecology of the plants and invertebrates is discussed. 21 refs., 3 figs., 2 tabs.

  19. National Dam Inspection Program. Stilwell Lake Dam (Inventory Number NY 770), Phase 1 Inspection Report

    DTIC Science & Technology

    1978-12-01

    Oran e Co nty, N w rk6. PERFORMING O RtG. REPORT NUMBERInventory No. NY 770 7 - AUTHO~R(*) S. C TRACT ORGRANT NUMBER(s) Eugene O’Brien, P.E.DA-5...CJO,1 joirn’, of Slr-ay Afonoll#h hg/ tl I , a~im~rd薽 hsushem o Fedo7dnfy 9/4 6 On Ma I’ - - -i’-- , b -wv-1. I OFWR S UL .% -o’ D- TII?3 STTE MAYIT4...3•. . ."i.,. , . I1 - f c s-w _ _4 .4t a . c .te sre * .* * SrCTIONe a-a erlI , tl . , *v164 3 ’-1 -1 - ’ -ale, "VA.. - - ’. tvr t . Noe,, 0, 1 JhJL

  20. Manufacturing of HfOxNy films using reactive magnetron sputtering for ISFET application

    NASA Astrophysics Data System (ADS)

    Firek, Piotr; Wysokiński, Piotr

    2016-12-01

    Hafnium Oxide-Nitride films were deposited using reactive magnetron sputtering in O2/N2/Ar gas mixture. Deposition was planned according to Taguchi optimization method. Morphology of fabricated layers was tested using AFM technique (Ra=0.2÷1,0 nm). Thickness of HfOXNY films was measured using spectroscopic ellipsometry (t=45÷54 nm). Afterwards MIS structures were created by Al metallization process then layers were electrically characterised using I-V and C-V measurements. This allowed to calculate the electrical parameters of layers such as: flat-band voltage UFB, dielectric constant Ki, interface state trap density Dit and effective charge Qeff. Subsequently, deposited HfOxNy layers were annealed in PDA process (40 min 400 °C 100% N2) after which the electrical characterization was performed again.

  1. Distributions and impact factors of antimony in topsoils and moss in Ny-Ålesund, Arctic.

    PubMed

    Jia, Nan; Sun, Liguang; He, Xin; You, Kehua; Zhou, Xin; Long, Nanye

    2012-12-01

    The distribution of antimony (Sb) in topsoil and moss (Dicranum angustum) in disturbed and undisturbed areas, as well as coal and gangue, in Ny-Ålesund, Arctic was examined. Results show that the weathering of coal bed could not contribute to the increase of Sb concentrations in topsoil and moss in the study area. The distribution of Sb is partially associated with traffic and historical mining activities. The occurrence of the maximum Sb concentration is due to the contribution of human activities. In addition, the decrease of Sb content in topsoil near the coastline may be caused by the washing of seawater. Compared with topsoils, moss could be a useful tool for monitoring Sb in both highly and lightly polluted areas.

  2. EPA and DuPont Reach Major Settlement After Fatal Chemical Explosion in Tonawanda, N.Y.

    EPA Pesticide Factsheets

    (New York, N.Y.) The U.S. Environmental Protection Agency announced that E.I. du Pont de Nemours & Co. (DuPont) has agreed to pay a fine of $724,000 in settlement of Clean Air Act violations relating to a fire and explosion at its chemical plant in Ton

  3. 77 FR 37569 - Establishment of Class D Airspace and Amendment of Class E Airspace; East Hampton, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-22

    ... Federal Aviation Administration 14 CFR Part 71 Establishment of Class D Airspace and Amendment of Class E Airspace; East Hampton, NY AGENCY: Federal Aviation Administration (FAA), DOT. ACTION: Final rule. SUMMARY..., Federal Aviation Administration, P.O. Box 20636, Atlanta, Georgia 30320; telephone (404) 305-6364...

  4. FIELD PERFORMANCE OF ADVANCED TECHNOLOGY WOODSTOVES IN GLEN FALLS, NY, 1988-89 - VOLUME II - TECHNICAL APPENDICES

    EPA Science Inventory

    The report gives results of an evaluation of particulate emission trends for three models of catalytic and two models of non- catalytic woodstoves under "in-home" burning conditions during the 1988-89 heating season in Glens Falls, NY. The results (averaging 9.4 g/h and 9.4 g/kg...

  5. 77 FR 65015 - Notice of Intent To Repatriate Cultural Items: American Museum of Natural History, New York, NY...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-24

    ... National Park Service Notice of Intent To Repatriate Cultural Items: American Museum of Natural History... of Natural History that meet the definition of unassociated funerary objects under 25 U.S.C. 3001... Resources, American Museum of Natural History, Central Park West at 79th Street, New York, NY...

  6. Examination of Below-Ground Structure and Soil Respiration Rates of Stable and Deteriorating Salt Marshes in Jamaica Bay (NY)

    EPA Science Inventory

    CAT scan imaging is currently being used to examine below-ground peat and root structure in cores collected from salt marshes of Jamaica Bay, part of the Gateway National Recreation Area (NY). CAT scans or Computer-Aided Tomography scans use X-ray equipment to produce multiple i...

  7. 33 CFR 100.121 - Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain's Cove Seaport...

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ... 33 Navigation and Navigable Waters 1 2011-07-01 2011-07-01 false Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain's Cove Seaport, Bridgeport, CT. 100.121 Section 100.121... SAFETY OF LIFE ON NAVIGABLE WATERS § 100.121 Swim Across the Sound, Long Island Sound, Port Jefferson,...

  8. 33 CFR 100.121 - Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain's Cove Seaport...

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Swim Across the Sound, Long Island Sound, Port Jefferson, NY to Captain's Cove Seaport, Bridgeport, CT. 100.121 Section 100.121... SAFETY OF LIFE ON NAVIGABLE WATERS § 100.121 Swim Across the Sound, Long Island Sound, Port Jefferson,...

  9. 78 FR 11116 - Safety Zone; Mamaroneck Beach and Yacht Club Fireworks, Mamaroneck Harbor, Long Island Sound, NY

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-15

    ..., Mamaroneck Harbor, Long Island Sound, NY AGENCY: Coast Guard, DHS. ACTION: Notice of proposed rulemaking... Island Sound in the vicinity of Mamaroneck Harbor for a fireworks display. This temporary safety zone is... is intended to restrict all vessels from a portion of Long Island Sound before, during,...

  10. EPA Finalizes $4 Million Cleanup Plan for Fulton Avenue Superfund Site in Hempstead and North Hempstead, N.Y.

    EPA Pesticide Factsheets

    (New York, N.Y.) The U.S. Environmental Protection Agency has finalized its decision to modify an interim cleanup plan originally issued in 2007 to address a portion of the contaminated groundwater at the Fulton Avenue Superfund site in the Towns of North

  11. 33 CFR 165.T01-0471 - Safety Zone; Belt Parkway Bridge Construction, Gerritsen Inlet, Brooklyn, NY.

    Code of Federal Regulations, 2014 CFR

    2014-07-01

    ... 33 Navigation and Navigable Waters 2 2014-07-01 2014-07-01 false Safety Zone; Belt Parkway Bridge Construction, Gerritsen Inlet, Brooklyn, NY. 165.T01-0471 Section 165.T01-0471 Navigation and Navigable Waters... Guard District § 165.T01-0471 Safety Zone; Belt Parkway Bridge Construction, Gerritsen Inlet, Brooklyn...

  12. 33 CFR 110.84 - Black Rock Channel opposite foot of Porter Avenue, Buffalo, N.Y.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 1 2010-07-01 2010-07-01 false Black Rock Channel opposite foot..., DEPARTMENT OF HOMELAND SECURITY ANCHORAGES ANCHORAGE REGULATIONS Special Anchorage Areas § 110.84 Black Rock Channel opposite foot of Porter Avenue, Buffalo, N.Y. An area extending northwesterly between Black...

  13. 76 FR 38383 - Albany Engineering Corporation, Town of Stuyvesant, NY; Notice of Site Visit and Technical Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-30

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF ENERGY Federal Energy Regulatory Commission Albany Engineering Corporation, Town of Stuyvesant, NY; Notice of Site Visit and Technical Meeting On July 12, 2011, Office of Energy Projects staff will participate in a site...

  14. Exploring the feasibility of Sclerotium rolfsii VrNY as a potential bioherbicide for control of Swallowworts (Vincetoxicum spp.)

    USDA-ARS?s Scientific Manuscript database

    Pale swallowwort (PSW) and black swallowwort (BSW) are two viney milkweeds native to Europe that have increasingly become problematic and noxious weeds in eastern North America. An indigenous fungal isolate, Sclerotium rolfsii VrNY, was discovered causing significant mortality in a dense stand of PS...

  15. FIELD PERFORMANCE OF ADVANCED TECHNOLOGY WOODSTOVES IN GLEN FALLS, NY, 1988-89 - VOLUME II - TECHNICAL APPENDICES

    EPA Science Inventory

    The report gives results of an evaluation of particulate emission trends for three models of catalytic and two models of non- catalytic woodstoves under "in-home" burning conditions during the 1988-89 heating season in Glens Falls, NY. The results (averaging 9.4 g/h and 9.4 g/kg...

  16. Development and Initial Validation of the NyTid Test: A Movement Assessment Tool for Compulsory School Pupils

    ERIC Educational Resources Information Center

    Tidén, Anna; Lundqvist, Carolina; Nyberg, Marie

    2015-01-01

    This study presents the development process and initial validation of the NyTid test, a process-oriented movement assessment tool for compulsory school pupils. A sample of 1,260 (627 girls and 633 boys; mean age of 14.39) Swedish school children participated in the study. In the first step, exploratory factor analyses (EFAs) were performed in…

  17. 76 FR 61747 - CompONE Services, LTD, Ithaca, NY; Notice of Negative Determination Regarding Application for...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-05

    ... Employment and Training Administration CompONE Services, LTD, Ithaca, NY; Notice of Negative Determination... administrative reconsideration of the negative ] determination regarding workers' eligibility to apply for Trade... York (CompONE Services). The negative determination was issued on August 3, 2011. The...

  18. 76 FR 36080 - Foreign-Trade Zone 37-Orange County, NY; Application for Reorganization (Expansion of Service...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-21

    ... Foreign-Trade Zones Board Foreign-Trade Zone 37--Orange County, NY; Application for Reorganization... Foreign-Trade Zones (FTZ) Board (the Board) by the County of Orange, New York, grantee of FTZ 37..., 75 FR 29727, 5/27/10). The zone project currently has a service area that includes Orange County. The...

  19. 78 FR 12033 - Foreign-Trade Zone 37-Orange County, NY, Application for Reorganization (Expansion of Service...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-21

    ... Foreign-Trade Zones Board Foreign-Trade Zone 37--Orange County, NY, Application for Reorganization...-Trade Zones (FTZ) Board (the Board) by the County of Orange, grantee of Foreign-Trade Zone 37..., 76 FR 67407, 11/1/2011). The zone project currently has a service area that includes Orange and...

  20. 76 FR 66685 - Foreign-Trade Zone 37-Orange County, NY, Application for Subzone, ITT Water Technology, Inc...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-27

    ... From the Federal Register Online via the Government Publishing Office DEPARTMENT OF COMMERCE Foreign-Trade Zones Board Foreign-Trade Zone 37--Orange County, NY, Application for Subzone, ITT Water... Foreign-Trade Zones Board (the Board) by the County of Orange, New York, grantee of FTZ 37, requesting...

  1. Examination of Below-Ground Structure and Soil Respiration Rates of Stable and Deteriorating Salt Marshes in Jamaica Bay (NY)

    EPA Science Inventory

    CAT scan imaging is currently being used to examine below-ground peat and root structure in cores collected from salt marshes of Jamaica Bay, part of the Gateway National Recreation Area (NY). CAT scans or Computer-Aided Tomography scans use X-ray equipment to produce multiple i...

  2. 33 CFR 165.164 - Security Zones: Dignitary Arrival/Departure and United Nations Meetings, New York, NY.

    Code of Federal Regulations, 2010 CFR

    2010-07-01

    ... 33 Navigation and Navigable Waters 2 2010-07-01 2010-07-01 false Security Zones: Dignitary Arrival/Departure and United Nations Meetings, New York, NY. 165.164 Section 165.164 Navigation and Navigable Waters... Guard District § 165.164 Security Zones: Dignitary Arrival/Departure and United Nations Meetings,...

  3. Arctic summer aerosols: a case study of Ny-Ålesund

    NASA Astrophysics Data System (ADS)

    Zhan, J.; Gao, Y.; Li, W.; Chen, L.

    2013-12-01

    Concentration of trace elements, ionic species and carbonaceous aerosol were investigated at Ny-Ålesund to assess the aerosols' origins and their impact on the chemical composition in the summer Arctic atmosphere. Air mass influenced by ship emissions was identified by elevated concentrations of non-crustal (nc) Vanadium (V), nc nickel (Ni), non-sea salt (nss) sulfate (SO42-) and by the ratios of nc-Ni/nc-V (1.7) and nss-SO42-/nc-V (200). The elevated Total Suspended Particulate (TSP) was observed when large cruise ships visited Ny-Ålesund during the observation period. The concentration was 2291 ng m-3, almost triple of the mean concentration (898.0 ng m-3). Elevated trace elements, as well as sulfate and nitrate, were observed in the same air mass. This suggests that ship emissions contributed significantly to Arctic atmospheric particulate matter. Additionally, backward trajectories and the ratio of nc manganese (Mn)/nc-V were used to identify the air mass'origins, which were Central Russia and the North Atlantic Ocean. However, the chemical compositions in these air masses were not significantly different from the composition of masses that originated in the Arctic Ocean. All the samples were enriched with Ni, copper (Cu), zinc(Zn), selenium (Se), silver(Ag), cadmium(Cd), antimony(Sb), thallium(Tl), even the sample collected from the Arctic Ocean air mass. Our limited data indicated that long-range transport didn't significantly contribute to the area' s atmospheric pollution, but local sources, such as transportation, coal mining, coal burning and energy production, were important contributors of heavy metals to the atmosphere, epically ship emissions.

  4. Exposure indices for the National Children's Study: application to inhalation exposures in Queens County, NY

    PubMed Central

    Isukapalli, Sastry S.; Brinkerhoff, Christopher J.; Xu, Shu; Dellarco, Michael; Landrigan, Philip J.; Lioy, Paul J.; Georgopoulos, Panos G.

    2014-01-01

    Characterization of environmental exposures to population subgroups within the National Children's Study (NCS), or other large-scale human environmental health studies is essential for developing a high-quality data platform for subsequent investigations. A computational formulation utilizing the tiered exposure ranking framework is presented for calculating inhalation exposure indices (EIs) for population subgroups. This formulation employs a probabilistic approach and combines information from diverse, publicly available exposure-relevant databases and information on biological mechanisms, for ranking study locations or population subgroups with respect to potential for specific end point-related environmental exposures. These EIs capture and summarize, within a set of numerical values/ranges, complex distributions of potential exposures to multiple airborne contaminants. These estimates capture spatial and demographic variability within each study segment, and allow for the relative comparison of study locations based on different statistical metrics of exposures. The EI formulation was applied to characterize and rank segments within Queens County, NY, which is one of the Vanguard centers for the NCS. Inhalation EI estimates relevant to respiratory outcomes, and potentially to pregnancy outcomes (low birth weight and preterm birth rates) were calculated at the study segment level. Results indicate that there is substantial variability across the study segments in Queens County, NY, and within segments, and showed an exposure gradient across the study segments that can help guide and target environmental and personal exposure sampling efforts in this county. The results also serve as an example application of the EI for use in other exposure and outcome studies. PMID:23072768

  5. Cancer-testis antigens PRAME and NY-ESO-1 correlate with tumour grade and poor prognosis in myxoid liposarcoma.

    PubMed

    Iura, Kunio; Kohashi, Kenichi; Hotokebuchi, Yuka; Ishii, Takeaki; Maekawa, Akira; Yamada, Yuichi; Yamamoto, Hidetaka; Iwamoto, Yukihide; Oda, Yoshinao

    2015-07-01

    Myxoid liposarcoma is the second most common liposarcoma. Although myxoid liposarcoma is relatively chemosensitive and thus a good candidate for chemotherapy, cases with relapsed or metastatic disease still have poor outcome. Here, we performed a gene microarray analysis to compare the gene expression profiles in six clinical myxoid liposarcoma samples and three normal adipose tissue samples, and to identify molecular biomarkers that would be useful as diagnostic markers or treatment targets in myxoid liposarcoma. This showed that the cancer-testis antigen PRAME was up-regulated in myxoid liposarcoma. We then performed immunohistochemical, western blotting and real-time polymerase chain reaction analyses to quantify the expression of PRAME and another cancer-testis antigen, NY-ESO-1, in clinical samples of myxoid liposarcoma (n = 93), dedifferentiated (n = 46), well-differentiated (n = 32) and pleomorphic liposarcomas (n = 14). Immunohistochemically, positivity for PRAME and NY-ESO-1 was observed in 84/93 (90%) and 83/93 (89%) of the myxoid liposarcomas, and in 20/46 (43%) and 3/46 (7%) of the dedifferentiated, 3/32 (9%) and 1/32 (3%) of the well-differentiated and 7/14 (50%) and 3/21 (21%) of the pleomorphic liposarcomas, respectively. High immunohistochemical expression of PRAME and/or NY-ESO-1 was significantly correlated with tumour diameter, the existence of tumour necrosis, a round-cell component of >5%, higher histological grade and advanced clinical stage. High PRAME and NY-ESO-1 expression correlated significantly with poor prognosis in a univariate analysis. The myxoid liposarcomas showed significantly higher protein and mRNA expression levels of PRAME and NY-ESO-1 (CTAG1B) than the other liposarcomas. In conclusion, PRAME and NY-ESO-1 (CTAG1B) were expressed in the vast majority of myxoid liposarcomas, and their high-level expression correlated with tumour grade and poor prognosis. Our results support the potential use of PRAME and NY

  6. Novel and cost-effective multiple patterning technology by means of invisible SiOxNy hardmask

    NASA Astrophysics Data System (ADS)

    Jang, Linus; Moon, Young Joon; Kim, Ryoung-Han; Bencher, Christopher; Dai, Huixiong; Xie, Peng; Diehl, Daniel L.; Cao, Yong; Zeng, Wilson; Ngai, Christopher S.

    2014-03-01

    The Cost of Ownership (CoO) for semiconductor processing has been primarily dominated by lithography. In multiple patterning processes, additional materials and the impact to throughput of multiple patterning passes appear to become additional major contributors to manufacturing cost as well. We introduce SiOxNy hardmask as a new memorization layer for multiple patterning that addresses the non-lithographic cost contributor to manufacturing. The optical constants of the SiOxNy hardmask are matched to those of the photoresist at the imaging wavelength, and that makes it invisible at the exposure wavelength, enabling lithography directly over the hardmask topography, while at the same time it will be visible to those wavelengths that are used for alignment and overlay. The SiOxNy hardmask is inserted below the photoresist which will make the rework and integration schemes much simpler and result in cost savings by replacing only photoresist layers during multiple patterning processes. Additionally, by eliminating the need for traditional spincast planarization and the associated tri-layer etch we can improve the critical dimension uniformity (CDU) and reduce proximity contributions from etch, and their respective etch proximity corrections. In this work, we engineered the lithographic stack to be compatible with the invisible SiOxNy hardmask. Lithographic process windows, CDU, and LER/LWR are compared with conventional tri-layer stack and we demonstrate triple patterning memorized into the SiOxNy hardmask after which patterns are then transferred, at once, into the bottom integrated stack. Finally, major benefits of using the invisible hardmask on device scaling and patterning challenges are discussed, such as for LE2, LE3, and trench and cut patterning.

  7. Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.

    PubMed

    Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan

    2011-11-01

    NY-ESO-1 protein formulated in ISCOMATRIX™ results in CD4+, CD8+ T cell and antibody-mediated immunity. We evaluated persistence of immunity, relapse-free survival and tumour antigen expression upon relapse in patients vaccinated in an earlier trial. Immunity was measured in 28 patients with resected NY-ESO-1-expressing tumours (melanoma 25, breast 3) 252-1,155 days (median = 681) after vaccination. In the earlier vaccination, trial patients received NY-ESO-1 with ISCOMATRIX™ adjuvant at three protein doses 10 μg, 30 μg or 100 μg (n = 14); 100 μg NY-ESO-1 protein (n = 8) or placebo (n = 6), together with 1 μg of intradermal (ID) NY-ESO-1 protein twice for DTH skin testing. Immune responses assessed in the current study included antibody titres, circulating NY-ESO-1-specific T cells and DTH reactivity 2 days after DTH skin testing with NY-ESO-1 protein (1 μg) or peptides (10 μg). Relapse-free survival was determined for 42 melanoma patients. On relapse NY-ESO-1 and HLA, class I was assessed by immunohistochemistry in 17. Persisting anti-NY-ESO-1 immunity was detected in 10/14 recipients who had previously received vaccine with ISCOMATRIX™ adjuvant. In contrast, immunity only persisted in 3/14 who received 100 μg un-adjuvanted NY-ESO-1 protein (3/8) or 2 μg DTH protein (0/6) P = 0.02. Hence, persisting NY-ESO-1 immunity was associated with prior adjuvant. Tumour NY-ESO-1 or HLA class I was downregulated in participants who relapsed suggesting immunoediting had occurred. Immunoediting suggests that a signal of anti-tumour activity was observed in high-risk resected melanoma patients vaccinated with NY-ESO-1/ISCOMATRIX™. This was associated with measurable persisting immunity in the majority of vaccinated subjects tested. A prospective randomised trial has been undertaken to confirm these results.

  8. Persistent deNOx Ability of CaAl2O4:(Eu, Nd)/TiO2-xNy Luminescent Photocatalyst.

    PubMed

    Li, Huihui; Yin, Shu; Sato, Tsugio

    2010-08-20

    CaAl2O4:(Eu, Nd)/TiO2-xNy composite luminescent photocatalyst was successfully synthesized by a simple planetary ball milling process. Improvement of photocatalytic deNOx ability of TiO2-xNy, together with the persistent photocatalytic activity for the decomposition of NO after turning off the light were realized, by coupling TiO2-xNy with long afterglow phosphor, CaAl2O4:(Eu, Nd). The novel persistent photocatalytic behavior was related to the overlap between the absorption wavelength of TiO2-xNy and the emission wavelength of the CaAl2O4:(Eu, Nd). It was found that CaAl2O4:(Eu, Nd)/TiO2-xNy composites provided the luminescence to persist photocatalytic reaction for more than 3 h after turning off the light. GRAPHICAL CaAl2O4:(Eu, Nd)/TiO2-xNy composite luminescent photocatalyst with persistent deNOx activity after turning off the light was successfully synthesized by a simple planetary ball milling process. The novel persistent photocatalytic behavior was related to the overlap between the absorption wavelength of TiO2-xNy and the emission wavelength of the CaAl2O4:(Eu, Nd).

  9. Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.

    PubMed

    Jäger, Dirk; Karbach, Julia; Pauligk, Claudia; Seil, Inka; Frei, Claudia; Chen, Yao-Tseng; Old, Lloyd J; Knuth, Alexander; Jäger, Elke

    2005-12-12

    Cancer immunotherapy depends on the identification of tumor-specific target antigens that are predominantly expressed in cancer cells and not in normal tissues. Here, we report the cloning and the expression analysis of the differentiation antigen NY-BR-1 that we have identified in a previous SEREX (serological analysis of recombinant cDNA expression libraries) screening. The cloning of the full length NY-BR-1 sequence led to the prediction of an open reading frame of 4.2 kb, encoding a protein of 158.9 kDa. NY-BR-1 mRNA expression analysis revealed tissue-specific expression in normal testis and breast tissues, as well as in 70% of breast tumors. We now show that NY-BR-1 is also sporadically expressed in normal prostate and in 32% of prostate tumors. Furthermore, we were able to identify two HLA-A2 restricted NY-BR-1 epitopes (p158-167 and p960-968) that are recognized by CD8+ T cell clones (NW1100-CTL-7 and NW1100-CTL-43, respectively), as determined by ELISPOT analysis and tetramer staining. Cotransfection assays of COS-7 cells also demonstrated that these two peptides are naturally processed and presented on HLA-A2 molecules. The identification of these two naturally processed NY-BR-1-specific CD8+ T cell epitopes opens the perspective for active immunotherapy of HLA-A2 positive patients with NY-BR-1 expressing tumors.

  10. Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.

    PubMed

    Komatsu, Nobukazu; Jackson, Heather M; Chan, Kok-fei; Oveissi, Sara; Cebon, Jonathan; Itoh, Kyogo; Chen, Weisan

    2013-07-01

    The tumor antigen NY-ESO-1 is one of the most antigenic cancer-testis antigens, first identified by serologic analysis of a recombinant cDNA expression library (SEREX). NY-ESO-1 is expressed in different types of cancers including melanoma. NY-ESO-1-specific spontaneous humoral and cellular immune responses are detected in a large proportion of patients with advanced NY-ESO-1-expressing cancers. Therefore NY-ESO-1 is a good candidate antigen for immunotherapy. Although cellular immune responses to NY-ESO-1 are well characterized, much less is known about the humoral immune responses. In this study, we finely mapped linear antibody epitopes using sera from melanoma patients and shorter overlapping peptide sets. We have shown that melanoma patients' humoral immune systems responded to NY-ESO-1 differently in each individual with widely differing antibody specificity, intensity and antibody subtypes. This knowledge will help us further understand anti-tumor immunity and may also help us to monitor cancer progress and cancer vaccine efficacy in the future. Copyright © 2013 Elsevier Ltd. All rights reserved.

  11. National Dam Safety Program. Otisco Lake Dam (Inventory Number N.Y. 753), Oswego River Basin, Onondaga County, New York. Phase I Inspection Report,

    DTIC Science & Technology

    1981-09-23

    ona Dam Safety Program Oswego River Basin, Onondaga County,.NY 6. PERFORam0G OG. Re.PoRT Nu EaRB.’ Inventory No . NY00753 7- AU MOK&PS OTRC RGAN U~R...PHASE I INSPECTION REPORT NATIONAL DAN SAFETY PROGRAM OTISCO LAKE DAN I.D. NO . NY-753 DEC #73B-2751A OSWEGO RIVER BASIN ONONDAGA...COUNTY TABLE OF CONTENTS PAGE NO . ASSESSMENT OVERVIEW PHOTOGRAPH 1 PROJECT INFORMATION 1 1.1 GENERAL 1 1.2 DESCRIPTION OF PROJECT 1 1.3 PERTINENT DATA 2 2

  12. National Dam Inspection Program. Thornes Dam (Inventory Number NY 00793). Housatonic River Basin. Town of Amenia. Dutchess County, New York. Phase I Inspection Report,

    DTIC Science & Technology

    1981-07-01

    A.D - . s" - MALE (C I) ASSOCIATES SCHENECTADY NY F/B 13/13N TIONAL DAM INSPECTION PROGRAM. THORNES DAM (INVENTORY NUMBER -- ETC(U) FFf JUL 81 K J...llNhllEEEmlI HOUSATONIC RIVER BASIN TOWN OF AMENIA OUTCHESS COUNTY, NEW YORK S" THORNES DAM NY 00793 (i~ Kenneth J. /maleT SW. M. /Sm~ith Jr 15 DACW51...81..C.0014 PHASE I INSPECTION REPORT ,.%NATIONAL DAM INSPECTION PROGRAM Thornes Dam (Inventory Number NY 00793). Housatonic River Basin. Town of Amenia

  13. The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas.

    PubMed

    Hemminger, Jessica A; Ewart Toland, Amanda; Scharschmidt, Thomas J; Mayerson, Joel L; Kraybill, William G; Guttridge, Denis C; Iwenofu, O Hans

    2013-02-01

    Liposarcomas are a heterogenous group of fat-derived sarcomas, and surgery with or without chemoradiation therapy remains the main stay of treatment. NY-ESO-1 is a cancer-testis antigen expressed in various cancers where it can induce both cellular and humoral immunity. Immunotherapy has shown promise in clinical trials involving NY-ESO-1-expressing tumors. Gene expression studies have shown upregulation of the gene for NY-ESO-1, CTAG1B, in myxoid and round cell liposarcomas. Herein, we evaluated the expression of NY-ESO-1 among liposarcoma subtypes by quantitative real-time PCR, western blot analysis, and immunohistochemistry. Frozen tissue for quantitative real-time PCR and western blot analysis was obtained for the following liposarcoma subtypes (n=15): myxoid and round cell (n=8); well-differentiated (n=4), and dedifferentiated (n=3). Formalin-fixed paraffin-embedded blocks were obtained for the following liposarcoma subtypes (n=44): myxoid and round cell (n=18); well-differentiated (n=10); dedifferentiated (n=10); and pleomorphic (n=6). Full sections were stained with monoclonal antibody NY-ESO-1, and staining was assessed for intensity (1-3+), percentage of tumor positivity, and location. In all, 7/8 (88%) and 16/18 (89%) myxoid and round cell expressed CTAG1B and NY-ESO-1 by quantitative real-time PCR and immunohistochemistry, respectively. Western blot correlated with mRNA expression levels. By immunohistochemistry, 94% (15/16) of positive cases stained homogenously with 2-3+ intensity. Also, 3/6 (50%) pleomorphic liposarcomas demonstrated a range of staining: 1+ intensity in 50% of cells; 2+ intensity in 5% of cells; and 3+ intensity in 90% of cells. One case of dedifferentiated liposarcoma showed strong, diffuse staining (3+ intensity in 75% of cells). Our study shows that both CTAG1B mRNA and protein are overexpressed with high frequency in myxoid and round cell liposarcoma, enabling the potential use of targeted immunotherapy in the treatment of this

  14. Long-Term Trends in Trace Metals Concentrations in Sediment in Lakes in Adirondack Park, NY

    NASA Astrophysics Data System (ADS)

    Bari, A.; Judd, C. D.; Swami, K.; Ahmed, T.; Husain, L.

    2007-12-01

    The industrial Midwestern states consume large quantities of fossil fuel and emit large quantities of trace elements, SO2 and other chemicals. Owing to their long residence time these pollutants can be transported hundreds of miles downwind. These chemical species are removed from the atmosphere by wet and dry deposition and are ultimately deposited in lake sediments. Through the sedimentation process the pollution records can be stored for centuries. In this work we have attempted to retrieve the deposition of 25 trace elements for the past ~170 years by analyzing lake sediment cores from lakes located in the Adirondack Mountains. Sediment cores were collected from four lakes (Clear Pond, West Pine Pond, Bear Pond and Deer Pond) located in the Adirondack Park, NY. These lakes are at high altitude and some are inaccessible except by boat, and have minimum human activity (no motor boats, no camping and away from major roads). Coring was carried out by a gravity driven coring device. The cores were sectioned, weighed, freeze-dried, ground to a fine powder, and homogenized for analysis. The sediment cores were dated using 210Pb radioactive dating. The 137Cs activity was measured for an independent verification of 210Pb technique. Trace metals concentration were determined by microwave digestion method followed by inductively coupled plasma mass spectrometric (ICP-MS) analysis. The top sixteen sections of the West Pine Pond sediment core (representing from about 1835 to 2005) were analyzed for Sr, Ba, As, Se, Mo, Cd, Sn, Sb, Co, Ni, Cu, Ag,Ti, V, Cr, Mn, Fe, Zn, K, Na, Ca, Mg, Be, Tl, and Pb. During pre industrial era the concentrations of Pb, Se and Tl were very low and constant. Pb showed a sharp increase in concentration after around 1880 and a sharp decrease in concentration after about 1990. The concentration of Se increased slowly after pre industrial era. The concentrations of about eight of these elements were determined in quarterly composites of daily aerosol

  15. PIXE Analysis of Atmospheric Aerosol Samples in an Urban Area in Upstate NY

    NASA Astrophysics Data System (ADS)

    Nadareski, Benjamin; Ali, Salina; Yoskowitz, Josh; Vineyard, Michael; Labrake, Scott

    2014-09-01

    Extremely fine particles (PM2.5) are found to penetrate deep into the lungs and hence, are found to have harmful health effects on humans. Atmospheric aerosol samples collected in Schenectady, NY were analyzed for evidence for air pollution; specifically lead pollution over the past 12 months. Air samples were collected on 7 μm Kapton foils using a nine-stage cascade impactor that separates the particulate matter by aerodynamic size. A 2.2 MeV proton beam impacts the target samples. X-ray intensity versus energy spectra was produced using an Amptek silicon drift detector. Proton-induced x-ray emission (PIXE) techniques were used to analyze the energy spectra and we determined a range of 16 elements present in the aerosol samples including, Al, Si, P, S, Cl, K, Ca, Ti, Cr, Mn, Fe, Ni, Cu, Zn, Br, and Pb. The elemental composition and concentrations of these elements were determined using GUPIX. Many of the elements suggest airborne soils, however we see trace amounts of lead concentrations only at the minimal level of detection around 1 ng / m3. Preliminary results suggest that lead pollution is not significant however; we believe that the trace amounts of lead detected are due to fuel emissions from small aircraft due to the sampling site near an airport. Extremely fine particles (PM2.5) are found to penetrate deep into the lungs and hence, are found to have harmful health effects on humans. Atmospheric aerosol samples collected in Schenectady, NY were analyzed for evidence for air pollution; specifically lead pollution over the past 12 months. Air samples were collected on 7 μm Kapton foils using a nine-stage cascade impactor that separates the particulate matter by aerodynamic size. A 2.2 MeV proton beam impacts the target samples. X-ray intensity versus energy spectra was produced using an Amptek silicon drift detector. Proton-induced x-ray emission (PIXE) techniques were used to analyze the energy spectra and we determined a range of 16 elements present in

  16. Negative differential resistance and switch behavior of T-BxNy (x, y = 5, 6, 11) molecular junctions

    NASA Astrophysics Data System (ADS)

    Wang, Shi-Liang; Yang, Chuan-Lu; Wang, Mei-Shan; Ma, Xiao-Guang; Xin, Jian-Guo

    2017-05-01

    The electronic transport properties of T-BxNy (x, y = 5, 6, 11) molecular junction are investigated based on first-principle density functional theory and non-equilibrium Green's function method. Strong negative differential resistance (NDR) behavior is observed for T-B5N6 molecule under negative and positive bias voltages, with an obvious switch effect for T-B6N5. However, only small NDR is shown for the complex of the two molecules. The projected device density of states, the spatial distribution of molecular orbitals, and the effect of transmission spectra under various bias voltages on the electronic transport properties are analyzed. The obvious effect of bias voltage on the changes in the electronic distribution of frontier molecular orbitals is responsible for the NDR or switch behavior. Therefore, different functional molecular devices can be obtained with different structures of T-BxNy.

  17. Improvement of silicon solar cell efficiency by ion beam sputtered deposition of AlOxNy thin films.

    PubMed

    Chen, Sheng-Hui; Hsu, Chun-Che; Wang, Hsuan-Wen; Yeh, Chi-Li; Tseng, Shao-Ze; Lin, Hung-Ju; Lee, Cheng-Chung; Peng, Cheng-Yu

    2011-03-20

    Negative charge material, AlOxNy, has been fabricated to passivate the surface of p-type silicon. The fabrication of AlOxNy was possible by using ion beam sputtering deposition to deposit AlN thin film on the surface of a p-type silicon wafer and following annealing in oxygen ambient. Capacitance-voltage analysis shows the fixed charge density has increased from 10(11) cm(-2) to 2.26×10(12) cm(-2) after annealing. The solar cell efficiency increased from 15.9% to 17.3%, which is also equivalent to the reduction of surface recombination velocity from 1×10(5)  to 32 cm/s.

  18. Hudson River Paleoclimate, Sea Level, and Human Impact: A Record From Piermont Marsh, NY

    NASA Technical Reports Server (NTRS)

    Kurdyla; Peteet, Dorothy; Liberman, Louisa; Sugar; Wong; Hansen, James E. (Technical Monitor)

    2001-01-01

    A 13.77 meter sediment core from Piermont Marsh, NY (40 00 N, 73 55W) records the local and regional vegetational and foraminiferal history of the Hudson Estuary. The sediments were sampled every 4 cm, which represents a decadal to centuryscale resolution. Basal sediment dating is in progress, and the 11-m depth represents about 4000 years. Changes in plant macrofossils and charcoal appear to indicate differences in salinIty and drought, suggesting changes in climate. Scirpus, Salicornia, and high levels of charcoal seem to indicate drier/more saline conditions, while lack of these macrofossils and increases in Chara/Nitella, aquatic leaves, and very little charcoal suggests wetter conditions. Other macrofossils include Carex, Juncus, Polygonum, Zanichellia, Ruppia. High resolution AMS dating of plant macrofossils is in progress, and will be compared with changes in Hudson River sediment cores offshore. Foraminiferal assemblages from key intervals of the core will be presented. Human impact in the upper sediments is visible from the influx of grass seeds, primarily Phragmites, and the ragweed pollen rise.

  19. Characterization of a Single Magnetotactic Bacterial Species from Devil's Bathtub, Mendon Ponds Park, Honeoye Falls, NY

    NASA Astrophysics Data System (ADS)

    Wagner, C.; Tarduno, J. A.; Stein, A.; Sia, E.

    2015-12-01

    Magnetotactic bacteria (MTB) belong to a lineage of prokaryotic bacteria that synthesize magnetosomes, single domain magnetic particles (typically magnetite or greigite) with an average size of 50 nanometers. MTB utilize magnetosomes through magnetotaxis, the alignment and movement along magnetic field lines to navigate towards preferred environmental conditions. MTB are sensitive to different environments and are thought to exhibit varying magnetosome morphologies, compositions, sizes, and quantities in regards to the environments which they inhabit. These characteristics allow MTB and magnetofossils (preserved magnetosomes) to be used as modern/paleoenvironmental recorders and biomarkers for environmental change(s). Devil's Bathtub (Mendon Ponds Park, Honeoye Falls, NY) is a meromictic glacial kettle pond surrounded by deciduous tree cover. Here we examine one species of MTB based on prominence of this particular morphology at this locale. Magnetotaxis and morphology of this species have been observed using light microscopy. Micrographs have also been taken using Transmission Electron Microscopy (TEM) to verify cell morphology and to determine magnetosome morphology. TEM and magnetic hysteresis measurements were done to find and test the composition of magnetosomes. In this study we also focus on DNA sequencing and characterization of this MTB, as there are few MTB species which have been DNA sequenced successfully. Data from these experiments are directly applicable to this up-and-coming area of research as it will aid in the understanding and correlation of magnetosome and magnetofossils with environmental characteristics.

  20. Hudson River Paleoclimate, Sea Level, and Human Impact: A Record From Piermont Marsh, NY

    NASA Technical Reports Server (NTRS)

    Kurdyla; Peteet, Dorothy; Liberman, Louisa; Sugar; Wong; Hansen, James E. (Technical Monitor)

    2001-01-01

    A 13.77 meter sediment core from Piermont Marsh, NY (40 00 N, 73 55W) records the local and regional vegetational and foraminiferal history of the Hudson Estuary. The sediments were sampled every 4 cm, which represents a decadal to centuryscale resolution. Basal sediment dating is in progress, and the 11-m depth represents about 4000 years. Changes in plant macrofossils and charcoal appear to indicate differences in salinIty and drought, suggesting changes in climate. Scirpus, Salicornia, and high levels of charcoal seem to indicate drier/more saline conditions, while lack of these macrofossils and increases in Chara/Nitella, aquatic leaves, and very little charcoal suggests wetter conditions. Other macrofossils include Carex, Juncus, Polygonum, Zanichellia, Ruppia. High resolution AMS dating of plant macrofossils is in progress, and will be compared with changes in Hudson River sediment cores offshore. Foraminiferal assemblages from key intervals of the core will be presented. Human impact in the upper sediments is visible from the influx of grass seeds, primarily Phragmites, and the ragweed pollen rise.

  1. Water residence times and nutrient budgets across an urbanizing gradient (Croton water supply area, NY)

    NASA Astrophysics Data System (ADS)

    Vitvar, T.; Burns, D. A.; Duncan, J. M.; Hassett, J. M.; Mitchell, M. J.

    2002-05-01

    Water residence times and nutrient budgets in 3 small watersheds in the Croton water supply area, NY, were examined. The watersheds (less than 1km 2) have different level of urbanization (natural, semi-developed and fully developed), different mechanisms of runoff generation (quick flow on roads and slow flow through subsurface) and different watershed landscape characteristics (wet zones, hillslopes) . Measurements of the comprehensive chemical suite incl. components of nitrogen budget in the throughfall, stream water, soil water and groundwater in the saturated zone were performed bi-weekly over a period up to 2 years. Mean water residence times of the stream water were estimated using Oxygen-18 and Helium-3/Tritium isotopes. There are significant differences in the chemical composition and decrease of nitrification intensity and of mean streamwater residence time along the increasing watershed development. Within each watershed, longer water residence times (up to over 2 years) were estimated in the wetland zones without direct communication with streams in comparison to hillslope areas (up to over 1 year). The results can be used in watershed management and planning of the further urbanization of this water supply area.

  2. Assessment and Molecular Characterization of Human Intestinal Parasites in Bivalves from Orchard Beach, NY, USA.

    PubMed

    Tei, Freda F; Kowalyk, Steven; Reid, Jhenelle A; Presta, Matthew A; Yesudas, Rekha; Mayer, D C Ghislaine

    2016-03-29

    Bivalves have been shown to be carriers of the human intestinal parasites Cryptosporidium parvum and Toxoplasma gondii. The goal of this study is to determine the prevalence of protozoan parasites in mollusks of New York City using a polymerase chain reaction (PCR)-based assay. Four species of mollusks, Mya arenaria, Geukensia demissa, Crassostrea virginica, and Mytilis edulis, were collected from Orchard Beach, NY in the fall of 2014, totaling 159 specimens. Each individual mollusk was dissected to harvest the digestive gland, the mantle, the gills, the foot and the siphon. The tissues were assayed for the presence of Cryptosporidium parvum, Giardia lamblia, and Toxoplasma gondii DNA by using primers that target parasite-specific genes. C. parvum was found at a prevalence of 50%, 11.3%, and 1%, respectively, in Mya arenaria, G. demissa, and Mytilis edulis. C. parvum DNA was detected in all the tissues of these bivalve species, except the gills. Furthermore, G. lamblia was detected in Mya arenaria, G. demissa, Crassostrea virginica and Mytilis edulis at a prevalence of 37.5%, 4.5%, 60%, and 20.6%, respectively, while T. gondii DNA was not detected.

  3. Ground-based lidar measurements from Ny-Ålesund during ASTAR 2007: a statistical overview

    NASA Astrophysics Data System (ADS)

    Hoffmann, A.; Ritter, C.; Stock, M.; Shiobara, M.; Lampert, A.; Maturilli, M.; Orgis, T.; Neuber, R.; Herber, A.

    2009-07-01

    During the Arctic Study of Tropospheric Aerosol, Clouds and Radiation (ASTAR) in March and April 2007, measurements obtained at the AWIPEV Research station in Ny-Ålesund, Spitsbergen (operated by the Alfred-Wegener-Institute for Polar and Marine Research and the Institut polaire français Paul-Emile Victor), supported the airborne campaign. This included Lidar data from the Koldewey Aerosol Raman Lidar (KARL) and the Micro Pulse Lidar (MPL), located in the atmospheric observatory as well as photometer data and the daily launched radiosonde. The MPL features nearly continuous measurements; the KARL was switched on whenever weather conditions allowed observations (145 h in 61 days). From 1 March to 30 April, 71 meteorological balloon soundings were performed and compared with the corresponding MPL measurements; photometer measurements are available from 18 March. For the KARL data, a statistical overview based on the optical properties backscatter ratio and volume depolarization can be given. The altitudes of the occurrence of the named features (subvisible and visible ice and water as well as mixed-phase clouds, aerosol layers) as well as their dependence on different air mass origins are analyzed. Although the spring 2007 was characterized by rather clean conditions, diverse case studies of cloud and aerosol occurrence during March and April 2007 are presented in more detail, including temporal development and main optical properties as backscatter, depolarization and extinction coefficients. Links between air mass origins and optical properties can be presumed but need further evidence.

  4. The AEROCREW mission: Training space session at Ny Ålesund Arctic Base

    NASA Astrophysics Data System (ADS)

    Gourinat, Yves; Apel, Uwe; Delbart, Franck

    2010-01-01

    The AEROCREW mission was realized at Ny-Ålesund Arctic Base in December 2007, in the frame of the International Polar Year, and in cooperation with the French Polar Institute. The team made an original training experience, constituting an integrated space crew, including physicians, aerospace trainers and engineers, implied in a seminar with four sessions, dealing with the training capabilities of arctic bases. This kind of base constitutes a pertinent and affordable facility for aerospace teams, and the specific aerospace crew training techniques are fruitful for the polar scientists (glaciologists, geologists, specialists of the atmosphere). The sessions, given by professionals of aerospace, robotics and medicine, covered the training methods for crews, robotics for outdoor and indoor activities, engineering of embedded systems and the arrangement of crafts. The experience has shown the efficiency of a transverse visiting multidisciplinary team for training, and possible synergies with the resident scientists. In addition, the sessions were enriched by demonstrations such as mini-robot for observation, micro-helicopter and also the comparison between extra vehicular activities (EVA) Russian glove and polar suits.

  5. Formation of Ge nanoparticles in SiOxNy by ion implantation and thermal annealing

    DOE PAGES

    Mirzaei, Sahar; Kremer, F.; Sprouster, D. J.; ...

    2015-10-20

    Germanium nanoparticles embedded within dielectric matrices hold much promise for applications in optoelectronic and electronic devices. Here we investigate the formation of Ge nanoparticles in amorphous SiO1.67N0.14 as a function of implanted atom concentration and thermal annealing temperature. Using x-ray absorption spectroscopy and other complementary techniques, we show Ge nanoparticles exhibit significant finite-size effects such that the coordination number decreases and structural disorder increases as the nanoparticle size decreases. While the composition of SiO1.67N0.14 is close to that of SiO2, we demonstrate that the addition of this small fraction of N yields a much reduced nanoparticle size relative to thosemore » formed in SiO2 under comparable implantation and annealing conditions. We attribute this difference to an increase in an atomic density and a much reduced diffusivity of Ge in the oxynitride matrix. Finally, these results demonstrate the potential for tailoring Ge nanoparticle sizes and structural properties in the SiOxNy matrices by controlling the oxynitride stoichiometry.« less

  6. Highly Polar Organic Compounds in Summer Cloud Water from Whiteface Mountain, NY

    NASA Astrophysics Data System (ADS)

    Sagona, J. A.; Dukett, J. E.; Mazurek, M.

    2010-12-01

    Highly polar organic compounds (HPOC) containing multiple oxygen atoms are of interest due to the aerosol direct and indirect effects and uncertainty they may contribute to climate forcing. Atmospheric HPOC exist as particulate or dissolved chemical species depending on relative humidity. HPOC solid mixtures are thought to scatter and absorb light due to particle size and color (white to yellow). Understanding the chemical composition of HPOC in cloud water (CW) is important for modeling and predicting the direct and indirect influences of this organic aerosol component on the climate system. In this initial study we present a detailed molecular examination of 10 CW samples. CW samples were collected in September 2009 using an automated CW collector at Whiteface Mountain (elevation 1483 m) in the Adirondack Mountains in upstate NY. We performed QA/QC experiments for the CW samples and analyzed the HPOC mixtures by ultratrace gas chromatography/mass spectrometry. Diacids such as oxalic acid and succinic acid were major components of the CW HPOC with concentrations on the order of 15 ng/mL. Substituted diacids, monoacids, and sugars also were present. We discuss the possible sources of these compounds in light of back-trajectory analysis.

  7. Modeling a High Resolution Stream Chloride Time Series from the Biscuit Brook Catchment, Catskills, NY

    NASA Astrophysics Data System (ADS)

    Shaw, S. B.; Walter, M. T.; Harpold, A. A.

    2006-12-01

    Compelling work by Kirchner and colleagues (e.g., Kirchner et al., 2001, J. of Hydro., 254:81-100) suggests that lengthy, high resolution chloride time series can reveal the underlying travel time distribution of water in a catchment. However, few data sets of suitable length or sampling frequency have been available for assessment. Our analysis of a ten-year, weekly stream chloride time series data set for the steep, forested Biscuit Brook catchment in the Catskill Mountains of NY resulted in a 1/f spectral density plot. We used a lumped, two reservoir model with an upper reservoir representing quickflow and a lower reservoir representing base flow to reasonably replicate stream flow and stream chloride concentrations. A spectral analysis of the modeled daily chloride signal also resulted in a 1/f spectral density plot. This suggests that in some systems a 1/f signature can result from processes other than superposition of lateral chemical transport pathways, as has been previously hypothesized by other researchers. In this case, it appears that a long-term periodicity established by seasonal moisture deficits combines with shorter wavelength variations from rainfall inputs to create a 1/f spectral density for chloride concentration.

  8. Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY.

    PubMed

    Pichichero, Michael E

    2016-09-01

    This review summarizes a prospective, longitudinal 10-year study in Rochester, NY, with virtually every clinically diagnosed acute otitis media (AOM) confirmed by bacterial culture of middle ear fluid. Children experiencing 3 episodes within 6 months or 4 episodes in 12 months were considered stringently defined otitis prone (sOP). We found stringent diagnosis compared with clinical diagnosis reduced the frequency of children meeting the OP definition from 27% to 6% resulting in 14.8% and 2.4% receiving tympanostomy tubes, respectively. Significantly more often respiratory syncytial virus infection led to AOM in sOP than non-otitis-prone children that correlated with diminished total respiratory syncytial virus-specific serum IgG. sOP children produced low levels of antibody to Streptococcus pneumoniae and Haemophilus influenzae candidate vaccine protein antigens and to routine pediatric vaccines. sOP children generated significantly fewer memory B cells, functional and memory T cells to otopathogens following nasopharyngeal colonization and AOM than non-otitis-prone children and they had defects in antigen-presenting cells.

  9. Madison County, NY, food and paper waste pilot compost program, March 1993

    SciTech Connect

    Zecca, J.A.; Pike, W.R.; Higgins, T.W.

    1995-05-01

    Madison County, NY has a program which promises to extend the life of their landfill, by as much as double, at minimal cost. The County already has an impressive list of successful recycling programs but recognized that there was a need for further action. The objective of the new program is to reduce the size of the stream entering the landfill by composting a source separated fraction of the waste stream. Costs of collection are minimized by co-collecting the separately bagged {open_quotes}clean{close_quotes} household compost fraction with the balance of the trash. This is separated from the balance of the waste on the landfill site and composted in windrows. When the program started, the composted material was targeted for use as landfill cover to minimize the quality requirements. However, testing has shown that the compost is acceptable for all applications. Although the opening phase of the program might properly be called a pilot, it was started with the intention to enlarge it as events indicate such was possible. Expansion to the balance of the county, inclusion of specific commercial waste and inclusion of a broader range of household compostables are currently in progress.

  10. Single-particle characterization of summertime arctic aerosols collected at Ny-Alesund, Svalbard.

    PubMed

    Geng, Hong; Ryu, Jiyeon; Jung, Hae-Jin; Chung, Hyeok; Ahn, Kang-Ho; Ro, Chul-Un

    2010-04-01

    Single-particle characterization of summertime Arctic aerosols is useful to understand the impact of air pollutants on the polar atmosphere. In the present study, a quantitative single particle analytical technique, low-Z particle electron probe X-ray microanalysis, was used to characterize 8100 individual particles overall in 16 sets of aerosol samples collected at Ny-Alesund, Svalbard, Norway on 25-31 July, 2007. Based on their X-ray spectral and secondary electron image data of individual particles, 13 particle types were identified, in which particles of marine origin were the most abundant, followed by carbonaceous and mineral dust particles. A number of aged (reacted) sea salt (and mixture) particles produced by the atmospheric reaction of genuine sea-salts, especially with NO(x) or HNO(3), were significantly encountered in almost all the aerosol samples. They greatly outnumbered genuine sea salt particles, implying that the summertime Arctic atmosphere, generally regarded as a clean background environment, is disturbed by anthropogenic air pollutants. The main sources of airborne NO(x) (or HNO(3)) are probably ship emissions around the Arctic Ocean, industry emission from northern Europe and northwestern Siberia, and renoxification of NO(3)(-) within or on the melting snow/ice surface.

  11. EnviroAtlas - New York, NY - One Meter Resolution Urban Land Cover Data (2008) Web Service

    EPA Pesticide Factsheets

    This EnviroAtlas web service supports research and online mapping activities related to EnviroAtlas (https://www.epa.gov/enviroatlas ). The New York, NY EnviroAtlas Meter-scale Urban Land Cover (MULC) Data were generated by the University of Vermont Spatial Analysis Laboratory (SAL) under the direction of Jarlath O'Neil-Dunne as part of the United States Forest Service Urban Tree Canopy (UTC) assessment program. Seven classes were mapped using LiDAR and high resolution orthophotography: Tree Canopy, Grass/Shrub, Bare Soil, Water, Buildings, Roads/Railroads, and Other Paved Surfaces. These data were subsequently merged to fit with the EPA classification. The SAL project covered the five boroughs within the NYC city limits. However the EPA study area encompassed that area plus a 1 kilometer buffer. Additional land cover for the buffer area was generated from United States Department of Agriculture (USDA) National Agricultural Imagery Program (NAIP) four band (red, green, blue, and near infrared) aerial photography at 1 m spatial resolution from July, 2011 and LiDAR from 2010. Six land cover classes were mapped: water, impervious surfaces, soil and barren land, trees, grass-herbaceous non-woody vegetation, and agriculture. An accuracy assessment of 600 completely random and 55 stratified random photo interpreted reference points yielded an overall User's fuzzy accuracy of 87 percent. The area mapped is the US Census Bureau's 2010 Urban Statistical Area for New Yor

  12. EnviroAtlas - New York City, NY - BenMAP Results by Block Group

    EPA Pesticide Factsheets

    This EnviroAtlas dataset demonstrates the effect of changes in pollution concentration on local populations in 6,378 block groups in New York City, New York. The US EPA's Environmental Benefits Mapping and Analysis Program (BenMAP) was used to estimate the incidence of adverse health effects (i.e., mortality and morbidity) and associated monetary value that result from changes in pollution concentrations for New York, Kings, Queens, Richmond, and Bronx Counties, NY. Incidence and value estimates for the block groups are calculated using i-Tree models (www.itreetools.org), local weather data, pollution data, and U.S. Census derived population data. This dataset was produced by the US Forest Service to support research and online mapping activities related to EnviroAtlas. EnviroAtlas (https://www.epa.gov/enviroatlas) allows the user to interact with a web-based, easy-to-use, mapping application to view and analyze multiple ecosystem services for the contiguous United States. The dataset is available as downloadable data (https://edg.epa.gov/data/Public/ORD/EnviroAtlas) or as an EnviroAtlas map service. Additional descriptive information about each attribute in this dataset can be found in its associated EnviroAtlas Fact Sheet (https://www.epa.gov/enviroatlas/enviroatlas-fact-sheets).

  13. EnviroAtlas - New York, NY - One Meter Resolution Urban Land Cover Data (2008)

    EPA Pesticide Factsheets

    The New York, NY EnviroAtlas Meter-scale Urban Land Cover (MULC) Data were generated by the University of Vermont Spatial Analysis Laboratory (SAL) under the direction of Jarlath O'Neil-Dunne as part of the United States Forest Service Urban Tree Canopy (UTC) assessment program. Seven classes were mapped using LiDAR and high resolution orthophotography: Tree Canopy, Grass/Shrub, Bare Soil, Water, Buildings, Roads/Railroads, and Other Paved Surfaces. These data were subsequently merged to fit with the EPA classification. The SAL project covered the five boroughs within the NYC city limits. However the EPA study area encompassed that area plus a 1 kilometer buffer. Additional land cover for the buffer area was generated from United States Department of Agriculture (USDA) National Agricultural Imagery Program (NAIP) four band (red, green, blue, and near infrared) aerial photography at 1 m spatial resolution from July, 2011 and LiDAR from 2010. Six land cover classes were mapped: water, impervious surfaces, soil and barren land, trees, grass-herbaceous non-woody vegetation, and agriculture. An accuracy assessment of 600 completely random and 55 stratified random photo interpreted reference points yielded an overall User's fuzzy accuracy of 87 percent. The area mapped is the US Census Bureau's 2010 Urban Statistical Area for New York City plus a 1 km buffer. This dataset was produced by the US EPA to support research and online mapping activities related to EnviroAt

  14. EnviroAtlas - New York, NY - Tree Cover Configuration and Connectivity Web Service

    EPA Pesticide Factsheets

    This EnviroAtlas web service supports research and online mapping activities related to EnviroAtlas (https://enviroatlas.epa.gov/EnviroAtlas). The EnviroAtlas New York, NY tree cover configuration and connectivity map categorizes forest land cover into structural elements (e.g. core, edge, connector, etc.). In this community, forest is defined as Trees & Forest. Water was considered background (value 129) during the analysis to create this dataset, however it has been converted into value 10 to distinguish it from land area background. This dataset was produced by the US EPA to support research and online mapping activities related to EnviroAtlas. EnviroAtlas (https://www.epa.gov/enviroatlas) allows the user to interact with a web-based, easy-to-use, mapping application to view and analyze multiple ecosystem services for the contiguous United States. The dataset is available as downloadable data (https://edg.epa.gov/data/Public/ORD/EnviroAtlas) or as an EnviroAtlas map service. Additional descriptive information about each attribute in this dataset can be found in its associated EnviroAtlas Fact Sheet (https://www.epa.gov/enviroatlas/enviroatlas-fact-sheets).

  15. Aromaticity of Heterofullerenes C18BxNy (x + y = 2) and Their Molecular Ions

    NASA Astrophysics Data System (ADS)

    Chen, Jia-li; Kerim, Ablikim

    2008-04-01

    The aromaticity of all possible substituted fullerene isomers of C18N2, C18B2, C18BN, and their molecular ions which originate from the C20 (Ih) cage were studied by the topological resonance energy (TRE) and the percentage topological resonance energy methods. The relationship between the aromaticity of C18BxNy isomers and the sites where the heteroatoms dope at the C20 (Ih) cage is discussed. Calculation results show that at the neutral and cationic states all the isomers are predicted to be antiaromatic with negative TREs, but their polyvalent anions are predicted to be aromatic with positive TREs. The most stable isomer is formed by heteroatom doping at the 1, 11-sites in C18N2, C18B2, and C18BN. Heterofullerenes are more aromatic than C20. The stability order in the neutral states is C18N2 > C18 BN > C18 B2 > C20. The stability order in closed-shell is C18B28- > C206- > C18BN6- > C18N24-. This predicts theoretically that their polyvalent anions have high aromaticity.

  16. Atmospheric methane at Zeppelin Station in Ny-Alesund: presentation and analysis of in situ measurements.

    PubMed

    Pedersen, Ine-Therese; Holmen, Kim; Hermansen, Ove

    2005-05-01

    In situ methane (CH(4)) measurement techniques and data from the Zeppelin Station in Ny-Alesund on Svalbard (N 78 degrees 54' E 11 degrees 53') on Mt. Zeppelin (475 m.a.s.l) are presented. The data span the time period from October 1998 to December 2003, though not continuously. The daily mean was calculated from 96 samples per day which are analysed by gas chromatography with flame ionisation detection. Details of the experimental methods and procedures are given. A harmonic function is fitted to the data with a constant trend and seasonal amplitude. The data are also presented in a regression plot showing the difference between the in situ measurements and flask measurements from the National Oceanic and Atmospheric Administration of the Climate Monitoring and Diagnostics Laboratory (NOAA/CMDL) in Boulder, Colorado (http://www.cmdl.noaa.gov/). The Zeppelin data show typical Arctic air characteristics with wintertime pollution episodes from Europe and Russia and a relatively calm summer state.

  17. Distribution of total mercury and methylmercury in lake sediments in Arctic Ny-Ålesund.

    PubMed

    Jiang, Shan; Liu, Xiaodong; Chen, Qianqian

    2011-05-01

    The toxicities and bioavailabilities of total mercury (THg) and methylmercury (MeHg) in aquatic systems have made them the subjects of recent research. In this study, we collected a lake sediment core from Ny-Ålesund in Svalbard and analyzed the distributions of THg and MeHg in the sediments. The increased trend of THg was caused by anthropogenic contamination since the 14th century through long-range transportation, especially after the industrial era. However, the peak values of Hg in surface sediment samples could be explained by the increased algal scavenging process in recent decades. All the biogeochemical proxies (e.g., pigments and diatom biomass) revealed recent sharp increases in aquatic primary production due to the current climate warming. Rock-Eval analyses indicated that algal-derived organic matter took up a large portion, and quantitative calculation showed that 89.6-95.8% of the Hg in post-1950 could be explained by scavenging. The distribution of MeHg has a close relationship with total Hg and organic matter. The oxidation-reduction condition is one of the possible factors affecting the methylation rates in H2 lake sediments. Higher algal productivity and organic matter actually led to the increased trend of methylation in the uppermost sediment. This study supports some new key hypotheses on climate-driven factors affecting Hg and MeHg cycling in High Arctic lake sediments. Copyright © 2011 Elsevier Ltd. All rights reserved.

  18. American Fisheries Society 136th Annual Meeting Lake Placid, NY 10-14 September, 2006

    USGS Publications Warehouse

    Einhouse, D.; Walsh, M.G.; Keeler, S.; Long, J.M.

    2005-01-01

    The New York Chapter of the American Fisheries Society and the New York State Department of Environmental Conservation invite you to experience the beauty of New York's famous Adirondack Park as the American Fisheries Society (AFS) convenes its 136th Annual Meeting in the legendary Olympic Village of Lake Placid, NY, 10-14 September 2006. Our meeting theme "Fish in the Balance" will explore the interrelation between fish, aquatic habitats, and man, highlighting the challenges facing aquatic resource professionals and the methods that have been employed to resolve conflicts between those that use or have an interest in our aquatic resources. As fragile as it is beautiful, the Adirondack Region is the perfect location to explore this theme. Bordered by Mirror Lake and its namesake, Lake Placid, the Village of Lake Placid has small town charm, but all of the conveniences that a big city would provide. Whether its reliving the magic of the 1980 hockey team's "Miracle on Ice" at the Lake Placid Olympic Center, getting a panoramic view of the Adirondack high peaks from the top of the 90 meter ski jumps, fishing or kayaking in adjacent Mirror Lake, hiking a mountain trail, or enjoying a quiet dinner or shopping excursion in the various shops and restaurants that line Main Street, Lake Placid has something for everyone.

  19. Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma

    PubMed Central

    Dyrskjøt, L; Zieger, K; Kissow Lildal, T; Reinert, T; Gruselle, O; Coche, T; Borre, M; Ørntoft, T F

    2012-01-01

    Background: The potential for cancer-testis (CT) antigens as targets for immunotherapy in cancer patients has been heavily investigated, and currently cancer vaccine trials based on the CT antigens, MAGE-A3 and NY-ESO-1, are being carried out. Methods: We used specific q-RT-PCR assays to analyse the expression of the CT genes MAGE-A3, NY-ESO-1 (CTAG1B), LAGE-1 (CTAG2) and PRAME in a panel of bladder tumours from 350 patients with long-term follow-up and detailed treatment information. Results: Overall, 43% of the tumours expressed MAGE-A3, 35% expressed NY-ESO-1, 27% expressed LAGE-1 and 20% expressed PRAME. In all, 56% of the tumours expressed at least one of the CT genes analysed. Univariate Cox regression analysis of CT gene expression in non-muscle-invasive tumours showed that expression of MAGE-A3 (P=0.026), LAGE-1 (P=0.001) and NY-ESO-1 (P=0.040) was significantly associated with a shorter progression-free survival. In addition, we found that patients with tumours expressing PRAME responded poorly to chemotherapy (P=0.02, χ2-test). Conclusion: Cancer-testis genes are frequently expressed in bladder cancer and especially in tumours of high stage and grade. In addition, the CT gene expression may have both prognostic and predictive value. Development of specific immunotherapy against the CT antigens in bladder cancer may ultimately increase patient survival. PMID:22596240

  20. Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy

    PubMed Central

    Kayser, Simone; Boβ, Cristina; Feucht, Judith; Witte, Kai-Erik; Scheu, Alexander; Bülow, Hans-Jörg; Joachim, Stefanie; Stevanović, Stefan; Schumm, Michael; Rittig, Susanne M; Lang, Peter; Röcken, Martin; Handgretinger, Rupert; Feuchtinger, Tobias

    2015-01-01

    Tumor-associated antigens such as NY-ESO-1 are expressed in a variety of solid tumors but absent in mature healthy tissues with the exception of germline cells. The immune system anti-cancer attack is mediated by cell lysis or induction of growth arrest through paralysis of tumor cells, the latter of which can be achieved by tumor-specific CD4+, IFNγ-producing THelper type 1 (TH1) cells. Translation of these immune-mediated mechanisms into clinical application has been limited by availability of immune effectors, as well as the need for complex in vitro protocols and regulatory hurdles. Here, we report a procedure to generate cancer-testis antigen NY-ESO-1-targeting CD4+ TH1 cells in vitro for cancer immunotherapy in the clinic. After in vitro sensitization by stimulating T cells with protein-spanning, overlapping peptide pools of NY-ESO-1 in combination with IL-7 and low dose IL-2, antigen-specific T cells were isolated using IFNγ capture technique and subsequently expanded with IL-2, IL-7 and IL-15. Large numbers of NY-ESO-1-specific CD4+ T cells with a TH1 cytokine profile and lower numbers of cytokine-secreting CD8+ T cells could be generated from healthy donors with a high specificity and expansion potential. Manufactured CD4+ T cells showed strong specific TH1-responses with IFNγ+, TNFα+, IL-2+ and induced cell cycle arrest and apoptosis in tumor cells. The protocol is GMP-grade and approved by the regulatory authorities. The tumor-antigen specific CD4+ TH1 lymphocytes can be adoptively transferred as a T-cell therapy to boost anticancer immunity and this novel cancer treatment approach is applicable to both T cells from healthy allogeneic donors as well as to autologous T cells derived from cancer patients. PMID:26155389

  1. Rapid generation of NY-ESO-1-specific CD4(+) THELPER1 cells for adoptive T-cell therapy.

    PubMed

    Kayser, Simone; Boβ, Cristina; Feucht, Judith; Witte, Kai-Erik; Scheu, Alexander; Bülow, Hans-Jörg; Joachim, Stefanie; Stevanović, Stefan; Schumm, Michael; Rittig, Susanne M; Lang, Peter; Röcken, Martin; Handgretinger, Rupert; Feuchtinger, Tobias

    2015-05-01

    Tumor-associated antigens such as NY-ESO-1 are expressed in a variety of solid tumors but absent in mature healthy tissues with the exception of germline cells. The immune system anti-cancer attack is mediated by cell lysis or induction of growth arrest through paralysis of tumor cells, the latter of which can be achieved by tumor-specific CD4(+), IFNγ-producing THelper type 1 (TH1) cells. Translation of these immune-mediated mechanisms into clinical application has been limited by availability of immune effectors, as well as the need for complex in vitro protocols and regulatory hurdles. Here, we report a procedure to generate cancer-testis antigen NY-ESO-1-targeting CD4(+) TH1 cells in vitro for cancer immunotherapy in the clinic. After in vitro sensitization by stimulating T cells with protein-spanning, overlapping peptide pools of NY-ESO-1 in combination with IL-7 and low dose IL-2, antigen-specific T cells were isolated using IFNγ capture technique and subsequently expanded with IL-2, IL-7 and IL-15. Large numbers of NY-ESO-1-specific CD4(+) T cells with a TH1 cytokine profile and lower numbers of cytokine-secreting CD8(+) T cells could be generated from healthy donors with a high specificity and expansion potential. Manufactured CD4(+) T cells showed strong specific TH1-responses with IFNγ(+), TNFα(+), IL-2(+) and induced cell cycle arrest and apoptosis in tumor cells. The protocol is GMP-grade and approved by the regulatory authorities. The tumor-antigen specific CD4(+) TH1 lymphocytes can be adoptively transferred as a T-cell therapy to boost anticancer immunity and this novel cancer treatment approach is applicable to both T cells from healthy allogeneic donors as well as to autologous T cells derived from cancer patients.

  2. The 'first' instead of the 'oldest'. St. John's Riverside, in Yonkers, N.Y., markets its history.

    PubMed

    Botvin, Judith D

    2002-01-01

    St. John's Riverside Hospital, Yonkers, N.Y., built an integrated campaign upon its long history. Using billboards, print ads, bus shelters, radio and TV it touted its 130-plus years and its long history of firsts. Its integrated campaign proclaimed these "firsts." It specifically targeted its marketing to middle to upper-middle income residents of the surrounding area, particularly females between ages 25 and 54.

  3. Tunable Stoichiometry of BCxNy Thin Films Through Multitarget Pulsed Laser Deposition Monitored via In Situ Ellipsometry (Postprint)

    DTIC Science & Technology

    2014-02-05

    this paper is that by synchronizing a pulsed laser with two different pulsed laser deposition (PLD) target materials and a programmable galvanometer ...Cambridge Technology galvanometer system (two axes servo mirror system with capacitive coupled position feedback for high speed) to a uniform elliptical... galvanometer : PLD A–carbon and PLD B–BN. Jones et al.: Tunable stoichiometry of BCxNy thin films through multitarget pulsed laser. . . Journal of

  4. 33 CFR 165.164 - Security Zones: Dignitary Arrival/Departure and United Nations Meetings, New York, NY.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ... York, NY. (a) The following areas are established as security zones: (1) Location. Wall Street heliport... following points: 40°44′37″ N, 073°58′16.5″ W (the base of East 35th Street, Manhattan), then east to 40°44...′37″ N, 073°58′16.5″ W (the base of East 35th Street, Manhattan), to approximate position 40°44′23″...

  5. Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1.

    PubMed

    Dos Santos, Luara Isabela; Galvão-Filho, Bruno; de Faria, Paula Cristina; Junqueira, Caroline; Dutra, Miriam Santos; Teixeira, Santuza Maria Ribeiro; Rodrigues, Maurício Martins; Ritter, Gerd; Bannard, Oliver; Fearon, Douglas Thomas; Antonelli, Lis Ribeiro; Gazzinelli, Ricardo Tostes

    2015-03-01

    The development of cancer immunotherapy has long been a challenge. Here, we report that prophylactic vaccination with a highly attenuated Trypanosoma cruzi strain expressing NY-ESO-1 (CL-14-NY-ESO-1) induces both effector memory and effector CD8(+) T lymphocytes that efficiently prevent tumor development. However, the therapeutic effect of such a vaccine is limited. We also demonstrate that blockade of Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) during vaccination enhances the frequency of NY-ESO-1-specific effector CD8(+) T cells producing IFN-γ and promotes lymphocyte migration to the tumor infiltrate. As a result, therapy with CL-14-NY-ESO-1 together with anti-CTLA-4 is highly effective in controlling the development of an established melanoma.

  6. The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer.

    PubMed

    Fonteneau, Jean Francois; Brilot, Fabienne; Münz, Christian; Gannagé, Monique

    2016-01-01

    NY-ESO-1-specific CD4(+) T cells are of interest for immune therapy against tumors, because it has been shown that their transfer into a patient with melanoma resulted in tumor regression. Therefore, we investigated how NY-ESO-1 is processed onto MHC class II molecules for direct CD4(+) T cell recognition of melanoma cells. We could rule out proteasome and autophagy-dependent endogenous Ag processing for MHC class II presentation. In contrast, intercellular Ag transfer, followed by classical MHC class II Ag processing via endocytosis, sensitized neighboring melanoma cells for CD4(+) T cell recognition. However, macroautophagy targeting of NY-ESO-1 enhanced MHC class II presentation. Therefore, both elevated NY-ESO-1 release and macroautophagy targeting could improve melanoma cell recognition by CD4(+) T cells and should be explored during immunotherapy of melanoma. Copyright © 2015 by The American Association of Immunologists, Inc.

  7. The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer

    PubMed Central

    Fonteneau, Jean Francois; Brilot, Fabienne; Münz, Christian

    2016-01-01

    NY-ESO-1–specific CD4+ T cells are of interest for immune therapy against tumors, because it has been shown that their transfer into a patient with melanoma resulted in tumor regression. Therefore, we investigated how NY-ESO-1 is processed onto MHC class II molecules for direct CD4+ T cell recognition of melanoma cells. We could rule out proteasome and autophagy-dependent endogenous Ag processing for MHC class II presentation. In contrast, intercellular Ag transfer, followed by classical MHC class II Ag processing via endocytosis, sensitized neighboring melanoma cells for CD4+ T cell recognition. However, macroautophagy targeting of NY-ESO-1 enhanced MHC class II presentation. Therefore, both elevated NY-ESO-1 release and macroautophagy targeting could improve melanoma cell recognition by CD4+ T cells and should be explored during immunotherapy of melanoma. PMID:26608910

  8. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

    PubMed Central

    Yuan, Jianda; Adamow, Matthew; Ginsberg, Brian A.; Rasalan, Teresa S.; Ritter, Erika; Gallardo, Humilidad F.; Xu, Yinyan; Pogoriler, Evelina; Terzulli, Stephanie L.; Kuk, Deborah; Panageas, Katherine S.; Ritter, Gerd; Sznol, Mario; Halaban, Ruth; Jungbluth, Achim A.; Allison, James P.; Old, Lloyd J.; Wolchok, Jedd D.; Gnjatic, Sacha

    2011-01-01

    Ipilimumab, a monoclonal antibody against cytotoxic T lymphocyte antigen 4 (CTLA-4), has been shown to improve survival in patients with advanced metastatic melanoma. It also enhances immunity to NY-ESO-1, a cancer/testis antigen expressed in a subset of patients with melanoma. To characterize the association between immune response and clinical outcome, we first analyzed NY-ESO-1 serum antibody by ELISA in 144 ipilimumab-treated patients with melanoma and found 22 of 140 (16%) seropositive at baseline and 31 of 144 (22%) seropositive following treatment. These NY-ESO-1–seropositive patients had a greater likelihood of experiencing clinical benefit 24 wk after ipilimumab treatment than NY-ESO-1–seronegative patients (P = 0.02, relative risk = 1.8, two-tailed Fisher test). To understand why some patients with NY-ESO-1 antibody failed to experience clinical benefit, we analyzed NY-ESO-1–specific CD4+ and CD8+ T-cell responses by intracellular multicytokine staining in 20 NY-ESO-1–seropositive patients and found a surprising dissociation between NY-ESO-1 antibody and CD8 responses in some patients. NY-ESO-1–seropositive patients with associated CD8+ T cells experienced more frequent clinical benefit (10 of 13; 77%) than those with undetectable CD8+ T-cell response (one of seven; 14%; P = 0.02; relative risk = 5.4, two-tailed Fisher test), as well as a significant survival advantage (P = 0.01; hazard ratio = 0.2, time-dependent Cox model). Together, our data suggest that integrated NY-ESO-1 immune responses may have predictive value for ipilimumab treatment and argue for prospective studies in patients with established NY-ESO-1 immunity. The current findings provide a strong rationale for the clinical use of modulators of immunosuppression with concurrent approaches to favor tumor antigen-specific immune responses, such as vaccines or adoptive transfer, in patients with cancer. PMID:21933959

  9. Contrasting groundwater quality in areas with and without gas production by hydraulic fracturing near the PA/NY border

    NASA Astrophysics Data System (ADS)

    Stute, M.; Yan, B.; Ross, J. M.; Chillrud, S. N.; Saberi, P.; Panettieri, R. A.

    2013-12-01

    Shale gas development, including drilling and hydraulic fracturing, is rapidly increasing throughout the United States and, indeed, the rest of the world. Systematic surveys of water quality both pre- and post drilling/production are sparse. To examine the impacts of shale gas production on water quality, pilot studies are being conducted in adjacent counties of western NY (Chemung, Tioga, Broome, and Delaware) and northern PA (Bradford, Susquehanna, and Tioga). These 7 counties along the border of NY and PA share similar geology and demographic compositions and have been identified as a key area to develop shale gas with the key difference that active fracking is occurring in PA but there is no fracking yet in NY due to the current moratorium in that state. Measurements include a suite of volatile organic compounds (VOCs), major and trace elements, methane and its stable isotopes, noble gases and tritium for dating purposes, and the primary radioactive elements of potential concern, radon and radium. We found elevated methane levels on both sides of the border, and some wells show elemental fingerprints characteristic for shale fluids. Field observations at several wells near drill sites in PA suggested elevated levels of organics, possibly from hydraulic fracturing activities. The full suite of lab analyses is currently ongoing and can be used to further characterize sources of these organics.

  10. a-SiCxNy:H thin films for applications in solar cells as passivation and antireflective coatings

    NASA Astrophysics Data System (ADS)

    Swatowska, Barbara; Kluska, Stanisława; Lewińska, Gabriela; Golańska, Julia; Stapiński, Tomasz

    2016-12-01

    Amorphous a-SiCxNy:H thin films may be an alternative to a-Si:N:H coatings which are commonly used in silicon solar cells. This material was obtained by PECVD (13.56 MHz) method. The reaction gases used: silane, methane, nitrogen and ammonia. The structure of the layers were investigated by scanning electron microscopy (SEM) and infrared spectroscopy (FTIR). IR absorption spectra of a-SiCxNy:H layers confirmed the presence of various hydrogen bonds - it is important for passivation of Si structural defects. The ellipsometric measurements were implemented to determine the thickness of layers d, refractive index n, extinction coefficient k and energy gap Eg. The values of the energy gap of a-SiCxNy:H layers are in the range from 1.89 to 4.34 eV. The correlation between energy gap of materials and refractive index was found. Generally the introduction of N and/or C into the amorphous silicon network rapidly increases the Eg values.

  11. NY-ESO-1 specific TCR engineered T-cells mediate sustained antigen-specific antitumor effects in myeloma

    PubMed Central

    Goloubeva, Olga; Vogl, Dan T.; Lacey, Simon F.; Badros, Ashraf Z.; Garfall, Alfred; Weiss, Brendan; Finklestein, Jeffrey; Kulikovskaya, Irina; Sinha, Sanjoy K.; Kronsberg, Shari; Gupta, Minnal; Bond, Sarah; Melchiori, Luca; Brewer, Joanna E.; Bennett, Alan D.; Gerry, Andrew B.; Pumphrey, Nicholas J.; Williams, Daniel; Tayton-Martin, Helen K.; Ribeiro, Lilliam; Holdich, Tom; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Kerr, Naseem; Philip, Sunita; Westphal, Sandra; Siegel, Don L.; Levine, Bruce L.; Jakobsen, Bent K.; Kalos, Michael; June, Carl H.

    2015-01-01

    Despite recent therapeutic advances, multiple myeloma (MM) remains largely incurable. Herein we report results of a phase I/II trial to evaluate the safety and activity of autologous T-cells engineered to express an affinity-enhanced T-cell receptor (TCR) recognizing a naturally processed peptide shared by the cancer-testis antigens NY-ESO-1 and LAGE-1. Twenty patients with antigen-positive MM received an average 2.4×109 engineered T cells two days after autologous stem cell transplant (ASCT). Infusions were well-tolerated without clinically apparent cytokine release syndrome, despite high IL-6 levels. Engineered T-cells expanded, persisted, trafficked to marrow and exhibited a cytotoxic phenotype. Persistence of engineered T cells in blood was inversely associated with NY-ESO-1 levels in the marrow. Disease progression was associated with loss of T cell persistence or antigen escape, consistent with the expected mechanism of action of the transferred T cells. Encouraging clinical responses were observed in 16 of 20 patients (80%) with advanced disease, with a median progression free survival of 19.1 months. NY-ESO-1/LAGE-1 TCR-engineered T-cells were safe, trafficked to marrow and showed extended persistence that correlated with clinical activity against antigen-positive myeloma. PMID:26193344

  12. Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.

    PubMed

    Karbach, Julia; Gnjatic, Sacha; Bender, Armin; Neumann, Antje; Weidmann, Eckhart; Yuan, Jianda; Ferrara, Cathy A; Hoffmann, Eric; Old, Lloyd J; Altorki, Nasser K; Jäger, Elke

    2010-02-15

    Peptide-based vaccines have led to the induction of antigen-specific CD8(+) T-cell responses in patients with NY-ESO-1 positive cancers. However, vaccine-induced T-cell responses did not generally correlate with improved survival. Therefore, we tested whether a synthetic CpG 7909 ODN (deoxycytidyl-deoxyguanosin oligodeoxy-nucleotides) mixed with NY-ESO-1 peptide p157-165 and incomplete Freund's adjuvants (Montanide(R) ISA-51) led to enhanced NY-ESO-1 antigen-specific CD8(+) immune responses in patients with NY-ESO-1 or LAGE-1 expressing tumors. Of 14 HLA-A2+ patients enrolled in the study, 5 patients withdrew prematurely because of progressive disease and 9 patients completed 1 cycle of immunization. Nine of 14 patients developed measurable and sustained antigen-specific CD8(+) T-cell responses: Four had detectable CD8+ T-cells against NY-ESO-1 after only 2 vaccinations, whereas 5 patients showed a late-onset but durable induction of NY-ESO-1 p157-165 specific T-cell response during continued vaccination after 4 months. In 6 patients, vaccine-induced antigen-specific T-cells became detectable ex vivo and reached frequencies of up to 0.16 % of all circulating CD8(+) T-cells. Postvaccine T-cell clones were shown to recognize and lyse NY-ESO-1 expressing tumor cell lines in vitro. In 6 of 9 patients developing NY-ESO-1-specific immune responses, a favorable clinical outcome with overall survival times of 43+, 42+, 42+, 39+, 36+ and 27+ months, respectively, was observed.

  13. Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis.

    PubMed

    Weide, Benjamin; Zelba, Henning; Derhovanessian, Evelyna; Pflugfelder, Annette; Eigentler, Thomas K; Di Giacomo, Anna Maria; Maio, Michele; Aarntzen, Erik H J G; de Vries, I Jolanda M; Sucker, Antje; Schadendorf, Dirk; Büttner, Petra; Garbe, Claus; Pawelec, Graham

    2012-05-20

    To analyze the prognostic relevance of circulating T cells responding to NY-ESO-1, Melan-A, MAGE-3, and survivin in patients with melanoma with distant metastasis. We examined 84 patients with follow-up after analysis (cohort A), 18 long-term survivors with an extraordinarily favorable course of disease before analysis (> 24 months survival after first occurrence of distant metastases; cohort B), and 14 healthy controls. Circulating antigen-reactive T cells were characterized by intracellular cytokine staining after in vitro stimulation. In cohort A patients, the presence of T cells responding to peptides from NY-ESO-1, Melan-A, or MAGE-3 and the M category according to the American Joint Committee on Cancer classification were significantly associated with survival. T cells responding to NY-ESO-1 and Melan-A (hazard ratios, 0.29 and 0.18, respectively) remained independent prognostic factors in Cox regression analysis and were superior to the M category in predicting outcome. Median survival of patients possessing T cells responding to NY-ESO-1, Melan-A, or both was 21 months, compared with 6 months for all others. NY-ESO-1-responsive T cells were detected in 70% of cohort A patients surviving > 18 months and in 50% of cohort B patients. Melan-A responses were found in 42% and 47% of patients in cohorts A and B, respectively. In contrast, the proportion was only 22% for NY-ESO-1 and 23% for Melan-A in those who died within 6 months. The presence of circulating T cells responding to Melan-A or NY-ESO-1 had strong independent prognostic impact on survival in advanced melanoma. Our findings support the therapeutic relevance of Melan-A and NY-ESO-1 as targets for immunotherapy.

  14. Centrosomal localisation of the cancer/testis (CT) antigens NY-ESO-1 and MAGE-C1 is regulated by proteasome activity in tumour cells.

    PubMed

    Pagotto, Anna; Caballero, Otavia L; Volkmar, Norbert; Devalle, Sylvie; Simpson, Andrew J G; Lu, Xin; Christianson, John C

    2013-01-01

    The Cancer/Testis (CT) antigen family of genes are transcriptionally repressed in most human tissues but are atypically re-expressed in many malignant tumour types. Their restricted expression profile makes CT antigens ideal targets for cancer immunotherapy. As little is known about whether CT antigens may be regulated by post-translational processing, we investigated the mechanisms governing degradation of NY-ESO-1 and MAGE-C1 in selected cancer cell lines. Inhibitors of proteasome-mediated degradation induced the partitioning of NY-ESO-1 and MAGE-C1 into a detergent insoluble fraction. Moreover, this treatment also resulted in increased localisation of NY-ESO-1 and MAGE-C1 at the centrosome. Despite their interaction, relocation of either NY-ESO-1 or MAGE-C1 to the centrosome could occur independently of each other. Using a series of truncated fragments, the regions corresponding to NY-ESO-1(91-150) and MAGE-C1(900-1116) were established as important for controlling both stability and localisation of these CT antigens. Our findings demonstrate that the steady state levels of NY-ESO-1 and MAGE-C1 are regulated by proteasomal degradation and that both behave as aggregation-prone proteins upon accumulation. With proteasome inhibitors being increasingly used as front-line treatment in cancer, these data raise issues about CT antigen processing for antigenic presentation and therefore immunogenicity in cancer patients.

  15. Centrosomal Localisation of the Cancer/Testis (CT) Antigens NY-ESO-1 and MAGE-C1 Is Regulated by Proteasome Activity in Tumour Cells

    PubMed Central

    Volkmar, Norbert; Devalle, Sylvie; Simpson, Andrew J. G.; Lu, Xin; Christianson, John C.

    2013-01-01

    The Cancer/Testis (CT) antigen family of genes are transcriptionally repressed in most human tissues but are atypically re-expressed in many malignant tumour types. Their restricted expression profile makes CT antigens ideal targets for cancer immunotherapy. As little is known about whether CT antigens may be regulated by post-translational processing, we investigated the mechanisms governing degradation of NY-ESO-1 and MAGE-C1 in selected cancer cell lines. Inhibitors of proteasome-mediated degradation induced the partitioning of NY-ESO-1 and MAGE-C1 into a detergent insoluble fraction. Moreover, this treatment also resulted in increased localisation of NY-ESO-1 and MAGE-C1 at the centrosome. Despite their interaction, relocation of either NY-ESO-1 or MAGE-C1 to the centrosome could occur independently of each other. Using a series of truncated fragments, the regions corresponding to NY-ESO-191-150 and MAGE-C1900-1116 were established as important for controlling both stability and localisation of these CT antigens. Our findings demonstrate that the steady state levels of NY-ESO-1 and MAGE-C1 are regulated by proteasomal degradation and that both behave as aggregation-prone proteins upon accumulation. With proteasome inhibitors being increasingly used as front-line treatment in cancer, these data raise issues about CT antigen processing for antigenic presentation and therefore immunogenicity in cancer patients. PMID:24340093

  16. MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.

    PubMed

    Kerkar, Sid P; Wang, Zeng-Feng; Lasota, Jerzy; Park, Tristen; Patel, Krishna; Groh, Eric; Rosenberg, Steven A; Miettinen, Markku M

    2016-05-01

    Two cancer testis antigens, the New York esophageal squamous cell carcinoma-1 (NY-ESO-1) and the melanoma-antigen family A (MAGE-A), represent promising immunotherapy targets due to the low expression of these antigens in nonmalignant tissue. To assess overexpression patterns in various cancers, we performed a systematic immunohistochemical analysis for NY-ESO-1 and MAGE-A on tissue array samples of 3668 common epithelial carcinomas (CA) and germ cell tumors of high prevalence and mortality. Here, we find significantly higher expression of MAGE-A (>50% on tumor cells) compared with NY-ESO-1 in several CAs including cutaneous squamous cell carcinomas (SCC) (52.8%/2.8%), esophageal SCC (50%/0%), head and neck SCC (41.1%/<1%), bladder urothelial CA (40.4%/8.3%), cervical/anal SCC (37.5%/0%), lung SCC (34%/3.8%), lung adenocarcinomas (27.6%/3.9%), ovarian CA (26.4%/3.6%), endometrial CA (26.3%/1.3%), lung small cell CA (24.4%/2.4%), gastric adenocarcinomas (20%/4%), breast mucinous CA (19.3%/0%), hepatocellular CA (18.8%/1.2%), breast infiltrating ductal CA (16.4%/1.8%), colorectal adenocarcinomas (10.7%/<1%), cholangiocarcinomas (9.8%/0%), thymic CA (9%/4.5%), and mesotheliomas (7.9%/<1%). Furthermore, high expression of MAGE-A, but not NY-ESO-1, was seen in whole slide evaluations of an independent cohort of metastatic SCC (45.5%/3.6%) and metastatic CA (13.5%/0%) of various primaries with significantly higher expression of MAGE-A in metastatic SCC compared with other metastatic CA. MAGE-A is also more highly expressed in germ cell tumors, seminomas (69%/3.5%) and nonseminomas (40.1%/4.7%). In summary, MAGE-A is more highly expressed than NY-ESO-1 in a majority of human malignancies, and targeting MAGE-A may benefit a large number of patients.

  17. Earthquake Source Scaling and Wave Propagation in Eastern North America: The Au Sable Forks, NY, Earthquake

    NASA Astrophysics Data System (ADS)

    Viegas, G.; Abercrombie, R.; Baise, L.; Kim, W.

    2005-12-01

    The 2002, M5 Au Sable Forks, NY earthquake and aftershocks are the best recorded sequence in the North Eastern USA. We use the local and regional recordings to investigate the characteristics of intraplate seismicity, focusing on source scaling relationships and regional wave propagation. A portable local network of 11 stations, recorded 74 aftershocks of M<3.2. We relocate the mainshock and early aftershocks using a master event technique. We then use the double-difference relocation method using differential travel times measured from waveform cross-correlation to relocate the aftershocks recorded by the local network. Both the master-event and double-difference location methods produce consistent results suggesting complex conjugate faulting during the sequence. We identify a number of highly clustered groups of earthquakes suitable for EGF analysis. We use the EGF method to calculate the stress drop and radiated energy of the larger aftershocks to determine how they compare to moderate magnitude earthquakes, and also whether they differ significantly from interplate earthquakes. We consider the 9 largest aftershocks (M3.7 to M2), which were recorded on the regional network, as potential EGFs for the mainshock, but they have focal mechanisms and locations that are sufficiently different that we cannot resolve the mainshock source time function well. They are good enough to enable us to place constraints on the shape and duration of the source pulse to use in modeling the regional waveforms. We investigate the crustal structure in New York (Grenville) and New England (Appalachian) through forward modeling of the Au Sable Forks regional broadband records. We compute synthetic records of wave propagation in a layered medium, using published crustal models of the two regions as a starting point. We identify differences between the recorded data and synthetics for the Grenville and the Appalachian regions and improve the crustal models to better fit the recorded

  18. The 2002 M5 Au Sable Forks, NY, earthquake sequence: Source scaling relationships and energy budget

    NASA Astrophysics Data System (ADS)

    Viegas, Gisela; Abercrombie, Rachel E.; Kim, Won-Young

    2010-07-01

    We find invariant high stress drops and radiated energies for a sequence of intraplate earthquakes. We estimate source parameters of the Au Sable Forks, NY, earthquake (M5, 2002) and aftershocks. This intraplate earthquake was the largest to occur in Eastern North America since 1988 and the largest to be recorded by regional broadband networks. We use the empirical Green's function (EGF) method and define a set of qualitative and quantitative rules for the selection of EGF earthquake pairs and for the quality verification of the obtained EGF spectral ratio. We use a multitaper code that performs the complex spectral division with minimum frequency leakage and allows transformation back to the time domain to check the validity of the EGF event. We estimate source parameters for 22 earthquakes (M1-M5) in the sequence. The median stress drop of 104 MPa (using Madariaga source model, and 19 MPa for a Brune model) is significantly larger than estimates for interplate earthquakes. The lower crustal strain rates, and longer fault healing times in intraplate environments, may be responsible for this high average value. We find constant stress drop between M2 and M5, up to the bandwidth resolution limit (80 Hz) of the study, and no evidence of stress drop breakdown for M2 to M1 earthquakes. We find consistently high radiated seismic energy and apparent stress, and a median radiated energy to seismic moment ratio of 9 × 10-5. This is significantly larger than estimates for interplate earthquakes (˜2 × 10-5) and consistent with higher stress drops and stronger faults.

  19. Ground-based lidar measurements from Ny-Ålesund during ASTAR 2007

    NASA Astrophysics Data System (ADS)

    Hoffmann, A.; Ritter, C.; Stock, M.; Shiobara, M.; Lampert, A.; Maturilli, M.; Orgis, T.; Neuber, R.; Herber, A.

    2009-11-01

    During the Arctic Study of Tropospheric Aerosol, Clouds and Radiation (ASTAR) in March and April 2007, measurements obtained at the AWIPEV Arctic Research Base in Ny-Ålesund, Spitsbergen at 78.9° N, 11.9° E (operated by the Alfred Wegener Institute for Polar and Marine Research - AWI and the Institut polaire français Paul-Emile Victor - IPEV), supported the airborne campaign. This included lidar data from the Koldewey Aerosol Raman Lidar (KARL) and the Micro Pulse Lidar (MPL), located in the atmospheric observatory as well as photometer data and the daily launched radiosonde. The MPL features nearly continuous measurements; the KARL was switched on whenever weather conditions allowed observations (145 h in 61 days). From 1 March to 30 April, 71 meteorological balloon soundings were performed and compared with the concurrent MPL measurements; photometer measurements are available from 18 March. For the KARL data, a statistical overview of particle detection based on their optical properties backscatter ratio and volume depolarization can be given. The altitudes of the occurrence of the named features (subvisible and visible ice and water as well as mixed-phase clouds, aerosol layers) as well as their dependence on different air mass origins are analyzed. Although the spring 2007 was characterized by rather clean conditions, diverse case studies of cloud and aerosol occurrence during March and April 2007 are presented in more detail, including temporal development and main optical properties as depolarization, backscatter and extinction coefficients. Links between air mass origins and optical properties can be presumed but need further evidence.

  20. Missing-Presumed Eroded: Holocene Sedimentation Patterns in Seneca Lake, NY

    NASA Astrophysics Data System (ADS)

    Loddengaard, K.; Curtin, T. M.

    2006-12-01

    The Finger Lakes of New York underwent a significant change in climate during the transition from the Hypsithermal to the Neoglacial at ~5 ka. To determine the effects of changes in climate on sedimentation patterns in the northern region of Seneca Lake, NY, we analyzed three cores that were collected along a shallow to deep water transect. Analyses of magnetic susceptibility, organic matter and carbonate content, fossil content, and grain size at a 1-cm interval were used to correlate cores, identify periods of erosion or non- deposition and assess the relative truncation of the Holocene sediment record. The stratigraphy and sedimentology of the cores indicate the lake contains a spatially and temporally discontinuous sediment record. Preliminary results indicate that the early to mid-Holocene sediment record was preferentially eroded in the deepwater cores, between 20 and 50 m water depth. At the deepwater sites, there is a gap in the sediment record that spans between ~12 and ~5 ka. Conversely, the late Holocene record is more complete in the deepwater cores than in the shallow water cores (12-20 m water depth). This data suggests a significant change on the controls and location of erosion and deposition in the lake during the Holocene. We hypothesize that the early to mid-Holocene sediment may have been eroded by strong internal seiches during stormy conditions that were initiated by cooler temperatures and a change in the position of the jet stream during the Hypsithermal-Neoglacial transition. Erosion occurred primarily in shallow water sites (<~30 m) during the Neoglacial, perhaps as a result of a change in the number and frequency of storms or strength of the internal seiche.

  1. Comparison of sources of submicron particle number concentrations measured at two sites in Rochester, NY.

    PubMed

    Kasumba, John; Hopke, Philip K; Chalupa, David C; Utell, Mark J

    2009-09-01

    Sources contributing to the submicron particles (100-470 nm) measured between January 2002 and December 2007 at two different New York State Department of Environmental Conservation (NYS DEC) sites in Rochester, NY were identified and apportioned using a bilinear receptor model, positive matrix factorization (PMF). Measurements of aerosol size distributions and number concentrations for particles in the size range of 10-500 nm have been made since December 2001 to date in Rochester. The measurements are being made using a scanning mobility particle sizer (SMPS) consisting of a DMA and a CPC (TSI models 3071 and 3010, respectively). From December 2001 to March 2004, particle measurements were made at the NYS DEC site in downtown Rochester, but it was moved to the eastside of Rochester in May 2004. Each measurement period was divided into three seasons i.e., winter (December, January, and February), summer (June, July, and August), and the transitional periods (March, April, May, September, October, and November) so as to avoid experimental uncertainty resulting from too large season-to-season variability in ambient temperature and solar photon intensity that would lead to unstable/non-stationary size distributions. Therefore, the seasons were analyzed independently for possible sources. Ten sources were identified at both sites and these include traffic, nucleation, residential/commercial heating, industrial emissions, secondary nitrate, ozone- rich secondary aerosol, secondary sulfate, regionally transported aerosol, and a mixed source of nucleation and traffic. These results show that the measured total outdoor particle number concentrations in Rochester generally vary with similar temporal patterns, suggesting that the central monitoring site data can be used to estimate outdoor exposure in other parts of the city.

  2. Hydrometeorological and climatological conditions associated with flash flooding in the Catskill Mountains, NY

    NASA Astrophysics Data System (ADS)

    Teale, N. G.; Quiring, S. M.

    2014-12-01

    Flash flooding is a concern in watersheds of the New York City Water Supply System, as the turbidity associated with rapid flooding is unacceptable in an unfiltered water supply. Previous studies suggest that flash flooding will occur more frequently in this region in a changing climate. Therefore, a thorough understanding of the conditions associated with flash flooding are important for effective watershed management. Seven flash floods were identified in the hydrologic record for the Neversink River near Claryville, NY from 1 April 1987 through 15 July 2014. Case studies using Weather Prediction Center forecast maps, National Centers for Environmental Prediction/ National Center for Atmospheric Research (NCEP/NCAR) reanalysis daily composites, and co-operative station data were used to characterize each event. Forecast maps indicate synoptic-scale frontal activity concurrent with all flash flood events. The four winter flash flood peaks are associated with rain on existing snowpack, with anomalously warm 1000 mb temperatures and anomalously high precipitation rates. The three summer flash flood peaks are associated with convective activity, high precipitation rates, anomalously warm 1000 mb temperatures, and southerly winds. NCEP/NCAR climate composites for winter and summer flash flood events are consistent with the case studies presented. The frequency of these broad-scale conditions suggest that localized effects of the basin conditions separate flash flood events from other high discharge events. Recognizing these conditions in the context of climate predictions is useful for effective and proactive water management in the region to maintain an unfiltered water supply for the greater New York City area.

  3. Local Volume TiNy Titans: gaseous dwarf-dwarf interactions in the Local Universe

    NASA Astrophysics Data System (ADS)

    Pearson, Sarah; Besla, Gurtina; Putman, Mary E.; Lutz, Katharina A.; Fernández, Ximena; Stierwalt, Sabrina; Patton, David R.; Kim, Jinhyub; Kallivayalil, Nitya; Johnson, Kelsey; Sung, Eon-Chang

    2016-06-01

    In this paper, we introduce the Local Volume TiNy Titans sample (LV-TNT), which is a part of a larger body of work on interacting dwarf galaxies: TNT . This LV-TNT sample consists of 10 dwarf galaxy pairs in the Local Universe (<30 Mpc from Milky Way), which span mass ratios of M*, 1/M*, 2 < 20, projected separations <100 kpc, and pair member masses of log(M*/M⊙) < 9.9. All 10 LV-TNT pairs have resolved synthesis maps of their neutral hydrogen, are located in a range of environments and captured at various interaction stages. This enables us to do a comparative study of the diffuse gas in dwarf-dwarf interactions and disentangle the gas lost due to interactions with haloes of massive galaxies, from the gas lost due to mutual interaction between the dwarfs. We find that the neutral gas is extended in the interacting pairs when compared to non-paired analogues, indicating that gas is tidally pre-processed. Additionally, we find that the environment can shape the H I distributions in the form of trailing tails and that the gas is not unbound and lost to the surroundings unless the dwarf pair is residing near a massive galaxy. We conclude that a nearby, massive host galaxy is what ultimately prevents the gas from being re-accreted. Dwarf-dwarf interactions thus represent an important part of the baryon cycle of low-mass galaxies, enabling the `parking' of gas at large distances to serve as a continual gas supply channel until accretion by a more massive host.

  4. Hydrodynamics and Sediment Transport Along and Across Shoreface-Connected Ridges: Fire Island, NY.

    NASA Astrophysics Data System (ADS)

    Liste, M.; Warner, J. C.; List, J. H.; Safak, I.; Schwab, W. C.

    2016-02-01

    Fire Island is a 50 km long barrier island located along the south shore of Long Island, NY. The inner continental shelf of the island is characterized by field of shore-face connected ridges (SFCR). Repeated geophysical studies have mapped the sediment distribution and morphology of the inner continental shelf and identified areas of erosion and deposition associated with ridge migration, as well as areas of sediment deposition on the inner shelf not associated with ridge mobility. This study describes storm driven flows along and across the inner continental shelf to investigate the hydrodynamic forcings and the possible maintenance mechanisms of these SFCR in the region using numerical experiments and field observations. We applied a nested grid, three-dimensional hydrodynamic model considering storm forcing and integrating sedimentological data using the COAWST model, which couples the oceanographic model (ROMS), the wave model (SWAN), and the Community Sediment Transport Modeling System (CSTMS) set of sediment transport modeling routines. The coarsest grid covers the entire US East Coast and grid refinement is used to nest down to the study zone along Fire Island with a final horizontal resolution of 100-m. Wave, flow, and sediment transport observations at 9 sites offshore of Fire Island from January to April 2014 were used to test the model. Results reveal the variability along the inner continental shelf during different storm events as well as a strong relation between currents (surface and bottom, alongshore and cross-shore) and wind patterns. Storms with northeast winds drive flow that promoted SFCR maintenance. Other storm types resulted in upwelling and circulation patterns which are in the opposite sense and may not be a supporting mechanism for ridge maintenance. This analysis supports storm-generated northeast wind-driven forcing play an important role controlling movement of the SFCR.

  5. Alongshore Momentum Balance Over Shoreface-Connected Ridges, Fire Island, NY

    NASA Astrophysics Data System (ADS)

    Ofsthun, C.; Wu, X.; Voulgaris, G.; Warner, J. C.

    2016-12-01

    he momentum balance of alongshore flows over straight, uniform shelfs has been analyzed extensively over the last few decades. More recently, the effect of coastline curvature and how this might alter the relative significance of the momentum terms has received additional attention. In this contribution, the alongshore momentum over shelves with straight coastline, but non-uniform bathymetry is examined. Hydrodynamic and hydrographic data collected by the US Geological Survey (Fire Island Coastal Change project) on the inner shelf of Fire Island, NY over a region of shore-face connected ridges (SFCRs) are used to describe wind-induced circulation and the terms of the alongshore momentum balance equation. Analysis of the data revealed a predominantly alongshore circulation, under westward wind forcing, with localized offshore (onshore) current veering over the ridge crests (troughs). Momentum balance analysis hinted that local acceleration, advective acceleration, and bottom stress are balanced by wind stress and regional (>100 km) pressure gradient force. In addition, a numerical model using an idealized SFCR bathymetry, forced by our observed winds, was employed to compare the momentum balance relationships identified by the data and those under steady-state conditions published earlier (Warner et al., 2014). A synthesis of the numerical and experimental data revealed that the true pressure gradient force results from the sum of local pressure gradient force, which maintains a Bernoulli-like relationship with alongshore advective acceleration, and regional pressure gradient force, which maintains a strong, negative relationship with wind stress. The differences between steady-state and realistic conditions is mainly on the contributions of regional scale pressure gradients that develop under realistic conditions, and the reduced contribution of local scale pressure gradients which develop best under steady-state conditions. Our analysis indicates that current

  6. Microbial Influences on Trace Metal Cycling in a Meromictic Lake, Fayetteville Green Lake, NY

    NASA Astrophysics Data System (ADS)

    Zerkle, A. L.; House, C.; Kump, L.

    2002-12-01

    Microorganisms can exist in aquatic environments at very high cell densities of up to 1011 cells/L, and can accumulate significant quantities of trace metals. Bacteria actively take up bioactive trace metals, including Fe, Zn, Mn, Co, Ni, Cu, and Mo, which function as catalytic centers in metalloproteins and metal-activated enzymes involved in virtually all cellular functions. In addition, bacteria may catalyze the release of trace metals from inorganic substrates by processes such as the reduction of iron and manganese oxides, suggesting that trace metal distributions within a natural environment dominated by microbial processes may be controlled primarily by microbial ecology. Fayetteville Green Lake (FGL), NY, is a permanently stratified meromictic lake that has a well-oxygenated surface water mass (mixolimnion) overlying a relatively stagnant, anoxic deep water mass (monimolimnion). A chemocline separates the water masses at around 20m depth, where oxygen concentrations decrease and sulfate and methane concentrations increase. In addition, previous studies have indicated that trace metals such as V, Cr, Co, Mn, and Fe reach elevated concentrations at the chemocline. Using fluorescent in situ hybridization (FISH) of FGL samples from depths of up to 40m with bacterial and archaeal probes, we have shown that fluctuating redox conditions within the FGL water column correlate with significant variations in the composition and distribution of microbial populations with depth. The mixolimnion is dominated by Eubacteria, with increasing concentrations of Archaea in the lower anoxic zone. Increases in microbial cell densities coincide with increases in trace metals at the chemocline, suggesting microbial activity may be responsible for trace metal release at this boundary. 16S rRNA PCR cloning techniques are currently being used to identify dominant microbial populations at various levels within the FGL water column. Future studies will focus on the potential for these

  7. IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2.

    PubMed

    Cochaud, Stéphanie; Giustiniani, Jérôme; Thomas, Clémence; Laprevotte, Emilie; Garbar, Christian; Savoye, Aude-Marie; Curé, Hervé; Mascaux, Corinne; Alberici, Gilles; Bonnefoy, Nathalie; Eliaou, Jean-François; Bensussan, Armand; Bastid, Jeremy

    2013-12-09

    The proinflammatory cytokine Interleukin 17A (hereafter named IL-17A) or IL-17A producing cells are elevated in breast tumors environment and correlate with poor prognosis. Increased IL-17A is associated with ER(-) or triple negative tumors and reduced Disease Free Survival. However, the pathophysiological role of IL-17A in breast cancer remains unclear although several studies suggested its involvement in cancer cell dissemination. Here we demonstrated that a subset of breast tumors is infiltrated with IL-17A-producing cells. Increased IL-17A seems mainly associated to ER(-) and triple negative/basal-like tumors. Isolation of tumor infiltrating T lymphocytes (TILs) from breast cancer biopsies revealed that these cells secreted significant amounts of IL-17A. We further established that recombinant IL-17A recruits the MAPK pathway by upregulating phosphorylated ERK1/2 in human breast cancer cell lines thereby promoting proliferation and resistance to conventional chemotherapeutic agents such as docetaxel. We also confirmed here that recombinant IL-17A stimulates migration and invasion of breast cancer cells as previously reported. Importantly, TILs also induced tumor cell proliferation, chemoresistance and migration and treatment with IL-17A-neutralizing antibodies abrogated these effects. Altogether these results demonstrated the pathophysiological role of IL-17A-producing cell infiltrate in a subset of breast cancers. Therefore, IL-17A appears as potential therapeutic target for breast cancer.

  8. Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status.

    PubMed

    Shiohama, Yasuo; Naito, Tadasuke; Matsuzaki, Toshio; Tanaka, Reiko; Tomoyose, Takeaki; Takashima, Hiroshi; Fukushima, Takuya; Tanaka, Yuetsu; Saito, Mineki

    2017-07-17

    Detection of specific immune responses against cancer/testis antigen NY-ESO-1 was recently reported in patients with adult T-cell leukemia/lymphoma (ATL) and human T-cell leukemia virus type 1 (HTLV-1)-infected asymptomatic carriers (ACs). However, the relationship of the responses with the HTLV-1 proviral load (PVL) and the levels of viral gene expression remain unclear. We measured plasma levels of autoantibodies to NY-ESO-1 immunogenic tumor antigen in HTLV-1-infected individuals with different clinical status, and in healthy controls. Data were compared to tax and HBZ mRNA levels, and PVL. Plasma anti-NY-ESO-1 antibody was detectable in 13.7% (7/51) of ACs, 29.2% (38/130) of patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), and 18.9% (10/53) of patients with ATL. Anti-NY-ESO-1 plasma levels were significantly higher in patients with HAM/TSP than in patients with ATL or ACs. Anti-NY-ESO-1 levels were not associated with PVL or the expression levels of tax and HBZ mRNA among HTLV-1-infected individuals, regardless of clinical status. The present results indicate the strong humoral immune response against NY-ESO-1 in natural HTLV-1 infection, irrespective of the clinical status. The higher immunoreactivity against NY-ESO-1 is not simply associated with the levels of both HTLV-1 gene expression and the number of infected cells in vivo. Rather, it might reflect chronic and generalized immune activation in infected individuals.

  9. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

    PubMed Central

    Odunsi, Kunle; Matsuzaki, Junko; Karbach, Julia; Neumann, Antje; Mhawech-Fauceglia, Paulette; Miller, Austin; Beck, Amy; Morrison, Carl D.; Ritter, Gerd; Godoy, Heidi; Lele, Shashikant; duPont, Nefertiti; Edwards, Robert; Shrikant, Protul; Old, Lloyd J.; Gnjatic, Sacha; Jäger, Elke

    2012-01-01

    Recombinant poxviruses (vaccinia and fowlpox) expressing tumor-associated antigens are currently being evaluated in clinical trials as cancer vaccines to induce tumor-specific immune responses that will improve clinical outcome. To test whether a diversified prime and boost regimen targeting NY-ESO-1 will result in clinical benefit, we conducted two parallel phase II clinical trials of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1), followed by booster vaccinations with recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in 25 melanoma and 22 epithelial ovarian cancer (EOC) patients with advanced disease who were at high risk for recurrence/progression. Integrated NY-ESO-1-specific antibody and CD4+ and CD8+ T cells were induced in a high proportion of melanoma and EOC patients. In melanoma patients, objective response rate [complete and partial response (CR+PR)] was 14%, mixed response was 5%, and disease stabilization was 52%, amounting to a clinical benefit rate (CBR) of 72% in melanoma patients. The median PFS in the melanoma patients was 9 mo (range, 0–84 mo) and the median OS was 48 mo (range, 3–106 mo). In EOC patients, the median PFS was 21 mo (95% CI, 16–29 mo), and median OS was 48 mo (CI, not estimable). CD8+ T cells derived from vaccinated patients were shown to lyse NY-ESO-1-expressing tumor targets. These data provide preliminary evidence of clinically meaningful benefit for diversified prime and boost recombinant pox-viral-based vaccines in melanoma and ovarian cancer and support further evaluation of this approach in these patient populations. PMID:22454499

  10. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.

    PubMed

    Oshima, Yoko; Shimada, Hideaki; Yajima, Satoshi; Nanami, Tatsuki; Matsushita, Kazuyuki; Nomura, Fumio; Kainuma, Osamu; Takiguchi, Nobuhiro; Soda, Hiroaki; Ueda, Takeshi; Iizasa, Toshihiko; Yamamoto, Naoto; Yamamoto, Hiroshi; Nagata, Matsuo; Yokoi, Sana; Tagawa, Masatoshi; Ohtsuka, Seiko; Kuwajima, Akiko; Murakami, Akihiro; Kaneko, Hironori

    2016-01-01

    Although serum NY-ESO-1 antibodies (s-NY-ESO-1-Abs) have been reported in patients with esophageal carcinoma, this assay system has not been used to study a large series of patients with various other cancers. Serum samples of 1969 cancer patients [esophageal cancer (n = 172), lung cancer (n = 269), hepatocellular carcinoma (n = 91), prostate cancer (n = 358), gastric cancer (n = 313), colorectal cancer (n = 262), breast cancer (n = 365)] and 74 healthy individuals were analyzed using an originally developed enzyme-linked immunosorbent assay system for s-NY-ESO-1-Abs. The optical density cut-off value, determined as the mean plus three standard deviations for serum samples from the healthy controls, was fixed at 0.165. Conventional tumor markers were also evaluated in patients with esophageal carcinoma. The positive rate of s-NY-ESO-1-Abs in patients with esophageal cancer (31 %) was significantly higher than that in the other groups: patients with lung cancer (13 %), patients with hepatocellular carcinoma (11 %), patients with prostate cancer (10 %), patients with gastric cancer (10 %), patients with colorectal cancer (8 %), patients with breast cancer (7 %), and healthy controls (0 %). The positive rate of s-NY-ESO-1-Abs was comparable to that of serum p53 antibodies (33 %), squamous cell carcinoma antigen (36 %), carcinoembryonic antigen (26 %), and CYFRA 21-1 (18 %) and gradually increased with the tumor stage. The positive rate of s-NY-ESO-1-Abs was significantly higher in patients with esophageal cancer than in patients with the other types of cancers. On the basis of its high specificity and sensitivity, even in patients with stage I tumors, s-NY-ESO-1-Abs may be one of the first choices for esophageal cancer.

  11. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.

    PubMed

    Odunsi, Kunle; Matsuzaki, Junko; Karbach, Julia; Neumann, Antje; Mhawech-Fauceglia, Paulette; Miller, Austin; Beck, Amy; Morrison, Carl D; Ritter, Gerd; Godoy, Heidi; Lele, Shashikant; duPont, Nefertiti; Edwards, Robert; Shrikant, Protul; Old, Lloyd J; Gnjatic, Sacha; Jäger, Elke

    2012-04-10

    Recombinant poxviruses (vaccinia and fowlpox) expressing tumor-associated antigens are currently being evaluated in clinical trials as cancer vaccines to induce tumor-specific immune responses that will improve clinical outcome. To test whether a diversified prime and boost regimen targeting NY-ESO-1 will result in clinical benefit, we conducted two parallel phase II clinical trials of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1), followed by booster vaccinations with recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in 25 melanoma and 22 epithelial ovarian cancer (EOC) patients with advanced disease who were at high risk for recurrence/progression. Integrated NY-ESO-1-specific antibody and CD4(+) and CD8(+) T cells were induced in a high proportion of melanoma and EOC patients. In melanoma patients, objective response rate [complete and partial response (CR+PR)] was 14%, mixed response was 5%, and disease stabilization was 52%, amounting to a clinical benefit rate (CBR) of 72% in melanoma patients. The median PFS in the melanoma patients was 9 mo (range, 0-84 mo) and the median OS was 48 mo (range, 3-106 mo). In EOC patients, the median PFS was 21 mo (95% CI, 16-29 mo), and median OS was 48 mo (CI, not estimable). CD8(+) T cells derived from vaccinated patients were shown to lyse NY-ESO-1-expressing tumor targets. These data provide preliminary evidence of clinically meaningful benefit for diversified prime and boost recombinant pox-viral-based vaccines in melanoma and ovarian cancer and support further evaluation of this approach in these patient populations.

  12. MAGEA4 expression in bone and soft tissue tumors: its utility as a target for immunotherapy and diagnostic marker combined with NY-ESO-1.

    PubMed

    Iura, Kunio; Kohashi, Kenichi; Ishii, Takeaki; Maekawa, Akira; Bekki, Hirofumi; Otsuka, Hiroshi; Yamada, Yuichi; Yamamoto, Hidetaka; Matsumoto, Yoshihiro; Iwamoto, Yukihide; Oda, Yoshinao

    2017-07-26

    Cancer-testis (CT) antigens have promise as targets for immunotherapy, because of their restricted expression in tumor or testis tissue. MAGEA4 is both a MAGE family member and a CT antigen, and has attracted attention as a potential immunotherapeutic target. We investigated MAGEA4 expression by immunohistochemistry in bone and soft tissue tumor specimens that consisted of 35 malignant or intermediate and 24 benign histological subtypes, in order to evaluate its possible utility as an immunotherapy target and its potential use as a diagnostic marker when combined with another CT antigen, NY-ESO-1. Among these tumors, MAGEA4 was detected in 82.2% of synovial sarcomas, 67.7% of myxoid liposarcomas, 43.8% of osteosarcomas, 41.4% of angiosarcomas, 24.6% of malignant peripheral nerve sheath tumors (MPNSTs), and 21.4% of chondrosarcomas. NY-ESO-1 expression was found in 88.2% of myxoid liposarcomas, 61.1% of synovial sarcomas, 31.3% of osteosarcomas, 21.4% of pleomorphic liposarcomas, 16.7% of desmoplastic small round cell tumors, and 14.3% of chondrosarcomas. Benign tumors and non-tumorous tissue, except for testis tissue, did not express MAGEA4 or NY-ESO-1. Combined use of MAGEA4 and NY-ESO-1 increased the sensitivity, specificity, positive predictive values, and negative predictive values for distinguishing synovial sarcoma from spindle cell tumors and other mimicking tumors, compared to individual use of MAGEA4 or NY-ESO-1. Our results support the immunotherapy targeting MAGEA4 or NY-ESO-1 can be an ancillary therapy in the above-mentioned tumors, and the potential utility of MAGEA4 as an ancillary diagnostic marker for synovial sarcoma combined with NY-ESO-1.

  13. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T cell receptor: Long term follow up and correlates with response

    PubMed Central

    Robbins, Paul F.; Kassim, Sadik H.; Tran, Thai Lan N.; Crystal, Jessica S.; Morgan, Richard A.; Feldman, Steven A.; Yang, James C.; Dudley, Mark E.; Wunderlich, John R.; Sherry, Richard M.; Kammula, Udai S.; Hughes, Marybeth S.; Restifo, Nicholas P.; Raffeld, Mark; Lee, Chyi-Chia Richard; Li, Yong F.; El-Gamil, Mona; Rosenberg, Steven A.

    2015-01-01

    Purpose Although adoptive cell therapy can be highly effective for the treatment of patients with melanoma, the application of this approach to the treatment of other solid tumors has been limited. The observation that the cancer germline (CG) antigen NY-ESO-1 is expressed in 70–80% and in approximately 25% of patients with synovial cell sarcoma and melanoma, respectively, prompted us to perform this first-in-man clinical trial employing the adoptive transfer of autologous PBMC that were retrovirally transduced with an NY-ESO-1 reactive TCR to heavily pretreated patients bearing these metastatic cancers. Experimental Design HLA-*0201 patients with metastatic synovial cell sarcoma or melanoma refractory to standard treatments and whose cancers expressed NY-ESO-1 received autologous TCR-transduced T cells following a lymphodepleting preparative chemotherapy. Response rates using Response Evaluation Criteria in Solid Tumors (RECIST), as well as immunologic correlates of response, are presented in this report. Results Eleven of 18 patients with NY-ESO-1+ synovial cell sarcomas (61%) and 11 of 20 patients with NY-ESO-1 positive melanomas (55%) who received autologous T cells transduced with an NY-ESO-1-reactive TCR demonstrated objective clinical responses. The estimated overall three and five year survival rates for patients with synovial cell sarcoma were 38 and 14%, respectively, while the corresponding estimated survival rates for patients with melanoma were both 33%. Conclusions The adoptive transfer of autologous T cells transduced with a retrovirus encoding a TCR against an HLA-A*0201 restricted NY-ESO-1 epitope can be an effective therapy for some patients bearing synovial cell sarcomas and melanomas that are refractory to other treatments. PMID:25538264

  14. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.

    PubMed

    Robbins, Paul F; Kassim, Sadik H; Tran, Thai L N; Crystal, Jessica S; Morgan, Richard A; Feldman, Steven A; Yang, James C; Dudley, Mark E; Wunderlich, John R; Sherry, Richard M; Kammula, Udai S; Hughes, Marybeth S; Restifo, Nicholas P; Raffeld, Mark; Lee, Chyi-Chia R; Li, Yong F; El-Gamil, Mona; Rosenberg, Steven A

    2015-03-01

    Although adoptive cell therapy can be highly effective for the treatment of patients with melanoma, the application of this approach to the treatment of other solid tumors has been limited. The observation that the cancer germline (CG) antigen NY-ESO-1 is expressed in 70% to 80% and in approximately 25% of patients with synovial cell sarcoma and melanoma, respectively, prompted us to perform this first-in-man clinical trial using the adoptive transfer of autologous peripheral blood mononuclear cells that were retrovirally transduced with an NY-ESO-1-reactive T-cell receptor (TCR) to heavily pretreated patients bearing these metastatic cancers. HLA-*0201 patients with metastatic synovial cell sarcoma or melanoma refractory to standard treatments and whose cancers expressed NY-ESO-1 received autologous TCR-transduced T cells following a lymphodepleting preparative chemotherapy. Response rates using Response Evaluation Criteria in Solid Tumors (RECIST), as well as immunologic correlates of response, are presented in this report. Eleven of 18 patients with NY-ESO-1(+) synovial cell sarcomas (61%) and 11 of 20 patients with NY-ESO-1(+) melanomas (55%) who received autologous T cells transduced with an NY-ESO-1-reactive TCR demonstrated objective clinical responses. The estimated overall 3- and 5-year survival rates for patients with synovial cell sarcoma were 38% and 14%, respectively, whereas the corresponding estimated survival rates for patients with melanoma were both 33%. The adoptive transfer of autologous T cells transduced with a retrovirus encoding a TCR against an HLA-A*0201 restricted NY-ESO-1 epitope can be an effective therapy for some patients bearing synovial cell sarcomas and melanomas that are refractory to other treatments. ©2014 American Association for Cancer Research.

  15. Arctic warming, moisture increase and circulation changes observed in the Ny-Ålesund homogenized radiosonde record

    NASA Astrophysics Data System (ADS)

    Maturilli, Marion; Kayser, Markus

    2016-07-01

    Radiosonde measurements obtained at the Arctic site Ny-Ålesund (78.9°N, 11.9°E), Svalbard, from 1993 to 2014 have been homogenized accounting for instrumentation discontinuities by correcting known errors in the manufacturer provided profiles. The resulting homogenized radiosonde record is provided as supplementary material at http://doi.pangaea.de/10.1594/PANGAEA.845373. From the homogenized data record, the first Ny-Ålesund upper-air climatology of wind, temperature and humidity is presented, forming the background for the analysis of changes during the 22-year period. Particularly during the winter season, a strong increase in atmospheric temperature and humidity is observed, with a significant warming of the free troposphere in January and February up to 3 K per decade. This winter warming is even more pronounced in the boundary layer below 1 km, presumably amplified by mesoscale processes including e.g. orographic effects or the boundary layer capping inversion. Though the largest contribution to the increasing atmospheric water vapour column in winter originates from the lowermost 2 km, no increase in the contribution by specific humidity inversions is detected. Instead, we find an increase in the humidity content of the large-scale background humidity profiles. At the same time, the tropospheric flow in winter is found to occur less frequent from northerly directions and to the same amount more frequent from the South. We conclude that changes in the atmospheric circulation lead to an enhanced advection of warm and moist air from lower latitudes to the Svalbard region in the winter season, causing the warming and moistening of the atmospheric column above Ny-Ålesund, and link the observations to changes in the Arctic Oscillation.

  16. Extreme metasomatism during high-P-T contact metamorphism in southeastern NY, and its tectonic implications

    NASA Astrophysics Data System (ADS)

    Dorfler, K. M.; Tracy, R. J.; Caddick, M. J.

    2011-12-01

    An important goal of high-T metamorphic petrology is to link the micrometer-scale details of mineral assemblages and textures to large-scale tectonic processes, by understanding the evolution of metamorphic conditions such as pressure and temperature. Pelitic schists from contact aureoles around mafic-ultramafic plutons in Westchester County, NY record a high-P (ca. 0.8 GPa) high-T (up to 775°C) contact overprint on a Taconic regional metamorphic assemblage (ca. 0.55 GPa). The contact metamorphic assemblage of a sample in the innermost aureole of the Croton Falls pluton, a small (<10 km2) gabbroic pluton, consists of qz+plg+bt+grt+sil+ilm+gr+Zn-rich Al-spl, with neither kfs nor mu, and with abundant bt, plg, sil, and qz inclusions within euhedral garnet crystals. Unusually low Na and K contents imply depletion of alkalic components and silica through anatexis and melt extraction during contact heating. This can be verified by tracing depleted lithologies in the contact aureole into typical metapelites outside the aureole. Theromobarometry on nearby samples lacking a contact overprint yields 620-640°C and 0.5-0.6 GPa. In the aureole sample, WDS X-ray maps show distinct Ca-enriched rims on both grt and matrix plg and significantly higher Mg content in bt inclusions within grt than in matrix bt. GASP and Grt-Bt Mg-Fe equilibria on the garnet host and inclusions interior to the high-Ca rim zone yield P=0.53 GPa and T=625°C. Pairs in the modified rim zone yield 0.8 GPa and 766°C. THERMOCALC average P-T calculations yield similar results for core (0.52 GPa, 648°C) and rim (0.78 GPa, 763°C) equilibria. These multi-phase equilibria suggest a degree of disequilibrium between phases, presumably reflecting partial resetting after metamorphic peak conditions. Garnet porphyroblasts grown during regional metamorphism at 465 Ma were substantially re-equilibrated during the contact event (~ 435 Ma). Pervasive melting at this stage is associated with development of a high

  17. Patterns of total gaseous mercury (TGM) at a former brownfield in Syracuse, NY

    NASA Astrophysics Data System (ADS)

    Meng, L.; Driscoll, C. T.; Montesdeoca, M.; Millard, G.; McHale, P.; Mitchell, M. J.

    2016-12-01

    Concerns about elevated atmospheric mercury and its effects have been recognized for decades, but the atmospheric cycle and land-atmosphere exchange of mercury remain poorly understood. Temporal variations of TGM concentration were measured at two different heights (42.3m - upper level; 1.8m - lower level) at an urban site located in Syracuse NY from 2010 to 2016. In May 2015 contaminated soil (approximately 4300 m2) was removed from the study site. Prior to soil removal, average TGM concentrations were 1.3±0.30 ng/m3 and 1.6±0.59 ng/m3 at the upper level and the lower level, respectively. There is considerable evidence that concentrations of TGM at this site are influenced by local emissions. TGM concentrations increase with increases in temperature and solar radiation. There was a strong relationship between TGM concentrations of the two heights, the concentration of TGM at upper level increased with increasing TGM concentrations at lower level. Concentrations of TGM decreased markedly with increasing wind speed and were highly dependent on wind direction. Following soil removal TGM concentrations decreased to 1.1±0.27 ng/m3 and 1.3±0.31 ng/m3, representing 15% and 19% decreases of TGM concentrations at the upper level and the lower level, respectively. Prior to soil removal TGM concentration at the upper level remained relatively constant throughout the day during summer except for a peak in the early daylight hours. After soil removal, the morning increase in TGM concentration at the tower elevation decreased through the day reaching a minimum value in mid-afternoon. Prior to soil removal, TGM concentration at the lower level had a sharply peak in the early morning and was followed by a gradual increase in the afternoon until midnight. After soil removal, TGM concentrations increased in the morning likely due to soil emissions rather than in the afternoon. This study suggests that TGM concentrations at urban sites can be significantly affected by exchange

  18. Sustained morphologic changes to the shoreface related to Hurricane Sandy: Fire Island, NY

    NASA Astrophysics Data System (ADS)

    Hapke, C. J.; Nelson, T. R.

    2014-12-01

    A variety of topographic and photographic data have revealed widespread impacts to the subaerial portion of the beach system during Hurricane Sandy in 2012 - from beach erosion to barrier island breaching. However, less is known about impacts to the offshore environment. In order to examine a more comprehensive response of the active beach system to Hurricane Sandy, we quantify morphologic changes to the shoreface using bathymetric data along the length of Fire Island, NY. Airborne bathymetric lidar data, collected two days before Sandy made landfall, are used as a pre-storm baseline. Morphologic changes are measured using field surveyed GPS profiles collected along a limited portion of western Fire Island two months following Sandy and along the length of the island one year after Sandy. The offshore extent of the data is variable and analyses are constrained by the resolving ability of the lidar sensor, which typically achieved penetration to depths of 6-8m. The surfzone morphology was extensively impacted by Hurricane Sandy and continued to evolve during subsequent winter storms. As is typical during large storm events, the outer bar moved offshore during Sandy. A year after the storm, however, the bar remains further offshore than it was prior to Sandy, resulting in a widened surfzone. Both the subaerial and submarine portions of the beach system lost considerable volumes of sand. The majority of the loss below mean high water (MHW) is in the surfzone, concentrated in the trough immediately landward of the outer bar and generally in the pre-storm location of the outer bar. The trough not only deepened in response to Sandy, but in many locations continued to deepen over the course of the following year, with an average change of more than a meter. The average volume of the shoreface seaward of the bar increased, which is attributed to the seaward translation of the outer bar and additional offshore transport and deposition of material from the inner surfzone

  19. Controls on Nitrogen Biogeochemistry in a Subterranean Estuary, Stony Brook Harbor, NY

    NASA Astrophysics Data System (ADS)

    Young, C.; Durand, J. M.; Hanson, G. N.; Wong, T.

    2012-12-01

    Current subterranean estuary models predict a well-defined submarine groundwater discharge (SGD) 'freshwater tube' discharging at or slightly below the low tide point. Nutrient modeling of the subterranean estuary relies on redox defined end -member mixing of fresh and marine waters to produce either nutrient attenuation or remineralization within the SGD 'freshwater tube'. This study, based in Stony Brook Harbor (Long Island, NY), employs a combination of electrical resistivity surveys, pore water sampling and seepage meter measurements. In a glacial sands aquifer setting we find the 'freshwater tube' actually occurs as diffuse freshwater zone that can discharge for tens of meters offshore and is capped by a thin harbor floor 'muck' layer. This 'muck' layer acts as a zone of nutrient attenuation, despite near saturation dissolved oxygen levels in both discharging groundwater and overlying sea water. Stony Brook Harbor is rated highest in ecosystem diversity among north shore Long Island Sound embayments and represents embayments currently experiencing minimal anthropogenic impact. Electrical resistivity surveys were used to determine the placement of piezometers for porewater sampling. Porewater sampling was done using retract-a-tip piezometers (AMS) to a maximum 10m depth, at intervals of 0.5- 1.0m. Porewater was sampled in May and October of 2011; an additional intertidal cluster well was sampled for 30 days to confirm stabile salinity distribution. A combination of N2/Ar and δ15N-NO3- are used to determine the extent of denitrification in the subterranean estuary. Samples were also analyzed for dissolved organic carbon (DOC), dissolved oxygen (DO), iron and manganese to determine the geochemical framework of nitrogen transformations. Month long intertidal cluster well measurements show stable porewater salinity and DO to a depth of 10m in the intertidal zone with a 2m tide range. Off shore sampling and electrical resistivity work indicate the freshwater zone

  20. Arctic warming, moisture increase and circulation changes observed in the Ny-Ålesund homogenized radiosonde record

    NASA Astrophysics Data System (ADS)

    Maturilli, Marion; Kayser, Markus

    2017-04-01

    Compared to global warming, the feedback mechanisms of Arctic Amplification lead to an increase of surface temperature in the Arctic by a factor of two. Yet, the vertical structure of Arctic warming and its resulting radiative feedbacks are poorly understood. Here, we focus on the analysis of the atmospheric column above Ny-Ålesund (78.9° N, 11.9° E), Svalbard. At Ny-Ålesund, radiosondes have been launched on a daily basis since 1993 in support of synoptic observations. The obtained radiosonde measurements 1993 to 2014 have been homogenized accounting for instrumentation discontinuities and known errors in the manufacturer provided profiles. From the homogenized data record, a first upper-air climatology of wind, humidity and temperature above Ny-Ålesund is presented, forming the background for the analysis of changes detected during the 22-year period. Particularly during the winter season, a strong increase in atmospheric humidity and temperature is observed, with a significant warming of the free troposphere in January and February of up to 3 K per decade. This winter warming is even more pronounced in the boundary layer below 1 km, presumably amplified by local conditions including e.g. orographic effects or the boundary layer capping inversion. Also the largest contribution to the increasing atmospheric water vapour column originates from the lowermost 2 km of the atmosphere where specific humidity inversions are frequently observed. Yet, no increase in the water vapour contribution by humidity inversions is detected. Instead, we find an increase in the humidity content of the large scale background humidity profiles to be responsible for the observed increase in winter integrated water vapour. The observed difference in the frequency occurrence of wind directions in the free troposphere between the first and second half of the 22-year period implies that the large scale synoptic flow over Svalbard has changed over the years. During the winter season, the

  1. Infection with non-lethal West Nile virus Eg101 strain induces immunity that protects mice against the lethal West Nile virus NY99 strain.

    PubMed

    Kumar, Mukesh; O'Connell, Maile; Namekar, Madhuri; Nerurkar, Vivek R

    2014-06-06

    Herein we demonstrate that infection of mice with West Nile virus (WNV) Eg101 provides protective immunity against lethal challenge with WNV NY99. Our data demonstrated that WNV Eg101 is largely non-virulent in adult mice when compared to WNV NY99. By day 6 after infection, WNV-specific IgM and IgG antibodies, and neutralizing antibodies were detected in the serum of all WNV Eg101 infected mice. Plaque reduction neutralization test data demonstrated that serum from WNV Eg101 infected mice neutralized WNV Eg101 and WNV NY99 strains with similar efficiency. Three weeks after infection, WNV Eg101 immunized mice were challenged subcutaneously or intracranially with lethal dose of WNV NY99 and observed for additional three weeks. All the challenged mice were protected against disease and no morbidity and mortality was observed in any mice. In conclusion, our data for the first time demonstrate that infection of mice with WNV Eg101 induced high titers of WNV specific IgM and IgG antibodies, and cross-reactive neutralizing antibodies, and the resulting immunity protected all immunized animals from both subcutaneous and intracranial challenge with WNV NY99. These observations suggest that WNV Eg101 may be a suitable strain for the development of a vaccine in humans against virulent strains of WNV.

  2. SEQUENCE AND ANNOTATION OF THE 369-KB NY-2A AND THE 345-KB AR158 VIRUSES THAT INFECT CHLORELLA NC64A

    PubMed Central

    Fitzgerald, Lisa A.; Graves, Michael V.; Li, Xiao; Feldblyum, Tamara; Nierman, William C.; Van Etten, James L.

    2007-01-01

    Viruses NY-2A and AR158, members of the family Phycodnaviridae, genus Chlorovirus, infect the fresh water, unicellular, eukaryotic, chlorella-like green alga, Chlorella NC64A. The 368,683-bp genome of NY-2A and the 344,690-bp genome of AR158 are the two largest chlorella virus genomes sequenced to date; NY-2A contains 404 putative protein-encoding and 7 tRNA-encoding genes and AR158 contains 360 putative protein-encoding and 6 tRNA-encoding genes. The protein-encoding genes are almost evenly distributed on both strands, and intergenic space is minimal. Two of the NY-2A genes encode inteins, the large subunit of ribonucleotide reductase and a superfamily II helicase. These are the first inteins to be detected in the chlorella viruses. Approximately 40% of the viral gene products resemble entries in the public databases, including some that are unexpected for a virus. These include GDP-D-mannose dehydratase, fucose synthase, aspartate transcarbamylase, Ca++ transporting ATPase and ubiquitin. Comparison of NY-2A and AR158 protein-encoding genes with the prototype chlorella virus PBCV-1 indicate that 85% of the genes are present in all three viruses. PMID:17027058

  3. Electrical behavior of MIS devices based on Si nanoclusters embedded in SiOxNy and SiO2 films

    PubMed Central

    2011-01-01

    We examined and compared the electrical properties of silica (SiO2) and silicon oxynitride (SiOxNy) layers embedding silicon nanoclusters (Sinc) integrated in metal-insulator-semiconductor (MIS) devices. The technique used for the deposition of such layers is the reactive magnetron sputtering of a pure SiO2 target under a mixture of hydrogen/argon plasma in which nitrogen is incorporated in the case of SiOxNy layer. Al/SiOxNy-Sinc/p-Si and Al/SiO2-Sinc/p-Si devices were fabricated and electrically characterized. Results showed a high rectification ratio (>104) for the SiOxNy-based device and a resistive behavior when nitrogen was not incorporating (SiO2-based device). For rectifier devices, the ideality factor depends on the SiOxNy layer thickness. The conduction mechanisms of both MIS diode structures were studied by analyzing thermal and bias dependences of the carriers transport in relation with the nitrogen content. PMID:21711698

  4. Expression and clinical significance of MAGE and NY-ESO-1 cancer-testis antigens in adenoid cystic carcinoma of the head and neck.

    PubMed

    Veit, Johannes A; Heine, Daniela; Thierauf, Julia; Lennerz, Jochen; Shetty, Subasch; Schuler, Patrick J; Whiteside, Theresa; Beutner, Dirk; Meyer, Moritz; Grünewald, Inga; Ritter, Gerd; Gnjatic, Sacha; Sikora, Andrew G; Hoffmann, Thomas K; Laban, Simon

    2016-07-01

    Adenoid cystic carcinoma (ACC) of the head and neck is a rare but highly malignant tumor. Cancer-testis antigens (CTAs) represent an immunogenic family of cancer-specific proteins and thus represent an attractive target for immunotherapy. Eighty-four cases of ACC were identified, the CTAs pan-Melanoma antigen (pan-MAGE; M3H67) and New York esophageal squamous cell carcinoma (NY-ESO-1; E978) were detected immunohistochemically (IHC) and correlated with clinical data. Expression of NY-ESO-1 was found in 48 of 84 patients (57.1%) and of pan-MAGE in 28 of 84 patients (31.2%). Median overall survival (OS) in NY-ESO-1 positive versus negative patients was 130.8 and 282.0 months (p = .223), respectively. OS in pan-MAGE positive versus negative patients was 105.3 and 190.5 months, respectively (p = .096). Patients expressing both NY-ESO-1 and pan-MAGE simultaneously had significantly reduced OS with a median of 90.5 months compared with 282.0 months in negative patients (p = .047). A significant fraction of patients with ACC show expression of the CTAs NY-ESO-1 and/or pan-MAGE with promising immunotherapeutic implications. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1008-1016, 2016. © 2016 Wiley Periodicals, Inc.

  5. Porous VOxNy nanoribbons supported on CNTs as efficient and stable non-noble electrocatalysts for the oxygen reduction reaction

    PubMed Central

    Huang, K.; Bi, K.; Lu, Y. K.; Zhang, R.; Liu, J.; Wang, W. J.; Tang, H. L.; Wang, Y. G.; Lei, M.

    2015-01-01

    Novel nanocomposites of carbon nanotubes supported porous VOxNy nonoribbons (VOxNy-CNTs) have been synthesized by the annealing of the sol-gel mixture of CNTs and V2O5 under NH3 atmosphere as well as the ageing process in air. Besides the morphological and structural characterizations revealed by TEM, SEAD, EDS, XRD and XPS measurements, typical electrochemical tests including cyclic voltammetry (CV), rotating disk electrode (RDE) and chronoamperometry have been employed to determine the oxygen reduction reaction (ORR) performance of VOxNy-CNTs. Inspiringly, the results indicate that VOxNy-CNTs catalyst exhibits a 0.4 mA/cm2 larger diffusion-limited current density, a 0.10  V smaller onset potential value, a 10.73% less of ORR current decay and an excellent methanol-tolerance compared with commercial Pt/C catalyst. Therefore, we have reasonable grounds to believe that this new VOxNy-CNTs nanocomposites can be regarded as a promising non-precious methanol-tolerant ORR catalyst candidate for alkaline fuel cells. PMID:26616719

  6. THE BANANA PROJECT. III. SPIN-ORBIT ALIGNMENT IN THE LONG-PERIOD ECLIPSING BINARY NY CEPHEI

    SciTech Connect

    Albrecht, Simon; Winn, Joshua N.; Carter, Joshua A.; Snellen, Ignas A. G.; De Mooij, Ernst J. W.

    2011-01-10

    Binaries are not always neatly aligned. Previous observations of the DI Her system showed that the spin axes of both stars are highly inclined with respect to one another and the orbital axis. Here, we report on a measurement of the spin-axis orientation of the primary star of the NY Cep system, which is similar to DI Her in many respects: it features two young early-type stars ({approx}6 Myr, B0.5V+B2V), in an eccentric and relatively long-period orbit (e = 0.48, P = 15fd3). The sky projections of the rotation vector and the spin vector are well aligned ({beta}{sub p} = 2{sup 0} {+-} 4{sup 0}), in strong contrast to DI Her. Although no convincing explanation has yet been given for the misalignment of DI Her, our results show that the phenomenon is not universal, and that a successful theory will need to account for the different outcome in the case of NY Cep.

  7. Discovery of Polarized Emission from Two Soft X-ray-emitting Intermediate Polars: UU Col and NY Lup

    NASA Astrophysics Data System (ADS)

    Katajainen, S.; Butters, O.; Norton, A. J.; Lehto, H. J.; Piirola, V.; Berdyugin, A.

    2010-11-01

    We aim to investigate the magnetic field strengths and cyclotron emission of the two soft X-ray-emitting intermediate polars (IPs) UU Col and NY Lup. We study the connection between polars and soft X-ray-emitting IPs by searching for evidence of circularly polarized light in these two systems, which may be examples of progenitors of polars. We carried out photopolarimetric observations of our targets using the Very Large Telescope (UT2) and FORS1 at Paranal. Imaging polarimetry with good signal-to-noise and relatively high time resolution is possible for these targets using such a large telescope. Detection of circular polarization, modulated according to a white dwarf (WD) spin period, is clear evidence of cyclotron emission processes near the WD surface. The color dependence of the polarization allows us to make estimates of the magnetic field strength. We found that both UU Col and NY Lup emit circularly polarized light in the B and I bands, modulated at the spin period of the WD in each case. We add further confirmation to the idea that soft X-ray-emitting IPs emit circularly polarized light and that cyclotron emission plays an important role in these systems. This also suggests that some soft X-ray-emitting IPs might be progenitors of polars.

  8. On the spin modulated circular polarization from the intermediate polars NY Lup and IGR J15094-6649

    NASA Astrophysics Data System (ADS)

    Potter, Stephen B.; Romero-Colmenero, Encarni; Kotze, Marissa; Zietsman, Ewald; Butters, O. W.; Pekeur, Nikki; Buckley, David A. H.

    2012-03-01

    We report on high-time-resolution, high-signal-to-noise ratio (S/N), photopolarimetry of the intermediate polars NY Lup and IGR J15094-6649. Our observations confirm the detection and colour dependence of circular polarization from NY Lup and additionally show a clear white dwarf, spin modulated signal. From our new high-S/N photometry, we have unambiguously detected wavelength-dependent spin and beat periods and harmonics thereof. IGR J15094-6649 is also discovered to have a particularly strong spin modulated circularly polarized signal. It appears double peaked through the I filter and single peaked through the B filter, consistent with cyclotron emission from a white dwarf with a relatively strong magnetic field. We discuss the implied accretion geometries in these two systems and any bearing this may have on the possible relationship with the connection between polars and soft X-ray-emitting intermediate polars. The relatively strong magnetic fields are also suggestive of them being polar progenitors.

  9. Surface radiation during the total solar eclipse over Ny-Ålesund, Svalbard, on 20 March 2015

    NASA Astrophysics Data System (ADS)

    Maturilli, Marion; Ritter, Christoph

    2016-04-01

    On 20 March 2015, a total solar eclipse occurred over Ny-Ålesund (78.9° N, 11.9° E), Svalbard, in the high Arctic. It was the first time that the surface radiation components during the totality of a solar eclipse were measured by a Baseline Surface Radiation Network (BSRN) station. With the Ny-Ålesund long-term radiation data set as background (available at doi:10.1594/PANGAEA.150000), we present here the peculiarities of the radiation components and basic meteorology observed during the eclipse event. The supplementary data set contains the basic BSRN radiation and surface meteorological data in 1 min resolution for March 2015, and is available at doi:10.1594/PANGAEA.854326. The eclipse radiation data will be a useful auxiliary data set for further studies on micrometeorological surface-atmosphere exchange processes in the Svalbard environment, and may serve as a test case for radiative transfer studies.

  10. The health status of patients of a student-run free medical clinic in inner-city Buffalo, NY.

    PubMed

    Cadzow, Renee B; Servoss, Timothy J; Fox, Chester H

    2007-01-01

    This study explores the health status and the social and economic correlates of adults 20 years of age and older who presented at an urban free medical clinic in Buffalo, NY, between 2002 and 2005. Clinic staff asked patients to fill out a Health Risk Assessment questionnaire that addressed their chronic disease and illness history, mental health, social support, substance use, income, education, and housing. Through statistical analysis of 469 anonymous patient questionnaires, we identified prevalent health conditions in this patient population and compared these rates to regional and national data. Of those patients 20 years of age and older, 70% earned less than US $10,000 a year. The rates of obesity, hypertension, asthma, diabetes, anxiety, and depression were higher in this population than in the Buffalo, NY, region and the general United States population. The data reflect the health disparity experienced by low-income minority populations in the United States and emphasize a need to plan additional services that target hypertension, heart disease, obesity, diabetes, and mental health disorders such as anxiety and depression. Findings also serve as an introduction to the patient population for volunteer medical students who have limited exposure to urban, low-income populations.

  11. DISCOVERY OF POLARIZED EMISSION FROM TWO SOFT X-RAY-EMITTING INTERMEDIATE POLARS: UU Col AND NY Lup

    SciTech Connect

    Katajainen, S.; Lehto, H. J.; Berdyugin, A.; Butters, O.; Norton, A. J.; Piirola, V.

    2010-11-20

    We aim to investigate the magnetic field strengths and cyclotron emission of the two soft X-ray-emitting intermediate polars (IPs) UU Col and NY Lup. We study the connection between polars and soft X-ray-emitting IPs by searching for evidence of circularly polarized light in these two systems, which may be examples of progenitors of polars. We carried out photopolarimetric observations of our targets using the Very Large Telescope (UT2) and FORS1 at Paranal. Imaging polarimetry with good signal-to-noise and relatively high time resolution is possible for these targets using such a large telescope. Detection of circular polarization, modulated according to a white dwarf (WD) spin period, is clear evidence of cyclotron emission processes near the WD surface. The color dependence of the polarization allows us to make estimates of the magnetic field strength. We found that both UU Col and NY Lup emit circularly polarized light in the B and I bands, modulated at the spin period of the WD in each case. We add further confirmation to the idea that soft X-ray-emitting IPs emit circularly polarized light and that cyclotron emission plays an important role in these systems. This also suggests that some soft X-ray-emitting IPs might be progenitors of polars.

  12. Characterizing the distribution of selected PBDEs in soil, moss and reindeer dung at Ny-Ålesund of the Arctic.

    PubMed

    Wang, Zhen; Na, Guangshui; Ma, Xindong; Ge, Linke; Lin, Zhongsheng; Yao, Ziwei

    2015-10-01

    Distribution of 12 selected polybrominated diphenyl ethers (PBDEs) was characterized in soil, moss and reindeer dung samples collected simultaneously at Ny-Ålesund of the Arctic. The average PBDE concentrations were 42 pg/g (dry weight) in soil, 122 pg/g in moss and 72 pg/g in reindeer dung. Significant log/log-linear relationship was observed between the soil/moss quotients (QSM) and the sub-cooled liquid vapor pressures of PBDEs (r(2)=0.80). Moreover, excellent log/log-linear relationships between QSM and the octanol/air partition coefficients as well as between the moss/dung quotient (QMD) and the octanol/water partition coefficients of PBDEs were also observed, indicating that the physicochemical properties of PBDEs are appropriate parameters for characterizing the distribution of PBDEs in soil, moss and reindeer dung at Ny-Ålesund. Capsule abstract: Significant log-linear correlations were observed between physicochemical properties of PBDEs and their soil/moss (moss/dung) quotients.

  13. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors

    PubMed Central

    Savelyeva, Natalia; McCann, Katy J.; Singh, Divya; Jones, Terry; Peel, Lailah; Breen, Michael S.; Ward, Matthew; Martin, Eva Garrido

    2016-01-01

    Human papilloma virus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) has a better prognosis than it's HPV negative (HPV(−)) counterpart. This may be due to the higher numbers of tumor-infiltrating lymphocytes (TILs) in HPV positive (HPV(+)) tumors. RNA-Sequencing (RNA-Seq) was used to evaluate whether the differences in clinical behaviour simply reflect a numerical difference in TILs or whether there is a fundamental behavioural difference between TILs in these two settings. Thirty-nine HNSCC tumors were scored for TIL density by immunohistochemistry. After the removal of 16 TILlow tumors, RNA-Seq analysis was performed on 23 TILhigh/med tumors (HPV(+) n=10 and HPV(−) n=13). Using EdgeR, differentially expressed genes (DEG) were identified. Immune subset analysis was performed using Functional Analysis of Individual RNA-Seq/ Microarray Expression (FAIME) and immune gene RNA transcript count analysis. In total, 1,634 DEGs were identified, with a dominant immune signature observed in HPV(+) tumors. After normalizing the expression profiles to account for differences in B- and T-cell number, 437 significantly DEGs remained. A B-cell associated signature distinguished HPV(+) from HPV(−) tumors, and included the DEGs CD200, GGA2, ADAM28, STAG3, SPIB, VCAM1, BCL2 and ICOSLG; the immune signal relative to T-cells was qualitatively similar between TILs of both tumor cohorts. Our findings were validated and confirmed in two independent cohorts using TCGA data and tumor-infiltrating B-cells from additional HPV(+) HNSCC patients. A B-cell associated signal segregated tumors relative to HPV status. Our data suggests that the role of B-cells in the adaptive immune response to HPV(+) HNSCC requires re-assessment. PMID:27462861

  14. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.

    PubMed

    Wood, Oliver; Woo, Jeongmin; Seumois, Gregory; Savelyeva, Natalia; McCann, Katy J; Singh, Divya; Jones, Terry; Peel, Lailah; Breen, Michael S; Ward, Matthew; Garrido Martin, Eva; Sanchez-Elsner, Tilman; Thomas, Gareth; Vijayanand, Pandurangan; Woelk, Christopher H; King, Emma; Ottensmeier, Christian

    2016-08-30

    Human papilloma virus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) has a better prognosis than it's HPV negative (HPV(-)) counterpart. This may be due to the higher numbers of tumor-infiltrating lymphocytes (TILs) in HPV positive (HPV(+)) tumors. RNA-Sequencing (RNA-Seq) was used to evaluate whether the differences in clinical behaviour simply reflect a numerical difference in TILs or whether there is a fundamental behavioural difference between TILs in these two settings. Thirty-nine HNSCC tumors were scored for TIL density by immunohistochemistry. After the removal of 16 TILlow tumors, RNA-Seq analysis was performed on 23 TILhigh/med tumors (HPV(+) n=10 and HPV(-) n=13). Using EdgeR, differentially expressed genes (DEG) were identified. Immune subset analysis was performed using Functional Analysis of Individual RNA-Seq/ Microarray Expression (FAIME) and immune gene RNA transcript count analysis. In total, 1,634 DEGs were identified, with a dominant immune signature observed in HPV(+) tumors. After normalizing the expression profiles to account for differences in B- and T-cell number, 437 significantly DEGs remained. A B-cell associated signature distinguished HPV(+) from HPV(-) tumors, and included the DEGs CD200, GGA2, ADAM28, STAG3, SPIB, VCAM1, BCL2 and ICOSLG; the immune signal relative to T-cells was qualitatively similar between TILs of both tumor cohorts. Our findings were validated and confirmed in two independent cohorts using TCGA data and tumor-infiltrating B-cells from additional HPV(+) HNSCC patients. A B-cell associated signal segregated tumors relative to HPV status. Our data suggests that the role of B-cells in the adaptive immune response to HPV(+) HNSCC requires re-assessment.

  15. Comparison of Temperature and Ozone Measured by the AROTEL Instrument on DC8 Overflights of Ny Aalesund during the SOLVE Mission

    NASA Technical Reports Server (NTRS)

    Hoegy, Walter R.; McGee, Thomas J.; Burris, John F.; Heaps, William; Silbert, Donald; Sumnicht, Grant; Twigg, Laurence; Neuber, Roland

    2000-01-01

    The AROTEL instrument, deployed on the NASA DC-8 at Kiruna, Sweden for the SAGE III Ozone Loss and Validation Experiment (SOLVE), flew over the NDSC station operated by the Alfred Wegner Institute at Ny Aalesund, Spitsbergen. AROTEL ozone and temperature measurements made during near overflights of Ny Aalesund are compared with sonde ozone and temperature, and lidar ozone measurements from the NDSC station. Nine of the seventeen science flights during the December through March measurement period overflew near Ny Aalesund. Agreement of AROTEL with the ground-based temperature and ozone values at altitudes from just above the aircraft to about 30 km gives strong confidence in using AROTEL temperature and ozone mixing ratio to study the mechanisms of ozone loss in the winter arctic polar region.

  16. Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.

    PubMed

    Nicholaou, Theo; Ebert, Lisa M; Davis, Ian D; McArthur, Grant A; Jackson, Heather; Dimopoulos, Nektaria; Tan, Bee; Maraskovsky, Eugene; Miloradovic, Lena; Hopkins, Wendie; Pan, Linda; Venhaus, Ralph; Hoffman, Eric W; Chen, Weisan; Cebon, Jonathan

    2009-03-15

    NY-ESO-1 is a highly immunogenic antigen expressed in a variety of malignancies, making it an excellent target for cancer vaccination. We recently developed a vaccine consisting of full-length recombinant NY-ESO-1 protein formulated with ISCOMATRIX adjuvant, which generated strong humoral and T-cell-mediated immune responses and seemed to reduce the risk of disease relapse in patients with fully resected melanoma. This study examines the clinical and immunologic efficacy of the same vaccine in patients with advanced metastatic melanoma. Delayed-type hypersensitivity responses, circulating NY-ESO-1-specific CD4(+) and CD8(+) T cells, and proportions of regulatory T cells (Treg) were assessed in patients. In contrast to patients with minimal residual disease, advanced melanoma patients showed no clinical responses to vaccination. Although strong antibody responses were mounted, the generation of delayed-type hypersensitivity responses was significantly impaired. The proportion of patients with circulating NY-ESO-1-specific CD4(+) T cells was also reduced, and although many patients had CD8(+) T cells specific to a broad range of NY-ESO-1 epitopes, the majority of these responses were preexisting. Tregs were enumerated in the blood by flow cytometric detection of cells with a CD4(+)CD25(+)FoxP3(+) and CD4(+)CD25(+)CD127(-) phenotype. Patients with advanced melanoma had a significantly higher proportion of circulating Treg compared with those with minimal residual disease. Our results point to a tumor-induced systemic immune suppression, showing a clear association between the stage of melanoma progression, the number of Treg in the blood, and the clinical and immunologic efficacy of the NY-ESO-1 ISCOMATRIX cancer vaccine.

  17. Immunization of HLA-A*0201 and/or HLA-DPβ1*04 Patients with Metastatic Melanoma Using Epitopes from the NY-ESO-1 Antigen

    PubMed Central

    Khong, Hung T.; Yang, James C.; Topalian, Suzanne L.; Sherry, Richard M.; Mavroukakis, Sharon A.; White, Donald E.; Rosenberg, Steven A.

    2008-01-01

    HLA class I-restricted peptides are often used in peptide vaccine regimens. There is strong evidence that many of these peptides can generate specific CD8+ T-cell responses in vivo; however, only occasional objective clinical responses have been reported. To test whether provision of “help” would enhance antitumor immunity, the authors initiated a clinical trial in which patients with metastatic melanoma were immunized against the NY-ESO-1 tumor antigen, using an HLA-A2-restricted peptide (ESO-1:165V), an HLA-DP4-restricted peptide (NY-ESO-1:161-180), or both peptides given concomitantly. The first cohorts received only ESO-1:165V, using three vaccination schedules. Immunologically, most patients developed immune responses to the HLA-A2-restricted native ESO-1 epitope after vaccination. Peptide vaccine given daily for 4 days appeared to induce immunologic responses more rapidly than if given once a week or once every 3 weeks. In contrast, vaccination using the NY-ESO-1:161-180 peptide induced immune responses in only a few patients. Clinically, one patient who received NY-ESO-1:161-180 peptide alone had a partial response lasing 12 months. Concomitant vaccination with the HLA class II-restricted peptide did not alter the immune response to the HLA class I-restricted peptide form NY-ESO-1. However, vaccination with the HLA-A2-restricted epitope generated primarily T cells that did not recognize tumor after in vitro sensitization. This result raises questions about the use of synthetic peptides derived from NY-ESO-1 as a sole form of immunization. PMID:15534491

  18. Deep Sequencing of T-Cell Receptor DNA as a biomarker of clonally expanded TILs in breast cancer after immunotherapy

    PubMed Central

    Page, David B.; Yuan, Jianda; Redmond, David; Wen, Y Hanna; Durack, Jeremy C.; Emerson, Ryan; Solomon, Stephen; Dong, Zhiwan; Wong, Phillip; Comstock, Christopher; Diab, Adi; Sung, Janice; Maybody, Majid; Morris, Elizabeth; Brogi, Edi; Morrow, Monica; Sacchini, Virgilio; Elemento, Olivier; Robins, Harlan; Patil, Sujata; Allison, James P.; Wolchok, Jedd D.; Hudis, Clifford; Norton, Larry; McArthur, Heather

    2016-01-01

    In early stage breast cancer, the degree of tumor-infiltrating lymphocytes (TILs) predicts response to chemotherapy and overall survival. Combination immunotherapy with immune checkpoint antibody plus tumor cryoablation can induce lymphocytic infiltrates and improve survival in mice. We used T-cell receptor (TCR) DNA sequencing to evaluate both the effect of cryo-immunotherapy in humans and the feasibility of TCR sequencing in early-stage breast cancer. In a pilot clinical trial, 18 women with early-stage breast cancer were treated preoperatively with cryoablation, single-dose anti-CTLA-4 (ipilimumab), or cryoablation + ipilimumab. TCRs within serially collected peripheral blood and tumor tissue were sequenced. In baseline tumor tissues, T-cell density as measured by TCR sequencing correlated with TIL scores obtained by hematoxylin and eosin (H&E) staining. However, tumors with little or no lymphocytes by H&E contained up to 3.6 × 106 TCR DNA sequences, highlighting the sensitivity of the ImmunoSEQ platform. In this dataset, ipilimumab increased intratumoral T-cell density over time, whereas cryoablation ± ipilimumab diversified and remodeled the intratumoral T-cell clonal repertoire. Compared to monotherapy, cryoablation plus ipilimumab was associated with numerically greater numbers of peripheral blood and intratumoral T-cell clones expanding robustly following therapy. In conclusion, TCR sequencing correlates with H&E lymphocyte scoring, and provides additional information on clonal diversity. These findings support further study of the use of TCR sequencing as a biomarker for T cell responses to therapy and for the study of cryo-immunotherapy in early-stage breast cancer. PMID:27587469

  19. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.

    PubMed

    Page, David B; Yuan, Jianda; Redmond, David; Wen, Y Hanna; Durack, Jeremy C; Emerson, Ryan; Solomon, Stephen; Dong, Zhiwan; Wong, Phillip; Comstock, Christopher; Diab, Adi; Sung, Janice; Maybody, Majid; Morris, Elizabeth; Brogi, Edi; Morrow, Monica; Sacchini, Virgilio; Elemento, Olivier; Robins, Harlan; Patil, Sujata; Allison, James P; Wolchok, Jedd D; Hudis, Clifford; Norton, Larry; McArthur, Heather L

    2016-10-01

    In early-stage breast cancer, the degree of tumor-infiltrating lymphocytes (TIL) predicts response to chemotherapy and overall survival. Combination immunotherapy with immune checkpoint antibody plus tumor cryoablation can induce lymphocytic infiltrates and improve survival in mice. We used T-cell receptor (TCR) DNA sequencing to evaluate both the effect of cryoimmunotherapy in humans and the feasibility of TCR sequencing in early-stage breast cancer. In a pilot clinical trial, 18 women with early-stage breast cancer were treated preoperatively with cryoablation, single-dose anti-CTLA-4 (ipilimumab), or cryoablation + ipilimumab. TCRs within serially collected peripheral blood and tumor tissue were sequenced. In baseline tumor tissues, T-cell density as measured by TCR sequencing correlated with TIL scores obtained by hematoxylin and eosin (H&E) staining. However, tumors with little or no lymphocytes by H&E contained up to 3.6 × 10(6) TCR DNA sequences, highlighting the sensitivity of the ImmunoSEQ platform. In this dataset, ipilimumab increased intratumoral T-cell density over time, whereas cryoablation ± ipilimumab diversified and remodeled the intratumoral T-cell clonal repertoire. Compared with monotherapy, cryoablation plus ipilimumab was associated with numerically greater numbers of peripheral blood and intratumoral T-cell clones expanding robustly following therapy. In conclusion, TCR sequencing correlates with H&E lymphocyte scoring and provides additional information on clonal diversity. These findings support further study of the use of TCR sequencing as a biomarker for T-cell responses to therapy and for the study of cryoimmunotherapy in early-stage breast cancer. Cancer Immunol Res; 4(10); 835-44. ©2016 AACR.

  20. TIL-type protease inhibitors may be used as targeted resistance factors to enhance silkworm defenses against invasive fungi.

    PubMed

    Li, Youshan; Zhao, Ping; Liu, Huawei; Guo, Xiaomeng; He, Huawei; Zhu, Rui; Xiang, Zhonghuai; Xia, Qingyou

    2015-02-01

    Entomopathogenic fungi penetrate the insect cuticle using their abundant hydrolases. These hydrolases, which include cuticle-degrading proteases and chitinases, are important virulence factors. Our recent findings suggest that many serine protease inhibitors, especially TIL-type protease inhibitors, are involved in insect resistance to pathogenic microorganisms. To clarify the molecular mechanism underlying this resistance to entomopathogenic fungi and identify novel genes to improve the silkworm antifungal capacity, we conducted an in-depth study of serine protease inhibitors. Here, we cloned and expressed a novel silkworm TIL-type protease inhibitor, BmSPI39. In activity assays, BmSPI39 potently inhibited the virulence protease CDEP-1 of Beauveria bassiana, suggesting that it might suppress the fungal penetration of the silkworm integument by inhibiting the cuticle-degrading proteases secreted by the fungus. Phenol oxidase activation studies showed that melanization is involved in the insect immune response to fungal invasion, and that fungus-induced excessive melanization is suppressed by BmSPI39 by inhibiting the fungal cuticle-degrading proteases. To better understand the mechanism involved in the inhibition of fungal virulence by protease inhibitors, their effects on the germination of B. bassiana conidia was examined. BmSPI38 and BmSPI39 significantly inhibited the germination of B. bassiana conidia. Survival assays showed that BmSPI38 and BmSPI39 markedly improved the survival rates of silkworms, and can therefore be used as targeted resistance proteins in the silkworm. These results provided new insight into the molecular mechanisms whereby insect protease inhibitors confer resistance against entomopathogenic fungi, suggesting their potential application in medicinal or agricultural fields.